data_1d3z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1d3z _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.537 -0.542 . . . . 17.17 109.537 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.403 HE22 ' HB2' ' A' ' 16' ' ' GLU . 67.1 mm-40 -95.83 142.35 28.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.474 0.654 . . . . 21.89 110.231 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -131.49 165.43 31.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 114.898 -1.046 . . . . 10.83 108.31 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.4 139.94 53.42 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.722 0.296 . . . . 10.61 111.273 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.87 123.74 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.62 -0.881 . . . . 9.13 108.62 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -100.05 142.3 31.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.908 0.385 . . . . 20.55 110.473 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 p -101.82 166.03 10.88 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 122.085 0.945 . . . . 11.78 111.064 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.96 -19.61 65.26 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.61 -1.632 . . . . 19.31 111.209 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -93.34 -0.02 56.77 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.151 0.426 . . . . 23.14 112.151 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 13.87 52.22 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.173 -0.537 . . . . 19.74 113.698 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -90.17 144.92 25.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.147 -0.621 . . . . 21.93 109.708 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -117.96 127.87 54.25 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.079 -0.711 . . . . 12.33 109.079 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.56 139.0 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.888 -0.412 . . . . 17.08 109.888 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.4 m -105.12 132.02 51.87 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.735 -0.839 . . . . 16.3 108.735 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -127.31 150.3 49.64 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.534 0.207 . . . . 15.88 110.572 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.403 ' HB2' HE22 ' A' ' 2' ' ' GLN . 86.5 tt0 -100.96 122.19 43.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.333 -1.729 . . . . 28.9 106.333 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.03 168.01 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.615 0.722 . . . . 12.05 111.859 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -118.5 150.86 48.82 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 107.172 -1.418 . . . . 18.17 107.172 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.14 -24.24 65.56 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 CA-C-N 120.926 1.366 . . . . 8.16 112.695 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 p -85.26 -1.79 57.33 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.062 0.393 . . . . 11.13 112.062 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -70.46 143.29 51.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.949 -1.13 . . . . 18.03 107.949 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.491 ' HG1' ' CG ' ' A' ' 25' ' ' ASN . 71.7 p -86.29 157.2 19.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.238 -1.346 . . . . 10.22 109.921 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.96 -39.75 84.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.715 -0.675 . . . . 12.3 109.29 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -38.32 82.18 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.728 -0.842 . . . . 36.51 108.728 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.491 ' CG ' ' HG1' ' A' ' 22' ' ' THR . 7.4 m-20 -66.17 -40.05 90.2 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.168 -0.679 . . . . 25.66 109.168 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.94 -43.73 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.833 -0.432 . . . . 8.12 109.833 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.265 -0.643 . . . . 15.47 109.265 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.85 87.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.748 -0.66 . . . . 11.45 110.339 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -65.72 -39.0 90.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.748 -0.464 . . . . 24.98 109.748 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -64.98 -39.98 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.642 -0.503 . . . . 9.46 109.642 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.08 -44.14 95.0 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.322 -0.622 . . . . 14.76 109.322 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 53.7 t0 -60.35 -40.57 91.19 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.032 -0.985 . . . . 26.29 110.733 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -81.71 -40.27 23.0 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.371 1.249 . . . . 30.06 114.371 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.77 -14.94 13.93 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.277 1.954 . . . . 25.19 116.277 -174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.42 11.15 82.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 120.952 -0.642 . . . . 7.41 113.114 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mt -86.43 116.98 67.89 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.751 -0.463 . . . . 9.49 109.751 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.83 134.8 62.71 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 CA-C-N 120.417 1.185 . . . . 11.42 112.118 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.36 -31.37 22.84 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 122.631 2.221 . . . . 12.0 114.441 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.03 -16.31 62.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.621 0.646 . . . . 35.55 112.079 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -99.98 1.78 42.9 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.754 0.279 . . . . 20.52 111.754 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -107.99 139.46 42.58 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.908 1.077 . . . . 7.13 113.908 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -126.17 123.94 39.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.745 -1.116 . . . . 36.39 108.166 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -105.71 130.08 53.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.32 0.581 . . . . 9.55 110.899 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.17 138.06 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.214 -0.903 . . . . 13.9 110.533 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -139.31 127.05 21.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.258 -0.883 . . . . 6.86 108.887 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 39.16 18.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.068 -0.514 . . . . 11.15 111.429 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.04 0.03 89.12 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.28 -0.733 . . . . 13.93 114.863 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -112.24 139.27 47.92 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.777 1.289 . . . . 23.92 111.77 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.37 128.98 34.01 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.602 -1.259 . . . . 23.23 107.602 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.7 mt -86.93 136.53 32.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 9.11 111.559 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.16 149.91 21.59 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.224 0.535 . . . . 33.44 112.02 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.83 -20.04 64.29 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.555 0.946 . . . . 28.37 113.555 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.04 3.48 70.17 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 121.133 -0.556 . . . . 15.0 113.062 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -110.1 165.94 11.35 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 117.639 0.72 . . . . 25.5 111.286 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.1 p -107.55 167.35 10.0 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.536 0.684 . . . . 11.95 111.976 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.95 -42.94 95.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.843 -1.071 . . . . 10.17 110.986 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.0 p -61.87 -30.31 70.78 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 119.677 -0.809 . . . . 13.59 111.92 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.07 -29.02 70.01 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.687 -0.405 . . . . 11.7 110.498 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -99.89 13.81 32.58 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.268 -0.424 . . . . 12.95 111.657 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 50.07 39.98 20.44 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 112.056 0.391 . . . . 25.45 112.056 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -81.04 121.54 34.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.362 -1.347 . . . . 14.6 107.362 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.49 169.13 8.77 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.324 0.583 . . . . 33.23 112.042 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -51.14 141.22 14.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.121 -0.945 . . . . 25.97 111.65 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.74 23.35 10.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.771 -1.104 . . . . 32.61 112.929 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.9 m -76.83 148.7 36.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.013 -1.106 . . . . 10.56 108.013 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -112.83 124.04 51.69 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.528 -0.545 . . . . 5.33 109.528 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -105.17 157.41 17.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.626 -1.25 . . . . 11.66 107.626 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -112.25 134.08 54.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.23 -0.655 . . . . 16.3 109.23 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.5 tp -106.16 132.7 51.92 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.919 -0.771 . . . . 9.96 108.919 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.71 144.83 28.35 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 107.609 -1.256 . . . . 9.76 107.609 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.3 mt -109.86 139.99 44.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.348 -0.842 . . . . 19.57 110.611 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 . . . . . 0 N--CA 1.464 0.266 0 CA-C-N 115.729 -0.669 . . . . 35.08 110.032 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.498 -0.556 . . . . 17.17 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.84 140.99 31.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.334 0.588 . . . . 21.89 110.165 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 pt -130.24 166.83 26.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.144 -0.935 . . . . 10.83 108.843 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -124.54 139.3 54.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.503 -0.317 . . . . 10.61 111.01 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.27 124.17 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.597 -0.89 . . . . 9.13 108.597 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -101.05 142.13 32.95 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.984 0.421 . . . . 20.55 110.499 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -103.96 162.58 13.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.716 0.77 . . . . 11.78 111.076 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.64 -14.46 52.04 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.38 -1.282 . . . . 19.31 111.768 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -95.72 2.45 53.95 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.734 -0.386 . . . . 23.14 111.566 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.4 13.67 56.84 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.355 -0.45 . . . . 19.74 113.919 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -91.17 142.1 28.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.286 -0.566 . . . . 21.93 110.42 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.1 m -116.96 127.56 54.33 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.681 -0.859 . . . . 12.33 108.681 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.3 mt -111.77 138.66 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 110.003 -0.369 . . . . 17.08 110.003 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -103.18 131.21 50.38 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.931 -0.766 . . . . 16.3 108.931 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.4 mt -127.19 149.92 49.76 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.703 0.287 . . . . 15.88 110.926 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.65 122.11 43.77 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.131 -1.803 . . . . 28.9 106.131 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.94 168.25 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.507 0.67 . . . . 12.05 111.485 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.81 149.22 44.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 107.227 -1.398 . . . . 18.17 107.227 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.24 -24.4 59.15 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 120.817 1.327 . . . . 8.16 112.844 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 p -85.28 -2.46 58.08 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 116.297 -0.41 . . . . 11.13 112.016 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.4 142.56 50.31 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.946 -1.131 . . . . 18.03 107.946 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -86.81 157.83 19.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.49 -1.232 . . . . 10.22 109.833 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.9 mm -61.27 -39.87 84.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.182 -0.917 . . . . 12.3 109.982 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.03 -37.63 80.35 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.73 -0.841 . . . . 36.51 108.73 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 55.2 t-20 -66.4 -42.82 87.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.475 -0.565 . . . . 25.66 109.475 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.5 t -60.61 -41.69 88.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 109.484 -0.562 . . . . 8.12 109.484 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.531 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 20.5 mttt -60.03 -39.98 87.79 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.342 -0.614 . . . . 15.47 109.342 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.25 89.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.755 -0.657 . . . . 11.45 110.543 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 47.5 mttp -65.21 -39.11 92.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.65 -0.5 . . . . 24.98 109.65 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mt -65.06 -40.05 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.713 -0.477 . . . . 9.46 109.713 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.01 -44.07 94.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.389 0.614 . . . . 14.76 109.361 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.83 -40.45 92.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.987 -1.006 . . . . 26.29 110.938 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -40.98 22.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.149 1.166 . . . . 30.06 114.149 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -111.12 -14.61 13.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.079 1.881 . . . . 25.19 116.079 -174.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.14 11.15 82.81 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.94 -0.648 . . . . 7.41 113.233 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.73 116.29 65.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 109.594 -0.521 . . . . 9.49 109.594 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.79 134.75 62.51 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.099 1.199 . . . . 11.42 112.415 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.46 -32.1 25.76 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 122.778 2.319 . . . . 12.0 114.684 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.8 -15.93 62.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.834 0.743 . . . . 35.55 112.179 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.06 2.45 43.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.765 0.284 . . . . 20.52 111.765 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -107.76 139.22 42.66 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.029 1.122 . . . . 7.13 114.029 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.57 124.34 39.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.217 -1.031 . . . . 36.39 108.217 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.24 131.05 54.61 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.238 0.542 . . . . 9.55 110.837 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -123.87 139.45 50.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.289 -0.869 . . . . 13.9 110.456 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -137.69 126.73 24.3 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.382 -0.827 . . . . 6.86 108.982 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.43 39.52 16.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.099 -0.5 . . . . 11.15 111.701 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.94 0.01 90.0 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.322 -0.71 . . . . 13.93 114.722 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -112.72 139.03 48.67 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.782 1.291 . . . . 23.92 111.74 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -78.86 129.67 34.82 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.216 -1.031 . . . . 23.23 108.216 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.02 136.88 32.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.847 0.356 . . . . 9.11 111.195 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -90.14 149.48 22.43 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.123 -0.49 . . . . 33.44 111.521 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.531 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 63.3 m-20 -69.64 -20.07 63.61 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.774 1.028 . . . . 28.37 113.774 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.25 5.99 68.4 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 120.992 -0.623 . . . . 15.0 112.487 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.31 164.03 13.71 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.18 0.49 . . . . 25.5 111.648 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.1 p -105.57 166.43 10.45 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.624 0.726 . . . . 11.95 112.519 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.97 -42.03 93.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.643 -1.162 . . . . 10.17 110.687 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.48 -31.08 71.04 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.021 -0.672 . . . . 13.59 111.848 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.99 -28.96 69.93 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.641 -0.424 . . . . 11.7 110.578 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.06 14.64 28.53 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.653 0.242 . . . . 12.95 111.653 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 50.01 39.42 18.9 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.944 0.498 . . . . 25.45 112.173 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -81.45 123.97 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.112 -1.07 . . . . 14.6 108.112 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.0 169.07 8.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.295 0.569 . . . . 33.23 112.122 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.4 141.41 15.51 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.218 -0.901 . . . . 25.97 111.489 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 67.03 23.21 9.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.941 -1.027 . . . . 32.61 112.768 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 m -77.2 149.36 35.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.996 -1.113 . . . . 10.56 107.996 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.2 m -110.61 126.74 54.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.302 0.573 . . . . 5.33 109.724 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.93 157.36 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.858 -1.164 . . . . 11.66 107.858 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -115.98 132.25 56.7 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.076 -0.713 . . . . 16.3 109.076 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -106.85 133.18 51.89 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.787 -0.449 . . . . 9.96 109.787 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.45 136.86 57.91 Favored 'Isoleucine or valine' 0 C--N 1.345 0.403 0 N-CA-C 107.931 -1.136 . . . . 9.76 107.931 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.16 129.84 48.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.301 -0.863 . . . . 19.57 111.564 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 . . . . . 0 N--CA 1.465 0.3 0 N-CA-C 108.942 -0.762 . . . . 35.08 108.942 178.578 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.641 -0.503 . . . . 17.17 109.641 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -97.06 140.89 30.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.403 0.62 . . . . 21.89 110.03 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -130.29 166.37 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.073 -0.967 . . . . 10.83 109.156 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.06 139.44 53.79 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.489 -0.323 . . . . 10.61 111.447 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.26 124.67 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.685 -0.857 . . . . 9.13 108.685 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -100.03 139.99 34.9 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.971 -0.381 . . . . 20.55 109.971 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -99.96 168.13 10.05 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.211 1.005 . . . . 11.78 110.703 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.42 -20.51 66.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.509 -1.678 . . . . 19.31 111.043 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -93.77 0.03 56.13 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.353 0.501 . . . . 23.14 112.353 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.91 14.96 50.83 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.28 -0.486 . . . . 19.74 113.809 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -90.0 144.15 26.16 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.359 -0.536 . . . . 21.93 109.999 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -118.27 128.68 54.91 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.293 -0.632 . . . . 12.33 109.293 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mt -112.04 138.42 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.962 -0.384 . . . . 17.08 109.962 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -103.49 131.16 50.84 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.811 -0.811 . . . . 16.3 108.811 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.2 mt -127.55 150.0 49.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.623 0.249 . . . . 15.88 110.882 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -100.33 121.93 42.3 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.178 -1.786 . . . . 28.9 106.178 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -139.94 167.15 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.573 0.702 . . . . 12.05 111.592 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -118.37 150.01 47.03 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.426 -1.324 . . . . 18.17 107.426 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -57.9 -24.99 67.52 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 CA-C-N 120.834 1.334 . . . . 8.16 113.293 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t -85.84 -1.75 57.56 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.901 0.334 . . . . 11.13 111.901 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -70.24 143.98 51.98 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.865 -1.161 . . . . 18.03 107.865 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.476 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 69.8 p -86.81 156.65 19.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.153 -1.385 . . . . 10.22 109.686 177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -60.37 -38.96 79.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.595 -0.729 . . . . 12.3 109.22 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.98 -39.23 85.01 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.059 -0.719 . . . . 36.51 109.059 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.476 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 22.0 m120 -65.13 -40.46 94.47 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 119.847 -0.741 . . . . 25.66 109.382 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.68 -43.9 99.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.712 -0.477 . . . . 8.12 109.712 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -60.03 -40.0 87.8 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 109.315 -0.624 . . . . 15.47 109.315 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.12 89.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.861 -0.609 . . . . 11.45 110.645 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -65.46 -39.19 91.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.716 -0.475 . . . . 24.98 109.716 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.93 -39.97 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.556 -0.535 . . . . 9.46 109.556 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.05 -44.14 94.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.451 0.643 . . . . 14.76 109.609 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 -41.16 91.59 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.993 -1.003 . . . . 26.29 110.545 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -81.92 -40.25 22.6 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.421 1.267 . . . . 30.06 114.421 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -111.51 -14.27 13.72 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.189 1.922 . . . . 25.19 116.189 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.94 10.64 84.77 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.892 -0.67 . . . . 7.41 113.047 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -84.86 116.86 67.18 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 119.092 -0.48 . . . . 9.49 109.793 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.85 140.91 95.42 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 CA-C-N 120.551 1.232 . . . . 11.42 112.519 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.12 -31.71 84.19 Favored 'Trans proline' 0 N--CA 1.51 2.45 0 C-N-CA 122.557 2.172 . . . . 12.0 114.928 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.93 -16.47 62.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.783 0.719 . . . . 35.55 112.439 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 72' ' ' ARG . 78.4 mm-40 -100.02 2.96 43.89 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.92 0.341 . . . . 20.52 111.92 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -107.79 139.92 41.65 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.743 1.016 . . . . 7.13 113.743 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -126.37 122.4 35.27 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.007 -1.109 . . . . 36.39 108.007 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -105.44 130.4 53.54 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.307 0.575 . . . . 9.55 110.629 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.59 137.72 55.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.198 -0.91 . . . . 13.9 110.593 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -138.93 126.95 22.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.051 -0.977 . . . . 6.86 108.947 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 38.7 17.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.957 -0.565 . . . . 11.15 111.563 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.32 0.04 89.41 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.432 -0.649 . . . . 13.93 114.547 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -112.44 139.04 48.34 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.589 1.194 . . . . 23.92 111.827 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -78.48 128.71 33.96 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.755 -1.202 . . . . 23.23 107.755 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -86.52 136.26 33.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.841 0.353 . . . . 9.11 111.318 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.8 149.1 21.77 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.103 -0.499 . . . . 33.44 112.151 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.21 -20.88 65.76 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.572 0.953 . . . . 28.37 113.572 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.15 2.58 71.8 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 121.101 -0.571 . . . . 15.0 113.28 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -110.88 166.42 11.05 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.834 0.817 . . . . 25.5 111.398 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.437 ' OG1' ' OD2' ' A' ' 58' ' ' ASP . 70.4 p -107.49 167.55 9.86 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.605 0.717 . . . . 11.95 112.22 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.0 -41.8 92.88 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.504 -1.226 . . . . 10.17 111.029 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -60.8 -31.56 70.95 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 119.832 -0.747 . . . . 13.59 111.871 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' OD2' ' OG1' ' A' ' 55' ' ' THR . 7.2 m-20 -61.78 -29.05 69.88 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.445 -0.502 . . . . 11.7 111.14 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -99.0 13.31 33.21 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.668 0.247 . . . . 12.95 111.668 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 50.03 39.98 20.3 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.784 0.434 . . . . 25.45 112.036 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.6 mt -81.25 122.27 36.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.626 -1.25 . . . . 14.6 107.626 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.402 ' O ' ' OG ' ' A' ' 65' ' ' SER . 22.9 mm100 -106.91 169.19 8.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.384 0.612 . . . . 33.23 112.149 -177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -51.39 141.33 15.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.047 -0.979 . . . . 25.97 111.607 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.86 23.16 10.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.941 -1.027 . . . . 32.61 112.702 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 37.0 m -77.38 149.15 35.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.041 -1.096 . . . . 10.56 108.041 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -113.6 123.82 50.86 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.62 -0.511 . . . . 5.33 109.62 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -104.02 158.98 16.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.557 -1.275 . . . . 11.66 107.557 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -114.23 132.95 55.94 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.205 -0.665 . . . . 16.3 109.205 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.6 tp -107.13 135.2 49.07 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.711 -0.477 . . . . 9.96 109.711 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -119.81 139.93 45.52 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 107.476 -1.305 . . . . 9.76 107.476 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.8 mt -104.53 145.19 30.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.073 -0.967 . . . . 19.57 111.526 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.434 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 63.2 mtp180 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 115.394 -0.821 . . . . 35.08 109.819 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 17' ' ' VAL . 4.3 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.413 -0.588 . . . . 17.17 109.413 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -97.86 140.67 31.87 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.402 0.62 . . . . 21.89 110.403 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.2 pt -130.02 166.97 26.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.067 -0.97 . . . . 10.83 108.851 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 27.4 m-85 -126.36 138.55 53.57 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.357 -0.383 . . . . 10.61 111.18 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -120.3 125.4 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 109.177 -0.675 . . . . 9.13 109.177 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -100.32 140.0 35.19 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.07 -0.345 . . . . 20.55 110.07 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -102.52 164.19 11.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.965 0.888 . . . . 11.78 110.764 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.409 HD11 ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -59.88 -20.01 54.73 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.887 -1.506 . . . . 19.31 110.809 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.3 p -94.38 5.57 51.37 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.313 0.486 . . . . 23.14 112.313 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.15 14.07 64.99 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 116.084 -0.507 . . . . 19.74 113.87 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -89.98 142.29 27.84 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.259 -0.576 . . . . 21.93 110.175 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.5 m -116.67 127.73 54.7 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.913 -0.773 . . . . 12.33 108.913 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 mt -111.45 138.23 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.677 -0.49 . . . . 17.08 109.677 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -102.25 130.87 49.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.645 -0.872 . . . . 16.3 108.645 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -127.07 149.36 49.96 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.667 0.27 . . . . 15.88 110.696 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -101.22 121.61 42.17 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 106.016 -1.846 . . . . 28.9 106.016 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.2 m -140.01 168.02 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.573 0.702 . . . . 12.05 111.35 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 16.3 mp0 -117.74 147.85 41.89 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 107.188 -1.412 . . . . 18.17 107.188 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -55.77 -24.29 45.84 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 CA-C-N 120.785 1.316 . . . . 8.16 112.769 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 p -85.02 -0.79 55.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.38 -0.373 . . . . 11.13 111.965 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -71.06 144.14 50.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.213 -1.032 . . . . 18.03 108.213 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.7 p -86.42 157.41 19.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.227 -1.352 . . . . 10.22 110.196 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.3 -40.7 86.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.717 -0.674 . . . . 12.3 109.881 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.98 -36.7 80.13 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.219 -0.66 . . . . 36.51 109.219 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -67.58 -44.13 78.94 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.779 -0.452 . . . . 25.66 109.779 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.02 -41.1 85.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.275 -1.009 . . . . 8.12 108.275 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -60.1 -40.08 88.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.848 -0.427 . . . . 15.47 109.848 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.03 89.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.255 -0.43 . . . . 11.45 110.238 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -65.85 -38.46 88.93 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.593 -0.521 . . . . 24.98 109.593 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mt -65.27 -40.22 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.574 -0.528 . . . . 9.46 109.574 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -60.02 -43.9 94.97 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.167 -0.679 . . . . 14.76 109.167 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -41.12 91.37 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.911 -1.04 . . . . 26.29 110.494 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -82.15 -39.45 23.22 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.472 1.286 . . . . 30.06 114.472 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.86 -15.47 13.35 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.131 1.901 . . . . 25.19 116.131 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.5 10.78 84.02 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.85 -0.691 . . . . 7.41 113.056 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.3 mt -84.66 116.1 63.67 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 109.67 -0.493 . . . . 9.49 109.67 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.77 135.87 66.6 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 CA-C-N 120.443 1.194 . . . . 11.42 112.911 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.02 -31.44 44.19 Favored 'Trans proline' 0 N--CA 1.509 2.39 0 C-N-CA 122.777 2.318 . . . . 12.0 115.076 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -71.42 -17.5 62.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.875 0.761 . . . . 35.55 112.025 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 72' ' ' ARG . 51.3 mm-40 -99.87 1.98 43.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.332 . . . . 20.52 111.279 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -106.86 138.8 42.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.601 0.963 . . . . 7.13 113.601 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.485 HH21 ' NH2' ' A' ' 72' ' ' ARG . 94.3 mtt-85 -126.41 122.47 35.4 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.968 -1.123 . . . . 36.39 107.968 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.5 mt -103.06 129.69 49.95 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.226 0.536 . . . . 9.55 110.383 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -127.84 137.54 57.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.313 -0.858 . . . . 13.9 111.571 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -139.0 130.13 26.67 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.361 -0.836 . . . . 6.86 109.977 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.18 40.35 21.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.864 -0.607 . . . . 11.15 111.9 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 0.62 85.71 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.73 -0.668 . . . . 13.93 114.109 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -113.36 138.36 50.18 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.572 1.186 . . . . 23.92 111.855 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -78.5 128.43 33.56 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.482 -0.933 . . . . 23.23 108.482 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.4 mt -87.03 136.68 32.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.825 0.345 . . . . 9.11 111.302 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -92.48 150.97 20.45 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.31 0.576 . . . . 33.44 112.459 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.78 -19.93 64.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.047 -0.979 . . . . 28.37 113.473 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.95 3.11 70.07 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 121.073 -0.584 . . . . 15.0 113.028 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -110.07 164.63 12.44 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.796 0.798 . . . . 25.5 111.465 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 p -106.76 167.11 10.09 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.62 0.724 . . . . 11.95 112.011 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.03 -43.52 95.24 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.692 -1.14 . . . . 10.17 110.863 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.9 m -60.34 -32.16 70.99 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 119.943 -0.703 . . . . 13.59 111.956 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.27 -27.89 68.79 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.478 -0.489 . . . . 11.7 110.829 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -99.98 14.7 29.65 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 111.89 0.33 . . . . 12.95 111.89 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 60' ' ' ASN . 28.7 t-20 50.05 39.55 19.35 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.81 0.338 . . . . 25.45 111.839 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.56 122.81 37.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.837 -1.172 . . . . 14.6 107.837 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.416 ' O ' ' OG ' ' A' ' 65' ' ' SER . 97.2 mt-30 -108.12 169.4 8.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.341 0.591 . . . . 33.23 112.279 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -51.59 141.78 15.59 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.066 -0.97 . . . . 25.97 111.626 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 67.18 23.17 9.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.127 -0.942 . . . . 32.61 112.455 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 38.1 m -78.11 148.71 34.06 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.017 -1.105 . . . . 10.56 108.017 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.6 m -110.49 126.11 54.01 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.202 0.525 . . . . 5.33 109.896 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.2 158.36 16.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.572 -1.269 . . . . 11.66 107.572 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -116.36 131.62 56.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.709 -0.678 . . . . 16.3 109.29 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -107.85 133.04 52.79 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.495 -0.557 . . . . 9.96 109.495 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.45 138.75 49.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 107.973 -1.121 . . . . 9.76 107.973 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.6 mt -100.01 130.03 46.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.635 -1.166 . . . . 19.57 111.28 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.485 ' NH2' HH21 ' A' ' 42' ' ' ARG . 59.2 ttp180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.476 -0.784 . . . . 35.08 109.826 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.688 -0.486 . . . . 17.17 109.688 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -98.59 142.2 30.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.29 0.567 . . . . 21.89 110.358 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -130.22 167.75 24.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.125 -0.943 . . . . 10.83 109.122 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.94 138.89 54.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.395 -0.366 . . . . 10.61 110.876 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.56 124.64 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.705 -0.85 . . . . 9.13 108.705 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -100.02 141.67 32.52 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.832 0.348 . . . . 20.55 110.419 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -102.08 170.04 8.36 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 122.367 1.08 . . . . 11.78 111.088 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.44 -21.26 66.63 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.004 -1.907 . . . . 19.31 111.178 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.9 p -93.6 7.54 44.28 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.481 0.548 . . . . 23.14 112.481 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.74 64.06 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.101 -0.571 . . . . 19.74 113.206 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -90.3 140.58 29.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.506 -0.477 . . . . 21.93 110.088 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -115.27 126.21 54.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.581 -0.896 . . . . 12.33 108.581 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -110.79 138.67 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.891 -0.411 . . . . 17.08 109.891 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -102.66 131.09 49.68 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.45 -0.944 . . . . 16.3 108.45 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' CD2' ' HZ3' ' A' ' 33' ' ' LYS . 75.8 mt -126.79 148.46 49.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.683 0.278 . . . . 15.88 110.569 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -103.11 122.24 44.26 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.964 -1.865 . . . . 28.9 105.964 176.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.408 ' C ' ' OE2' ' A' ' 18' ' ' GLU . 35.7 m -140.08 168.96 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.415 0.626 . . . . 12.05 111.228 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' OE2' ' C ' ' A' ' 17' ' ' VAL . 1.7 mp0 -116.93 149.24 43.77 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 107.357 -1.349 . . . . 18.17 107.357 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -57.28 -25.09 63.25 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 CA-C-N 120.912 1.361 . . . . 8.16 112.837 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 t -85.69 -1.69 57.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.371 -0.377 . . . . 11.13 111.715 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -69.99 144.01 52.43 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.714 -1.217 . . . . 18.03 107.714 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -86.29 156.78 20.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.084 -1.416 . . . . 10.22 109.898 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -61.27 -39.54 82.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.677 -0.692 . . . . 12.3 109.242 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.21 -38.06 82.19 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.896 -0.779 . . . . 36.51 108.896 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -66.41 -42.03 88.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.278 -0.638 . . . . 25.66 109.278 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.35 -42.27 93.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.482 -0.562 . . . . 8.12 109.482 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HZ2' ' CG ' ' A' ' 52' ' ' ASP . 24.1 mttt -60.0 -40.08 87.96 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.076 -0.713 . . . . 15.47 109.076 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.55 90.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.763 -0.653 . . . . 11.45 110.636 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.06 -38.92 92.36 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.428 -0.509 . . . . 24.98 109.91 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -64.94 -40.38 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.631 -0.507 . . . . 9.46 109.631 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.92 -44.73 94.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.381 0.61 . . . . 14.76 109.587 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.5 -40.19 90.48 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.941 -1.027 . . . . 26.29 110.918 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HZ3' ' CD2' ' A' ' 15' ' ' LEU . 16.1 mttp -82.0 -39.72 23.17 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.27 1.211 . . . . 30.06 114.27 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.29 -15.46 13.61 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.217 1.932 . . . . 25.19 116.217 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.14 10.96 83.1 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 120.912 -0.661 . . . . 7.41 113.115 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.1 mt -85.56 117.12 68.14 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 119.158 -0.449 . . . . 9.49 109.832 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.54 133.07 49.51 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 120.528 1.224 . . . . 11.42 112.315 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.32 -30.68 15.67 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 122.851 2.367 . . . . 12.0 114.53 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.88 -16.04 62.12 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.21 -0.596 . . . . 35.55 111.606 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.04 1.27 42.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.831 0.308 . . . . 20.52 111.831 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -105.91 138.57 41.88 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.586 0.958 . . . . 7.13 113.586 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -125.71 121.66 34.08 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.727 -1.212 . . . . 36.39 107.727 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -104.52 129.97 52.52 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.241 0.543 . . . . 9.55 110.842 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -123.71 138.61 52.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.335 -0.848 . . . . 13.9 110.451 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -136.53 126.26 25.56 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.074 -0.966 . . . . 6.86 109.049 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.85 39.43 14.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.974 -0.557 . . . . 11.15 111.472 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.72 0.02 89.7 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.302 -0.721 . . . . 13.93 114.772 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -112.92 138.82 49.2 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.856 1.328 . . . . 23.92 111.872 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -78.61 129.56 34.9 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.421 -0.955 . . . . 23.23 108.421 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.12 136.9 32.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.723 0.297 . . . . 9.11 111.197 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.87 150.1 21.67 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.16 0.505 . . . . 33.44 111.61 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.507 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS . 39.3 m-20 -69.13 -19.99 64.04 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.631 0.975 . . . . 28.37 113.631 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.41 4.34 69.86 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 121.055 -0.593 . . . . 15.0 112.824 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -110.78 166.32 11.12 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.512 0.656 . . . . 25.5 111.253 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -107.58 167.33 10.03 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.579 0.704 . . . . 11.95 112.214 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.0 -42.24 93.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.702 -1.135 . . . . 10.17 111.138 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -61.96 -29.99 70.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 119.725 -0.79 . . . . 13.59 112.025 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.21 -27.98 69.36 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.607 -0.437 . . . . 11.7 110.822 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -99.7 15.34 27.12 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.625 0.231 . . . . 12.95 111.625 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 14.0 p30 49.78 38.85 16.61 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.768 0.427 . . . . 25.45 111.861 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 61' ' ' ILE . 96.5 mt -81.42 124.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.027 -1.101 . . . . 14.6 108.027 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.421 ' O ' ' OG ' ' A' ' 65' ' ' SER . 64.1 mt-30 -107.07 168.89 8.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.362 0.601 . . . . 33.23 112.139 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -51.81 141.46 17.17 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.137 -0.938 . . . . 25.97 111.821 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 67.01 23.6 9.74 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.949 -1.023 . . . . 32.61 112.633 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 37.3 m -77.01 149.93 35.84 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.064 -1.087 . . . . 10.56 108.064 176.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -110.46 126.19 54.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.228 0.537 . . . . 5.33 109.791 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -104.38 156.61 17.78 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.594 -1.261 . . . . 11.66 107.594 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -115.42 131.81 56.81 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.762 -0.829 . . . . 16.3 108.762 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.3 131.56 53.37 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.349 -0.611 . . . . 9.96 109.349 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.72 141.45 41.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 107.651 -1.24 . . . . 9.76 107.651 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 73.7 mt -103.48 137.11 42.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.098 -0.956 . . . . 19.57 110.863 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 . . . . . 0 N--CA 1.466 0.354 0 CA-C-N 115.971 -0.558 . . . . 35.08 110.185 179.665 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.524 -0.547 . . . . 17.17 109.524 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -98.1 140.73 31.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.356 0.598 . . . . 21.89 110.228 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 pt -130.05 167.22 25.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.132 -0.94 . . . . 10.83 109.102 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -125.24 138.33 54.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.228 -0.442 . . . . 10.61 111.328 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.4 124.83 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.553 -0.906 . . . . 9.13 108.553 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -100.35 140.03 35.19 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.676 -0.491 . . . . 20.55 109.676 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -103.3 163.7 12.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.857 0.837 . . . . 11.78 110.68 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.87 -16.06 57.27 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.074 -1.421 . . . . 19.31 111.077 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -95.2 4.35 53.66 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.752 -0.379 . . . . 23.14 111.759 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.63 14.1 63.98 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 116.17 -0.468 . . . . 19.74 113.915 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -91.1 143.74 26.38 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.092 -0.643 . . . . 21.93 110.09 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -117.34 127.06 53.68 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.095 -0.705 . . . . 12.33 109.095 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.8 mt -110.81 137.82 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.809 -0.441 . . . . 17.08 109.809 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -102.78 131.12 49.85 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.796 -0.816 . . . . 16.3 108.796 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -126.63 148.55 49.79 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.679 0.276 . . . . 15.88 110.852 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -101.91 121.69 42.61 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 105.948 -1.871 . . . . 28.9 105.948 176.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.533 ' N ' ' OE2' ' A' ' 16' ' ' GLU . 33.8 m -140.74 169.65 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.461 0.648 . . . . 12.05 111.485 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 6.4 mp0 -117.08 147.64 40.66 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 106.772 -1.566 . . . . 18.17 106.772 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -55.41 -23.37 38.23 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 CA-C-N 120.787 1.317 . . . . 8.16 112.515 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -85.82 -0.32 54.99 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.254 0.464 . . . . 11.13 112.254 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 18' ' ' GLU . 4.1 m-20 -69.53 144.37 53.15 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.028 -1.101 . . . . 18.03 108.028 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -86.19 157.4 19.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.593 -1.185 . . . . 10.22 109.628 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.76 -39.99 83.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.597 -0.729 . . . . 12.3 109.284 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.98 -38.17 81.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.935 -0.765 . . . . 36.51 108.935 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -66.43 -43.14 86.52 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.411 -0.516 . . . . 25.66 109.72 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.43 -43.1 93.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.506 -0.553 . . . . 8.12 109.506 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -60.01 -40.0 87.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 109.405 -0.591 . . . . 15.47 109.405 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.13 89.33 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.752 -0.658 . . . . 11.45 110.474 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -64.94 -39.46 93.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.905 -0.405 . . . . 24.98 109.905 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.8 mt -64.41 -39.92 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.686 -0.487 . . . . 9.46 109.686 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.03 -44.42 94.65 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.306 -0.627 . . . . 14.76 109.306 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.04 -40.69 90.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.133 -0.939 . . . . 26.29 110.73 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -81.85 -40.34 22.6 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.51 1.3 . . . . 30.06 114.51 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.61 -13.98 14.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.189 1.922 . . . . 25.19 116.189 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.48 11.08 83.65 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 120.91 -0.662 . . . . 7.41 113.061 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.46 116.93 67.71 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.517 -0.549 . . . . 9.49 109.517 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -59.1 133.36 52.67 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 CA-C-N 120.54 1.229 . . . . 11.42 112.411 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.57 -29.94 15.14 Favored 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 122.836 2.357 . . . . 12.0 114.324 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.3 -16.87 61.9 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.208 -0.597 . . . . 35.55 111.263 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -100.07 -0.01 39.92 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.751 0.31 . . . . 20.52 111.523 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -106.06 138.82 41.58 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.53 0.937 . . . . 7.13 113.53 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtt85 -126.9 122.57 35.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.985 -1.007 . . . . 36.39 108.594 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.6 mt -104.42 129.99 52.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.26 0.552 . . . . 9.55 110.193 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mt -127.89 138.37 54.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.266 -0.879 . . . . 13.9 111.274 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -136.77 129.35 30.31 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.685 -0.689 . . . . 6.86 110.01 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 40.18 16.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.829 -0.623 . . . . 11.15 111.899 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.93 0.13 89.13 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.28 -0.733 . . . . 13.93 114.607 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -112.4 139.01 48.32 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.848 1.324 . . . . 23.92 111.425 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -79.31 129.09 34.12 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 107.906 -1.146 . . . . 23.23 107.906 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.6 mt -86.92 136.81 32.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.824 0.345 . . . . 9.11 111.453 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -91.4 149.97 21.47 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.056 0.455 . . . . 33.44 112.059 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -67.98 -20.09 65.0 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.599 0.963 . . . . 28.37 113.599 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.49 5.36 70.46 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 121.016 -0.611 . . . . 15.0 112.97 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -110.93 165.04 12.18 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.508 0.654 . . . . 25.5 111.456 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.3 p -107.83 167.3 10.07 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.498 0.666 . . . . 11.95 111.87 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.92 -42.11 93.22 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.85 -1.068 . . . . 10.17 110.898 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.9 m -60.83 -31.76 71.17 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 119.934 -0.706 . . . . 13.59 111.975 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.3 -28.53 69.26 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.641 -0.424 . . . . 11.7 110.85 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.98 15.2 27.95 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.935 0.346 . . . . 12.95 111.935 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 m120 49.95 39.66 19.2 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 122.811 0.445 . . . . 25.45 111.94 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.56 123.03 37.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.109 -1.071 . . . . 14.6 108.109 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -108.67 169.88 8.38 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.267 0.556 . . . . 33.23 112.238 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -51.66 141.82 15.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.132 -0.94 . . . . 25.97 111.43 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 66.78 22.57 10.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.013 -0.994 . . . . 32.61 112.636 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.8 m -77.32 149.25 35.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.952 -1.129 . . . . 10.56 107.952 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -110.26 126.03 53.74 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 121.275 0.559 . . . . 5.33 110.054 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -103.65 156.44 17.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.431 -1.322 . . . . 11.66 107.431 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -115.43 131.13 57.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.673 -0.862 . . . . 16.3 108.673 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.28 133.11 51.48 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.603 -0.518 . . . . 9.96 109.603 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.01 129.96 74.83 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 N-CA-C 107.791 -1.189 . . . . 9.76 107.791 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.6 mt -100.61 130.1 46.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.588 -1.187 . . . . 19.57 110.967 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.399 -0.593 . . . . 35.08 109.399 179.299 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.654 -0.499 . . . . 17.17 109.654 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -97.41 140.66 31.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.41 0.624 . . . . 21.89 110.067 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -130.25 166.62 27.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.033 -0.985 . . . . 10.83 108.859 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -124.63 139.99 53.36 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.451 -0.341 . . . . 10.61 111.194 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.97 124.58 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.873 -0.788 . . . . 9.13 108.873 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -99.72 140.02 34.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.965 -0.383 . . . . 20.55 109.965 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -99.82 169.98 8.85 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 122.228 1.014 . . . . 11.78 110.627 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.5 mt -63.42 -23.9 67.6 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.269 -1.787 . . . . 19.31 111.161 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -91.54 0.04 57.55 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.765 0.654 . . . . 23.14 112.765 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.44 15.15 51.76 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.082 -0.58 . . . . 19.74 113.478 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -89.61 144.87 25.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.699 -0.482 . . . . 21.93 109.699 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -118.4 128.9 55.06 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.626 -0.509 . . . . 12.33 109.626 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -112.02 139.39 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.9 -0.407 . . . . 17.08 109.9 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -101.03 130.68 47.08 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.699 -0.852 . . . . 16.3 108.699 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -125.41 147.39 49.2 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 110.043 -0.354 . . . . 15.88 110.043 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -102.2 121.72 42.78 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 105.753 -1.943 . . . . 28.9 105.753 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.0 167.75 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.659 0.742 . . . . 12.05 111.768 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 25.4 mp0 -118.66 149.7 46.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 107.418 -1.327 . . . . 18.17 107.418 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -57.35 -24.73 61.84 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 CA-C-N 120.847 1.338 . . . . 8.16 113.103 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 p -85.14 -1.61 57.08 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.003 0.372 . . . . 11.13 112.003 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.61 142.97 51.64 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.059 -1.089 . . . . 18.03 108.059 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -86.07 157.77 19.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.444 -1.253 . . . . 10.22 109.939 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.15 -39.91 84.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 12.3 109.344 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -60.08 -38.58 83.34 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.912 -0.773 . . . . 36.51 108.912 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -65.68 -39.96 91.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.973 -0.691 . . . . 25.66 109.495 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.79 -43.95 99.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.671 -0.492 . . . . 8.12 109.671 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -60.06 -39.93 87.71 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.379 -0.6 . . . . 15.47 109.379 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.18 89.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.799 -0.637 . . . . 11.45 110.422 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -64.69 -39.67 94.06 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.702 -0.481 . . . . 24.98 109.702 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.4 mt -64.5 -40.08 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.852 -0.425 . . . . 9.46 109.852 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -59.96 -44.26 94.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.382 0.61 . . . . 14.76 109.464 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -62.03 -40.2 94.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.099 -0.955 . . . . 26.29 111.252 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -80.96 -42.37 21.38 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.95 1.093 . . . . 30.06 113.95 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.35 -11.26 14.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.856 1.799 . . . . 25.19 115.856 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.74 10.44 85.14 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 120.799 -0.715 . . . . 7.41 113.136 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mt -83.77 130.6 54.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.291 -0.633 . . . . 9.49 109.291 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.57 133.07 16.78 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.392 1.394 . . . . 11.42 112.2 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.91 -30.66 24.5 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 122.833 2.355 . . . . 12.0 115.084 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 60.8 t0 -71.9 -17.96 62.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.413 0.552 . . . . 35.55 111.559 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 72' ' ' ARG . 16.1 mm100 -99.98 -0.02 40.16 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.927 0.343 . . . . 20.52 111.927 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -106.1 139.59 40.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.948 1.092 . . . . 7.13 113.948 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -126.28 122.66 36.13 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.469 -1.242 . . . . 36.39 108.125 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -103.36 129.99 50.56 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.246 0.546 . . . . 9.55 110.082 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.36 136.13 61.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.25 -0.887 . . . . 13.9 111.589 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -138.08 128.99 27.04 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.105 -0.952 . . . . 6.86 109.62 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 40.16 21.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.968 -0.56 . . . . 11.15 112.006 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.95 0.47 85.44 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.764 -0.653 . . . . 13.93 114.296 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -112.88 138.56 49.54 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.44 1.12 . . . . 23.92 111.691 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -78.33 129.42 34.98 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.349 -0.982 . . . . 23.23 108.349 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 mt -86.85 136.4 32.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.827 0.346 . . . . 9.11 111.192 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.406 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 98.9 mt-10 -91.99 149.94 21.26 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.142 -0.481 . . . . 33.44 112.254 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.22 -20.05 65.63 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.493 0.923 . . . . 28.37 113.493 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.48 3.13 68.41 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 121.04 -0.6 . . . . 15.0 113.203 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -110.94 166.21 11.23 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.768 0.784 . . . . 25.5 111.37 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.2 p -107.52 167.38 9.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.568 0.699 . . . . 11.95 112.294 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.06 -42.35 94.3 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.842 -1.072 . . . . 10.17 111.143 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.2 p -61.92 -30.05 70.63 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.613 -0.835 . . . . 13.59 111.777 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -62.39 -28.3 69.68 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.524 -0.47 . . . . 11.7 110.813 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 87.2 m-85 -99.77 14.21 31.05 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 111.6 0.222 . . . . 12.95 111.6 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 50.03 39.8 19.83 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.022 0.378 . . . . 25.45 112.022 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.18 121.73 35.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 107.547 -1.279 . . . . 14.6 107.547 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.4 ' O ' ' OG ' ' A' ' 65' ' ' SER . 96.7 mt-30 -106.64 168.96 8.82 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.294 0.569 . . . . 33.23 112.089 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -51.2 141.31 14.82 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.129 -0.941 . . . . 25.97 111.479 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 66.9 22.96 10.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.085 -0.961 . . . . 32.61 112.667 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 38.2 m -77.6 148.37 35.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.946 -1.131 . . . . 10.56 107.946 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.5 m -111.85 124.47 52.42 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.447 -0.575 . . . . 5.33 109.447 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.44 159.15 15.97 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.511 -1.292 . . . . 11.66 107.511 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -113.44 132.48 55.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.547 -0.751 . . . . 16.3 109.431 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 tp -105.92 132.48 51.98 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.705 -0.85 . . . . 9.96 108.705 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.02 137.78 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.027 -1.472 . . . . 9.76 107.027 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.7 mt -103.73 137.74 41.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.25 -0.886 . . . . 19.57 110.044 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.544 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 75.1 ttt180 . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.18 -0.463 . . . . 35.08 109.832 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.612 -0.514 . . . . 17.17 109.612 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -98.77 140.85 32.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.251 0.548 . . . . 21.89 110.387 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.9 pt -130.08 167.91 24.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.183 -0.917 . . . . 10.83 109.463 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -124.01 138.77 54.41 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.182 -0.463 . . . . 10.61 111.16 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.54 124.0 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.327 -0.99 . . . . 9.13 108.327 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -99.94 142.7 31.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.854 0.359 . . . . 20.55 110.577 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.7 p -102.27 165.73 10.97 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 122.029 0.918 . . . . 11.78 110.976 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.89 -18.75 64.5 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.65 -1.614 . . . . 19.31 111.214 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.9 p -94.22 2.58 55.9 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.205 0.446 . . . . 23.14 112.205 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.14 14.19 56.43 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.192 -0.528 . . . . 19.74 113.627 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -90.26 143.09 27.09 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.299 -0.56 . . . . 21.93 110.157 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -117.41 127.55 54.14 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.642 -0.873 . . . . 12.33 108.642 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mt -111.84 139.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.825 -0.435 . . . . 17.08 109.825 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.0 m -103.62 131.78 50.45 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 108.571 -0.9 . . . . 16.3 108.571 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -127.53 149.98 49.89 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.577 0.227 . . . . 15.88 110.533 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -102.14 122.21 43.7 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.326 -1.731 . . . . 28.9 106.326 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.01 167.7 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.629 0.728 . . . . 12.05 111.73 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -117.85 151.53 48.86 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.362 -1.347 . . . . 18.17 107.362 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.37 -24.46 74.6 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 CA-C-N 120.911 1.361 . . . . 8.16 112.974 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 t -85.98 -1.88 57.76 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 112.025 0.38 . . . . 11.13 112.025 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -70.79 143.9 51.02 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.832 -1.173 . . . . 18.03 107.832 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.422 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 71.4 p -87.07 157.0 19.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.086 -1.415 . . . . 10.22 109.746 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -60.73 -38.57 79.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.392 -0.822 . . . . 12.3 109.497 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -60.08 -39.48 86.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.206 -0.664 . . . . 36.51 109.206 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.422 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 21.9 m120 -64.66 -40.23 95.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.753 -0.779 . . . . 25.66 108.958 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -62.27 -43.82 98.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.25 -0.432 . . . . 8.12 109.936 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 21.5 mttt -59.97 -40.13 88.03 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 109.519 -0.548 . . . . 15.47 109.519 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.94 88.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.831 -0.622 . . . . 11.45 110.436 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -65.6 -38.13 88.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.672 -0.492 . . . . 24.98 109.672 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.3 mt -65.71 -40.37 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.569 -0.53 . . . . 9.46 109.569 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.0 -44.78 94.31 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.331 -0.618 . . . . 14.76 109.331 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -60.26 -39.94 88.58 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.014 -0.994 . . . . 26.29 110.607 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -80.66 -42.32 22.28 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.297 1.221 . . . . 30.06 114.297 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.23 -13.75 13.93 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.272 1.953 . . . . 25.19 116.272 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.3 10.85 84.15 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 120.823 -0.703 . . . . 7.41 113.003 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -85.31 115.73 62.55 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.473 -0.566 . . . . 9.49 109.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.41 134.72 63.19 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 CA-C-N 120.463 1.201 . . . . 11.42 112.384 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.63 -31.06 23.75 Favored 'Trans proline' 0 N--CA 1.506 2.239 0 C-N-CA 122.791 2.327 . . . . 12.0 114.375 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -71.59 -15.48 62.26 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.119 -0.632 . . . . 35.55 111.673 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -100.01 0.7 41.5 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.813 0.301 . . . . 20.52 111.813 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -107.1 139.87 40.83 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.279 1.214 . . . . 7.13 114.279 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -126.47 123.37 37.67 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.501 -1.227 . . . . 36.39 108.109 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.9 mt -106.01 130.1 54.0 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.208 0.528 . . . . 9.55 110.573 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mp -124.06 139.48 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.381 -0.827 . . . . 13.9 110.582 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -138.8 127.58 23.53 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.139 -0.937 . . . . 6.86 109.011 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 39.99 20.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.987 -0.552 . . . . 11.15 111.717 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.17 0.19 88.51 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.356 -0.691 . . . . 13.93 114.648 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -112.63 139.08 48.53 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.708 1.254 . . . . 23.92 111.686 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -78.8 128.72 33.76 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.177 -1.045 . . . . 23.23 108.177 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.25 136.86 32.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.438 -0.346 . . . . 9.11 111.197 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -90.49 149.98 21.98 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.204 0.526 . . . . 33.44 111.81 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 40.5 m-20 -69.01 -20.04 64.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.256 -0.884 . . . . 28.37 113.244 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.76 3.71 71.35 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 121.168 -0.539 . . . . 15.0 112.881 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -110.71 165.42 11.84 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.61 0.705 . . . . 25.5 111.372 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.9 p -106.82 167.16 10.06 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.604 0.716 . . . . 11.95 112.215 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.95 -42.65 94.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.682 -1.145 . . . . 10.17 110.906 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.9 p -61.81 -30.25 70.7 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.723 -0.791 . . . . 13.59 111.881 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -62.34 -28.29 69.65 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.503 -0.479 . . . . 11.7 110.484 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.73 14.61 29.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.648 -0.251 . . . . 12.95 111.619 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 50.02 39.46 19.03 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.797 0.439 . . . . 25.45 112.055 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.43 124.51 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.045 -1.094 . . . . 14.6 108.045 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.411 ' O ' ' OG ' ' A' ' 65' ' ' SER . 97.9 mt-30 -107.02 169.03 8.8 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.34 0.591 . . . . 33.23 112.287 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -51.97 140.76 19.4 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.034 -0.985 . . . . 25.97 112.032 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 67.4 23.92 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.82 -1.082 . . . . 32.61 112.211 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 37.0 m -77.31 150.24 35.25 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.227 -1.027 . . . . 10.56 108.227 176.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -110.6 126.05 54.04 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.248 0.547 . . . . 5.33 110.033 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.21 157.49 17.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.582 -1.266 . . . . 11.66 107.582 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -116.32 131.35 56.97 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.188 -0.671 . . . . 16.3 109.188 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -105.2 131.77 52.25 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.38 -0.6 . . . . 9.96 109.38 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.38 135.71 60.66 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 N-CA-C 107.862 -1.162 . . . . 9.76 107.862 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.2 mt -99.93 130.01 46.07 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.967 -1.015 . . . . 19.57 110.27 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 116.379 -0.373 . . . . 35.08 110.006 179.697 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 17' ' ' VAL . 6.3 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.633 -0.506 . . . . 17.17 109.633 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -98.65 140.43 32.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.34 0.59 . . . . 21.89 110.585 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 pt -130.15 167.35 25.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.104 -0.953 . . . . 10.83 108.999 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -124.35 139.06 54.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.307 -0.406 . . . . 10.61 111.277 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.62 124.23 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.414 -0.958 . . . . 9.13 108.414 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -100.01 142.56 31.32 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.891 0.377 . . . . 20.55 110.484 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 p -102.41 166.13 10.72 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 122.1 0.952 . . . . 11.78 110.861 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.96 -19.25 65.0 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.548 -1.66 . . . . 19.31 111.534 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -93.79 4.02 54.56 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.142 0.423 . . . . 23.14 112.142 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.7 14.32 58.35 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.215 -0.517 . . . . 19.74 113.617 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -90.45 143.58 26.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.163 -0.615 . . . . 21.93 109.938 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -116.94 127.55 54.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.888 -0.782 . . . . 12.33 108.888 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mt -111.22 138.73 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.798 -0.445 . . . . 17.08 109.798 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.8 m -103.7 131.36 50.93 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.53 -0.915 . . . . 16.3 108.53 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.4 mt -127.04 149.98 49.66 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.553 0.215 . . . . 15.88 110.676 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -102.73 122.44 44.46 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 106.213 -1.773 . . . . 28.9 106.213 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -139.96 167.85 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.565 0.698 . . . . 12.05 111.79 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -117.55 150.64 47.07 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.142 -1.429 . . . . 18.17 107.142 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.56 -24.86 71.98 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 CA-C-N 120.907 1.36 . . . . 8.16 113.248 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 p -85.03 -0.38 54.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.072 0.397 . . . . 11.13 112.072 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -71.29 142.54 50.49 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.01 -1.108 . . . . 18.03 108.01 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.614 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 74.0 p -86.14 157.55 19.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.449 -1.25 . . . . 10.22 109.903 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -61.47 -40.05 85.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.807 -0.633 . . . . 12.3 109.585 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -60.17 -36.81 78.43 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.246 -0.65 . . . . 36.51 109.246 177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.614 ' H ' ' HG1' ' A' ' 22' ' ' THR . 54.3 t-20 -67.55 -42.89 81.94 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.356 -0.609 . . . . 25.66 109.356 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.57 -41.31 87.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.435 -0.58 . . . . 8.12 109.435 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 19.2 mttt -60.0 -40.16 88.27 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 109.216 -0.661 . . . . 15.47 109.216 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.62 -38.29 89.62 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.714 -0.676 . . . . 11.45 110.857 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 44.8 mttp -65.13 -39.38 92.96 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.638 -0.425 . . . . 24.98 109.907 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.1 mt -64.67 -40.09 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 109.498 -0.556 . . . . 9.46 109.498 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.95 -43.97 94.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.33 -0.618 . . . . 14.76 109.33 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.77 90.26 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.977 -1.011 . . . . 26.29 110.557 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -81.61 -40.6 22.73 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.582 1.327 . . . . 30.06 114.582 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.64 -14.47 14.04 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 116.286 1.958 . . . . 25.19 116.286 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.78 11.41 82.85 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 121.025 -0.607 . . . . 7.41 113.153 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mt -86.04 117.1 68.11 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 109.585 -0.524 . . . . 9.49 109.585 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.99 135.18 64.89 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 120.479 1.207 . . . . 11.42 111.995 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.72 -31.46 25.68 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.536 2.157 . . . . 12.0 114.501 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.22 -16.07 62.49 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.064 -0.654 . . . . 35.55 111.88 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -99.56 0.82 43.05 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.138 -0.225 . . . . 20.52 111.487 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -105.24 140.01 39.04 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.319 0.859 . . . . 7.13 113.319 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -128.63 120.82 27.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 108.072 -1.084 . . . . 36.39 108.072 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.3 mt -103.21 130.01 50.31 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.382 0.61 . . . . 9.55 111.187 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.43 139.79 50.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.017 -0.992 . . . . 13.9 111.178 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -140.27 130.98 25.74 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.583 -0.735 . . . . 6.86 109.965 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 35.76 10.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.057 0.391 . . . . 11.15 112.057 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.17 -0.56 89.67 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.015 -0.881 . . . . 13.93 115.139 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -112.5 139.91 47.68 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.186 1.493 . . . . 23.92 111.104 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -77.86 127.45 32.4 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.496 -0.927 . . . . 23.23 108.496 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.24 136.25 33.24 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.917 0.389 . . . . 9.11 111.117 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.93 149.9 21.71 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.282 0.563 . . . . 33.44 111.891 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 62.5 m-20 -68.38 -20.08 64.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.219 -0.9 . . . . 28.37 113.027 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.86 3.81 74.46 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 121.222 -0.513 . . . . 15.0 113.144 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -109.21 165.22 11.77 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 117.884 0.842 . . . . 25.5 111.134 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.1 p -106.67 167.35 9.92 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.559 0.695 . . . . 11.95 111.706 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.98 -44.38 94.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.929 -1.032 . . . . 10.17 110.417 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -62.01 -30.21 70.8 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 119.95 -0.7 . . . . 13.59 111.83 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.11 -27.72 69.58 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.37 -0.532 . . . . 11.7 110.218 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.429 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 66.0 m-85 -99.8 14.43 30.33 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.355 -0.384 . . . . 12.95 111.442 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 2.6 p-10 49.8 39.3 17.74 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 122.844 0.458 . . . . 25.45 112.158 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.54 124.04 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.003 -1.11 . . . . 14.6 108.003 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -107.34 169.07 8.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.409 0.623 . . . . 33.23 112.084 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -51.4 141.69 14.98 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.027 -0.988 . . . . 25.97 111.613 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 66.85 23.57 9.97 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.966 -1.015 . . . . 32.61 112.751 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -78.01 149.22 34.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.05 -1.093 . . . . 10.56 108.05 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.4 m -110.64 126.56 54.63 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.293 0.568 . . . . 5.33 109.951 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -103.79 157.21 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.71 -1.219 . . . . 11.66 107.71 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -115.18 131.08 57.04 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.729 -0.841 . . . . 16.3 108.729 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.4 tp -105.42 131.7 52.51 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.76 -0.829 . . . . 9.96 108.76 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.79 148.47 24.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 107.945 -1.131 . . . . 9.76 107.945 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.9 mt -105.24 139.92 39.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.892 -1.049 . . . . 19.57 109.907 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 35.08 109.961 -179.616 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.597 -0.52 . . . . 17.17 109.597 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -98.77 141.54 31.44 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.322 0.582 . . . . 21.89 110.301 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 pt -129.98 167.9 24.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.218 -0.901 . . . . 10.83 109.452 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -124.49 138.49 54.34 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.15 -0.477 . . . . 10.61 110.937 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.54 124.62 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.836 -0.801 . . . . 9.13 108.836 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -100.78 138.84 37.3 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.895 -0.409 . . . . 20.55 109.895 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -99.01 162.45 13.06 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.368 0.604 . . . . 11.78 110.444 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -64.64 -11.77 38.82 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.947 -1.024 . . . . 19.31 110.704 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -96.62 0.95 50.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.848 0.356 . . . . 23.14 110.879 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.05 11.84 60.93 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 116.07 -0.514 . . . . 19.74 114.23 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -88.99 142.16 27.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.072 -0.651 . . . . 21.93 109.715 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -114.85 127.11 55.52 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 120.366 -0.534 . . . . 12.33 109.627 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mt -110.77 137.9 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.632 -0.507 . . . . 17.08 109.632 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -104.36 130.01 52.24 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.397 -0.964 . . . . 16.3 108.397 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.49 149.8 43.39 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.883 -0.414 . . . . 15.88 109.883 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -102.63 121.53 42.6 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 104.951 -2.24 . . . . 28.9 104.951 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.08 169.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.475 0.655 . . . . 12.05 111.557 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -117.79 149.34 45.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.332 -1.359 . . . . 18.17 107.332 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.38 -24.92 63.12 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 CA-C-N 120.908 1.36 . . . . 8.16 113.201 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 t -85.76 -1.0 56.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.569 -0.287 . . . . 11.13 111.743 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -70.74 143.59 51.21 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.769 -1.197 . . . . 18.03 107.769 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -86.45 157.2 19.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.195 -1.366 . . . . 10.22 109.924 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.7 mm -61.76 -38.83 81.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.76 -0.655 . . . . 12.3 109.398 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -59.96 -37.78 80.55 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.544 -0.91 . . . . 36.51 108.544 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.06 -42.32 89.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.286 -0.635 . . . . 25.66 109.286 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.16 -44.32 98.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.845 -0.428 . . . . 8.12 109.845 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.162 -0.681 . . . . 15.47 109.162 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.86 87.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.692 -0.685 . . . . 11.45 110.612 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -65.08 -39.08 92.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.859 -0.422 . . . . 24.98 109.859 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.9 mt -65.2 -40.02 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 109.836 -0.431 . . . . 9.46 109.836 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -60.0 -44.57 94.45 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.384 0.612 . . . . 14.76 109.654 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.81 -40.4 92.56 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.033 -0.985 . . . . 26.29 111.0 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -81.8 -39.91 23.35 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.031 1.122 . . . . 30.06 114.031 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -111.89 -14.37 13.52 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.089 1.885 . . . . 25.19 116.089 -174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 11.32 82.5 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.867 -0.682 . . . . 7.41 113.472 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.3 mt -86.29 116.94 67.75 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 109.745 -0.465 . . . . 9.49 109.745 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.27 134.53 59.63 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 120.535 1.227 . . . . 11.42 112.243 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.29 -30.11 18.98 Favored 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.693 2.262 . . . . 12.0 114.536 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.26 -16.19 61.92 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.082 -0.647 . . . . 35.55 111.701 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -99.99 1.07 42.21 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.75 0.278 . . . . 20.52 111.75 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -107.16 139.46 41.56 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.851 1.056 . . . . 7.13 113.851 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.616 ' NH2' HH11 ' A' ' 72' ' ' ARG . 88.2 mtt180 -125.95 121.91 34.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.727 -1.124 . . . . 36.39 108.123 176.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.7 mt -105.53 130.3 53.62 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.142 0.496 . . . . 9.55 110.694 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.64 138.25 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.506 -0.77 . . . . 13.9 110.654 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -137.37 126.17 24.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.339 -0.846 . . . . 6.86 109.051 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.47 38.45 14.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.017 -0.538 . . . . 11.15 111.613 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.01 89.49 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.48 -0.622 . . . . 13.93 114.64 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -112.3 138.56 48.85 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.637 1.218 . . . . 23.92 111.886 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -79.45 129.45 34.48 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 107.524 -1.287 . . . . 23.23 107.524 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.7 mt -86.93 136.96 32.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.816 0.341 . . . . 9.11 111.66 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.73 148.66 22.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.166 -0.47 . . . . 33.44 112.113 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -66.44 -22.43 66.21 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.782 1.03 . . . . 28.37 113.782 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.1 2.99 76.25 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 121.117 -0.563 . . . . 15.0 113.364 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -110.07 165.44 11.73 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.895 0.848 . . . . 25.5 111.517 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.0 p -106.96 167.01 10.18 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.547 0.689 . . . . 11.95 111.88 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.7 mt -59.99 -42.85 95.12 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.837 -1.074 . . . . 10.17 110.852 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.6 p -61.61 -30.32 70.62 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 119.804 -0.759 . . . . 13.59 111.956 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.23 -28.96 70.06 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.68 -0.408 . . . . 11.7 110.334 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -99.81 14.21 31.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.34 -0.391 . . . . 12.95 111.645 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 49.98 39.88 19.82 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.84 0.456 . . . . 25.45 112.137 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -81.62 124.73 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.011 -1.107 . . . . 14.6 108.011 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -108.58 169.79 8.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.465 0.65 . . . . 33.23 112.144 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -51.77 141.69 16.53 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.899 -1.046 . . . . 25.97 111.708 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.94 23.07 9.95 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.039 -0.982 . . . . 32.61 112.872 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -77.49 148.53 35.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.993 -1.114 . . . . 10.56 107.993 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.5 m -110.48 126.27 54.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.391 0.615 . . . . 5.33 109.67 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.59 156.79 17.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.61 -1.256 . . . . 11.66 107.61 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -114.83 132.73 56.4 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.149 -0.686 . . . . 16.3 109.149 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 tp -108.2 131.19 54.92 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.469 -0.567 . . . . 9.96 109.469 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.78 132.71 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 N-CA-C 107.351 -1.352 . . . . 9.76 107.351 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.0 mt -102.18 130.19 48.76 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.377 -0.829 . . . . 19.57 111.303 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.616 HH11 ' NH2' ' A' ' 42' ' ' ARG . 80.2 ttt180 . . . . . 0 N--CA 1.464 0.262 0 N-CA-C 109.423 -0.584 . . . . 35.08 109.423 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.537 -0.542 . . . . 17.17 109.537 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.403 HE22 ' HB2' ' A' ' 16' ' ' GLU . 67.1 mm-40 -95.83 142.35 28.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.474 0.654 . . . . 21.89 110.231 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -131.49 165.43 31.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 114.898 -1.046 . . . . 10.83 108.31 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.4 139.94 53.42 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.722 0.296 . . . . 10.61 111.273 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.87 123.74 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.62 -0.881 . . . . 9.13 108.62 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -100.05 142.3 31.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.908 0.385 . . . . 20.55 110.473 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 p -101.82 166.03 10.88 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 122.085 0.945 . . . . 11.78 111.064 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.96 -19.61 65.26 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.61 -1.632 . . . . 19.31 111.209 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -93.34 -0.02 56.77 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.151 0.426 . . . . 23.14 112.151 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 13.87 52.22 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.173 -0.537 . . . . 19.74 113.698 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -90.17 144.92 25.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.147 -0.621 . . . . 21.93 109.708 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -117.96 127.87 54.25 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.079 -0.711 . . . . 12.33 109.079 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.56 139.0 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.888 -0.412 . . . . 17.08 109.888 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.4 m -105.12 132.02 51.87 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.735 -0.839 . . . . 16.3 108.735 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -127.31 150.3 49.64 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.534 0.207 . . . . 15.88 110.572 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.403 ' HB2' HE22 ' A' ' 2' ' ' GLN . 86.5 tt0 -100.96 122.19 43.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.333 -1.729 . . . . 28.9 106.333 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.03 168.01 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.615 0.722 . . . . 12.05 111.859 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -118.5 150.86 48.82 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 107.172 -1.418 . . . . 18.17 107.172 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.14 -24.24 65.56 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 CA-C-N 120.926 1.366 . . . . 8.16 112.695 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 p -85.26 -1.79 57.33 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.062 0.393 . . . . 11.13 112.062 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -70.46 143.29 51.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.949 -1.13 . . . . 18.03 107.949 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.491 ' HG1' ' CG ' ' A' ' 25' ' ' ASN . 71.7 p -86.29 157.2 19.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.238 -1.346 . . . . 10.22 109.921 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.96 -39.75 84.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.715 -0.675 . . . . 12.3 109.29 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -38.32 82.18 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.728 -0.842 . . . . 36.51 108.728 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.491 ' CG ' ' HG1' ' A' ' 22' ' ' THR . 7.4 m-20 -66.17 -40.05 90.2 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.168 -0.679 . . . . 25.66 109.168 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.94 -43.73 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.833 -0.432 . . . . 8.12 109.833 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.265 -0.643 . . . . 15.47 109.265 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.85 87.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.748 -0.66 . . . . 11.45 110.339 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -65.72 -39.0 90.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.748 -0.464 . . . . 24.98 109.748 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -64.98 -39.98 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.642 -0.503 . . . . 9.46 109.642 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.08 -44.14 95.0 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.322 -0.622 . . . . 14.76 109.322 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 53.7 t0 -60.35 -40.57 91.19 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.032 -0.985 . . . . 26.29 110.733 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -81.71 -40.27 23.0 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.371 1.249 . . . . 30.06 114.371 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.77 -14.94 13.93 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.277 1.954 . . . . 25.19 116.277 -174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.42 11.15 82.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 120.952 -0.642 . . . . 7.41 113.114 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mt -86.43 116.98 67.89 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.751 -0.463 . . . . 9.49 109.751 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.83 134.8 62.71 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 CA-C-N 120.417 1.185 . . . . 11.42 112.118 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.36 -31.37 22.84 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 122.631 2.221 . . . . 12.0 114.441 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.03 -16.31 62.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.621 0.646 . . . . 35.55 112.079 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -99.98 1.78 42.9 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.754 0.279 . . . . 20.52 111.754 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -107.99 139.46 42.58 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.908 1.077 . . . . 7.13 113.908 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -126.17 123.94 39.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.745 -1.116 . . . . 36.39 108.166 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -105.71 130.08 53.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.32 0.581 . . . . 9.55 110.899 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.17 138.06 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.214 -0.903 . . . . 13.9 110.533 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -139.31 127.05 21.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.258 -0.883 . . . . 6.86 108.887 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 39.16 18.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.068 -0.514 . . . . 11.15 111.429 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.04 0.03 89.12 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.28 -0.733 . . . . 13.93 114.863 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -112.24 139.27 47.92 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.777 1.289 . . . . 23.92 111.77 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.37 128.98 34.01 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.602 -1.259 . . . . 23.23 107.602 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.7 mt -86.93 136.53 32.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 9.11 111.559 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.16 149.91 21.59 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.224 0.535 . . . . 33.44 112.02 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.83 -20.04 64.29 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.555 0.946 . . . . 28.37 113.555 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.04 3.48 70.17 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 121.133 -0.556 . . . . 15.0 113.062 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -110.1 165.94 11.35 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 117.639 0.72 . . . . 25.5 111.286 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.1 p -107.55 167.35 10.0 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.536 0.684 . . . . 11.95 111.976 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.95 -42.94 95.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.843 -1.071 . . . . 10.17 110.986 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.0 p -61.87 -30.31 70.78 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 119.677 -0.809 . . . . 13.59 111.92 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.07 -29.02 70.01 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.687 -0.405 . . . . 11.7 110.498 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -99.89 13.81 32.58 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.268 -0.424 . . . . 12.95 111.657 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 50.07 39.98 20.44 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 112.056 0.391 . . . . 25.45 112.056 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -81.04 121.54 34.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.362 -1.347 . . . . 14.6 107.362 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.49 169.13 8.77 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.324 0.583 . . . . 33.23 112.042 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -51.14 141.22 14.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.121 -0.945 . . . . 25.97 111.65 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.74 23.35 10.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.771 -1.104 . . . . 32.61 112.929 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.9 m -76.83 148.7 36.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.013 -1.106 . . . . 10.56 108.013 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -112.83 124.04 51.69 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.528 -0.545 . . . . 5.33 109.528 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -105.17 157.41 17.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.626 -1.25 . . . . 11.66 107.626 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -112.25 134.08 54.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.23 -0.655 . . . . 16.3 109.23 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.5 tp -106.16 132.7 51.92 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.919 -0.771 . . . . 9.96 108.919 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.71 144.83 28.35 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 107.609 -1.256 . . . . 9.76 107.609 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.3 mt -109.86 139.99 44.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.348 -0.842 . . . . 19.57 110.611 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -119.2 130.11 55.32 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.729 -0.669 . . . . 35.08 110.032 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.7 mt -120.04 128.74 53.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.449 -0.341 . . . . 32.31 110.356 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -69.79 -39.88 76.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 42.75 110.062 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.89 -179.96 44.38 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.787 -0.925 . . . . 36.31 110.787 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.73 0 CA-C-O 118.002 -1.444 . . . . 36.2 110.955 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.498 -0.556 . . . . 17.17 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.84 140.99 31.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.334 0.588 . . . . 21.89 110.165 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 pt -130.24 166.83 26.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.144 -0.935 . . . . 10.83 108.843 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -124.54 139.3 54.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.503 -0.317 . . . . 10.61 111.01 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.27 124.17 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.597 -0.89 . . . . 9.13 108.597 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -101.05 142.13 32.95 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.984 0.421 . . . . 20.55 110.499 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -103.96 162.58 13.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.716 0.77 . . . . 11.78 111.076 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.64 -14.46 52.04 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.38 -1.282 . . . . 19.31 111.768 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -95.72 2.45 53.95 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.734 -0.386 . . . . 23.14 111.566 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.4 13.67 56.84 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.355 -0.45 . . . . 19.74 113.919 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -91.17 142.1 28.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.286 -0.566 . . . . 21.93 110.42 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.1 m -116.96 127.56 54.33 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.681 -0.859 . . . . 12.33 108.681 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.3 mt -111.77 138.66 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 110.003 -0.369 . . . . 17.08 110.003 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -103.18 131.21 50.38 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.931 -0.766 . . . . 16.3 108.931 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.4 mt -127.19 149.92 49.76 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.703 0.287 . . . . 15.88 110.926 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.65 122.11 43.77 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.131 -1.803 . . . . 28.9 106.131 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.94 168.25 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.507 0.67 . . . . 12.05 111.485 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.81 149.22 44.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 107.227 -1.398 . . . . 18.17 107.227 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.24 -24.4 59.15 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 120.817 1.327 . . . . 8.16 112.844 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 p -85.28 -2.46 58.08 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 116.297 -0.41 . . . . 11.13 112.016 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.4 142.56 50.31 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.946 -1.131 . . . . 18.03 107.946 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -86.81 157.83 19.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.49 -1.232 . . . . 10.22 109.833 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.9 mm -61.27 -39.87 84.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.182 -0.917 . . . . 12.3 109.982 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.03 -37.63 80.35 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.73 -0.841 . . . . 36.51 108.73 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 55.2 t-20 -66.4 -42.82 87.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.475 -0.565 . . . . 25.66 109.475 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.5 t -60.61 -41.69 88.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 109.484 -0.562 . . . . 8.12 109.484 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.531 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 20.5 mttt -60.03 -39.98 87.79 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.342 -0.614 . . . . 15.47 109.342 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.25 89.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.755 -0.657 . . . . 11.45 110.543 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 47.5 mttp -65.21 -39.11 92.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.65 -0.5 . . . . 24.98 109.65 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mt -65.06 -40.05 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.713 -0.477 . . . . 9.46 109.713 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.01 -44.07 94.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.389 0.614 . . . . 14.76 109.361 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.83 -40.45 92.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.987 -1.006 . . . . 26.29 110.938 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -40.98 22.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.149 1.166 . . . . 30.06 114.149 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -111.12 -14.61 13.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.079 1.881 . . . . 25.19 116.079 -174.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.14 11.15 82.81 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.94 -0.648 . . . . 7.41 113.233 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.73 116.29 65.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 109.594 -0.521 . . . . 9.49 109.594 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.79 134.75 62.51 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.099 1.199 . . . . 11.42 112.415 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.46 -32.1 25.76 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 122.778 2.319 . . . . 12.0 114.684 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.8 -15.93 62.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.834 0.743 . . . . 35.55 112.179 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.06 2.45 43.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.765 0.284 . . . . 20.52 111.765 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -107.76 139.22 42.66 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.029 1.122 . . . . 7.13 114.029 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.57 124.34 39.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.217 -1.031 . . . . 36.39 108.217 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.24 131.05 54.61 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.238 0.542 . . . . 9.55 110.837 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -123.87 139.45 50.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.289 -0.869 . . . . 13.9 110.456 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -137.69 126.73 24.3 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.382 -0.827 . . . . 6.86 108.982 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.43 39.52 16.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.099 -0.5 . . . . 11.15 111.701 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.94 0.01 90.0 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.322 -0.71 . . . . 13.93 114.722 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -112.72 139.03 48.67 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.782 1.291 . . . . 23.92 111.74 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -78.86 129.67 34.82 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.216 -1.031 . . . . 23.23 108.216 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.02 136.88 32.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.847 0.356 . . . . 9.11 111.195 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -90.14 149.48 22.43 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.123 -0.49 . . . . 33.44 111.521 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.531 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 63.3 m-20 -69.64 -20.07 63.61 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.774 1.028 . . . . 28.37 113.774 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.25 5.99 68.4 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 120.992 -0.623 . . . . 15.0 112.487 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.31 164.03 13.71 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.18 0.49 . . . . 25.5 111.648 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.1 p -105.57 166.43 10.45 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.624 0.726 . . . . 11.95 112.519 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.97 -42.03 93.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.643 -1.162 . . . . 10.17 110.687 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.48 -31.08 71.04 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.021 -0.672 . . . . 13.59 111.848 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.99 -28.96 69.93 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.641 -0.424 . . . . 11.7 110.578 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.06 14.64 28.53 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.653 0.242 . . . . 12.95 111.653 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 50.01 39.42 18.9 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.944 0.498 . . . . 25.45 112.173 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -81.45 123.97 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.112 -1.07 . . . . 14.6 108.112 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.0 169.07 8.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.295 0.569 . . . . 33.23 112.122 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.4 141.41 15.51 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.218 -0.901 . . . . 25.97 111.489 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 67.03 23.21 9.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.941 -1.027 . . . . 32.61 112.768 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 m -77.2 149.36 35.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.996 -1.113 . . . . 10.56 107.996 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.2 m -110.61 126.74 54.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.302 0.573 . . . . 5.33 109.724 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.93 157.36 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.858 -1.164 . . . . 11.66 107.858 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -115.98 132.25 56.7 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.076 -0.713 . . . . 16.3 109.076 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -106.85 133.18 51.89 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.787 -0.449 . . . . 9.96 109.787 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.45 136.86 57.91 Favored 'Isoleucine or valine' 0 C--N 1.345 0.403 0 N-CA-C 107.931 -1.136 . . . . 9.76 107.931 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 mp -102.16 129.84 48.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.301 -0.863 . . . . 19.57 111.564 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -109.53 120.0 41.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.942 -0.762 . . . . 35.08 108.942 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.8 mt -104.99 120.99 42.82 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.968 0.413 . . . . 32.31 111.186 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -64.33 -40.9 96.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 42.75 110.512 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.26 -179.98 43.85 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.306 -0.861 . . . . 36.31 111.393 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.701 0 CA-C-O 117.976 -1.458 . . . . 36.2 110.919 179.818 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.641 -0.503 . . . . 17.17 109.641 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -97.06 140.89 30.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.403 0.62 . . . . 21.89 110.03 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -130.29 166.37 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.073 -0.967 . . . . 10.83 109.156 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.06 139.44 53.79 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.489 -0.323 . . . . 10.61 111.447 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.26 124.67 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.685 -0.857 . . . . 9.13 108.685 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -100.03 139.99 34.9 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.971 -0.381 . . . . 20.55 109.971 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -99.96 168.13 10.05 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.211 1.005 . . . . 11.78 110.703 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.42 -20.51 66.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.509 -1.678 . . . . 19.31 111.043 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -93.77 0.03 56.13 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.353 0.501 . . . . 23.14 112.353 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.91 14.96 50.83 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.28 -0.486 . . . . 19.74 113.809 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -90.0 144.15 26.16 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.359 -0.536 . . . . 21.93 109.999 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -118.27 128.68 54.91 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.293 -0.632 . . . . 12.33 109.293 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mt -112.04 138.42 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.962 -0.384 . . . . 17.08 109.962 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -103.49 131.16 50.84 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.811 -0.811 . . . . 16.3 108.811 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.2 mt -127.55 150.0 49.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.623 0.249 . . . . 15.88 110.882 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -100.33 121.93 42.3 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.178 -1.786 . . . . 28.9 106.178 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -139.94 167.15 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.573 0.702 . . . . 12.05 111.592 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -118.37 150.01 47.03 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.426 -1.324 . . . . 18.17 107.426 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -57.9 -24.99 67.52 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 CA-C-N 120.834 1.334 . . . . 8.16 113.293 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t -85.84 -1.75 57.56 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.901 0.334 . . . . 11.13 111.901 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -70.24 143.98 51.98 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.865 -1.161 . . . . 18.03 107.865 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.476 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 69.8 p -86.81 156.65 19.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.153 -1.385 . . . . 10.22 109.686 177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -60.37 -38.96 79.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.595 -0.729 . . . . 12.3 109.22 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.98 -39.23 85.01 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.059 -0.719 . . . . 36.51 109.059 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.476 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 22.0 m120 -65.13 -40.46 94.47 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 119.847 -0.741 . . . . 25.66 109.382 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.68 -43.9 99.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.712 -0.477 . . . . 8.12 109.712 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -60.03 -40.0 87.8 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 109.315 -0.624 . . . . 15.47 109.315 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.12 89.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.861 -0.609 . . . . 11.45 110.645 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -65.46 -39.19 91.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.716 -0.475 . . . . 24.98 109.716 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.93 -39.97 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.556 -0.535 . . . . 9.46 109.556 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.05 -44.14 94.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.451 0.643 . . . . 14.76 109.609 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 -41.16 91.59 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.993 -1.003 . . . . 26.29 110.545 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -81.92 -40.25 22.6 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.421 1.267 . . . . 30.06 114.421 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -111.51 -14.27 13.72 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.189 1.922 . . . . 25.19 116.189 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.94 10.64 84.77 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.892 -0.67 . . . . 7.41 113.047 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -84.86 116.86 67.18 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 119.092 -0.48 . . . . 9.49 109.793 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.85 140.91 95.42 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 CA-C-N 120.551 1.232 . . . . 11.42 112.519 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.12 -31.71 84.19 Favored 'Trans proline' 0 N--CA 1.51 2.45 0 C-N-CA 122.557 2.172 . . . . 12.0 114.928 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.93 -16.47 62.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.783 0.719 . . . . 35.55 112.439 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 72' ' ' ARG . 78.4 mm-40 -100.02 2.96 43.89 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.92 0.341 . . . . 20.52 111.92 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -107.79 139.92 41.65 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.743 1.016 . . . . 7.13 113.743 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -126.37 122.4 35.27 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.007 -1.109 . . . . 36.39 108.007 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -105.44 130.4 53.54 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.307 0.575 . . . . 9.55 110.629 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.59 137.72 55.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.198 -0.91 . . . . 13.9 110.593 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -138.93 126.95 22.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.051 -0.977 . . . . 6.86 108.947 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 38.7 17.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.957 -0.565 . . . . 11.15 111.563 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.32 0.04 89.41 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.432 -0.649 . . . . 13.93 114.547 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -112.44 139.04 48.34 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.589 1.194 . . . . 23.92 111.827 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -78.48 128.71 33.96 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.755 -1.202 . . . . 23.23 107.755 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -86.52 136.26 33.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.841 0.353 . . . . 9.11 111.318 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.8 149.1 21.77 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.103 -0.499 . . . . 33.44 112.151 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.21 -20.88 65.76 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.572 0.953 . . . . 28.37 113.572 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.15 2.58 71.8 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 121.101 -0.571 . . . . 15.0 113.28 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -110.88 166.42 11.05 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.834 0.817 . . . . 25.5 111.398 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.437 ' OG1' ' OD2' ' A' ' 58' ' ' ASP . 70.4 p -107.49 167.55 9.86 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.605 0.717 . . . . 11.95 112.22 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.0 -41.8 92.88 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.504 -1.226 . . . . 10.17 111.029 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -60.8 -31.56 70.95 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 119.832 -0.747 . . . . 13.59 111.871 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' OD2' ' OG1' ' A' ' 55' ' ' THR . 7.2 m-20 -61.78 -29.05 69.88 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.445 -0.502 . . . . 11.7 111.14 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -99.0 13.31 33.21 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.668 0.247 . . . . 12.95 111.668 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 50.03 39.98 20.3 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.784 0.434 . . . . 25.45 112.036 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.6 mt -81.25 122.27 36.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.626 -1.25 . . . . 14.6 107.626 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.402 ' O ' ' OG ' ' A' ' 65' ' ' SER . 22.9 mm100 -106.91 169.19 8.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.384 0.612 . . . . 33.23 112.149 -177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -51.39 141.33 15.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.047 -0.979 . . . . 25.97 111.607 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.86 23.16 10.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.941 -1.027 . . . . 32.61 112.702 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 37.0 m -77.38 149.15 35.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.041 -1.096 . . . . 10.56 108.041 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -113.6 123.82 50.86 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.62 -0.511 . . . . 5.33 109.62 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -104.02 158.98 16.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.557 -1.275 . . . . 11.66 107.557 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -114.23 132.95 55.94 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.205 -0.665 . . . . 16.3 109.205 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.6 tp -107.13 135.2 49.07 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.711 -0.477 . . . . 9.96 109.711 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -119.81 139.93 45.52 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 107.476 -1.305 . . . . 9.76 107.476 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.8 mt -104.53 145.19 30.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.073 -0.967 . . . . 19.57 111.526 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.434 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 63.2 mtp180 -119.98 139.9 51.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.394 -0.821 . . . . 35.08 109.819 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.8 mt -123.16 129.32 51.27 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.98 -0.378 . . . . 32.31 109.98 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -79.02 -28.15 43.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 42.75 110.668 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.04 -161.79 45.85 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.08 -0.808 . . . . 36.31 111.08 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.78 0 CA-C-O 117.997 -1.446 . . . . 36.2 110.921 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 17' ' ' VAL . 4.3 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.413 -0.588 . . . . 17.17 109.413 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -97.86 140.67 31.87 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.402 0.62 . . . . 21.89 110.403 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.2 pt -130.02 166.97 26.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.067 -0.97 . . . . 10.83 108.851 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 27.4 m-85 -126.36 138.55 53.57 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.357 -0.383 . . . . 10.61 111.18 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -120.3 125.4 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 109.177 -0.675 . . . . 9.13 109.177 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -100.32 140.0 35.19 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.07 -0.345 . . . . 20.55 110.07 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -102.52 164.19 11.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.965 0.888 . . . . 11.78 110.764 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.409 HD11 ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -59.88 -20.01 54.73 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.887 -1.506 . . . . 19.31 110.809 179.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.3 p -94.38 5.57 51.37 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.313 0.486 . . . . 23.14 112.313 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.15 14.07 64.99 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 116.084 -0.507 . . . . 19.74 113.87 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -89.98 142.29 27.84 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.259 -0.576 . . . . 21.93 110.175 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.5 m -116.67 127.73 54.7 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.913 -0.773 . . . . 12.33 108.913 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 mt -111.45 138.23 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.677 -0.49 . . . . 17.08 109.677 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -102.25 130.87 49.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.645 -0.872 . . . . 16.3 108.645 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -127.07 149.36 49.96 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.667 0.27 . . . . 15.88 110.696 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -101.22 121.61 42.17 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 106.016 -1.846 . . . . 28.9 106.016 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.2 m -140.01 168.02 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.573 0.702 . . . . 12.05 111.35 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 16.3 mp0 -117.74 147.85 41.89 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 107.188 -1.412 . . . . 18.17 107.188 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -55.77 -24.29 45.84 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 CA-C-N 120.785 1.316 . . . . 8.16 112.769 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 p -85.02 -0.79 55.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.38 -0.373 . . . . 11.13 111.965 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -71.06 144.14 50.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.213 -1.032 . . . . 18.03 108.213 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.7 p -86.42 157.41 19.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.227 -1.352 . . . . 10.22 110.196 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.3 -40.7 86.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.717 -0.674 . . . . 12.3 109.881 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.98 -36.7 80.13 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.219 -0.66 . . . . 36.51 109.219 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -67.58 -44.13 78.94 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.779 -0.452 . . . . 25.66 109.779 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.02 -41.1 85.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.275 -1.009 . . . . 8.12 108.275 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -60.1 -40.08 88.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.848 -0.427 . . . . 15.47 109.848 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.03 89.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.255 -0.43 . . . . 11.45 110.238 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -65.85 -38.46 88.93 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.593 -0.521 . . . . 24.98 109.593 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mt -65.27 -40.22 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.574 -0.528 . . . . 9.46 109.574 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -60.02 -43.9 94.97 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.167 -0.679 . . . . 14.76 109.167 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -41.12 91.37 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.911 -1.04 . . . . 26.29 110.494 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -82.15 -39.45 23.22 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.472 1.286 . . . . 30.06 114.472 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.86 -15.47 13.35 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.131 1.901 . . . . 25.19 116.131 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.5 10.78 84.02 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.85 -0.691 . . . . 7.41 113.056 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.3 mt -84.66 116.1 63.67 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 109.67 -0.493 . . . . 9.49 109.67 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.77 135.87 66.6 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 CA-C-N 120.443 1.194 . . . . 11.42 112.911 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.02 -31.44 44.19 Favored 'Trans proline' 0 N--CA 1.509 2.39 0 C-N-CA 122.777 2.318 . . . . 12.0 115.076 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -71.42 -17.5 62.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.875 0.761 . . . . 35.55 112.025 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 72' ' ' ARG . 51.3 mm-40 -99.87 1.98 43.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.332 . . . . 20.52 111.279 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -106.86 138.8 42.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.601 0.963 . . . . 7.13 113.601 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.485 HH21 ' NH2' ' A' ' 72' ' ' ARG . 94.3 mtt-85 -126.41 122.47 35.4 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.968 -1.123 . . . . 36.39 107.968 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.5 mt -103.06 129.69 49.95 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.226 0.536 . . . . 9.55 110.383 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -127.84 137.54 57.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.313 -0.858 . . . . 13.9 111.571 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -139.0 130.13 26.67 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.361 -0.836 . . . . 6.86 109.977 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.18 40.35 21.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.864 -0.607 . . . . 11.15 111.9 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 0.62 85.71 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.73 -0.668 . . . . 13.93 114.109 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -113.36 138.36 50.18 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.572 1.186 . . . . 23.92 111.855 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -78.5 128.43 33.56 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.482 -0.933 . . . . 23.23 108.482 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.4 mt -87.03 136.68 32.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.825 0.345 . . . . 9.11 111.302 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -92.48 150.97 20.45 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.31 0.576 . . . . 33.44 112.459 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.78 -19.93 64.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.047 -0.979 . . . . 28.37 113.473 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.95 3.11 70.07 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 121.073 -0.584 . . . . 15.0 113.028 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -110.07 164.63 12.44 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.796 0.798 . . . . 25.5 111.465 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 p -106.76 167.11 10.09 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.62 0.724 . . . . 11.95 112.011 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.03 -43.52 95.24 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.692 -1.14 . . . . 10.17 110.863 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.9 m -60.34 -32.16 70.99 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 119.943 -0.703 . . . . 13.59 111.956 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.27 -27.89 68.79 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.478 -0.489 . . . . 11.7 110.829 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -99.98 14.7 29.65 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 111.89 0.33 . . . . 12.95 111.89 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 60' ' ' ASN . 28.7 t-20 50.05 39.55 19.35 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.81 0.338 . . . . 25.45 111.839 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.56 122.81 37.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.837 -1.172 . . . . 14.6 107.837 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.416 ' O ' ' OG ' ' A' ' 65' ' ' SER . 97.2 mt-30 -108.12 169.4 8.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.341 0.591 . . . . 33.23 112.279 -177.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -51.59 141.78 15.59 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.066 -0.97 . . . . 25.97 111.626 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 67.18 23.17 9.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.127 -0.942 . . . . 32.61 112.455 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 38.1 m -78.11 148.71 34.06 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.017 -1.105 . . . . 10.56 108.017 175.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.6 m -110.49 126.11 54.01 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.202 0.525 . . . . 5.33 109.896 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.2 158.36 16.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.572 -1.269 . . . . 11.66 107.572 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -116.36 131.62 56.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.709 -0.678 . . . . 16.3 109.29 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -107.85 133.04 52.79 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.495 -0.557 . . . . 9.96 109.495 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.45 138.75 49.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 107.973 -1.121 . . . . 9.76 107.973 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.6 mt -100.01 130.03 46.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.635 -1.166 . . . . 19.57 111.28 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.485 ' NH2' HH21 ' A' ' 42' ' ' ARG . 59.2 ttp180 -106.68 137.09 45.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.476 -0.784 . . . . 35.08 109.826 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -126.33 144.62 50.74 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.794 0.331 . . . . 32.31 110.422 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -129.98 130.6 45.24 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.249 -0.432 . . . . 42.75 110.258 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.74 172.55 29.98 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.731 -0.948 . . . . 36.31 110.731 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.766 0 CA-C-O 117.992 -1.449 . . . . 36.2 110.977 179.916 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.688 -0.486 . . . . 17.17 109.688 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -98.59 142.2 30.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.29 0.567 . . . . 21.89 110.358 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -130.22 167.75 24.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.125 -0.943 . . . . 10.83 109.122 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.94 138.89 54.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.395 -0.366 . . . . 10.61 110.876 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.56 124.64 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.705 -0.85 . . . . 9.13 108.705 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -100.02 141.67 32.52 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.832 0.348 . . . . 20.55 110.419 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -102.08 170.04 8.36 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 122.367 1.08 . . . . 11.78 111.088 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.44 -21.26 66.63 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.004 -1.907 . . . . 19.31 111.178 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.9 p -93.6 7.54 44.28 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.481 0.548 . . . . 23.14 112.481 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.74 64.06 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.101 -0.571 . . . . 19.74 113.206 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -90.3 140.58 29.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.506 -0.477 . . . . 21.93 110.088 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -115.27 126.21 54.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.581 -0.896 . . . . 12.33 108.581 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -110.79 138.67 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.891 -0.411 . . . . 17.08 109.891 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -102.66 131.09 49.68 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.45 -0.944 . . . . 16.3 108.45 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' CD2' ' HZ3' ' A' ' 33' ' ' LYS . 75.8 mt -126.79 148.46 49.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.683 0.278 . . . . 15.88 110.569 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -103.11 122.24 44.26 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.964 -1.865 . . . . 28.9 105.964 176.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.408 ' C ' ' OE2' ' A' ' 18' ' ' GLU . 35.7 m -140.08 168.96 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.415 0.626 . . . . 12.05 111.228 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' OE2' ' C ' ' A' ' 17' ' ' VAL . 1.7 mp0 -116.93 149.24 43.77 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 107.357 -1.349 . . . . 18.17 107.357 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -57.28 -25.09 63.25 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 CA-C-N 120.912 1.361 . . . . 8.16 112.837 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 t -85.69 -1.69 57.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.371 -0.377 . . . . 11.13 111.715 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -69.99 144.01 52.43 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.714 -1.217 . . . . 18.03 107.714 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -86.29 156.78 20.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.084 -1.416 . . . . 10.22 109.898 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -61.27 -39.54 82.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.677 -0.692 . . . . 12.3 109.242 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.21 -38.06 82.19 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.896 -0.779 . . . . 36.51 108.896 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -66.41 -42.03 88.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.278 -0.638 . . . . 25.66 109.278 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.35 -42.27 93.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.482 -0.562 . . . . 8.12 109.482 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.507 ' HZ2' ' CG ' ' A' ' 52' ' ' ASP . 24.1 mttt -60.0 -40.08 87.96 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.076 -0.713 . . . . 15.47 109.076 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.55 90.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.763 -0.653 . . . . 11.45 110.636 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.06 -38.92 92.36 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.428 -0.509 . . . . 24.98 109.91 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -64.94 -40.38 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.631 -0.507 . . . . 9.46 109.631 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.92 -44.73 94.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.381 0.61 . . . . 14.76 109.587 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.5 -40.19 90.48 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.941 -1.027 . . . . 26.29 110.918 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HZ3' ' CD2' ' A' ' 15' ' ' LEU . 16.1 mttp -82.0 -39.72 23.17 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.27 1.211 . . . . 30.06 114.27 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.29 -15.46 13.61 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.217 1.932 . . . . 25.19 116.217 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.14 10.96 83.1 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 120.912 -0.661 . . . . 7.41 113.115 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.1 mt -85.56 117.12 68.14 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 119.158 -0.449 . . . . 9.49 109.832 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.54 133.07 49.51 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 120.528 1.224 . . . . 11.42 112.315 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.32 -30.68 15.67 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 122.851 2.367 . . . . 12.0 114.53 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.88 -16.04 62.12 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.21 -0.596 . . . . 35.55 111.606 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.04 1.27 42.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.831 0.308 . . . . 20.52 111.831 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -105.91 138.57 41.88 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.586 0.958 . . . . 7.13 113.586 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -125.71 121.66 34.08 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.727 -1.212 . . . . 36.39 107.727 176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -104.52 129.97 52.52 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.241 0.543 . . . . 9.55 110.842 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -123.71 138.61 52.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.335 -0.848 . . . . 13.9 110.451 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -136.53 126.26 25.56 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.074 -0.966 . . . . 6.86 109.049 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.85 39.43 14.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.974 -0.557 . . . . 11.15 111.472 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.72 0.02 89.7 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.302 -0.721 . . . . 13.93 114.772 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -112.92 138.82 49.2 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.856 1.328 . . . . 23.92 111.872 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -78.61 129.56 34.9 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.421 -0.955 . . . . 23.23 108.421 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.12 136.9 32.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.723 0.297 . . . . 9.11 111.197 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.87 150.1 21.67 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.16 0.505 . . . . 33.44 111.61 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.507 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS . 39.3 m-20 -69.13 -19.99 64.04 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.631 0.975 . . . . 28.37 113.631 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.41 4.34 69.86 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 121.055 -0.593 . . . . 15.0 112.824 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -110.78 166.32 11.12 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.512 0.656 . . . . 25.5 111.253 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -107.58 167.33 10.03 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.579 0.704 . . . . 11.95 112.214 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.0 -42.24 93.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.702 -1.135 . . . . 10.17 111.138 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -61.96 -29.99 70.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 119.725 -0.79 . . . . 13.59 112.025 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.21 -27.98 69.36 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.607 -0.437 . . . . 11.7 110.822 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -99.7 15.34 27.12 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.625 0.231 . . . . 12.95 111.625 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 14.0 p30 49.78 38.85 16.61 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.768 0.427 . . . . 25.45 111.861 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 61' ' ' ILE . 96.5 mt -81.42 124.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.027 -1.101 . . . . 14.6 108.027 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.421 ' O ' ' OG ' ' A' ' 65' ' ' SER . 64.1 mt-30 -107.07 168.89 8.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.362 0.601 . . . . 33.23 112.139 -177.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -51.81 141.46 17.17 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.137 -0.938 . . . . 25.97 111.821 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 67.01 23.6 9.74 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.949 -1.023 . . . . 32.61 112.633 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 37.3 m -77.01 149.93 35.84 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.064 -1.087 . . . . 10.56 108.064 176.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -110.46 126.19 54.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.228 0.537 . . . . 5.33 109.791 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -104.38 156.61 17.78 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.594 -1.261 . . . . 11.66 107.594 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -115.42 131.81 56.81 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.762 -0.829 . . . . 16.3 108.762 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.3 131.56 53.37 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.349 -0.611 . . . . 9.96 109.349 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.72 141.45 41.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 107.651 -1.24 . . . . 9.76 107.651 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 73.7 mt -103.48 137.11 42.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.098 -0.956 . . . . 19.57 110.863 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -120.01 134.94 55.1 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.971 -0.558 . . . . 35.08 110.185 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.0 140.04 51.57 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.21 -0.45 . . . . 32.31 110.093 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -128.2 129.54 46.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.152 -0.477 . . . . 42.75 110.153 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.33 -178.19 38.63 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.912 -0.875 . . . . 36.31 110.912 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.803 0 CA-C-O 118.027 -1.429 . . . . 36.2 110.872 179.802 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.524 -0.547 . . . . 17.17 109.524 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -98.1 140.73 31.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.356 0.598 . . . . 21.89 110.228 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 pt -130.05 167.22 25.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.132 -0.94 . . . . 10.83 109.102 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -125.24 138.33 54.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.228 -0.442 . . . . 10.61 111.328 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.4 124.83 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.553 -0.906 . . . . 9.13 108.553 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -100.35 140.03 35.19 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.676 -0.491 . . . . 20.55 109.676 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -103.3 163.7 12.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.857 0.837 . . . . 11.78 110.68 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.87 -16.06 57.27 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.074 -1.421 . . . . 19.31 111.077 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -95.2 4.35 53.66 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.752 -0.379 . . . . 23.14 111.759 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.63 14.1 63.98 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 116.17 -0.468 . . . . 19.74 113.915 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -91.1 143.74 26.38 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.092 -0.643 . . . . 21.93 110.09 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -117.34 127.06 53.68 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.095 -0.705 . . . . 12.33 109.095 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.8 mt -110.81 137.82 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.809 -0.441 . . . . 17.08 109.809 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -102.78 131.12 49.85 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.796 -0.816 . . . . 16.3 108.796 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -126.63 148.55 49.79 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.679 0.276 . . . . 15.88 110.852 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -101.91 121.69 42.61 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 105.948 -1.871 . . . . 28.9 105.948 176.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.533 ' N ' ' OE2' ' A' ' 16' ' ' GLU . 33.8 m -140.74 169.65 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.461 0.648 . . . . 12.05 111.485 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 6.4 mp0 -117.08 147.64 40.66 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 106.772 -1.566 . . . . 18.17 106.772 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -55.41 -23.37 38.23 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 CA-C-N 120.787 1.317 . . . . 8.16 112.515 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -85.82 -0.32 54.99 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.254 0.464 . . . . 11.13 112.254 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 18' ' ' GLU . 4.1 m-20 -69.53 144.37 53.15 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.028 -1.101 . . . . 18.03 108.028 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -86.19 157.4 19.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.593 -1.185 . . . . 10.22 109.628 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.76 -39.99 83.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.597 -0.729 . . . . 12.3 109.284 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.98 -38.17 81.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.935 -0.765 . . . . 36.51 108.935 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -66.43 -43.14 86.52 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.411 -0.516 . . . . 25.66 109.72 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.43 -43.1 93.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.506 -0.553 . . . . 8.12 109.506 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -60.01 -40.0 87.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 109.405 -0.591 . . . . 15.47 109.405 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.13 89.33 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.752 -0.658 . . . . 11.45 110.474 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -64.94 -39.46 93.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.905 -0.405 . . . . 24.98 109.905 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.8 mt -64.41 -39.92 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.686 -0.487 . . . . 9.46 109.686 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.03 -44.42 94.65 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.306 -0.627 . . . . 14.76 109.306 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.04 -40.69 90.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.133 -0.939 . . . . 26.29 110.73 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -81.85 -40.34 22.6 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.51 1.3 . . . . 30.06 114.51 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.61 -13.98 14.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.189 1.922 . . . . 25.19 116.189 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.48 11.08 83.65 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 120.91 -0.662 . . . . 7.41 113.061 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.46 116.93 67.71 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.517 -0.549 . . . . 9.49 109.517 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -59.1 133.36 52.67 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 CA-C-N 120.54 1.229 . . . . 11.42 112.411 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.57 -29.94 15.14 Favored 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 122.836 2.357 . . . . 12.0 114.324 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.3 -16.87 61.9 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.208 -0.597 . . . . 35.55 111.263 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -100.07 -0.01 39.92 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.751 0.31 . . . . 20.52 111.523 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -106.06 138.82 41.58 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.53 0.937 . . . . 7.13 113.53 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtt85 -126.9 122.57 35.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.985 -1.007 . . . . 36.39 108.594 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.6 mt -104.42 129.99 52.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.26 0.552 . . . . 9.55 110.193 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mt -127.89 138.37 54.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.266 -0.879 . . . . 13.9 111.274 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -136.77 129.35 30.31 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.685 -0.689 . . . . 6.86 110.01 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 40.18 16.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.829 -0.623 . . . . 11.15 111.899 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.93 0.13 89.13 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.28 -0.733 . . . . 13.93 114.607 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -112.4 139.01 48.32 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.848 1.324 . . . . 23.92 111.425 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -79.31 129.09 34.12 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 107.906 -1.146 . . . . 23.23 107.906 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.6 mt -86.92 136.81 32.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.824 0.345 . . . . 9.11 111.453 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -91.4 149.97 21.47 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.056 0.455 . . . . 33.44 112.059 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -67.98 -20.09 65.0 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.599 0.963 . . . . 28.37 113.599 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.49 5.36 70.46 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 121.016 -0.611 . . . . 15.0 112.97 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -110.93 165.04 12.18 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.508 0.654 . . . . 25.5 111.456 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.3 p -107.83 167.3 10.07 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.498 0.666 . . . . 11.95 111.87 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.92 -42.11 93.22 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.85 -1.068 . . . . 10.17 110.898 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.9 m -60.83 -31.76 71.17 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 119.934 -0.706 . . . . 13.59 111.975 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.3 -28.53 69.26 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.641 -0.424 . . . . 11.7 110.85 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.98 15.2 27.95 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.935 0.346 . . . . 12.95 111.935 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 m120 49.95 39.66 19.2 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 122.811 0.445 . . . . 25.45 111.94 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.56 123.03 37.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.109 -1.071 . . . . 14.6 108.109 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -108.67 169.88 8.38 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.267 0.556 . . . . 33.23 112.238 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -51.66 141.82 15.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.132 -0.94 . . . . 25.97 111.43 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 66.78 22.57 10.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.013 -0.994 . . . . 32.61 112.636 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.8 m -77.32 149.25 35.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.952 -1.129 . . . . 10.56 107.952 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -110.26 126.03 53.74 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 121.275 0.559 . . . . 5.33 110.054 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -103.65 156.44 17.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.431 -1.322 . . . . 11.66 107.431 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -115.43 131.13 57.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.673 -0.862 . . . . 16.3 108.673 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.28 133.11 51.48 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.603 -0.518 . . . . 9.96 109.603 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.01 129.96 74.83 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 N-CA-C 107.791 -1.189 . . . . 9.76 107.791 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.6 mt -100.61 130.1 46.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.588 -1.187 . . . . 19.57 110.967 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 74' ' ' ARG . 45.2 ttt180 -108.81 130.11 55.4 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.399 -0.593 . . . . 35.08 109.399 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.97 32.25 3.28 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.01 0.374 . . . . 32.31 112.01 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 72' ' ' ARG . 65.2 ttt-85 -160.78 160.0 30.72 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.967 -0.293 . . . . 42.75 110.576 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.4 ' N ' ' CG ' ' A' ' 74' ' ' ARG . . . 89.97 -9.02 78.69 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.921 -0.871 . . . . 36.31 110.921 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.736 0 CA-C-O 118.046 -1.419 . . . . 36.2 110.821 -179.914 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.654 -0.499 . . . . 17.17 109.654 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -97.41 140.66 31.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.41 0.624 . . . . 21.89 110.067 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -130.25 166.62 27.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.033 -0.985 . . . . 10.83 108.859 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -124.63 139.99 53.36 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.451 -0.341 . . . . 10.61 111.194 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.97 124.58 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.873 -0.788 . . . . 9.13 108.873 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -99.72 140.02 34.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.965 -0.383 . . . . 20.55 109.965 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -99.82 169.98 8.85 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 122.228 1.014 . . . . 11.78 110.627 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.5 mt -63.42 -23.9 67.6 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.269 -1.787 . . . . 19.31 111.161 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -91.54 0.04 57.55 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.765 0.654 . . . . 23.14 112.765 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.44 15.15 51.76 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.082 -0.58 . . . . 19.74 113.478 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -89.61 144.87 25.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.699 -0.482 . . . . 21.93 109.699 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -118.4 128.9 55.06 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.626 -0.509 . . . . 12.33 109.626 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -112.02 139.39 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.9 -0.407 . . . . 17.08 109.9 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -101.03 130.68 47.08 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.699 -0.852 . . . . 16.3 108.699 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -125.41 147.39 49.2 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 110.043 -0.354 . . . . 15.88 110.043 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -102.2 121.72 42.78 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 105.753 -1.943 . . . . 28.9 105.753 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.0 167.75 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.659 0.742 . . . . 12.05 111.768 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 25.4 mp0 -118.66 149.7 46.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 107.418 -1.327 . . . . 18.17 107.418 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -57.35 -24.73 61.84 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 CA-C-N 120.847 1.338 . . . . 8.16 113.103 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 p -85.14 -1.61 57.08 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.003 0.372 . . . . 11.13 112.003 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.61 142.97 51.64 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.059 -1.089 . . . . 18.03 108.059 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -86.07 157.77 19.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.444 -1.253 . . . . 10.22 109.939 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.15 -39.91 84.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 12.3 109.344 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -60.08 -38.58 83.34 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.912 -0.773 . . . . 36.51 108.912 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -65.68 -39.96 91.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.973 -0.691 . . . . 25.66 109.495 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.79 -43.95 99.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.671 -0.492 . . . . 8.12 109.671 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -60.06 -39.93 87.71 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.379 -0.6 . . . . 15.47 109.379 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.18 89.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.799 -0.637 . . . . 11.45 110.422 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -64.69 -39.67 94.06 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.702 -0.481 . . . . 24.98 109.702 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.4 mt -64.5 -40.08 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.852 -0.425 . . . . 9.46 109.852 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -59.96 -44.26 94.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.382 0.61 . . . . 14.76 109.464 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -62.03 -40.2 94.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.099 -0.955 . . . . 26.29 111.252 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -80.96 -42.37 21.38 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.95 1.093 . . . . 30.06 113.95 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.35 -11.26 14.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.856 1.799 . . . . 25.19 115.856 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.74 10.44 85.14 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 120.799 -0.715 . . . . 7.41 113.136 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mt -83.77 130.6 54.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.291 -0.633 . . . . 9.49 109.291 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.57 133.07 16.78 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.392 1.394 . . . . 11.42 112.2 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.91 -30.66 24.5 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 122.833 2.355 . . . . 12.0 115.084 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 60.8 t0 -71.9 -17.96 62.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.413 0.552 . . . . 35.55 111.559 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 72' ' ' ARG . 16.1 mm100 -99.98 -0.02 40.16 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.927 0.343 . . . . 20.52 111.927 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -106.1 139.59 40.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.948 1.092 . . . . 7.13 113.948 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -126.28 122.66 36.13 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.469 -1.242 . . . . 36.39 108.125 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -103.36 129.99 50.56 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.246 0.546 . . . . 9.55 110.082 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.36 136.13 61.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.25 -0.887 . . . . 13.9 111.589 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -138.08 128.99 27.04 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.105 -0.952 . . . . 6.86 109.62 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 40.16 21.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.968 -0.56 . . . . 11.15 112.006 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.95 0.47 85.44 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.764 -0.653 . . . . 13.93 114.296 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -112.88 138.56 49.54 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.44 1.12 . . . . 23.92 111.691 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -78.33 129.42 34.98 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.349 -0.982 . . . . 23.23 108.349 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 mt -86.85 136.4 32.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.827 0.346 . . . . 9.11 111.192 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.406 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 98.9 mt-10 -91.99 149.94 21.26 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.142 -0.481 . . . . 33.44 112.254 -179.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.22 -20.05 65.63 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.493 0.923 . . . . 28.37 113.493 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.48 3.13 68.41 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 121.04 -0.6 . . . . 15.0 113.203 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -110.94 166.21 11.23 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.768 0.784 . . . . 25.5 111.37 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.2 p -107.52 167.38 9.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.568 0.699 . . . . 11.95 112.294 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.06 -42.35 94.3 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.842 -1.072 . . . . 10.17 111.143 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.2 p -61.92 -30.05 70.63 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.613 -0.835 . . . . 13.59 111.777 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -62.39 -28.3 69.68 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.524 -0.47 . . . . 11.7 110.813 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 87.2 m-85 -99.77 14.21 31.05 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 111.6 0.222 . . . . 12.95 111.6 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 50.03 39.8 19.83 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.022 0.378 . . . . 25.45 112.022 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.18 121.73 35.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 107.547 -1.279 . . . . 14.6 107.547 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.4 ' O ' ' OG ' ' A' ' 65' ' ' SER . 96.7 mt-30 -106.64 168.96 8.82 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.294 0.569 . . . . 33.23 112.089 -177.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -51.2 141.31 14.82 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.129 -0.941 . . . . 25.97 111.479 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 66.9 22.96 10.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.085 -0.961 . . . . 32.61 112.667 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 38.2 m -77.6 148.37 35.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.946 -1.131 . . . . 10.56 107.946 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.5 m -111.85 124.47 52.42 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.447 -0.575 . . . . 5.33 109.447 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.44 159.15 15.97 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.511 -1.292 . . . . 11.66 107.511 177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -113.44 132.48 55.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.547 -0.751 . . . . 16.3 109.431 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 tp -105.92 132.48 51.98 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.705 -0.85 . . . . 9.96 108.705 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.02 137.78 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.027 -1.472 . . . . 9.76 107.027 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.7 mt -103.73 137.74 41.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.25 -0.886 . . . . 19.57 110.044 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.544 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 75.1 ttt180 -119.88 139.99 51.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.18 -0.463 . . . . 35.08 109.832 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.8 mt -117.37 173.96 6.4 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.401 -0.363 . . . . 32.31 110.923 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 60.02 82.37 0.16 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.779 -0.646 . . . . 42.75 110.262 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.96 -164.36 32.24 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.038 -0.825 . . . . 36.31 111.038 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.434 ' O ' ' OE1' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.219 -0.801 0 CA-C-O 118.042 -1.421 . . . . 36.2 111.052 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.612 -0.514 . . . . 17.17 109.612 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -98.77 140.85 32.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.251 0.548 . . . . 21.89 110.387 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.9 pt -130.08 167.91 24.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.183 -0.917 . . . . 10.83 109.463 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -124.01 138.77 54.41 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.182 -0.463 . . . . 10.61 111.16 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.54 124.0 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.327 -0.99 . . . . 9.13 108.327 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -99.94 142.7 31.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.854 0.359 . . . . 20.55 110.577 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.7 p -102.27 165.73 10.97 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 122.029 0.918 . . . . 11.78 110.976 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.89 -18.75 64.5 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.65 -1.614 . . . . 19.31 111.214 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.9 p -94.22 2.58 55.9 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.205 0.446 . . . . 23.14 112.205 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.14 14.19 56.43 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.192 -0.528 . . . . 19.74 113.627 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -90.26 143.09 27.09 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.299 -0.56 . . . . 21.93 110.157 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -117.41 127.55 54.14 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.642 -0.873 . . . . 12.33 108.642 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mt -111.84 139.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.825 -0.435 . . . . 17.08 109.825 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.0 m -103.62 131.78 50.45 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 108.571 -0.9 . . . . 16.3 108.571 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -127.53 149.98 49.89 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.577 0.227 . . . . 15.88 110.533 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -102.14 122.21 43.7 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.326 -1.731 . . . . 28.9 106.326 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.01 167.7 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.629 0.728 . . . . 12.05 111.73 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -117.85 151.53 48.86 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.362 -1.347 . . . . 18.17 107.362 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.37 -24.46 74.6 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 CA-C-N 120.911 1.361 . . . . 8.16 112.974 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 t -85.98 -1.88 57.76 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 112.025 0.38 . . . . 11.13 112.025 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -70.79 143.9 51.02 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.832 -1.173 . . . . 18.03 107.832 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.422 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 71.4 p -87.07 157.0 19.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.086 -1.415 . . . . 10.22 109.746 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.5 mm -60.73 -38.57 79.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.392 -0.822 . . . . 12.3 109.497 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -60.08 -39.48 86.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.206 -0.664 . . . . 36.51 109.206 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.422 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 21.9 m120 -64.66 -40.23 95.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.753 -0.779 . . . . 25.66 108.958 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -62.27 -43.82 98.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.25 -0.432 . . . . 8.12 109.936 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 21.5 mttt -59.97 -40.13 88.03 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 109.519 -0.548 . . . . 15.47 109.519 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.94 88.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.831 -0.622 . . . . 11.45 110.436 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -65.6 -38.13 88.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.672 -0.492 . . . . 24.98 109.672 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.3 mt -65.71 -40.37 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.569 -0.53 . . . . 9.46 109.569 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.0 -44.78 94.31 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.331 -0.618 . . . . 14.76 109.331 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -60.26 -39.94 88.58 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.014 -0.994 . . . . 26.29 110.607 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -80.66 -42.32 22.28 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.297 1.221 . . . . 30.06 114.297 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.23 -13.75 13.93 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.272 1.953 . . . . 25.19 116.272 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.3 10.85 84.15 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 120.823 -0.703 . . . . 7.41 113.003 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -85.31 115.73 62.55 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.473 -0.566 . . . . 9.49 109.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.41 134.72 63.19 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 CA-C-N 120.463 1.201 . . . . 11.42 112.384 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.63 -31.06 23.75 Favored 'Trans proline' 0 N--CA 1.506 2.239 0 C-N-CA 122.791 2.327 . . . . 12.0 114.375 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -71.59 -15.48 62.26 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.119 -0.632 . . . . 35.55 111.673 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -100.01 0.7 41.5 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.813 0.301 . . . . 20.52 111.813 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -107.1 139.87 40.83 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.279 1.214 . . . . 7.13 114.279 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -126.47 123.37 37.67 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.501 -1.227 . . . . 36.39 108.109 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.9 mt -106.01 130.1 54.0 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.208 0.528 . . . . 9.55 110.573 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mp -124.06 139.48 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.381 -0.827 . . . . 13.9 110.582 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -138.8 127.58 23.53 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.139 -0.937 . . . . 6.86 109.011 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 39.99 20.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.987 -0.552 . . . . 11.15 111.717 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.17 0.19 88.51 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.356 -0.691 . . . . 13.93 114.648 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -112.63 139.08 48.53 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.708 1.254 . . . . 23.92 111.686 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -78.8 128.72 33.76 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.177 -1.045 . . . . 23.23 108.177 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.25 136.86 32.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.438 -0.346 . . . . 9.11 111.197 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -90.49 149.98 21.98 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.204 0.526 . . . . 33.44 111.81 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 40.5 m-20 -69.01 -20.04 64.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.256 -0.884 . . . . 28.37 113.244 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.76 3.71 71.35 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 121.168 -0.539 . . . . 15.0 112.881 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -110.71 165.42 11.84 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.61 0.705 . . . . 25.5 111.372 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.9 p -106.82 167.16 10.06 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.604 0.716 . . . . 11.95 112.215 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.95 -42.65 94.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.682 -1.145 . . . . 10.17 110.906 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.9 p -61.81 -30.25 70.7 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.723 -0.791 . . . . 13.59 111.881 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -62.34 -28.29 69.65 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.503 -0.479 . . . . 11.7 110.484 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.73 14.61 29.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.648 -0.251 . . . . 12.95 111.619 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 50.02 39.46 19.03 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.797 0.439 . . . . 25.45 112.055 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.43 124.51 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.045 -1.094 . . . . 14.6 108.045 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.411 ' O ' ' OG ' ' A' ' 65' ' ' SER . 97.9 mt-30 -107.02 169.03 8.8 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.34 0.591 . . . . 33.23 112.287 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -51.97 140.76 19.4 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.034 -0.985 . . . . 25.97 112.032 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 67.4 23.92 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.82 -1.082 . . . . 32.61 112.211 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 37.0 m -77.31 150.24 35.25 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.227 -1.027 . . . . 10.56 108.227 176.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -110.6 126.05 54.04 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.248 0.547 . . . . 5.33 110.033 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.21 157.49 17.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.582 -1.266 . . . . 11.66 107.582 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -116.32 131.35 56.97 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.188 -0.671 . . . . 16.3 109.188 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -105.2 131.77 52.25 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.38 -0.6 . . . . 9.96 109.38 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.38 135.71 60.66 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 N-CA-C 107.862 -1.162 . . . . 9.76 107.862 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.2 mt -99.93 130.01 46.07 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.967 -1.015 . . . . 19.57 110.27 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -105.33 74.5 1.1 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.379 -0.373 . . . . 35.08 110.006 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 tp -125.21 16.74 8.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.526 0.679 . . . . 32.31 110.235 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -150.77 159.81 44.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.186 -0.916 . . . . 42.75 110.445 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.26 -44.83 97.6 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.22 -0.752 . . . . 36.31 111.22 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.778 0 CA-C-O 117.986 -1.452 . . . . 36.2 110.879 -179.817 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.455 ' N ' ' O ' ' A' ' 17' ' ' VAL . 6.3 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.633 -0.506 . . . . 17.17 109.633 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -98.65 140.43 32.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.34 0.59 . . . . 21.89 110.585 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 pt -130.15 167.35 25.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.104 -0.953 . . . . 10.83 108.999 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -124.35 139.06 54.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.307 -0.406 . . . . 10.61 111.277 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.62 124.23 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.414 -0.958 . . . . 9.13 108.414 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -100.01 142.56 31.32 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.891 0.377 . . . . 20.55 110.484 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 p -102.41 166.13 10.72 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 122.1 0.952 . . . . 11.78 110.861 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.96 -19.25 65.0 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.548 -1.66 . . . . 19.31 111.534 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -93.79 4.02 54.56 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.142 0.423 . . . . 23.14 112.142 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.7 14.32 58.35 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.215 -0.517 . . . . 19.74 113.617 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -90.45 143.58 26.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.163 -0.615 . . . . 21.93 109.938 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -116.94 127.55 54.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.888 -0.782 . . . . 12.33 108.888 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mt -111.22 138.73 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.798 -0.445 . . . . 17.08 109.798 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.8 m -103.7 131.36 50.93 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.53 -0.915 . . . . 16.3 108.53 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.4 mt -127.04 149.98 49.66 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.553 0.215 . . . . 15.88 110.676 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -102.73 122.44 44.46 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 106.213 -1.773 . . . . 28.9 106.213 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 1' ' ' MET . 34.5 m -139.96 167.85 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.565 0.698 . . . . 12.05 111.79 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -117.55 150.64 47.07 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.142 -1.429 . . . . 18.17 107.142 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.56 -24.86 71.98 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 CA-C-N 120.907 1.36 . . . . 8.16 113.248 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 p -85.03 -0.38 54.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.072 0.397 . . . . 11.13 112.072 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -71.29 142.54 50.49 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.01 -1.108 . . . . 18.03 108.01 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.614 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 74.0 p -86.14 157.55 19.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.449 -1.25 . . . . 10.22 109.903 178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -61.47 -40.05 85.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.807 -0.633 . . . . 12.3 109.585 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -60.17 -36.81 78.43 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.246 -0.65 . . . . 36.51 109.246 177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.614 ' H ' ' HG1' ' A' ' 22' ' ' THR . 54.3 t-20 -67.55 -42.89 81.94 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.356 -0.609 . . . . 25.66 109.356 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.57 -41.31 87.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.435 -0.58 . . . . 8.12 109.435 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 19.2 mttt -60.0 -40.16 88.27 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 109.216 -0.661 . . . . 15.47 109.216 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.62 -38.29 89.62 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.714 -0.676 . . . . 11.45 110.857 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 44.8 mttp -65.13 -39.38 92.96 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.638 -0.425 . . . . 24.98 109.907 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.1 mt -64.67 -40.09 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 109.498 -0.556 . . . . 9.46 109.498 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.95 -43.97 94.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.33 -0.618 . . . . 14.76 109.33 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.77 90.26 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.977 -1.011 . . . . 26.29 110.557 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -81.61 -40.6 22.73 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.582 1.327 . . . . 30.06 114.582 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.64 -14.47 14.04 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 116.286 1.958 . . . . 25.19 116.286 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.78 11.41 82.85 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 121.025 -0.607 . . . . 7.41 113.153 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mt -86.04 117.1 68.11 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 109.585 -0.524 . . . . 9.49 109.585 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.99 135.18 64.89 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 120.479 1.207 . . . . 11.42 111.995 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.72 -31.46 25.68 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.536 2.157 . . . . 12.0 114.501 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.22 -16.07 62.49 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.064 -0.654 . . . . 35.55 111.88 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -99.56 0.82 43.05 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.138 -0.225 . . . . 20.52 111.487 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -105.24 140.01 39.04 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.319 0.859 . . . . 7.13 113.319 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -128.63 120.82 27.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 108.072 -1.084 . . . . 36.39 108.072 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.3 mt -103.21 130.01 50.31 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.382 0.61 . . . . 9.55 111.187 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.43 139.79 50.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.017 -0.992 . . . . 13.9 111.178 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -140.27 130.98 25.74 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.583 -0.735 . . . . 6.86 109.965 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 35.76 10.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.057 0.391 . . . . 11.15 112.057 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.17 -0.56 89.67 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.015 -0.881 . . . . 13.93 115.139 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -112.5 139.91 47.68 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.186 1.493 . . . . 23.92 111.104 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -77.86 127.45 32.4 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.496 -0.927 . . . . 23.23 108.496 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.24 136.25 33.24 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.917 0.389 . . . . 9.11 111.117 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.93 149.9 21.71 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.282 0.563 . . . . 33.44 111.891 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 62.5 m-20 -68.38 -20.08 64.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.219 -0.9 . . . . 28.37 113.027 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.86 3.81 74.46 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 121.222 -0.513 . . . . 15.0 113.144 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -109.21 165.22 11.77 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 117.884 0.842 . . . . 25.5 111.134 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.1 p -106.67 167.35 9.92 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.559 0.695 . . . . 11.95 111.706 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.98 -44.38 94.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.929 -1.032 . . . . 10.17 110.417 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -62.01 -30.21 70.8 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 119.95 -0.7 . . . . 13.59 111.83 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.11 -27.72 69.58 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.37 -0.532 . . . . 11.7 110.218 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.429 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 66.0 m-85 -99.8 14.43 30.33 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.355 -0.384 . . . . 12.95 111.442 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 2.6 p-10 49.8 39.3 17.74 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 122.844 0.458 . . . . 25.45 112.158 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.54 124.04 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.003 -1.11 . . . . 14.6 108.003 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -107.34 169.07 8.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.409 0.623 . . . . 33.23 112.084 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -51.4 141.69 14.98 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.027 -0.988 . . . . 25.97 111.613 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 66.85 23.57 9.97 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.966 -1.015 . . . . 32.61 112.751 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -78.01 149.22 34.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.05 -1.093 . . . . 10.56 108.05 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.4 m -110.64 126.56 54.63 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.293 0.568 . . . . 5.33 109.951 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -103.79 157.21 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.71 -1.219 . . . . 11.66 107.71 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -115.18 131.08 57.04 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.729 -0.841 . . . . 16.3 108.729 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.4 tp -105.42 131.7 52.51 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.76 -0.829 . . . . 9.96 108.76 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.79 148.47 24.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 107.945 -1.131 . . . . 9.76 107.945 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.9 mt -105.24 139.92 39.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.892 -1.049 . . . . 19.57 109.907 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -119.81 137.41 54.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 35.08 109.961 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.9 mt -120.03 139.99 51.68 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.265 -0.425 . . . . 32.31 110.059 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -128.62 129.99 46.66 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.229 -0.441 . . . . 42.75 110.368 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.06 -179.95 44.14 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.88 -0.888 . . . . 36.31 110.88 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.825 0 CA-C-O 118.053 -1.415 . . . . 36.2 111.105 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.597 -0.52 . . . . 17.17 109.597 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -98.77 141.54 31.44 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.322 0.582 . . . . 21.89 110.301 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 pt -129.98 167.9 24.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.218 -0.901 . . . . 10.83 109.452 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -124.49 138.49 54.34 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.15 -0.477 . . . . 10.61 110.937 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.54 124.62 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.836 -0.801 . . . . 9.13 108.836 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -100.78 138.84 37.3 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.895 -0.409 . . . . 20.55 109.895 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -99.01 162.45 13.06 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.368 0.604 . . . . 11.78 110.444 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -64.64 -11.77 38.82 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.947 -1.024 . . . . 19.31 110.704 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -96.62 0.95 50.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.848 0.356 . . . . 23.14 110.879 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.05 11.84 60.93 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 116.07 -0.514 . . . . 19.74 114.23 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -88.99 142.16 27.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.072 -0.651 . . . . 21.93 109.715 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -114.85 127.11 55.52 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 120.366 -0.534 . . . . 12.33 109.627 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mt -110.77 137.9 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.632 -0.507 . . . . 17.08 109.632 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -104.36 130.01 52.24 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.397 -0.964 . . . . 16.3 108.397 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.49 149.8 43.39 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.883 -0.414 . . . . 15.88 109.883 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -102.63 121.53 42.6 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 104.951 -2.24 . . . . 28.9 104.951 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.08 169.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.475 0.655 . . . . 12.05 111.557 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -117.79 149.34 45.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.332 -1.359 . . . . 18.17 107.332 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.38 -24.92 63.12 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 CA-C-N 120.908 1.36 . . . . 8.16 113.201 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 t -85.76 -1.0 56.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.569 -0.287 . . . . 11.13 111.743 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -70.74 143.59 51.21 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.769 -1.197 . . . . 18.03 107.769 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -86.45 157.2 19.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.195 -1.366 . . . . 10.22 109.924 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.7 mm -61.76 -38.83 81.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.76 -0.655 . . . . 12.3 109.398 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -59.96 -37.78 80.55 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.544 -0.91 . . . . 36.51 108.544 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.06 -42.32 89.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.286 -0.635 . . . . 25.66 109.286 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.16 -44.32 98.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.845 -0.428 . . . . 8.12 109.845 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.162 -0.681 . . . . 15.47 109.162 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.86 87.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.692 -0.685 . . . . 11.45 110.612 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -65.08 -39.08 92.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.859 -0.422 . . . . 24.98 109.859 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.9 mt -65.2 -40.02 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 109.836 -0.431 . . . . 9.46 109.836 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -60.0 -44.57 94.45 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.384 0.612 . . . . 14.76 109.654 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.81 -40.4 92.56 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.033 -0.985 . . . . 26.29 111.0 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -81.8 -39.91 23.35 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.031 1.122 . . . . 30.06 114.031 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -111.89 -14.37 13.52 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.089 1.885 . . . . 25.19 116.089 -174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 11.32 82.5 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.867 -0.682 . . . . 7.41 113.472 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.3 mt -86.29 116.94 67.75 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 109.745 -0.465 . . . . 9.49 109.745 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.27 134.53 59.63 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 120.535 1.227 . . . . 11.42 112.243 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.29 -30.11 18.98 Favored 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.693 2.262 . . . . 12.0 114.536 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.26 -16.19 61.92 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.082 -0.647 . . . . 35.55 111.701 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -99.99 1.07 42.21 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.75 0.278 . . . . 20.52 111.75 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -107.16 139.46 41.56 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.851 1.056 . . . . 7.13 113.851 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.616 ' NH2' HH11 ' A' ' 72' ' ' ARG . 88.2 mtt180 -125.95 121.91 34.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.727 -1.124 . . . . 36.39 108.123 176.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.7 mt -105.53 130.3 53.62 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.142 0.496 . . . . 9.55 110.694 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.64 138.25 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.506 -0.77 . . . . 13.9 110.654 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -137.37 126.17 24.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.339 -0.846 . . . . 6.86 109.051 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.47 38.45 14.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.017 -0.538 . . . . 11.15 111.613 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.01 89.49 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.48 -0.622 . . . . 13.93 114.64 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -112.3 138.56 48.85 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.637 1.218 . . . . 23.92 111.886 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -79.45 129.45 34.48 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 107.524 -1.287 . . . . 23.23 107.524 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.7 mt -86.93 136.96 32.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.816 0.341 . . . . 9.11 111.66 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.73 148.66 22.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.166 -0.47 . . . . 33.44 112.113 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -66.44 -22.43 66.21 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.782 1.03 . . . . 28.37 113.782 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.1 2.99 76.25 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 121.117 -0.563 . . . . 15.0 113.364 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -110.07 165.44 11.73 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.895 0.848 . . . . 25.5 111.517 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.0 p -106.96 167.01 10.18 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.547 0.689 . . . . 11.95 111.88 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.7 mt -59.99 -42.85 95.12 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.837 -1.074 . . . . 10.17 110.852 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.6 p -61.61 -30.32 70.62 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 119.804 -0.759 . . . . 13.59 111.956 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.23 -28.96 70.06 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.68 -0.408 . . . . 11.7 110.334 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -99.81 14.21 31.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.34 -0.391 . . . . 12.95 111.645 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 49.98 39.88 19.82 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.84 0.456 . . . . 25.45 112.137 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -81.62 124.73 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.011 -1.107 . . . . 14.6 108.011 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -108.58 169.79 8.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.465 0.65 . . . . 33.23 112.144 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -51.77 141.69 16.53 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.899 -1.046 . . . . 25.97 111.708 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.94 23.07 9.95 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.039 -0.982 . . . . 32.61 112.872 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -77.49 148.53 35.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.993 -1.114 . . . . 10.56 107.993 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.5 m -110.48 126.27 54.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.391 0.615 . . . . 5.33 109.67 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.59 156.79 17.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.61 -1.256 . . . . 11.66 107.61 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -114.83 132.73 56.4 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.149 -0.686 . . . . 16.3 109.149 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 tp -108.2 131.19 54.92 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.469 -0.567 . . . . 9.96 109.469 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.78 132.71 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 N-CA-C 107.351 -1.352 . . . . 9.76 107.351 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.0 mt -102.18 130.19 48.76 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.377 -0.829 . . . . 19.57 111.303 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.616 HH11 ' NH2' ' A' ' 42' ' ' ARG . 80.2 ttt180 -111.68 121.4 45.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.423 -0.584 . . . . 35.08 109.423 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.53 119.72 39.63 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.651 0.262 . . . . 32.31 110.761 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -60.38 -41.15 93.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.17 0.51 . . . . 42.75 110.465 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.02 98.44 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.7 -0.96 . . . . 36.31 110.7 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.72 0 CA-C-O 117.967 -1.463 . . . . 36.2 110.842 -179.848 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.537 -0.542 . . . . 17.170000000000002 109.537 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.425 HE22 ' HB2' ' A' ' 16' ' ' GLU . 67.1 mm-40 -95.83 142.35 28.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.474 0.654 . . . . 21.890000000000001 110.231 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -131.49 165.43 31.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 114.898 -1.046 . . . . 10.83 108.31 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.4 139.94 53.42 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.722 0.296 . . . . 10.609999999999999 111.273 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.87 123.74 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.62 -0.881 . . . . 9.1300000000000008 108.62 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -100.05 142.3 31.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.908 0.385 . . . . 20.550000000000001 110.473 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 p -101.82 166.03 10.88 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 122.085 0.945 . . . . 11.779999999999999 111.064 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.96 -19.61 65.26 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.61 -1.632 . . . . 19.309999999999999 111.209 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -93.34 -0.02 56.77 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.151 0.426 . . . . 23.140000000000001 112.151 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 13.87 52.22 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.173 -0.537 . . . . 19.739999999999998 113.698 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -90.17 144.92 25.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.147 -0.621 . . . . 21.93 109.708 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -117.96 127.87 54.25 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.079 -0.711 . . . . 12.33 109.079 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.56 139.0 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.888 -0.412 . . . . 17.079999999999998 109.888 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.4 m -105.12 132.02 51.87 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.735 -0.839 . . . . 16.300000000000001 108.735 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -127.31 150.3 49.64 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.534 0.207 . . . . 15.880000000000001 110.572 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' HB2' HE22 ' A' ' 2' ' ' GLN . 86.5 tt0 -100.96 122.19 43.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.333 -1.729 . . . . 28.899999999999999 106.333 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.03 168.01 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.615 0.722 . . . . 12.050000000000001 111.859 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -118.5 150.86 48.82 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 107.172 -1.418 . . . . 18.170000000000002 107.172 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.14 -24.24 65.56 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 CA-C-N 120.926 1.366 . . . . 8.1600000000000001 112.695 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 p -85.26 -1.79 57.33 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.062 0.393 . . . . 11.130000000000001 112.062 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -70.46 143.29 51.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.949 -1.13 . . . . 18.030000000000001 107.949 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 71.7 p -86.29 157.2 19.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.238 -1.346 . . . . 10.220000000000001 109.921 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.96 -39.75 84.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.715 -0.675 . . . . 12.300000000000001 109.29 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -38.32 82.18 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.728 -0.842 . . . . 36.509999999999998 108.728 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 7.4 m-20 -66.17 -40.05 90.2 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.168 -0.679 . . . . 25.66 109.168 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.94 -43.73 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.833 -0.432 . . . . 8.1199999999999992 109.833 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.265 -0.643 . . . . 15.470000000000001 109.265 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.85 87.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.748 -0.66 . . . . 11.449999999999999 110.339 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -65.72 -39.0 90.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.748 -0.464 . . . . 24.98 109.748 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -64.98 -39.98 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.642 -0.503 . . . . 9.4600000000000009 109.642 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.08 -44.14 95.0 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.322 -0.622 . . . . 14.76 109.322 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 53.7 t0 -60.35 -40.57 91.19 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.032 -0.985 . . . . 26.289999999999999 110.733 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -81.71 -40.27 23.0 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.371 1.249 . . . . 30.059999999999999 114.371 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.77 -14.94 13.93 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.277 1.954 . . . . 25.190000000000001 116.277 -174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.42 11.15 82.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 120.952 -0.642 . . . . 7.4100000000000001 113.114 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mt -86.43 116.98 67.89 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.751 -0.463 . . . . 9.4900000000000002 109.751 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.83 134.8 62.71 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 CA-C-N 120.417 1.185 . . . . 11.42 112.118 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.36 -31.37 22.84 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 122.631 2.221 . . . . 12.0 114.441 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.03 -16.31 62.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.621 0.646 . . . . 35.549999999999997 112.079 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -99.98 1.78 42.9 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.754 0.279 . . . . 20.52 111.754 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -107.99 139.46 42.58 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.908 1.077 . . . . 7.1299999999999999 113.908 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -126.17 123.94 39.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.745 -1.116 . . . . 36.390000000000001 108.166 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -105.71 130.08 53.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.32 0.581 . . . . 9.5500000000000007 110.899 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.17 138.06 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.214 -0.903 . . . . 13.9 110.533 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -139.31 127.05 21.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.258 -0.883 . . . . 6.8600000000000003 108.887 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 39.16 18.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.068 -0.514 . . . . 11.15 111.429 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.04 0.03 89.12 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.28 -0.733 . . . . 13.93 114.863 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -112.24 139.27 47.92 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.777 1.289 . . . . 23.920000000000002 111.77 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.37 128.98 34.01 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.602 -1.259 . . . . 23.23 107.602 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.7 mt -86.93 136.53 32.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 9.1099999999999994 111.559 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.16 149.91 21.59 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.224 0.535 . . . . 33.439999999999998 112.02 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.83 -20.04 64.29 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.555 0.946 . . . . 28.370000000000001 113.555 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.04 3.48 70.17 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 121.133 -0.556 . . . . 15.0 113.062 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -110.1 165.94 11.35 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 117.639 0.72 . . . . 25.5 111.286 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.1 p -107.55 167.35 10.0 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.536 0.684 . . . . 11.949999999999999 111.976 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.95 -42.94 95.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.843 -1.071 . . . . 10.17 110.986 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.0 p -61.87 -30.31 70.78 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 119.677 -0.809 . . . . 13.59 111.92 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.07 -29.02 70.01 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.687 -0.405 . . . . 11.699999999999999 110.498 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -99.89 13.81 32.58 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.268 -0.424 . . . . 12.949999999999999 111.657 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 50.07 39.98 20.44 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 112.056 0.391 . . . . 25.449999999999999 112.056 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -81.04 121.54 34.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.362 -1.347 . . . . 14.6 107.362 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.49 169.13 8.77 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.324 0.583 . . . . 33.229999999999997 112.042 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -51.14 141.22 14.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.121 -0.945 . . . . 25.969999999999999 111.65 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.74 23.35 10.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.771 -1.104 . . . . 32.609999999999999 112.929 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.9 m -76.83 148.7 36.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.013 -1.106 . . . . 10.56 108.013 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -112.83 124.04 51.69 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.528 -0.545 . . . . 5.3300000000000001 109.528 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.0 mp -105.17 157.41 17.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.626 -1.25 . . . . 11.66 107.626 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -112.25 134.08 54.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.23 -0.655 . . . . 16.300000000000001 109.23 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.5 tp -106.16 132.7 51.92 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.919 -0.771 . . . . 9.9600000000000009 108.919 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.71 144.83 28.35 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 107.609 -1.256 . . . . 9.7599999999999998 107.609 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.3 mt -109.86 139.99 44.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.348 -0.842 . . . . 19.57 110.611 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 . . . . . 0 N--CA 1.464 0.266 0 CA-C-N 115.729 -0.669 . . . . 35.079999999999998 110.032 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.498 -0.556 . . . . 17.170000000000002 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.84 140.99 31.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.334 0.588 . . . . 21.890000000000001 110.165 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 pt -130.24 166.83 26.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.144 -0.935 . . . . 10.83 108.843 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -124.54 139.3 54.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.503 -0.317 . . . . 10.609999999999999 111.01 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.27 124.17 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.597 -0.89 . . . . 9.1300000000000008 108.597 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -101.05 142.13 32.95 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.984 0.421 . . . . 20.550000000000001 110.499 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -103.96 162.58 13.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.716 0.77 . . . . 11.779999999999999 111.076 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.64 -14.46 52.04 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.38 -1.282 . . . . 19.309999999999999 111.768 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -95.72 2.45 53.95 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.734 -0.386 . . . . 23.140000000000001 111.566 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.4 13.67 56.84 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.355 -0.45 . . . . 19.739999999999998 113.919 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -91.17 142.1 28.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.286 -0.566 . . . . 21.93 110.42 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.1 m -116.96 127.56 54.33 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.681 -0.859 . . . . 12.33 108.681 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.3 mt -111.77 138.66 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 110.003 -0.369 . . . . 17.079999999999998 110.003 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -103.18 131.21 50.38 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.931 -0.766 . . . . 16.300000000000001 108.931 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.4 mt -127.19 149.92 49.76 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.703 0.287 . . . . 15.880000000000001 110.926 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.65 122.11 43.77 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.131 -1.803 . . . . 28.899999999999999 106.131 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.94 168.25 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.507 0.67 . . . . 12.050000000000001 111.485 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.81 149.22 44.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 107.227 -1.398 . . . . 18.170000000000002 107.227 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.24 -24.4 59.15 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 120.817 1.327 . . . . 8.1600000000000001 112.844 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 p -85.28 -2.46 58.08 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 116.297 -0.41 . . . . 11.130000000000001 112.016 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.4 142.56 50.31 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.946 -1.131 . . . . 18.030000000000001 107.946 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -86.81 157.83 19.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.49 -1.232 . . . . 10.220000000000001 109.833 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.9 mm -61.27 -39.87 84.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.182 -0.917 . . . . 12.300000000000001 109.982 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.03 -37.63 80.35 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.73 -0.841 . . . . 36.509999999999998 108.73 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 55.2 t-20 -66.4 -42.82 87.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.475 -0.565 . . . . 25.66 109.475 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.5 t -60.61 -41.69 88.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 109.484 -0.562 . . . . 8.1199999999999992 109.484 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.531 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 20.5 mttt -60.03 -39.98 87.79 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.342 -0.614 . . . . 15.470000000000001 109.342 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.25 89.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.755 -0.657 . . . . 11.449999999999999 110.543 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 47.5 mttp -65.21 -39.11 92.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.65 -0.5 . . . . 24.98 109.65 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mt -65.06 -40.05 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.713 -0.477 . . . . 9.4600000000000009 109.713 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.01 -44.07 94.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.389 0.614 . . . . 14.76 109.361 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.83 -40.45 92.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.987 -1.006 . . . . 26.289999999999999 110.938 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -40.98 22.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.149 1.166 . . . . 30.059999999999999 114.149 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -111.12 -14.61 13.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.079 1.881 . . . . 25.190000000000001 116.079 -174.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.14 11.15 82.81 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.94 -0.648 . . . . 7.4100000000000001 113.233 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.73 116.29 65.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 109.594 -0.521 . . . . 9.4900000000000002 109.594 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.79 134.75 62.51 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.099 1.199 . . . . 11.42 112.415 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.46 -32.1 25.76 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 122.778 2.319 . . . . 12.0 114.684 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.8 -15.93 62.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.834 0.743 . . . . 35.549999999999997 112.179 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -100.06 2.45 43.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.765 0.284 . . . . 20.52 111.765 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -107.76 139.22 42.66 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.029 1.122 . . . . 7.1299999999999999 114.029 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.57 124.34 39.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.217 -1.031 . . . . 36.390000000000001 108.217 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.24 131.05 54.61 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.238 0.542 . . . . 9.5500000000000007 110.837 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -123.87 139.45 50.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.289 -0.869 . . . . 13.9 110.456 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -137.69 126.73 24.3 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.382 -0.827 . . . . 6.8600000000000003 108.982 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.43 39.52 16.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.099 -0.5 . . . . 11.15 111.701 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.94 0.01 90.0 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.322 -0.71 . . . . 13.93 114.722 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -112.72 139.03 48.67 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.782 1.291 . . . . 23.920000000000002 111.74 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -78.86 129.67 34.82 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.216 -1.031 . . . . 23.23 108.216 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.02 136.88 32.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.847 0.356 . . . . 9.1099999999999994 111.195 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -90.14 149.48 22.43 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.123 -0.49 . . . . 33.439999999999998 111.521 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.531 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 63.3 m-20 -69.64 -20.07 63.61 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.774 1.028 . . . . 28.370000000000001 113.774 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.25 5.99 68.4 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 120.992 -0.623 . . . . 15.0 112.487 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.31 164.03 13.71 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.18 0.49 . . . . 25.5 111.648 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.1 p -105.57 166.43 10.45 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.624 0.726 . . . . 11.949999999999999 112.519 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.97 -42.03 93.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.643 -1.162 . . . . 10.17 110.687 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.48 -31.08 71.04 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.021 -0.672 . . . . 13.59 111.848 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.99 -28.96 69.93 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.641 -0.424 . . . . 11.699999999999999 110.578 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.06 14.64 28.53 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.653 0.242 . . . . 12.949999999999999 111.653 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 50.01 39.42 18.9 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.944 0.498 . . . . 25.449999999999999 112.173 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -81.45 123.97 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.112 -1.07 . . . . 14.6 108.112 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.0 169.07 8.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.295 0.569 . . . . 33.229999999999997 112.122 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.4 141.41 15.51 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.218 -0.901 . . . . 25.969999999999999 111.489 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 67.03 23.21 9.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.941 -1.027 . . . . 32.609999999999999 112.768 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 m -77.2 149.36 35.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.996 -1.113 . . . . 10.56 107.996 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.2 m -110.61 126.74 54.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.302 0.573 . . . . 5.3300000000000001 109.724 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.93 157.36 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.858 -1.164 . . . . 11.66 107.858 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -115.98 132.25 56.7 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.076 -0.713 . . . . 16.300000000000001 109.076 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -106.85 133.18 51.89 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.787 -0.449 . . . . 9.9600000000000009 109.787 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.45 136.86 57.91 Favored 'Isoleucine or valine' 0 C--N 1.345 0.403 0 N-CA-C 107.931 -1.136 . . . . 9.7599999999999998 107.931 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 71' ' ' LEU . 6.7 mp -102.16 129.84 48.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.301 -0.863 . . . . 19.57 111.564 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 . . . . . 0 N--CA 1.465 0.3 0 N-CA-C 108.942 -0.762 . . . . 35.079999999999998 108.942 178.578 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.641 -0.503 . . . . 17.170000000000002 109.641 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -97.06 140.89 30.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.403 0.62 . . . . 21.890000000000001 110.03 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -130.29 166.37 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.073 -0.967 . . . . 10.83 109.156 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.06 139.44 53.79 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.489 -0.323 . . . . 10.609999999999999 111.447 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.26 124.67 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.685 -0.857 . . . . 9.1300000000000008 108.685 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -100.03 139.99 34.9 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.971 -0.381 . . . . 20.550000000000001 109.971 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -99.96 168.13 10.05 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.211 1.005 . . . . 11.779999999999999 110.703 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.409 HD11 ' H ' ' A' ' 71' ' ' LEU . 72.2 mt -64.42 -20.51 66.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.509 -1.678 . . . . 19.309999999999999 111.043 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -93.77 0.03 56.13 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.353 0.501 . . . . 23.140000000000001 112.353 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.91 14.96 50.83 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.28 -0.486 . . . . 19.739999999999998 113.809 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -90.0 144.15 26.16 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.359 -0.536 . . . . 21.93 109.999 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -118.27 128.68 54.91 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.293 -0.632 . . . . 12.33 109.293 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mt -112.04 138.42 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.962 -0.384 . . . . 17.079999999999998 109.962 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -103.49 131.16 50.84 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.811 -0.811 . . . . 16.300000000000001 108.811 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.2 mt -127.55 150.0 49.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.623 0.249 . . . . 15.880000000000001 110.882 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -100.33 121.93 42.3 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.178 -1.786 . . . . 28.899999999999999 106.178 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -139.94 167.15 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.573 0.702 . . . . 12.050000000000001 111.592 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -118.37 150.01 47.03 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.426 -1.324 . . . . 18.170000000000002 107.426 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -57.9 -24.99 67.52 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 CA-C-N 120.834 1.334 . . . . 8.1600000000000001 113.293 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t -85.84 -1.75 57.56 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.901 0.334 . . . . 11.130000000000001 111.901 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -70.24 143.98 51.98 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.865 -1.161 . . . . 18.030000000000001 107.865 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.8 p -86.81 156.65 19.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.153 -1.385 . . . . 10.220000000000001 109.686 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -60.37 -38.96 79.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.595 -0.729 . . . . 12.300000000000001 109.22 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.98 -39.23 85.01 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.059 -0.719 . . . . 36.509999999999998 109.059 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -65.13 -40.46 94.47 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 119.847 -0.741 . . . . 25.66 109.382 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.68 -43.9 99.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.712 -0.477 . . . . 8.1199999999999992 109.712 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -60.03 -40.0 87.8 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 109.315 -0.624 . . . . 15.470000000000001 109.315 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.12 89.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.861 -0.609 . . . . 11.449999999999999 110.645 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -65.46 -39.19 91.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.716 -0.475 . . . . 24.98 109.716 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.93 -39.97 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.556 -0.535 . . . . 9.4600000000000009 109.556 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.05 -44.14 94.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.451 0.643 . . . . 14.76 109.609 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 -41.16 91.59 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.993 -1.003 . . . . 26.289999999999999 110.545 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -81.92 -40.25 22.6 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.421 1.267 . . . . 30.059999999999999 114.421 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -111.51 -14.27 13.72 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.189 1.922 . . . . 25.190000000000001 116.189 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.94 10.64 84.77 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.892 -0.67 . . . . 7.4100000000000001 113.047 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -84.86 116.86 67.18 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 119.092 -0.48 . . . . 9.4900000000000002 109.793 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.85 140.91 95.42 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 CA-C-N 120.551 1.232 . . . . 11.42 112.519 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.12 -31.71 84.19 Favored 'Trans proline' 0 N--CA 1.51 2.45 0 C-N-CA 122.557 2.172 . . . . 12.0 114.928 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.93 -16.47 62.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.783 0.719 . . . . 35.549999999999997 112.439 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 72' ' ' ARG . 78.4 mm-40 -100.02 2.96 43.89 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.92 0.341 . . . . 20.52 111.92 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -107.79 139.92 41.65 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.743 1.016 . . . . 7.1299999999999999 113.743 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -126.37 122.4 35.27 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.007 -1.109 . . . . 36.390000000000001 108.007 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -105.44 130.4 53.54 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.307 0.575 . . . . 9.5500000000000007 110.629 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.59 137.72 55.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.198 -0.91 . . . . 13.9 110.593 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -138.93 126.95 22.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.051 -0.977 . . . . 6.8600000000000003 108.947 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 38.7 17.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.957 -0.565 . . . . 11.15 111.563 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.32 0.04 89.41 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.432 -0.649 . . . . 13.93 114.547 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -112.44 139.04 48.34 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.589 1.194 . . . . 23.920000000000002 111.827 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -78.48 128.71 33.96 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.755 -1.202 . . . . 23.23 107.755 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -86.52 136.26 33.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.841 0.353 . . . . 9.1099999999999994 111.318 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.8 149.1 21.77 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.103 -0.499 . . . . 33.439999999999998 112.151 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.21 -20.88 65.76 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.572 0.953 . . . . 28.370000000000001 113.572 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.15 2.58 71.8 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 121.101 -0.571 . . . . 15.0 113.28 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -110.88 166.42 11.05 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.834 0.817 . . . . 25.5 111.398 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.437 ' OG1' ' OD2' ' A' ' 58' ' ' ASP . 70.4 p -107.49 167.55 9.86 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.605 0.717 . . . . 11.949999999999999 112.22 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.0 -41.8 92.88 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.504 -1.226 . . . . 10.17 111.029 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -60.8 -31.56 70.95 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 119.832 -0.747 . . . . 13.59 111.871 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' OD2' ' OG1' ' A' ' 55' ' ' THR . 7.2 m-20 -61.78 -29.05 69.88 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.445 -0.502 . . . . 11.699999999999999 111.14 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -99.0 13.31 33.21 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.668 0.247 . . . . 12.949999999999999 111.668 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 50.03 39.98 20.3 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.784 0.434 . . . . 25.449999999999999 112.036 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.6 mt -81.25 122.27 36.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.626 -1.25 . . . . 14.6 107.626 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.402 ' O ' ' OG ' ' A' ' 65' ' ' SER . 94.8 mm-40 -106.91 169.19 8.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.384 0.612 . . . . 33.229999999999997 112.149 -177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -51.39 141.33 15.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.047 -0.979 . . . . 25.969999999999999 111.607 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.86 23.16 10.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.941 -1.027 . . . . 32.609999999999999 112.702 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 37.0 m -77.38 149.15 35.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.041 -1.096 . . . . 10.56 108.041 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -113.6 123.82 50.86 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.62 -0.511 . . . . 5.3300000000000001 109.62 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.1 mp -104.02 158.98 16.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.557 -1.275 . . . . 11.66 107.557 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -114.23 132.95 55.94 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.205 -0.665 . . . . 16.300000000000001 109.205 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.6 tp -107.13 135.2 49.07 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.711 -0.477 . . . . 9.9600000000000009 109.711 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -119.81 139.93 45.52 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 107.476 -1.305 . . . . 9.7599999999999998 107.476 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.409 ' H ' HD11 ' A' ' 8' ' ' LEU . 62.8 mt -104.53 145.19 30.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.073 -0.967 . . . . 19.57 111.526 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.434 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 63.2 mtp180 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 115.394 -0.821 . . . . 35.079999999999998 109.819 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.413 -0.588 . . . . 17.170000000000002 109.413 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -97.86 140.67 31.87 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.402 0.62 . . . . 21.890000000000001 110.403 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.2 pt -130.02 166.97 26.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.067 -0.97 . . . . 10.83 108.851 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 27.4 m-85 -126.36 138.55 53.57 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.357 -0.383 . . . . 10.609999999999999 111.18 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -120.3 125.4 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 109.177 -0.675 . . . . 9.1300000000000008 109.177 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -100.32 140.0 35.19 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.07 -0.345 . . . . 20.550000000000001 110.07 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -102.52 164.19 11.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.965 0.888 . . . . 11.779999999999999 110.764 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -20.01 54.73 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.887 -1.506 . . . . 19.309999999999999 110.809 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.3 p -94.38 5.57 51.37 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.313 0.486 . . . . 23.140000000000001 112.313 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.15 14.07 64.99 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 116.084 -0.507 . . . . 19.739999999999998 113.87 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -89.98 142.29 27.84 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.259 -0.576 . . . . 21.93 110.175 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.5 m -116.67 127.73 54.7 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.913 -0.773 . . . . 12.33 108.913 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 mt -111.45 138.23 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.677 -0.49 . . . . 17.079999999999998 109.677 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -102.25 130.87 49.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.645 -0.872 . . . . 16.300000000000001 108.645 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -127.07 149.36 49.96 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.667 0.27 . . . . 15.880000000000001 110.696 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -101.22 121.61 42.17 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 106.016 -1.846 . . . . 28.899999999999999 106.016 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.01 168.02 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.573 0.702 . . . . 12.050000000000001 111.35 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' CD ' ' N ' ' A' ' 18' ' ' GLU . 16.3 mp0 -117.74 147.85 41.89 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 107.188 -1.412 . . . . 18.170000000000002 107.188 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -55.77 -24.29 45.84 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 CA-C-N 120.785 1.316 . . . . 8.1600000000000001 112.769 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 p -85.02 -0.79 55.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.38 -0.373 . . . . 11.130000000000001 111.965 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -71.06 144.14 50.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.213 -1.032 . . . . 18.030000000000001 108.213 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.7 p -86.42 157.41 19.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.227 -1.352 . . . . 10.220000000000001 110.196 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.3 -40.7 86.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.717 -0.674 . . . . 12.300000000000001 109.881 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.98 -36.7 80.13 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.219 -0.66 . . . . 36.509999999999998 109.219 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -67.58 -44.13 78.94 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.779 -0.452 . . . . 25.66 109.779 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.02 -41.1 85.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.275 -1.009 . . . . 8.1199999999999992 108.275 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HZ2' ' HB2' ' A' ' 27' ' ' LYS . 5.4 mtmp? -60.1 -40.08 88.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.848 -0.427 . . . . 15.470000000000001 109.848 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.03 89.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.255 -0.43 . . . . 11.449999999999999 110.238 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -65.85 -38.46 88.93 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.593 -0.521 . . . . 24.98 109.593 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mt -65.27 -40.22 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.574 -0.528 . . . . 9.4600000000000009 109.574 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -60.02 -43.9 94.97 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.167 -0.679 . . . . 14.76 109.167 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -41.12 91.37 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.911 -1.04 . . . . 26.289999999999999 110.494 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -82.15 -39.45 23.22 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.472 1.286 . . . . 30.059999999999999 114.472 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.86 -15.47 13.35 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.131 1.901 . . . . 25.190000000000001 116.131 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.5 10.78 84.02 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.85 -0.691 . . . . 7.4100000000000001 113.056 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.3 mt -84.66 116.1 63.67 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 109.67 -0.493 . . . . 9.4900000000000002 109.67 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.77 135.87 66.6 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 CA-C-N 120.443 1.194 . . . . 11.42 112.911 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.02 -31.44 44.19 Favored 'Trans proline' 0 N--CA 1.509 2.39 0 C-N-CA 122.777 2.318 . . . . 12.0 115.076 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -71.42 -17.5 62.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.875 0.761 . . . . 35.549999999999997 112.025 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 72' ' ' ARG . 51.3 mm-40 -99.87 1.98 43.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.332 . . . . 20.52 111.279 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -106.86 138.8 42.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.601 0.963 . . . . 7.1299999999999999 113.601 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.496 HH21 ' NH2' ' A' ' 72' ' ' ARG . 94.3 mtt-85 -126.41 122.47 35.4 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.968 -1.123 . . . . 36.390000000000001 107.968 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.5 mt -103.06 129.69 49.95 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.226 0.536 . . . . 9.5500000000000007 110.383 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -127.84 137.54 57.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.313 -0.858 . . . . 13.9 111.571 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -139.0 130.13 26.67 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.361 -0.836 . . . . 6.8600000000000003 109.977 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.18 40.35 21.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.864 -0.607 . . . . 11.15 111.9 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 0.62 85.71 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.73 -0.668 . . . . 13.93 114.109 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -113.36 138.36 50.18 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.572 1.186 . . . . 23.920000000000002 111.855 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -78.5 128.43 33.56 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.482 -0.933 . . . . 23.23 108.482 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.4 mt -87.03 136.68 32.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.825 0.345 . . . . 9.1099999999999994 111.302 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -92.48 150.97 20.45 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.31 0.576 . . . . 33.439999999999998 112.459 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.78 -19.93 64.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.047 -0.979 . . . . 28.370000000000001 113.473 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.95 3.11 70.07 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 121.073 -0.584 . . . . 15.0 113.028 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -110.07 164.63 12.44 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.796 0.798 . . . . 25.5 111.465 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 p -106.76 167.11 10.09 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.62 0.724 . . . . 11.949999999999999 112.011 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.03 -43.52 95.24 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.692 -1.14 . . . . 10.17 110.863 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.9 m -60.34 -32.16 70.99 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 119.943 -0.703 . . . . 13.59 111.956 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.27 -27.89 68.79 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.478 -0.489 . . . . 11.699999999999999 110.829 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -99.98 14.7 29.65 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 111.89 0.33 . . . . 12.949999999999999 111.89 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 60' ' ' ASN . 28.7 t-20 50.05 39.55 19.35 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.81 0.338 . . . . 25.449999999999999 111.839 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.56 122.81 37.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.837 -1.172 . . . . 14.6 107.837 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -108.12 169.4 8.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.341 0.591 . . . . 33.229999999999997 112.279 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -51.59 141.78 15.59 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.066 -0.97 . . . . 25.969999999999999 111.626 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 67.18 23.17 9.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.127 -0.942 . . . . 32.609999999999999 112.455 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.1 m -78.11 148.71 34.06 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.017 -1.105 . . . . 10.56 108.017 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.6 m -110.49 126.11 54.01 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.202 0.525 . . . . 5.3300000000000001 109.896 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.2 158.36 16.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.572 -1.269 . . . . 11.66 107.572 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -116.36 131.62 56.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.709 -0.678 . . . . 16.300000000000001 109.29 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -107.85 133.04 52.79 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.495 -0.557 . . . . 9.9600000000000009 109.495 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.45 138.75 49.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 107.973 -1.121 . . . . 9.7599999999999998 107.973 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.6 mt -100.01 130.03 46.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.635 -1.166 . . . . 19.57 111.28 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.496 ' NH2' HH21 ' A' ' 42' ' ' ARG . 59.2 ttp180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.476 -0.784 . . . . 35.079999999999998 109.826 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.688 -0.486 . . . . 17.170000000000002 109.688 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -98.59 142.2 30.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.29 0.567 . . . . 21.890000000000001 110.358 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -130.22 167.75 24.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.125 -0.943 . . . . 10.83 109.122 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.94 138.89 54.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.395 -0.366 . . . . 10.609999999999999 110.876 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.56 124.64 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.705 -0.85 . . . . 9.1300000000000008 108.705 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -100.02 141.67 32.52 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.832 0.348 . . . . 20.550000000000001 110.419 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -102.08 170.04 8.36 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 122.367 1.08 . . . . 11.779999999999999 111.088 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.44 -21.26 66.63 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.004 -1.907 . . . . 19.309999999999999 111.178 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.9 p -93.6 7.54 44.28 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.481 0.548 . . . . 23.140000000000001 112.481 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.74 64.06 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.101 -0.571 . . . . 19.739999999999998 113.206 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.435 ' HZ3' ' HB3' ' A' ' 11' ' ' LYS . 6.7 ttpm? -90.3 140.58 29.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.506 -0.477 . . . . 21.93 110.088 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -115.27 126.21 54.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.581 -0.896 . . . . 12.33 108.581 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -110.79 138.67 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.891 -0.411 . . . . 17.079999999999998 109.891 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -102.66 131.09 49.68 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.45 -0.944 . . . . 16.300000000000001 108.45 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.8 mt -126.79 148.46 49.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.683 0.278 . . . . 15.880000000000001 110.569 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -103.11 122.24 44.26 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.964 -1.865 . . . . 28.899999999999999 105.964 176.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.408 ' C ' ' OE2' ' A' ' 18' ' ' GLU . 35.7 m -140.08 168.96 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.415 0.626 . . . . 12.050000000000001 111.228 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' OE2' ' C ' ' A' ' 17' ' ' VAL . 1.7 mp0 -116.93 149.24 43.77 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 107.357 -1.349 . . . . 18.170000000000002 107.357 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -57.28 -25.09 63.25 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 CA-C-N 120.912 1.361 . . . . 8.1600000000000001 112.837 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 t -85.69 -1.69 57.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.371 -0.377 . . . . 11.130000000000001 111.715 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -69.99 144.01 52.43 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.714 -1.217 . . . . 18.030000000000001 107.714 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -86.29 156.78 20.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.084 -1.416 . . . . 10.220000000000001 109.898 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -61.27 -39.54 82.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.677 -0.692 . . . . 12.300000000000001 109.242 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.21 -38.06 82.19 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.896 -0.779 . . . . 36.509999999999998 108.896 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -66.41 -42.03 88.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.278 -0.638 . . . . 25.66 109.278 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.35 -42.27 93.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.482 -0.562 . . . . 8.1199999999999992 109.482 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 24.1 mttt -60.0 -40.08 87.96 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.076 -0.713 . . . . 15.470000000000001 109.076 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.55 90.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.763 -0.653 . . . . 11.449999999999999 110.636 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.06 -38.92 92.36 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.428 -0.509 . . . . 24.98 109.91 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -64.94 -40.38 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.631 -0.507 . . . . 9.4600000000000009 109.631 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.92 -44.73 94.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.381 0.61 . . . . 14.76 109.587 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.5 -40.19 90.48 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.941 -1.027 . . . . 26.289999999999999 110.918 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -82.0 -39.72 23.17 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.27 1.211 . . . . 30.059999999999999 114.27 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.29 -15.46 13.61 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.217 1.932 . . . . 25.190000000000001 116.217 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.14 10.96 83.1 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 120.912 -0.661 . . . . 7.4100000000000001 113.115 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.1 mt -85.56 117.12 68.14 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 119.158 -0.449 . . . . 9.4900000000000002 109.832 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.54 133.07 49.51 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 120.528 1.224 . . . . 11.42 112.315 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.32 -30.68 15.67 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 122.851 2.367 . . . . 12.0 114.53 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.88 -16.04 62.12 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.21 -0.596 . . . . 35.549999999999997 111.606 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.04 1.27 42.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.831 0.308 . . . . 20.52 111.831 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -105.91 138.57 41.88 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.586 0.958 . . . . 7.1299999999999999 113.586 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.412 ' HE ' ' HD2' ' A' ' 72' ' ' ARG . 85.1 mtt-85 -125.71 121.66 34.08 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.727 -1.212 . . . . 36.390000000000001 107.727 176.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -104.52 129.97 52.52 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.241 0.543 . . . . 9.5500000000000007 110.842 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -123.71 138.61 52.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.335 -0.848 . . . . 13.9 110.451 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -136.53 126.26 25.56 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.074 -0.966 . . . . 6.8600000000000003 109.049 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.85 39.43 14.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.974 -0.557 . . . . 11.15 111.472 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.72 0.02 89.7 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.302 -0.721 . . . . 13.93 114.772 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -112.92 138.82 49.2 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.856 1.328 . . . . 23.920000000000002 111.872 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -78.61 129.56 34.9 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.421 -0.955 . . . . 23.23 108.421 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.12 136.9 32.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.723 0.297 . . . . 9.1099999999999994 111.197 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.87 150.1 21.67 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.16 0.505 . . . . 33.439999999999998 111.61 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.496 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 39.3 m-20 -69.13 -19.99 64.04 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.631 0.975 . . . . 28.370000000000001 113.631 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.41 4.34 69.86 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 121.055 -0.593 . . . . 15.0 112.824 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -110.78 166.32 11.12 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.512 0.656 . . . . 25.5 111.253 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -107.58 167.33 10.03 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.579 0.704 . . . . 11.949999999999999 112.214 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.0 -42.24 93.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.702 -1.135 . . . . 10.17 111.138 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -61.96 -29.99 70.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 119.725 -0.79 . . . . 13.59 112.025 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.21 -27.98 69.36 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.607 -0.437 . . . . 11.699999999999999 110.822 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -99.7 15.34 27.12 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.625 0.231 . . . . 12.949999999999999 111.625 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 49.78 38.85 16.61 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.768 0.427 . . . . 25.449999999999999 111.861 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.42 124.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.027 -1.101 . . . . 14.6 108.027 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -107.07 168.89 8.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.362 0.601 . . . . 33.229999999999997 112.139 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -51.81 141.46 17.17 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.137 -0.938 . . . . 25.969999999999999 111.821 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 67.01 23.6 9.74 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.949 -1.023 . . . . 32.609999999999999 112.633 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 m -77.01 149.93 35.84 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.064 -1.087 . . . . 10.56 108.064 176.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -110.46 126.19 54.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.228 0.537 . . . . 5.3300000000000001 109.791 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -104.38 156.61 17.78 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.594 -1.261 . . . . 11.66 107.594 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -115.42 131.81 56.81 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.762 -0.829 . . . . 16.300000000000001 108.762 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.3 131.56 53.37 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.349 -0.611 . . . . 9.9600000000000009 109.349 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.72 141.45 41.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 107.651 -1.24 . . . . 9.7599999999999998 107.651 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 73.7 mt -103.48 137.11 42.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.098 -0.956 . . . . 19.57 110.863 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.412 ' HD2' ' HE ' ' A' ' 42' ' ' ARG . 70.0 ttt180 . . . . . 0 N--CA 1.466 0.354 0 CA-C-N 115.971 -0.558 . . . . 35.079999999999998 110.185 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.524 -0.547 . . . . 17.170000000000002 109.524 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -98.1 140.73 31.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.356 0.598 . . . . 21.890000000000001 110.228 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 pt -130.05 167.22 25.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.132 -0.94 . . . . 10.83 109.102 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -125.24 138.33 54.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.228 -0.442 . . . . 10.609999999999999 111.328 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.4 124.83 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.553 -0.906 . . . . 9.1300000000000008 108.553 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -100.35 140.03 35.19 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.676 -0.491 . . . . 20.550000000000001 109.676 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -103.3 163.7 12.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.857 0.837 . . . . 11.779999999999999 110.68 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.87 -16.06 57.27 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.074 -1.421 . . . . 19.309999999999999 111.077 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -95.2 4.35 53.66 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.752 -0.379 . . . . 23.140000000000001 111.759 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.63 14.1 63.98 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 116.17 -0.468 . . . . 19.739999999999998 113.915 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -91.1 143.74 26.38 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.092 -0.643 . . . . 21.93 110.09 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -117.34 127.06 53.68 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.095 -0.705 . . . . 12.33 109.095 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.8 mt -110.81 137.82 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.809 -0.441 . . . . 17.079999999999998 109.809 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -102.78 131.12 49.85 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.796 -0.816 . . . . 16.300000000000001 108.796 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -126.63 148.55 49.79 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.679 0.276 . . . . 15.880000000000001 110.852 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -101.91 121.69 42.61 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 105.948 -1.871 . . . . 28.899999999999999 105.948 176.36 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.533 ' N ' ' OE2' ' A' ' 16' ' ' GLU . 33.8 m -140.74 169.65 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.461 0.648 . . . . 12.050000000000001 111.485 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 18' ' ' GLU . 6.4 mp0 -117.08 147.64 40.66 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 106.772 -1.566 . . . . 18.170000000000002 106.772 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -55.41 -23.37 38.23 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 CA-C-N 120.787 1.317 . . . . 8.1600000000000001 112.515 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -85.82 -0.32 54.99 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.254 0.464 . . . . 11.130000000000001 112.254 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 18' ' ' GLU . 4.1 m-20 -69.53 144.37 53.15 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.028 -1.101 . . . . 18.030000000000001 108.028 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -86.19 157.4 19.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.593 -1.185 . . . . 10.220000000000001 109.628 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.76 -39.99 83.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.597 -0.729 . . . . 12.300000000000001 109.284 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.98 -38.17 81.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.935 -0.765 . . . . 36.509999999999998 108.935 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -66.43 -43.14 86.52 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.411 -0.516 . . . . 25.66 109.72 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.43 -43.1 93.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.506 -0.553 . . . . 8.1199999999999992 109.506 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -60.01 -40.0 87.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 109.405 -0.591 . . . . 15.470000000000001 109.405 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.13 89.33 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.752 -0.658 . . . . 11.449999999999999 110.474 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -64.94 -39.46 93.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.905 -0.405 . . . . 24.98 109.905 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.8 mt -64.41 -39.92 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.686 -0.487 . . . . 9.4600000000000009 109.686 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -60.03 -44.42 94.65 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.306 -0.627 . . . . 14.76 109.306 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.04 -40.69 90.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.133 -0.939 . . . . 26.289999999999999 110.73 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -81.85 -40.34 22.6 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.51 1.3 . . . . 30.059999999999999 114.51 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.61 -13.98 14.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.189 1.922 . . . . 25.190000000000001 116.189 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.48 11.08 83.65 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 120.91 -0.662 . . . . 7.4100000000000001 113.061 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.46 116.93 67.71 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.517 -0.549 . . . . 9.4900000000000002 109.517 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -59.1 133.36 52.67 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 CA-C-N 120.54 1.229 . . . . 11.42 112.411 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.57 -29.94 15.14 Favored 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 122.836 2.357 . . . . 12.0 114.324 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.3 -16.87 61.9 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.208 -0.597 . . . . 35.549999999999997 111.263 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -100.07 -0.01 39.92 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.751 0.31 . . . . 20.52 111.523 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -106.06 138.82 41.58 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.53 0.937 . . . . 7.1299999999999999 113.53 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtt85 -126.9 122.57 35.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.985 -1.007 . . . . 36.390000000000001 108.594 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.6 mt -104.42 129.99 52.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.26 0.552 . . . . 9.5500000000000007 110.193 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mt -127.89 138.37 54.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.266 -0.879 . . . . 13.9 111.274 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -136.77 129.35 30.31 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.685 -0.689 . . . . 6.8600000000000003 110.01 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 40.18 16.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.829 -0.623 . . . . 11.15 111.899 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.93 0.13 89.13 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.28 -0.733 . . . . 13.93 114.607 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -112.4 139.01 48.32 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.848 1.324 . . . . 23.920000000000002 111.425 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -79.31 129.09 34.12 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 107.906 -1.146 . . . . 23.23 107.906 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.6 mt -86.92 136.81 32.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.824 0.345 . . . . 9.1099999999999994 111.453 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -91.4 149.97 21.47 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.056 0.455 . . . . 33.439999999999998 112.059 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -67.98 -20.09 65.0 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.599 0.963 . . . . 28.370000000000001 113.599 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.49 5.36 70.46 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 121.016 -0.611 . . . . 15.0 112.97 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -110.93 165.04 12.18 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.508 0.654 . . . . 25.5 111.456 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.3 p -107.83 167.3 10.07 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.498 0.666 . . . . 11.949999999999999 111.87 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.92 -42.11 93.22 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.85 -1.068 . . . . 10.17 110.898 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.9 m -60.83 -31.76 71.17 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 119.934 -0.706 . . . . 13.59 111.975 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.3 -28.53 69.26 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.641 -0.424 . . . . 11.699999999999999 110.85 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.98 15.2 27.95 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.935 0.346 . . . . 12.949999999999999 111.935 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 m120 49.95 39.66 19.2 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 122.811 0.445 . . . . 25.449999999999999 111.94 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.56 123.03 37.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.109 -1.071 . . . . 14.6 108.109 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -108.67 169.88 8.38 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.267 0.556 . . . . 33.229999999999997 112.238 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -51.66 141.82 15.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.132 -0.94 . . . . 25.969999999999999 111.43 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 66.78 22.57 10.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.013 -0.994 . . . . 32.609999999999999 112.636 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.8 m -77.32 149.25 35.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.952 -1.129 . . . . 10.56 107.952 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -110.26 126.03 53.74 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 121.275 0.559 . . . . 5.3300000000000001 110.054 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -103.65 156.44 17.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.431 -1.322 . . . . 11.66 107.431 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -115.43 131.13 57.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.673 -0.862 . . . . 16.300000000000001 108.673 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.28 133.11 51.48 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.603 -0.518 . . . . 9.9600000000000009 109.603 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.01 129.96 74.83 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 N-CA-C 107.791 -1.189 . . . . 9.7599999999999998 107.791 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.6 mt -100.61 130.1 46.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.588 -1.187 . . . . 19.57 110.967 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.399 -0.593 . . . . 35.079999999999998 109.399 179.299 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.654 -0.499 . . . . 17.170000000000002 109.654 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -97.41 140.66 31.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.41 0.624 . . . . 21.890000000000001 110.067 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -130.25 166.62 27.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.033 -0.985 . . . . 10.83 108.859 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -124.63 139.99 53.36 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.451 -0.341 . . . . 10.609999999999999 111.194 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.97 124.58 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.873 -0.788 . . . . 9.1300000000000008 108.873 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -99.72 140.02 34.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.965 -0.383 . . . . 20.550000000000001 109.965 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -99.82 169.98 8.85 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 122.228 1.014 . . . . 11.779999999999999 110.627 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.5 mt -63.42 -23.9 67.6 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.269 -1.787 . . . . 19.309999999999999 111.161 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -91.54 0.04 57.55 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.765 0.654 . . . . 23.140000000000001 112.765 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.44 15.15 51.76 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.082 -0.58 . . . . 19.739999999999998 113.478 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -89.61 144.87 25.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.699 -0.482 . . . . 21.93 109.699 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -118.4 128.9 55.06 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.626 -0.509 . . . . 12.33 109.626 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -112.02 139.39 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.9 -0.407 . . . . 17.079999999999998 109.9 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -101.03 130.68 47.08 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.699 -0.852 . . . . 16.300000000000001 108.699 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -125.41 147.39 49.2 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 110.043 -0.354 . . . . 15.880000000000001 110.043 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -102.2 121.72 42.78 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 105.753 -1.943 . . . . 28.899999999999999 105.753 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.0 167.75 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.659 0.742 . . . . 12.050000000000001 111.768 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 18' ' ' GLU . 25.4 mp0 -118.66 149.7 46.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 107.418 -1.327 . . . . 18.170000000000002 107.418 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -57.35 -24.73 61.84 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 CA-C-N 120.847 1.338 . . . . 8.1600000000000001 113.103 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 p -85.14 -1.61 57.08 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.003 0.372 . . . . 11.130000000000001 112.003 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.61 142.97 51.64 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.059 -1.089 . . . . 18.030000000000001 108.059 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -86.07 157.77 19.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.444 -1.253 . . . . 10.220000000000001 109.939 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.15 -39.91 84.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 12.300000000000001 109.344 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -60.08 -38.58 83.34 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.912 -0.773 . . . . 36.509999999999998 108.912 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.417 ' HA ' HD21 ' A' ' 25' ' ' ASN . 10.6 m120 -65.68 -39.96 91.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.973 -0.691 . . . . 25.66 109.495 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.79 -43.95 99.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.671 -0.492 . . . . 8.1199999999999992 109.671 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -60.06 -39.93 87.71 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.379 -0.6 . . . . 15.470000000000001 109.379 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.18 89.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.799 -0.637 . . . . 11.449999999999999 110.422 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -64.69 -39.67 94.06 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.702 -0.481 . . . . 24.98 109.702 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.41 HG21 ' OE1' ' A' ' 41' ' ' GLN . 63.4 mt -64.5 -40.08 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.852 -0.425 . . . . 9.4600000000000009 109.852 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -59.96 -44.26 94.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.382 0.61 . . . . 14.76 109.464 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -62.03 -40.2 94.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.099 -0.955 . . . . 26.289999999999999 111.252 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -80.96 -42.37 21.38 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.95 1.093 . . . . 30.059999999999999 113.95 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.35 -11.26 14.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.856 1.799 . . . . 25.190000000000001 115.856 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.74 10.44 85.14 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 120.799 -0.715 . . . . 7.4100000000000001 113.136 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mt -83.77 130.6 54.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.291 -0.633 . . . . 9.4900000000000002 109.291 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.57 133.07 16.78 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.392 1.394 . . . . 11.42 112.2 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.91 -30.66 24.5 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 122.833 2.355 . . . . 12.0 115.084 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 60.8 t0 -71.9 -17.96 62.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.413 0.552 . . . . 35.549999999999997 111.559 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -99.98 -0.02 40.16 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.927 0.343 . . . . 20.52 111.927 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' OE1' HG21 ' A' ' 30' ' ' ILE . 62.7 mt-30 -106.1 139.59 40.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.948 1.092 . . . . 7.1299999999999999 113.948 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -126.28 122.66 36.13 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.469 -1.242 . . . . 36.390000000000001 108.125 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -103.36 129.99 50.56 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.246 0.546 . . . . 9.5500000000000007 110.082 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.36 136.13 61.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.25 -0.887 . . . . 13.9 111.589 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -138.08 128.99 27.04 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.105 -0.952 . . . . 6.8600000000000003 109.62 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 40.16 21.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.968 -0.56 . . . . 11.15 112.006 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.95 0.47 85.44 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.764 -0.653 . . . . 13.93 114.296 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -112.88 138.56 49.54 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.44 1.12 . . . . 23.920000000000002 111.691 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -78.33 129.42 34.98 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.349 -0.982 . . . . 23.23 108.349 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 mt -86.85 136.4 32.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.827 0.346 . . . . 9.1099999999999994 111.192 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.99 149.94 21.26 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.142 -0.481 . . . . 33.439999999999998 112.254 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.22 -20.05 65.63 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.493 0.923 . . . . 28.370000000000001 113.493 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.48 3.13 68.41 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 121.04 -0.6 . . . . 15.0 113.203 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -110.94 166.21 11.23 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.768 0.784 . . . . 25.5 111.37 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.2 p -107.52 167.38 9.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.568 0.699 . . . . 11.949999999999999 112.294 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.06 -42.35 94.3 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.842 -1.072 . . . . 10.17 111.143 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.2 p -61.92 -30.05 70.63 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.613 -0.835 . . . . 13.59 111.777 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -62.39 -28.3 69.68 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.524 -0.47 . . . . 11.699999999999999 110.813 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.77 14.21 31.05 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 111.6 0.222 . . . . 12.949999999999999 111.6 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 50.03 39.8 19.83 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.022 0.378 . . . . 25.449999999999999 112.022 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.18 121.73 35.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 107.547 -1.279 . . . . 14.6 107.547 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -106.64 168.96 8.82 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.294 0.569 . . . . 33.229999999999997 112.089 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -51.2 141.31 14.82 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.129 -0.941 . . . . 25.969999999999999 111.479 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 66.9 22.96 10.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.085 -0.961 . . . . 32.609999999999999 112.667 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 m -77.6 148.37 35.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.946 -1.131 . . . . 10.56 107.946 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.5 m -111.85 124.47 52.42 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.447 -0.575 . . . . 5.3300000000000001 109.447 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.2 mp -104.44 159.15 15.97 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.511 -1.292 . . . . 11.66 107.511 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -113.44 132.48 55.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.547 -0.751 . . . . 16.300000000000001 109.431 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 tp -105.92 132.48 51.98 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.705 -0.85 . . . . 9.9600000000000009 108.705 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.02 137.78 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.027 -1.472 . . . . 9.7599999999999998 107.027 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.7 mt -103.73 137.74 41.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.25 -0.886 . . . . 19.57 110.044 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.18 -0.463 . . . . 35.079999999999998 109.832 -179.864 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.612 -0.514 . . . . 17.170000000000002 109.612 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -98.77 140.85 32.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.251 0.548 . . . . 21.890000000000001 110.387 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.9 pt -130.08 167.91 24.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.183 -0.917 . . . . 10.83 109.463 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -124.01 138.77 54.41 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.182 -0.463 . . . . 10.609999999999999 111.16 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.54 124.0 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.327 -0.99 . . . . 9.1300000000000008 108.327 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -99.94 142.7 31.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.854 0.359 . . . . 20.550000000000001 110.577 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.7 p -102.27 165.73 10.97 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 122.029 0.918 . . . . 11.779999999999999 110.976 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.89 -18.75 64.5 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.65 -1.614 . . . . 19.309999999999999 111.214 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.9 p -94.22 2.58 55.9 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.205 0.446 . . . . 23.140000000000001 112.205 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.14 14.19 56.43 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.192 -0.528 . . . . 19.739999999999998 113.627 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -90.26 143.09 27.09 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.299 -0.56 . . . . 21.93 110.157 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -117.41 127.55 54.14 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.642 -0.873 . . . . 12.33 108.642 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mt -111.84 139.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.825 -0.435 . . . . 17.079999999999998 109.825 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.0 m -103.62 131.78 50.45 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 108.571 -0.9 . . . . 16.300000000000001 108.571 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -127.53 149.98 49.89 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.577 0.227 . . . . 15.880000000000001 110.533 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -102.14 122.21 43.7 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.326 -1.731 . . . . 28.899999999999999 106.326 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.01 167.7 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.629 0.728 . . . . 12.050000000000001 111.73 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -117.85 151.53 48.86 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.362 -1.347 . . . . 18.170000000000002 107.362 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.37 -24.46 74.6 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 CA-C-N 120.911 1.361 . . . . 8.1600000000000001 112.974 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 t -85.98 -1.88 57.76 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 112.025 0.38 . . . . 11.130000000000001 112.025 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -70.79 143.9 51.02 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.832 -1.173 . . . . 18.030000000000001 107.832 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.422 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 71.4 p -87.07 157.0 19.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.086 -1.415 . . . . 10.220000000000001 109.746 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 23' ' ' ILE . 34.5 mm -60.73 -38.57 79.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.392 -0.822 . . . . 12.300000000000001 109.497 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -60.08 -39.48 86.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.206 -0.664 . . . . 36.509999999999998 109.206 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.422 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 21.9 m120 -64.66 -40.23 95.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.753 -0.779 . . . . 25.66 108.958 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -62.27 -43.82 98.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.25 -0.432 . . . . 8.1199999999999992 109.936 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 21.5 mttt -59.97 -40.13 88.03 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 109.519 -0.548 . . . . 15.470000000000001 109.519 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.94 88.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.831 -0.622 . . . . 11.449999999999999 110.436 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -65.6 -38.13 88.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.672 -0.492 . . . . 24.98 109.672 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.3 mt -65.71 -40.37 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.569 -0.53 . . . . 9.4600000000000009 109.569 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.0 -44.78 94.31 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.331 -0.618 . . . . 14.76 109.331 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -60.26 -39.94 88.58 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.014 -0.994 . . . . 26.289999999999999 110.607 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -80.66 -42.32 22.28 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.297 1.221 . . . . 30.059999999999999 114.297 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.23 -13.75 13.93 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.272 1.953 . . . . 25.190000000000001 116.272 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.3 10.85 84.15 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 120.823 -0.703 . . . . 7.4100000000000001 113.003 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -85.31 115.73 62.55 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.473 -0.566 . . . . 9.4900000000000002 109.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.41 134.72 63.19 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 CA-C-N 120.463 1.201 . . . . 11.42 112.384 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.63 -31.06 23.75 Favored 'Trans proline' 0 N--CA 1.506 2.239 0 C-N-CA 122.791 2.327 . . . . 12.0 114.375 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -71.59 -15.48 62.26 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.119 -0.632 . . . . 35.549999999999997 111.673 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -100.01 0.7 41.5 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.813 0.301 . . . . 20.52 111.813 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -107.1 139.87 40.83 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.279 1.214 . . . . 7.1299999999999999 114.279 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -126.47 123.37 37.67 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.501 -1.227 . . . . 36.390000000000001 108.109 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.9 mt -106.01 130.1 54.0 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.208 0.528 . . . . 9.5500000000000007 110.573 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mp -124.06 139.48 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.381 -0.827 . . . . 13.9 110.582 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -138.8 127.58 23.53 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.139 -0.937 . . . . 6.8600000000000003 109.011 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 39.99 20.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.987 -0.552 . . . . 11.15 111.717 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.17 0.19 88.51 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.356 -0.691 . . . . 13.93 114.648 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -112.63 139.08 48.53 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.708 1.254 . . . . 23.920000000000002 111.686 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -78.8 128.72 33.76 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.177 -1.045 . . . . 23.23 108.177 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.25 136.86 32.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.438 -0.346 . . . . 9.1099999999999994 111.197 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -90.49 149.98 21.98 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.204 0.526 . . . . 33.439999999999998 111.81 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 40.5 m-20 -69.01 -20.04 64.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.256 -0.884 . . . . 28.370000000000001 113.244 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.76 3.71 71.35 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 121.168 -0.539 . . . . 15.0 112.881 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -110.71 165.42 11.84 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.61 0.705 . . . . 25.5 111.372 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.9 p -106.82 167.16 10.06 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.604 0.716 . . . . 11.949999999999999 112.215 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.95 -42.65 94.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.682 -1.145 . . . . 10.17 110.906 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.9 p -61.81 -30.25 70.7 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.723 -0.791 . . . . 13.59 111.881 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -62.34 -28.29 69.65 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.503 -0.479 . . . . 11.699999999999999 110.484 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.73 14.61 29.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.648 -0.251 . . . . 12.949999999999999 111.619 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 50.02 39.46 19.03 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.797 0.439 . . . . 25.449999999999999 112.055 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.43 124.51 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.045 -1.094 . . . . 14.6 108.045 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -107.02 169.03 8.8 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.34 0.591 . . . . 33.229999999999997 112.287 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -51.97 140.76 19.4 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.034 -0.985 . . . . 25.969999999999999 112.032 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 67.4 23.92 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.82 -1.082 . . . . 32.609999999999999 112.211 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.0 m -77.31 150.24 35.25 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.227 -1.027 . . . . 10.56 108.227 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -110.6 126.05 54.04 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.248 0.547 . . . . 5.3300000000000001 110.033 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.21 157.49 17.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.582 -1.266 . . . . 11.66 107.582 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -116.32 131.35 56.97 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.188 -0.671 . . . . 16.300000000000001 109.188 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -105.2 131.77 52.25 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.38 -0.6 . . . . 9.9600000000000009 109.38 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.38 135.71 60.66 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 N-CA-C 107.862 -1.162 . . . . 9.7599999999999998 107.862 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.2 mt -99.93 130.01 46.07 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.967 -1.015 . . . . 19.57 110.27 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 116.379 -0.373 . . . . 35.079999999999998 110.006 179.697 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.633 -0.506 . . . . 17.170000000000002 109.633 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -98.65 140.43 32.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.34 0.59 . . . . 21.890000000000001 110.585 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 pt -130.15 167.35 25.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.104 -0.953 . . . . 10.83 108.999 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -124.35 139.06 54.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.307 -0.406 . . . . 10.609999999999999 111.277 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.62 124.23 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.414 -0.958 . . . . 9.1300000000000008 108.414 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -100.01 142.56 31.32 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.891 0.377 . . . . 20.550000000000001 110.484 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 p -102.41 166.13 10.72 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 122.1 0.952 . . . . 11.779999999999999 110.861 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.96 -19.25 65.0 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.548 -1.66 . . . . 19.309999999999999 111.534 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -93.79 4.02 54.56 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.142 0.423 . . . . 23.140000000000001 112.142 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.7 14.32 58.35 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.215 -0.517 . . . . 19.739999999999998 113.617 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -90.45 143.58 26.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.163 -0.615 . . . . 21.93 109.938 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -116.94 127.55 54.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.888 -0.782 . . . . 12.33 108.888 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mt -111.22 138.73 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.798 -0.445 . . . . 17.079999999999998 109.798 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.8 m -103.7 131.36 50.93 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.53 -0.915 . . . . 16.300000000000001 108.53 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.4 mt -127.04 149.98 49.66 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.553 0.215 . . . . 15.880000000000001 110.676 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -102.73 122.44 44.46 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 106.213 -1.773 . . . . 28.899999999999999 106.213 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.96 167.85 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.565 0.698 . . . . 12.050000000000001 111.79 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -117.55 150.64 47.07 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.142 -1.429 . . . . 18.170000000000002 107.142 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.56 -24.86 71.98 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 CA-C-N 120.907 1.36 . . . . 8.1600000000000001 113.248 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 p -85.03 -0.38 54.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.072 0.397 . . . . 11.130000000000001 112.072 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -71.29 142.54 50.49 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.01 -1.108 . . . . 18.030000000000001 108.01 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -86.14 157.55 19.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.449 -1.25 . . . . 10.220000000000001 109.903 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 23' ' ' ILE . 29.0 mm -61.47 -40.05 85.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.807 -0.633 . . . . 12.300000000000001 109.585 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -60.17 -36.81 78.43 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.246 -0.65 . . . . 36.509999999999998 109.246 177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 54.3 t-20 -67.55 -42.89 81.94 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.356 -0.609 . . . . 25.66 109.356 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.57 -41.31 87.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.435 -0.58 . . . . 8.1199999999999992 109.435 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 19.2 mttt -60.0 -40.16 88.27 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 109.216 -0.661 . . . . 15.470000000000001 109.216 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.62 -38.29 89.62 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.714 -0.676 . . . . 11.449999999999999 110.857 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 44.8 mttp -65.13 -39.38 92.96 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.638 -0.425 . . . . 24.98 109.907 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.1 mt -64.67 -40.09 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 109.498 -0.556 . . . . 9.4600000000000009 109.498 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.95 -43.97 94.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.33 -0.618 . . . . 14.76 109.33 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.77 90.26 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.977 -1.011 . . . . 26.289999999999999 110.557 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -81.61 -40.6 22.73 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.582 1.327 . . . . 30.059999999999999 114.582 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.64 -14.47 14.04 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 116.286 1.958 . . . . 25.190000000000001 116.286 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.78 11.41 82.85 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 121.025 -0.607 . . . . 7.4100000000000001 113.153 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mt -86.04 117.1 68.11 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 109.585 -0.524 . . . . 9.4900000000000002 109.585 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.99 135.18 64.89 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 120.479 1.207 . . . . 11.42 111.995 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.72 -31.46 25.68 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.536 2.157 . . . . 12.0 114.501 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.22 -16.07 62.49 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.064 -0.654 . . . . 35.549999999999997 111.88 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -99.56 0.82 43.05 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.138 -0.225 . . . . 20.52 111.487 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -105.24 140.01 39.04 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.319 0.859 . . . . 7.1299999999999999 113.319 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -128.63 120.82 27.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 108.072 -1.084 . . . . 36.390000000000001 108.072 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.3 mt -103.21 130.01 50.31 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.382 0.61 . . . . 9.5500000000000007 111.187 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.43 139.79 50.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.017 -0.992 . . . . 13.9 111.178 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -140.27 130.98 25.74 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.583 -0.735 . . . . 6.8600000000000003 109.965 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 35.76 10.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.057 0.391 . . . . 11.15 112.057 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.17 -0.56 89.67 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.015 -0.881 . . . . 13.93 115.139 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -112.5 139.91 47.68 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.186 1.493 . . . . 23.920000000000002 111.104 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -77.86 127.45 32.4 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.496 -0.927 . . . . 23.23 108.496 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.24 136.25 33.24 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.917 0.389 . . . . 9.1099999999999994 111.117 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.93 149.9 21.71 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.282 0.563 . . . . 33.439999999999998 111.891 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 62.5 m-20 -68.38 -20.08 64.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.219 -0.9 . . . . 28.370000000000001 113.027 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.86 3.81 74.46 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 121.222 -0.513 . . . . 15.0 113.144 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -109.21 165.22 11.77 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 117.884 0.842 . . . . 25.5 111.134 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.1 p -106.67 167.35 9.92 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.559 0.695 . . . . 11.949999999999999 111.706 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.98 -44.38 94.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.929 -1.032 . . . . 10.17 110.417 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -62.01 -30.21 70.8 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 119.95 -0.7 . . . . 13.59 111.83 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.11 -27.72 69.58 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.37 -0.532 . . . . 11.699999999999999 110.218 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.429 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 66.0 m-85 -99.8 14.43 30.33 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.355 -0.384 . . . . 12.949999999999999 111.442 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 60' ' ' ASN . 2.6 p-10 49.8 39.3 17.74 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 122.844 0.458 . . . . 25.449999999999999 112.158 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.54 124.04 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.003 -1.11 . . . . 14.6 108.003 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -107.34 169.07 8.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.409 0.623 . . . . 33.229999999999997 112.084 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -51.4 141.69 14.98 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.027 -0.988 . . . . 25.969999999999999 111.613 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 66.85 23.57 9.97 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.966 -1.015 . . . . 32.609999999999999 112.751 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -78.01 149.22 34.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.05 -1.093 . . . . 10.56 108.05 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.4 m -110.64 126.56 54.63 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.293 0.568 . . . . 5.3300000000000001 109.951 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -103.79 157.21 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.71 -1.219 . . . . 11.66 107.71 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -115.18 131.08 57.04 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.729 -0.841 . . . . 16.300000000000001 108.729 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.4 tp -105.42 131.7 52.51 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.76 -0.829 . . . . 9.9600000000000009 108.76 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.79 148.47 24.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 107.945 -1.131 . . . . 9.7599999999999998 107.945 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.9 mt -105.24 139.92 39.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.892 -1.049 . . . . 19.57 109.907 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 35.079999999999998 109.961 -179.616 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.597 -0.52 . . . . 17.170000000000002 109.597 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -98.77 141.54 31.44 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.322 0.582 . . . . 21.890000000000001 110.301 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 pt -129.98 167.9 24.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.218 -0.901 . . . . 10.83 109.452 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -124.49 138.49 54.34 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.15 -0.477 . . . . 10.609999999999999 110.937 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.54 124.62 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.836 -0.801 . . . . 9.1300000000000008 108.836 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -100.78 138.84 37.3 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.895 -0.409 . . . . 20.550000000000001 109.895 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -99.01 162.45 13.06 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.368 0.604 . . . . 11.779999999999999 110.444 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -64.64 -11.77 38.82 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.947 -1.024 . . . . 19.309999999999999 110.704 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -96.62 0.95 50.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.848 0.356 . . . . 23.140000000000001 110.879 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.05 11.84 60.93 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 116.07 -0.514 . . . . 19.739999999999998 114.23 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -88.99 142.16 27.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.072 -0.651 . . . . 21.93 109.715 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -114.85 127.11 55.52 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 120.366 -0.534 . . . . 12.33 109.627 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mt -110.77 137.9 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.632 -0.507 . . . . 17.079999999999998 109.632 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -104.36 130.01 52.24 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.397 -0.964 . . . . 16.300000000000001 108.397 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.49 149.8 43.39 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.883 -0.414 . . . . 15.880000000000001 109.883 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -102.63 121.53 42.6 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 104.951 -2.24 . . . . 28.899999999999999 104.951 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.08 169.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.475 0.655 . . . . 12.050000000000001 111.557 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -117.79 149.34 45.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.332 -1.359 . . . . 18.170000000000002 107.332 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.38 -24.92 63.12 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 CA-C-N 120.908 1.36 . . . . 8.1600000000000001 113.201 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 t -85.76 -1.0 56.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.569 -0.287 . . . . 11.130000000000001 111.743 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -70.74 143.59 51.21 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.769 -1.197 . . . . 18.030000000000001 107.769 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -86.45 157.2 19.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.195 -1.366 . . . . 10.220000000000001 109.924 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.7 mm -61.76 -38.83 81.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.76 -0.655 . . . . 12.300000000000001 109.398 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -59.96 -37.78 80.55 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.544 -0.91 . . . . 36.509999999999998 108.544 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.06 -42.32 89.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.286 -0.635 . . . . 25.66 109.286 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.16 -44.32 98.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.845 -0.428 . . . . 8.1199999999999992 109.845 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.162 -0.681 . . . . 15.470000000000001 109.162 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.86 87.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.692 -0.685 . . . . 11.449999999999999 110.612 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -65.08 -39.08 92.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.859 -0.422 . . . . 24.98 109.859 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.9 mt -65.2 -40.02 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 109.836 -0.431 . . . . 9.4600000000000009 109.836 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -60.0 -44.57 94.45 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.384 0.612 . . . . 14.76 109.654 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.81 -40.4 92.56 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.033 -0.985 . . . . 26.289999999999999 111.0 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -81.8 -39.91 23.35 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.031 1.122 . . . . 30.059999999999999 114.031 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -111.89 -14.37 13.52 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.089 1.885 . . . . 25.190000000000001 116.089 -174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 11.32 82.5 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.867 -0.682 . . . . 7.4100000000000001 113.472 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.3 mt -86.29 116.94 67.75 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 109.745 -0.465 . . . . 9.4900000000000002 109.745 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.27 134.53 59.63 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 120.535 1.227 . . . . 11.42 112.243 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.29 -30.11 18.98 Favored 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.693 2.262 . . . . 12.0 114.536 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.26 -16.19 61.92 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.082 -0.647 . . . . 35.549999999999997 111.701 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -99.99 1.07 42.21 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.75 0.278 . . . . 20.52 111.75 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -107.16 139.46 41.56 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.851 1.056 . . . . 7.1299999999999999 113.851 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.634 ' NH2' HH11 ' A' ' 72' ' ' ARG . 88.2 mtt180 -125.95 121.91 34.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.727 -1.124 . . . . 36.390000000000001 108.123 176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.7 mt -105.53 130.3 53.62 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.142 0.496 . . . . 9.5500000000000007 110.694 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.64 138.25 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.506 -0.77 . . . . 13.9 110.654 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -137.37 126.17 24.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.339 -0.846 . . . . 6.8600000000000003 109.051 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.47 38.45 14.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.017 -0.538 . . . . 11.15 111.613 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.01 89.49 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.48 -0.622 . . . . 13.93 114.64 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -112.3 138.56 48.85 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.637 1.218 . . . . 23.920000000000002 111.886 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -79.45 129.45 34.48 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 107.524 -1.287 . . . . 23.23 107.524 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.7 mt -86.93 136.96 32.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.816 0.341 . . . . 9.1099999999999994 111.66 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.73 148.66 22.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.166 -0.47 . . . . 33.439999999999998 112.113 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -66.44 -22.43 66.21 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.782 1.03 . . . . 28.370000000000001 113.782 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.1 2.99 76.25 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 121.117 -0.563 . . . . 15.0 113.364 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -110.07 165.44 11.73 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.895 0.848 . . . . 25.5 111.517 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.0 p -106.96 167.01 10.18 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.547 0.689 . . . . 11.949999999999999 111.88 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.7 mt -59.99 -42.85 95.12 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.837 -1.074 . . . . 10.17 110.852 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.6 p -61.61 -30.32 70.62 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 119.804 -0.759 . . . . 13.59 111.956 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.23 -28.96 70.06 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.68 -0.408 . . . . 11.699999999999999 110.334 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -99.81 14.21 31.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.34 -0.391 . . . . 12.949999999999999 111.645 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 49.98 39.88 19.82 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.84 0.456 . . . . 25.449999999999999 112.137 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -81.62 124.73 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.011 -1.107 . . . . 14.6 108.011 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -108.58 169.79 8.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.465 0.65 . . . . 33.229999999999997 112.144 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -51.77 141.69 16.53 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.899 -1.046 . . . . 25.969999999999999 111.708 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.94 23.07 9.95 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.039 -0.982 . . . . 32.609999999999999 112.872 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -77.49 148.53 35.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.993 -1.114 . . . . 10.56 107.993 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.5 m -110.48 126.27 54.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.391 0.615 . . . . 5.3300000000000001 109.67 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.59 156.79 17.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.61 -1.256 . . . . 11.66 107.61 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -114.83 132.73 56.4 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.149 -0.686 . . . . 16.300000000000001 109.149 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 tp -108.2 131.19 54.92 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.469 -0.567 . . . . 9.9600000000000009 109.469 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.78 132.71 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 N-CA-C 107.351 -1.352 . . . . 9.7599999999999998 107.351 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.0 mt -102.18 130.19 48.76 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.377 -0.829 . . . . 19.57 111.303 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.634 HH11 ' NH2' ' A' ' 42' ' ' ARG . 80.2 ttt180 . . . . . 0 N--CA 1.464 0.262 0 N-CA-C 109.423 -0.584 . . . . 35.079999999999998 109.423 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.537 -0.542 . . . . 17.170000000000002 109.537 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.425 HE22 ' HB2' ' A' ' 16' ' ' GLU . 67.1 mm-40 -95.83 142.35 28.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.474 0.654 . . . . 21.890000000000001 110.231 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -131.49 165.43 31.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 114.898 -1.046 . . . . 10.83 108.31 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.4 139.94 53.42 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.722 0.296 . . . . 10.609999999999999 111.273 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.87 123.74 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.62 -0.881 . . . . 9.1300000000000008 108.62 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -100.05 142.3 31.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.908 0.385 . . . . 20.550000000000001 110.473 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 p -101.82 166.03 10.88 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 122.085 0.945 . . . . 11.779999999999999 111.064 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.96 -19.61 65.26 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.61 -1.632 . . . . 19.309999999999999 111.209 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -93.34 -0.02 56.77 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.151 0.426 . . . . 23.140000000000001 112.151 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 13.87 52.22 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.173 -0.537 . . . . 19.739999999999998 113.698 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -90.17 144.92 25.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.147 -0.621 . . . . 21.93 109.708 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -117.96 127.87 54.25 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.079 -0.711 . . . . 12.33 109.079 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.56 139.0 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.888 -0.412 . . . . 17.079999999999998 109.888 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.4 m -105.12 132.02 51.87 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.735 -0.839 . . . . 16.300000000000001 108.735 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -127.31 150.3 49.64 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.534 0.207 . . . . 15.880000000000001 110.572 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' HB2' HE22 ' A' ' 2' ' ' GLN . 86.5 tt0 -100.96 122.19 43.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.333 -1.729 . . . . 28.899999999999999 106.333 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.03 168.01 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.615 0.722 . . . . 12.050000000000001 111.859 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -118.5 150.86 48.82 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 107.172 -1.418 . . . . 18.170000000000002 107.172 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.14 -24.24 65.56 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 CA-C-N 120.926 1.366 . . . . 8.1600000000000001 112.695 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 p -85.26 -1.79 57.33 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.062 0.393 . . . . 11.130000000000001 112.062 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -70.46 143.29 51.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.949 -1.13 . . . . 18.030000000000001 107.949 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 71.7 p -86.29 157.2 19.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.238 -1.346 . . . . 10.220000000000001 109.921 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.96 -39.75 84.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.715 -0.675 . . . . 12.300000000000001 109.29 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -38.32 82.18 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.728 -0.842 . . . . 36.509999999999998 108.728 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 7.4 m-20 -66.17 -40.05 90.2 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.168 -0.679 . . . . 25.66 109.168 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.94 -43.73 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.833 -0.432 . . . . 8.1199999999999992 109.833 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.265 -0.643 . . . . 15.470000000000001 109.265 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.85 87.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.748 -0.66 . . . . 11.449999999999999 110.339 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -65.72 -39.0 90.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.748 -0.464 . . . . 24.98 109.748 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -64.98 -39.98 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.642 -0.503 . . . . 9.4600000000000009 109.642 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.08 -44.14 95.0 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.322 -0.622 . . . . 14.76 109.322 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 53.7 t0 -60.35 -40.57 91.19 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.032 -0.985 . . . . 26.289999999999999 110.733 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -81.71 -40.27 23.0 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.371 1.249 . . . . 30.059999999999999 114.371 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.77 -14.94 13.93 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.277 1.954 . . . . 25.190000000000001 116.277 -174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.42 11.15 82.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 120.952 -0.642 . . . . 7.4100000000000001 113.114 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mt -86.43 116.98 67.89 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.751 -0.463 . . . . 9.4900000000000002 109.751 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.83 134.8 62.71 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 CA-C-N 120.417 1.185 . . . . 11.42 112.118 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.36 -31.37 22.84 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 122.631 2.221 . . . . 12.0 114.441 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.03 -16.31 62.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.621 0.646 . . . . 35.549999999999997 112.079 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -99.98 1.78 42.9 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.754 0.279 . . . . 20.52 111.754 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -107.99 139.46 42.58 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.908 1.077 . . . . 7.1299999999999999 113.908 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -126.17 123.94 39.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.745 -1.116 . . . . 36.390000000000001 108.166 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -105.71 130.08 53.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.32 0.581 . . . . 9.5500000000000007 110.899 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.17 138.06 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.214 -0.903 . . . . 13.9 110.533 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -139.31 127.05 21.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.258 -0.883 . . . . 6.8600000000000003 108.887 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 39.16 18.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.068 -0.514 . . . . 11.15 111.429 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.04 0.03 89.12 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.28 -0.733 . . . . 13.93 114.863 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -112.24 139.27 47.92 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.777 1.289 . . . . 23.920000000000002 111.77 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.37 128.98 34.01 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.602 -1.259 . . . . 23.23 107.602 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.7 mt -86.93 136.53 32.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 9.1099999999999994 111.559 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.16 149.91 21.59 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.224 0.535 . . . . 33.439999999999998 112.02 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.83 -20.04 64.29 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.555 0.946 . . . . 28.370000000000001 113.555 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.04 3.48 70.17 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 121.133 -0.556 . . . . 15.0 113.062 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -110.1 165.94 11.35 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 117.639 0.72 . . . . 25.5 111.286 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.1 p -107.55 167.35 10.0 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.536 0.684 . . . . 11.949999999999999 111.976 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.95 -42.94 95.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.843 -1.071 . . . . 10.17 110.986 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.0 p -61.87 -30.31 70.78 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 119.677 -0.809 . . . . 13.59 111.92 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.07 -29.02 70.01 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.687 -0.405 . . . . 11.699999999999999 110.498 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -99.89 13.81 32.58 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.268 -0.424 . . . . 12.949999999999999 111.657 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 50.07 39.98 20.44 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 112.056 0.391 . . . . 25.449999999999999 112.056 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -81.04 121.54 34.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.362 -1.347 . . . . 14.6 107.362 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.49 169.13 8.77 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.324 0.583 . . . . 33.229999999999997 112.042 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -51.14 141.22 14.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.121 -0.945 . . . . 25.969999999999999 111.65 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.74 23.35 10.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.771 -1.104 . . . . 32.609999999999999 112.929 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.9 m -76.83 148.7 36.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.013 -1.106 . . . . 10.56 108.013 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -112.83 124.04 51.69 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.528 -0.545 . . . . 5.3300000000000001 109.528 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.0 mp -105.17 157.41 17.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.626 -1.25 . . . . 11.66 107.626 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -112.25 134.08 54.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.23 -0.655 . . . . 16.300000000000001 109.23 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.5 tp -106.16 132.7 51.92 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.919 -0.771 . . . . 9.9600000000000009 108.919 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.71 144.83 28.35 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 107.609 -1.256 . . . . 9.7599999999999998 107.609 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.3 mt -109.86 139.99 44.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.348 -0.842 . . . . 19.57 110.611 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -119.2 130.11 55.32 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.729 -0.669 . . . . 35.079999999999998 110.032 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.7 mt -120.04 128.74 53.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.449 -0.341 . . . . 32.310000000000002 110.356 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -69.79 -39.88 76.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 42.75 110.062 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.89 -179.96 44.38 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.787 -0.925 . . . . 36.310000000000002 110.787 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.73 0 CA-C-O 118.002 -1.444 . . . . 36.200000000000003 110.955 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.498 -0.556 . . . . 17.170000000000002 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.84 140.99 31.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.334 0.588 . . . . 21.890000000000001 110.165 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 pt -130.24 166.83 26.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.144 -0.935 . . . . 10.83 108.843 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -124.54 139.3 54.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.503 -0.317 . . . . 10.609999999999999 111.01 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.27 124.17 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.597 -0.89 . . . . 9.1300000000000008 108.597 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -101.05 142.13 32.95 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.984 0.421 . . . . 20.550000000000001 110.499 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -103.96 162.58 13.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.716 0.77 . . . . 11.779999999999999 111.076 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.64 -14.46 52.04 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.38 -1.282 . . . . 19.309999999999999 111.768 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -95.72 2.45 53.95 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.734 -0.386 . . . . 23.140000000000001 111.566 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.4 13.67 56.84 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.355 -0.45 . . . . 19.739999999999998 113.919 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -91.17 142.1 28.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.286 -0.566 . . . . 21.93 110.42 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.1 m -116.96 127.56 54.33 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.681 -0.859 . . . . 12.33 108.681 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.3 mt -111.77 138.66 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 110.003 -0.369 . . . . 17.079999999999998 110.003 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -103.18 131.21 50.38 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.931 -0.766 . . . . 16.300000000000001 108.931 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.4 mt -127.19 149.92 49.76 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.703 0.287 . . . . 15.880000000000001 110.926 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.65 122.11 43.77 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.131 -1.803 . . . . 28.899999999999999 106.131 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.94 168.25 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.507 0.67 . . . . 12.050000000000001 111.485 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.81 149.22 44.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 107.227 -1.398 . . . . 18.170000000000002 107.227 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.24 -24.4 59.15 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 120.817 1.327 . . . . 8.1600000000000001 112.844 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 p -85.28 -2.46 58.08 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 116.297 -0.41 . . . . 11.130000000000001 112.016 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.4 142.56 50.31 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.946 -1.131 . . . . 18.030000000000001 107.946 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -86.81 157.83 19.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.49 -1.232 . . . . 10.220000000000001 109.833 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.9 mm -61.27 -39.87 84.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.182 -0.917 . . . . 12.300000000000001 109.982 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.03 -37.63 80.35 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.73 -0.841 . . . . 36.509999999999998 108.73 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 55.2 t-20 -66.4 -42.82 87.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.475 -0.565 . . . . 25.66 109.475 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.5 t -60.61 -41.69 88.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 109.484 -0.562 . . . . 8.1199999999999992 109.484 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.531 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 20.5 mttt -60.03 -39.98 87.79 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.342 -0.614 . . . . 15.470000000000001 109.342 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.25 89.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.755 -0.657 . . . . 11.449999999999999 110.543 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 47.5 mttp -65.21 -39.11 92.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.65 -0.5 . . . . 24.98 109.65 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mt -65.06 -40.05 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.713 -0.477 . . . . 9.4600000000000009 109.713 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.01 -44.07 94.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.389 0.614 . . . . 14.76 109.361 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.83 -40.45 92.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.987 -1.006 . . . . 26.289999999999999 110.938 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -40.98 22.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.149 1.166 . . . . 30.059999999999999 114.149 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -111.12 -14.61 13.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.079 1.881 . . . . 25.190000000000001 116.079 -174.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.14 11.15 82.81 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.94 -0.648 . . . . 7.4100000000000001 113.233 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.73 116.29 65.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 109.594 -0.521 . . . . 9.4900000000000002 109.594 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.79 134.75 62.51 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.099 1.199 . . . . 11.42 112.415 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.46 -32.1 25.76 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 122.778 2.319 . . . . 12.0 114.684 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.8 -15.93 62.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.834 0.743 . . . . 35.549999999999997 112.179 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -100.06 2.45 43.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.765 0.284 . . . . 20.52 111.765 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -107.76 139.22 42.66 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.029 1.122 . . . . 7.1299999999999999 114.029 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.57 124.34 39.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.217 -1.031 . . . . 36.390000000000001 108.217 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.24 131.05 54.61 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.238 0.542 . . . . 9.5500000000000007 110.837 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -123.87 139.45 50.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.289 -0.869 . . . . 13.9 110.456 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -137.69 126.73 24.3 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.382 -0.827 . . . . 6.8600000000000003 108.982 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.43 39.52 16.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.099 -0.5 . . . . 11.15 111.701 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.94 0.01 90.0 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.322 -0.71 . . . . 13.93 114.722 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -112.72 139.03 48.67 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.782 1.291 . . . . 23.920000000000002 111.74 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -78.86 129.67 34.82 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.216 -1.031 . . . . 23.23 108.216 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.02 136.88 32.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.847 0.356 . . . . 9.1099999999999994 111.195 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -90.14 149.48 22.43 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.123 -0.49 . . . . 33.439999999999998 111.521 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.531 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 63.3 m-20 -69.64 -20.07 63.61 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.774 1.028 . . . . 28.370000000000001 113.774 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.25 5.99 68.4 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 120.992 -0.623 . . . . 15.0 112.487 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.31 164.03 13.71 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.18 0.49 . . . . 25.5 111.648 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.1 p -105.57 166.43 10.45 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.624 0.726 . . . . 11.949999999999999 112.519 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.97 -42.03 93.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.643 -1.162 . . . . 10.17 110.687 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.48 -31.08 71.04 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.021 -0.672 . . . . 13.59 111.848 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.99 -28.96 69.93 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.641 -0.424 . . . . 11.699999999999999 110.578 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.06 14.64 28.53 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.653 0.242 . . . . 12.949999999999999 111.653 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 50.01 39.42 18.9 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.944 0.498 . . . . 25.449999999999999 112.173 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -81.45 123.97 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.112 -1.07 . . . . 14.6 108.112 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.0 169.07 8.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.295 0.569 . . . . 33.229999999999997 112.122 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.4 141.41 15.51 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.218 -0.901 . . . . 25.969999999999999 111.489 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 67.03 23.21 9.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.941 -1.027 . . . . 32.609999999999999 112.768 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 m -77.2 149.36 35.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.996 -1.113 . . . . 10.56 107.996 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.2 m -110.61 126.74 54.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.302 0.573 . . . . 5.3300000000000001 109.724 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.93 157.36 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.858 -1.164 . . . . 11.66 107.858 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -115.98 132.25 56.7 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.076 -0.713 . . . . 16.300000000000001 109.076 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -106.85 133.18 51.89 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.787 -0.449 . . . . 9.9600000000000009 109.787 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.45 136.86 57.91 Favored 'Isoleucine or valine' 0 C--N 1.345 0.403 0 N-CA-C 107.931 -1.136 . . . . 9.7599999999999998 107.931 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 71' ' ' LEU . 6.7 mp -102.16 129.84 48.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.301 -0.863 . . . . 19.57 111.564 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -109.53 120.0 41.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.942 -0.762 . . . . 35.079999999999998 108.942 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.8 mt -104.99 120.99 42.82 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.968 0.413 . . . . 32.310000000000002 111.186 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -64.33 -40.9 96.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 42.75 110.512 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.26 -179.98 43.85 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.306 -0.861 . . . . 36.310000000000002 111.393 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.701 0 CA-C-O 117.976 -1.458 . . . . 36.200000000000003 110.919 179.818 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.641 -0.503 . . . . 17.170000000000002 109.641 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -97.06 140.89 30.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.403 0.62 . . . . 21.890000000000001 110.03 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -130.29 166.37 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.073 -0.967 . . . . 10.83 109.156 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.06 139.44 53.79 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.489 -0.323 . . . . 10.609999999999999 111.447 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.26 124.67 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.685 -0.857 . . . . 9.1300000000000008 108.685 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -100.03 139.99 34.9 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.971 -0.381 . . . . 20.550000000000001 109.971 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -99.96 168.13 10.05 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.211 1.005 . . . . 11.779999999999999 110.703 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.409 HD11 ' H ' ' A' ' 71' ' ' LEU . 72.2 mt -64.42 -20.51 66.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.509 -1.678 . . . . 19.309999999999999 111.043 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -93.77 0.03 56.13 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.353 0.501 . . . . 23.140000000000001 112.353 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.91 14.96 50.83 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.28 -0.486 . . . . 19.739999999999998 113.809 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -90.0 144.15 26.16 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.359 -0.536 . . . . 21.93 109.999 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -118.27 128.68 54.91 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.293 -0.632 . . . . 12.33 109.293 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mt -112.04 138.42 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.962 -0.384 . . . . 17.079999999999998 109.962 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -103.49 131.16 50.84 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.811 -0.811 . . . . 16.300000000000001 108.811 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.2 mt -127.55 150.0 49.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.623 0.249 . . . . 15.880000000000001 110.882 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -100.33 121.93 42.3 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.178 -1.786 . . . . 28.899999999999999 106.178 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -139.94 167.15 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.573 0.702 . . . . 12.050000000000001 111.592 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -118.37 150.01 47.03 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.426 -1.324 . . . . 18.170000000000002 107.426 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -57.9 -24.99 67.52 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 CA-C-N 120.834 1.334 . . . . 8.1600000000000001 113.293 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t -85.84 -1.75 57.56 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.901 0.334 . . . . 11.130000000000001 111.901 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -70.24 143.98 51.98 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.865 -1.161 . . . . 18.030000000000001 107.865 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.8 p -86.81 156.65 19.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.153 -1.385 . . . . 10.220000000000001 109.686 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -60.37 -38.96 79.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.595 -0.729 . . . . 12.300000000000001 109.22 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.98 -39.23 85.01 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.059 -0.719 . . . . 36.509999999999998 109.059 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -65.13 -40.46 94.47 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 119.847 -0.741 . . . . 25.66 109.382 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.68 -43.9 99.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.712 -0.477 . . . . 8.1199999999999992 109.712 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -60.03 -40.0 87.8 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 109.315 -0.624 . . . . 15.470000000000001 109.315 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.12 89.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.861 -0.609 . . . . 11.449999999999999 110.645 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -65.46 -39.19 91.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.716 -0.475 . . . . 24.98 109.716 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.93 -39.97 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.556 -0.535 . . . . 9.4600000000000009 109.556 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.05 -44.14 94.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.451 0.643 . . . . 14.76 109.609 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 -41.16 91.59 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.993 -1.003 . . . . 26.289999999999999 110.545 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -81.92 -40.25 22.6 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.421 1.267 . . . . 30.059999999999999 114.421 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -111.51 -14.27 13.72 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.189 1.922 . . . . 25.190000000000001 116.189 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.94 10.64 84.77 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.892 -0.67 . . . . 7.4100000000000001 113.047 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -84.86 116.86 67.18 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 119.092 -0.48 . . . . 9.4900000000000002 109.793 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.85 140.91 95.42 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 CA-C-N 120.551 1.232 . . . . 11.42 112.519 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.12 -31.71 84.19 Favored 'Trans proline' 0 N--CA 1.51 2.45 0 C-N-CA 122.557 2.172 . . . . 12.0 114.928 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.93 -16.47 62.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.783 0.719 . . . . 35.549999999999997 112.439 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 72' ' ' ARG . 78.4 mm-40 -100.02 2.96 43.89 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.92 0.341 . . . . 20.52 111.92 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -107.79 139.92 41.65 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.743 1.016 . . . . 7.1299999999999999 113.743 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -126.37 122.4 35.27 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.007 -1.109 . . . . 36.390000000000001 108.007 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -105.44 130.4 53.54 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.307 0.575 . . . . 9.5500000000000007 110.629 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.59 137.72 55.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.198 -0.91 . . . . 13.9 110.593 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -138.93 126.95 22.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.051 -0.977 . . . . 6.8600000000000003 108.947 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 38.7 17.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.957 -0.565 . . . . 11.15 111.563 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.32 0.04 89.41 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.432 -0.649 . . . . 13.93 114.547 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -112.44 139.04 48.34 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.589 1.194 . . . . 23.920000000000002 111.827 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -78.48 128.71 33.96 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.755 -1.202 . . . . 23.23 107.755 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -86.52 136.26 33.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.841 0.353 . . . . 9.1099999999999994 111.318 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.8 149.1 21.77 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.103 -0.499 . . . . 33.439999999999998 112.151 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.21 -20.88 65.76 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.572 0.953 . . . . 28.370000000000001 113.572 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.15 2.58 71.8 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 121.101 -0.571 . . . . 15.0 113.28 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -110.88 166.42 11.05 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.834 0.817 . . . . 25.5 111.398 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.437 ' OG1' ' OD2' ' A' ' 58' ' ' ASP . 70.4 p -107.49 167.55 9.86 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.605 0.717 . . . . 11.949999999999999 112.22 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.0 -41.8 92.88 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.504 -1.226 . . . . 10.17 111.029 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -60.8 -31.56 70.95 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 119.832 -0.747 . . . . 13.59 111.871 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' OD2' ' OG1' ' A' ' 55' ' ' THR . 7.2 m-20 -61.78 -29.05 69.88 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.445 -0.502 . . . . 11.699999999999999 111.14 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -99.0 13.31 33.21 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.668 0.247 . . . . 12.949999999999999 111.668 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 50.03 39.98 20.3 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.784 0.434 . . . . 25.449999999999999 112.036 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.6 mt -81.25 122.27 36.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.626 -1.25 . . . . 14.6 107.626 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.402 ' O ' ' OG ' ' A' ' 65' ' ' SER . 94.8 mm-40 -106.91 169.19 8.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.384 0.612 . . . . 33.229999999999997 112.149 -177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -51.39 141.33 15.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.047 -0.979 . . . . 25.969999999999999 111.607 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.86 23.16 10.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.941 -1.027 . . . . 32.609999999999999 112.702 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 37.0 m -77.38 149.15 35.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.041 -1.096 . . . . 10.56 108.041 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -113.6 123.82 50.86 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.62 -0.511 . . . . 5.3300000000000001 109.62 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.1 mp -104.02 158.98 16.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.557 -1.275 . . . . 11.66 107.557 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -114.23 132.95 55.94 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.205 -0.665 . . . . 16.300000000000001 109.205 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.6 tp -107.13 135.2 49.07 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.711 -0.477 . . . . 9.9600000000000009 109.711 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -119.81 139.93 45.52 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 107.476 -1.305 . . . . 9.7599999999999998 107.476 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.409 ' H ' HD11 ' A' ' 8' ' ' LEU . 62.8 mt -104.53 145.19 30.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.073 -0.967 . . . . 19.57 111.526 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.434 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 63.2 mtp180 -119.98 139.9 51.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.394 -0.821 . . . . 35.079999999999998 109.819 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.8 mt -123.16 129.32 51.27 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.98 -0.378 . . . . 32.310000000000002 109.98 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -79.02 -28.15 43.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 42.75 110.668 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.04 -161.79 45.85 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.08 -0.808 . . . . 36.310000000000002 111.08 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.78 0 CA-C-O 117.997 -1.446 . . . . 36.200000000000003 110.921 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.413 -0.588 . . . . 17.170000000000002 109.413 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -97.86 140.67 31.87 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.402 0.62 . . . . 21.890000000000001 110.403 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.2 pt -130.02 166.97 26.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.067 -0.97 . . . . 10.83 108.851 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 27.4 m-85 -126.36 138.55 53.57 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.357 -0.383 . . . . 10.609999999999999 111.18 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -120.3 125.4 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 109.177 -0.675 . . . . 9.1300000000000008 109.177 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -100.32 140.0 35.19 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.07 -0.345 . . . . 20.550000000000001 110.07 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -102.52 164.19 11.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.965 0.888 . . . . 11.779999999999999 110.764 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -20.01 54.73 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.887 -1.506 . . . . 19.309999999999999 110.809 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.3 p -94.38 5.57 51.37 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.313 0.486 . . . . 23.140000000000001 112.313 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.15 14.07 64.99 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 116.084 -0.507 . . . . 19.739999999999998 113.87 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -89.98 142.29 27.84 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.259 -0.576 . . . . 21.93 110.175 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.5 m -116.67 127.73 54.7 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.913 -0.773 . . . . 12.33 108.913 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 mt -111.45 138.23 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.677 -0.49 . . . . 17.079999999999998 109.677 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -102.25 130.87 49.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.645 -0.872 . . . . 16.300000000000001 108.645 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -127.07 149.36 49.96 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.667 0.27 . . . . 15.880000000000001 110.696 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -101.22 121.61 42.17 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 106.016 -1.846 . . . . 28.899999999999999 106.016 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.01 168.02 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.573 0.702 . . . . 12.050000000000001 111.35 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' CD ' ' N ' ' A' ' 18' ' ' GLU . 16.3 mp0 -117.74 147.85 41.89 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 107.188 -1.412 . . . . 18.170000000000002 107.188 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -55.77 -24.29 45.84 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 CA-C-N 120.785 1.316 . . . . 8.1600000000000001 112.769 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 p -85.02 -0.79 55.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.38 -0.373 . . . . 11.130000000000001 111.965 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -71.06 144.14 50.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.213 -1.032 . . . . 18.030000000000001 108.213 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.7 p -86.42 157.41 19.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.227 -1.352 . . . . 10.220000000000001 110.196 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.3 -40.7 86.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.717 -0.674 . . . . 12.300000000000001 109.881 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.98 -36.7 80.13 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.219 -0.66 . . . . 36.509999999999998 109.219 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -67.58 -44.13 78.94 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.779 -0.452 . . . . 25.66 109.779 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.02 -41.1 85.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.275 -1.009 . . . . 8.1199999999999992 108.275 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HZ2' ' HB2' ' A' ' 27' ' ' LYS . 5.4 mtmp? -60.1 -40.08 88.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.848 -0.427 . . . . 15.470000000000001 109.848 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.03 89.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.255 -0.43 . . . . 11.449999999999999 110.238 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -65.85 -38.46 88.93 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.593 -0.521 . . . . 24.98 109.593 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mt -65.27 -40.22 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.574 -0.528 . . . . 9.4600000000000009 109.574 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -60.02 -43.9 94.97 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.167 -0.679 . . . . 14.76 109.167 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -41.12 91.37 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.911 -1.04 . . . . 26.289999999999999 110.494 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -82.15 -39.45 23.22 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.472 1.286 . . . . 30.059999999999999 114.472 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.86 -15.47 13.35 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.131 1.901 . . . . 25.190000000000001 116.131 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.5 10.78 84.02 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.85 -0.691 . . . . 7.4100000000000001 113.056 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.3 mt -84.66 116.1 63.67 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 109.67 -0.493 . . . . 9.4900000000000002 109.67 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.77 135.87 66.6 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 CA-C-N 120.443 1.194 . . . . 11.42 112.911 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.02 -31.44 44.19 Favored 'Trans proline' 0 N--CA 1.509 2.39 0 C-N-CA 122.777 2.318 . . . . 12.0 115.076 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -71.42 -17.5 62.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.875 0.761 . . . . 35.549999999999997 112.025 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 72' ' ' ARG . 51.3 mm-40 -99.87 1.98 43.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.332 . . . . 20.52 111.279 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -106.86 138.8 42.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.601 0.963 . . . . 7.1299999999999999 113.601 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.496 HH21 ' NH2' ' A' ' 72' ' ' ARG . 94.3 mtt-85 -126.41 122.47 35.4 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.968 -1.123 . . . . 36.390000000000001 107.968 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.5 mt -103.06 129.69 49.95 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.226 0.536 . . . . 9.5500000000000007 110.383 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -127.84 137.54 57.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.313 -0.858 . . . . 13.9 111.571 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -139.0 130.13 26.67 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.361 -0.836 . . . . 6.8600000000000003 109.977 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.18 40.35 21.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.864 -0.607 . . . . 11.15 111.9 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 0.62 85.71 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.73 -0.668 . . . . 13.93 114.109 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -113.36 138.36 50.18 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.572 1.186 . . . . 23.920000000000002 111.855 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -78.5 128.43 33.56 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.482 -0.933 . . . . 23.23 108.482 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.4 mt -87.03 136.68 32.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.825 0.345 . . . . 9.1099999999999994 111.302 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -92.48 150.97 20.45 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.31 0.576 . . . . 33.439999999999998 112.459 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.78 -19.93 64.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.047 -0.979 . . . . 28.370000000000001 113.473 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.95 3.11 70.07 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 121.073 -0.584 . . . . 15.0 113.028 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -110.07 164.63 12.44 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.796 0.798 . . . . 25.5 111.465 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 p -106.76 167.11 10.09 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.62 0.724 . . . . 11.949999999999999 112.011 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.03 -43.52 95.24 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.692 -1.14 . . . . 10.17 110.863 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.9 m -60.34 -32.16 70.99 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 119.943 -0.703 . . . . 13.59 111.956 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.27 -27.89 68.79 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.478 -0.489 . . . . 11.699999999999999 110.829 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -99.98 14.7 29.65 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 111.89 0.33 . . . . 12.949999999999999 111.89 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 60' ' ' ASN . 28.7 t-20 50.05 39.55 19.35 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.81 0.338 . . . . 25.449999999999999 111.839 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.56 122.81 37.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.837 -1.172 . . . . 14.6 107.837 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -108.12 169.4 8.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.341 0.591 . . . . 33.229999999999997 112.279 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -51.59 141.78 15.59 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.066 -0.97 . . . . 25.969999999999999 111.626 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 67.18 23.17 9.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.127 -0.942 . . . . 32.609999999999999 112.455 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.1 m -78.11 148.71 34.06 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.017 -1.105 . . . . 10.56 108.017 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.6 m -110.49 126.11 54.01 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.202 0.525 . . . . 5.3300000000000001 109.896 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.2 158.36 16.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.572 -1.269 . . . . 11.66 107.572 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -116.36 131.62 56.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.709 -0.678 . . . . 16.300000000000001 109.29 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -107.85 133.04 52.79 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.495 -0.557 . . . . 9.9600000000000009 109.495 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.45 138.75 49.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 107.973 -1.121 . . . . 9.7599999999999998 107.973 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.6 mt -100.01 130.03 46.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.635 -1.166 . . . . 19.57 111.28 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' NH2' HH21 ' A' ' 42' ' ' ARG . 59.2 ttp180 -106.68 137.09 45.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.476 -0.784 . . . . 35.079999999999998 109.826 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -126.33 144.62 50.74 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.794 0.331 . . . . 32.310000000000002 110.422 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -129.98 130.6 45.24 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.249 -0.432 . . . . 42.75 110.258 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.74 172.55 29.98 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.731 -0.948 . . . . 36.310000000000002 110.731 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.766 0 CA-C-O 117.992 -1.449 . . . . 36.200000000000003 110.977 179.916 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.688 -0.486 . . . . 17.170000000000002 109.688 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -98.59 142.2 30.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.29 0.567 . . . . 21.890000000000001 110.358 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -130.22 167.75 24.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.125 -0.943 . . . . 10.83 109.122 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.94 138.89 54.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.395 -0.366 . . . . 10.609999999999999 110.876 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.56 124.64 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.705 -0.85 . . . . 9.1300000000000008 108.705 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -100.02 141.67 32.52 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.832 0.348 . . . . 20.550000000000001 110.419 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -102.08 170.04 8.36 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 122.367 1.08 . . . . 11.779999999999999 111.088 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.44 -21.26 66.63 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.004 -1.907 . . . . 19.309999999999999 111.178 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.9 p -93.6 7.54 44.28 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.481 0.548 . . . . 23.140000000000001 112.481 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.74 64.06 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.101 -0.571 . . . . 19.739999999999998 113.206 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.435 ' HZ3' ' HB3' ' A' ' 11' ' ' LYS . 6.7 ttpm? -90.3 140.58 29.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.506 -0.477 . . . . 21.93 110.088 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -115.27 126.21 54.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.581 -0.896 . . . . 12.33 108.581 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -110.79 138.67 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.891 -0.411 . . . . 17.079999999999998 109.891 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -102.66 131.09 49.68 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.45 -0.944 . . . . 16.300000000000001 108.45 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.8 mt -126.79 148.46 49.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.683 0.278 . . . . 15.880000000000001 110.569 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -103.11 122.24 44.26 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.964 -1.865 . . . . 28.899999999999999 105.964 176.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.408 ' C ' ' OE2' ' A' ' 18' ' ' GLU . 35.7 m -140.08 168.96 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.415 0.626 . . . . 12.050000000000001 111.228 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' OE2' ' C ' ' A' ' 17' ' ' VAL . 1.7 mp0 -116.93 149.24 43.77 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 107.357 -1.349 . . . . 18.170000000000002 107.357 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -57.28 -25.09 63.25 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 CA-C-N 120.912 1.361 . . . . 8.1600000000000001 112.837 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 t -85.69 -1.69 57.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.371 -0.377 . . . . 11.130000000000001 111.715 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -69.99 144.01 52.43 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.714 -1.217 . . . . 18.030000000000001 107.714 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -86.29 156.78 20.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.084 -1.416 . . . . 10.220000000000001 109.898 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -61.27 -39.54 82.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.677 -0.692 . . . . 12.300000000000001 109.242 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.21 -38.06 82.19 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.896 -0.779 . . . . 36.509999999999998 108.896 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -66.41 -42.03 88.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.278 -0.638 . . . . 25.66 109.278 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.35 -42.27 93.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.482 -0.562 . . . . 8.1199999999999992 109.482 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 24.1 mttt -60.0 -40.08 87.96 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.076 -0.713 . . . . 15.470000000000001 109.076 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.55 90.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.763 -0.653 . . . . 11.449999999999999 110.636 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.06 -38.92 92.36 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.428 -0.509 . . . . 24.98 109.91 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -64.94 -40.38 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.631 -0.507 . . . . 9.4600000000000009 109.631 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -59.92 -44.73 94.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.381 0.61 . . . . 14.76 109.587 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.5 -40.19 90.48 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.941 -1.027 . . . . 26.289999999999999 110.918 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -82.0 -39.72 23.17 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.27 1.211 . . . . 30.059999999999999 114.27 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.29 -15.46 13.61 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.217 1.932 . . . . 25.190000000000001 116.217 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.14 10.96 83.1 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 120.912 -0.661 . . . . 7.4100000000000001 113.115 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.1 mt -85.56 117.12 68.14 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 119.158 -0.449 . . . . 9.4900000000000002 109.832 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.54 133.07 49.51 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 120.528 1.224 . . . . 11.42 112.315 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.32 -30.68 15.67 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 122.851 2.367 . . . . 12.0 114.53 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.88 -16.04 62.12 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.21 -0.596 . . . . 35.549999999999997 111.606 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.04 1.27 42.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.831 0.308 . . . . 20.52 111.831 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -105.91 138.57 41.88 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.586 0.958 . . . . 7.1299999999999999 113.586 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.412 ' HE ' ' HD2' ' A' ' 72' ' ' ARG . 85.1 mtt-85 -125.71 121.66 34.08 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.727 -1.212 . . . . 36.390000000000001 107.727 176.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -104.52 129.97 52.52 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.241 0.543 . . . . 9.5500000000000007 110.842 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -123.71 138.61 52.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.335 -0.848 . . . . 13.9 110.451 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -136.53 126.26 25.56 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.074 -0.966 . . . . 6.8600000000000003 109.049 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.85 39.43 14.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.974 -0.557 . . . . 11.15 111.472 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.72 0.02 89.7 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.302 -0.721 . . . . 13.93 114.772 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -112.92 138.82 49.2 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.856 1.328 . . . . 23.920000000000002 111.872 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -78.61 129.56 34.9 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.421 -0.955 . . . . 23.23 108.421 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.12 136.9 32.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.723 0.297 . . . . 9.1099999999999994 111.197 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.87 150.1 21.67 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.16 0.505 . . . . 33.439999999999998 111.61 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.496 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 39.3 m-20 -69.13 -19.99 64.04 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.631 0.975 . . . . 28.370000000000001 113.631 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.41 4.34 69.86 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 121.055 -0.593 . . . . 15.0 112.824 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -110.78 166.32 11.12 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.512 0.656 . . . . 25.5 111.253 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -107.58 167.33 10.03 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.579 0.704 . . . . 11.949999999999999 112.214 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.0 -42.24 93.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.702 -1.135 . . . . 10.17 111.138 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -61.96 -29.99 70.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 119.725 -0.79 . . . . 13.59 112.025 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.21 -27.98 69.36 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.607 -0.437 . . . . 11.699999999999999 110.822 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -99.7 15.34 27.12 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.625 0.231 . . . . 12.949999999999999 111.625 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.59 ' ND2' ' O ' ' A' ' 60' ' ' ASN . 0.8 OUTLIER 49.78 38.85 16.61 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.768 0.427 . . . . 25.449999999999999 111.861 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.42 124.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.027 -1.101 . . . . 14.6 108.027 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -107.07 168.89 8.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.362 0.601 . . . . 33.229999999999997 112.139 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -51.81 141.46 17.17 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.137 -0.938 . . . . 25.969999999999999 111.821 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 67.01 23.6 9.74 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.949 -1.023 . . . . 32.609999999999999 112.633 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 m -77.01 149.93 35.84 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.064 -1.087 . . . . 10.56 108.064 176.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -110.46 126.19 54.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.228 0.537 . . . . 5.3300000000000001 109.791 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -104.38 156.61 17.78 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.594 -1.261 . . . . 11.66 107.594 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -115.42 131.81 56.81 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.762 -0.829 . . . . 16.300000000000001 108.762 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.3 131.56 53.37 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.349 -0.611 . . . . 9.9600000000000009 109.349 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.72 141.45 41.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 107.651 -1.24 . . . . 9.7599999999999998 107.651 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 73.7 mt -103.48 137.11 42.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.098 -0.956 . . . . 19.57 110.863 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.412 ' HD2' ' HE ' ' A' ' 42' ' ' ARG . 70.0 ttt180 -120.01 134.94 55.1 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.971 -0.558 . . . . 35.079999999999998 110.185 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.0 140.04 51.57 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.21 -0.45 . . . . 32.310000000000002 110.093 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -128.2 129.54 46.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.152 -0.477 . . . . 42.75 110.153 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.33 -178.19 38.63 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.912 -0.875 . . . . 36.310000000000002 110.912 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.803 0 CA-C-O 118.027 -1.429 . . . . 36.200000000000003 110.872 179.802 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.524 -0.547 . . . . 17.170000000000002 109.524 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -98.1 140.73 31.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.356 0.598 . . . . 21.890000000000001 110.228 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 pt -130.05 167.22 25.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.132 -0.94 . . . . 10.83 109.102 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -125.24 138.33 54.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.228 -0.442 . . . . 10.609999999999999 111.328 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.4 124.83 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.553 -0.906 . . . . 9.1300000000000008 108.553 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -100.35 140.03 35.19 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.676 -0.491 . . . . 20.550000000000001 109.676 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -103.3 163.7 12.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.857 0.837 . . . . 11.779999999999999 110.68 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.87 -16.06 57.27 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.074 -1.421 . . . . 19.309999999999999 111.077 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -95.2 4.35 53.66 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.752 -0.379 . . . . 23.140000000000001 111.759 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.63 14.1 63.98 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 116.17 -0.468 . . . . 19.739999999999998 113.915 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -91.1 143.74 26.38 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.092 -0.643 . . . . 21.93 110.09 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -117.34 127.06 53.68 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.095 -0.705 . . . . 12.33 109.095 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.8 mt -110.81 137.82 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.809 -0.441 . . . . 17.079999999999998 109.809 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -102.78 131.12 49.85 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.796 -0.816 . . . . 16.300000000000001 108.796 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -126.63 148.55 49.79 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.679 0.276 . . . . 15.880000000000001 110.852 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -101.91 121.69 42.61 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 105.948 -1.871 . . . . 28.899999999999999 105.948 176.36 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.533 ' N ' ' OE2' ' A' ' 16' ' ' GLU . 33.8 m -140.74 169.65 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.461 0.648 . . . . 12.050000000000001 111.485 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' CD ' ' N ' ' A' ' 18' ' ' GLU . 6.4 mp0 -117.08 147.64 40.66 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 106.772 -1.566 . . . . 18.170000000000002 106.772 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -55.41 -23.37 38.23 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 CA-C-N 120.787 1.317 . . . . 8.1600000000000001 112.515 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -85.82 -0.32 54.99 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.254 0.464 . . . . 11.130000000000001 112.254 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 18' ' ' GLU . 4.1 m-20 -69.53 144.37 53.15 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.028 -1.101 . . . . 18.030000000000001 108.028 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -86.19 157.4 19.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.593 -1.185 . . . . 10.220000000000001 109.628 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.76 -39.99 83.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.597 -0.729 . . . . 12.300000000000001 109.284 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.98 -38.17 81.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.935 -0.765 . . . . 36.509999999999998 108.935 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -66.43 -43.14 86.52 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.411 -0.516 . . . . 25.66 109.72 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.43 -43.1 93.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.506 -0.553 . . . . 8.1199999999999992 109.506 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -60.01 -40.0 87.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 109.405 -0.591 . . . . 15.470000000000001 109.405 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.13 89.33 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.752 -0.658 . . . . 11.449999999999999 110.474 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -64.94 -39.46 93.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.905 -0.405 . . . . 24.98 109.905 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.8 mt -64.41 -39.92 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.686 -0.487 . . . . 9.4600000000000009 109.686 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -60.03 -44.42 94.65 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.306 -0.627 . . . . 14.76 109.306 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.04 -40.69 90.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.133 -0.939 . . . . 26.289999999999999 110.73 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -81.85 -40.34 22.6 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.51 1.3 . . . . 30.059999999999999 114.51 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.61 -13.98 14.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.189 1.922 . . . . 25.190000000000001 116.189 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.48 11.08 83.65 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 120.91 -0.662 . . . . 7.4100000000000001 113.061 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.46 116.93 67.71 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.517 -0.549 . . . . 9.4900000000000002 109.517 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -59.1 133.36 52.67 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 CA-C-N 120.54 1.229 . . . . 11.42 112.411 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.57 -29.94 15.14 Favored 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 122.836 2.357 . . . . 12.0 114.324 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.3 -16.87 61.9 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.208 -0.597 . . . . 35.549999999999997 111.263 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -100.07 -0.01 39.92 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.751 0.31 . . . . 20.52 111.523 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -106.06 138.82 41.58 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.53 0.937 . . . . 7.1299999999999999 113.53 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtt85 -126.9 122.57 35.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.985 -1.007 . . . . 36.390000000000001 108.594 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.6 mt -104.42 129.99 52.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.26 0.552 . . . . 9.5500000000000007 110.193 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mt -127.89 138.37 54.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.266 -0.879 . . . . 13.9 111.274 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -136.77 129.35 30.31 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.685 -0.689 . . . . 6.8600000000000003 110.01 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 40.18 16.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.829 -0.623 . . . . 11.15 111.899 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.93 0.13 89.13 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.28 -0.733 . . . . 13.93 114.607 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -112.4 139.01 48.32 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.848 1.324 . . . . 23.920000000000002 111.425 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -79.31 129.09 34.12 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 107.906 -1.146 . . . . 23.23 107.906 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.6 mt -86.92 136.81 32.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.824 0.345 . . . . 9.1099999999999994 111.453 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -91.4 149.97 21.47 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.056 0.455 . . . . 33.439999999999998 112.059 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -67.98 -20.09 65.0 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.599 0.963 . . . . 28.370000000000001 113.599 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.49 5.36 70.46 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 121.016 -0.611 . . . . 15.0 112.97 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -110.93 165.04 12.18 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.508 0.654 . . . . 25.5 111.456 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.3 p -107.83 167.3 10.07 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.498 0.666 . . . . 11.949999999999999 111.87 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.92 -42.11 93.22 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.85 -1.068 . . . . 10.17 110.898 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.9 m -60.83 -31.76 71.17 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 119.934 -0.706 . . . . 13.59 111.975 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.3 -28.53 69.26 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.641 -0.424 . . . . 11.699999999999999 110.85 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.98 15.2 27.95 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.935 0.346 . . . . 12.949999999999999 111.935 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 m120 49.95 39.66 19.2 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 122.811 0.445 . . . . 25.449999999999999 111.94 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.56 123.03 37.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.109 -1.071 . . . . 14.6 108.109 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -108.67 169.88 8.38 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.267 0.556 . . . . 33.229999999999997 112.238 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -51.66 141.82 15.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.132 -0.94 . . . . 25.969999999999999 111.43 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 66.78 22.57 10.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.013 -0.994 . . . . 32.609999999999999 112.636 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.8 m -77.32 149.25 35.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.952 -1.129 . . . . 10.56 107.952 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -110.26 126.03 53.74 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 121.275 0.559 . . . . 5.3300000000000001 110.054 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -103.65 156.44 17.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.431 -1.322 . . . . 11.66 107.431 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -115.43 131.13 57.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.673 -0.862 . . . . 16.300000000000001 108.673 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.28 133.11 51.48 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.603 -0.518 . . . . 9.9600000000000009 109.603 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.01 129.96 74.83 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 N-CA-C 107.791 -1.189 . . . . 9.7599999999999998 107.791 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.6 mt -100.61 130.1 46.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.588 -1.187 . . . . 19.57 110.967 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.485 ' HG2' ' H ' ' A' ' 74' ' ' ARG . 45.2 ttt180 -108.81 130.11 55.4 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.399 -0.593 . . . . 35.079999999999998 109.399 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 73' ' ' LEU . 7.0 mp -100.97 32.25 3.28 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.01 0.374 . . . . 32.310000000000002 112.01 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.485 ' H ' ' HG2' ' A' ' 72' ' ' ARG . 65.2 ttt-85 -160.78 160.0 30.72 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.967 -0.293 . . . . 42.75 110.576 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.4 ' N ' ' CG ' ' A' ' 74' ' ' ARG . . . 89.97 -9.02 78.69 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.921 -0.871 . . . . 36.310000000000002 110.921 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.736 0 CA-C-O 118.046 -1.419 . . . . 36.200000000000003 110.821 -179.914 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.654 -0.499 . . . . 17.170000000000002 109.654 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -97.41 140.66 31.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.41 0.624 . . . . 21.890000000000001 110.067 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -130.25 166.62 27.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.033 -0.985 . . . . 10.83 108.859 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -124.63 139.99 53.36 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.451 -0.341 . . . . 10.609999999999999 111.194 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.97 124.58 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.873 -0.788 . . . . 9.1300000000000008 108.873 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -99.72 140.02 34.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.965 -0.383 . . . . 20.550000000000001 109.965 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -99.82 169.98 8.85 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 122.228 1.014 . . . . 11.779999999999999 110.627 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.5 mt -63.42 -23.9 67.6 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.269 -1.787 . . . . 19.309999999999999 111.161 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -91.54 0.04 57.55 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.765 0.654 . . . . 23.140000000000001 112.765 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.44 15.15 51.76 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.082 -0.58 . . . . 19.739999999999998 113.478 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -89.61 144.87 25.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.699 -0.482 . . . . 21.93 109.699 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -118.4 128.9 55.06 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.626 -0.509 . . . . 12.33 109.626 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -112.02 139.39 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.9 -0.407 . . . . 17.079999999999998 109.9 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -101.03 130.68 47.08 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.699 -0.852 . . . . 16.300000000000001 108.699 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -125.41 147.39 49.2 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 110.043 -0.354 . . . . 15.880000000000001 110.043 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -102.2 121.72 42.78 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 105.753 -1.943 . . . . 28.899999999999999 105.753 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.0 167.75 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.659 0.742 . . . . 12.050000000000001 111.768 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 18' ' ' GLU . 25.4 mp0 -118.66 149.7 46.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 107.418 -1.327 . . . . 18.170000000000002 107.418 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -57.35 -24.73 61.84 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 CA-C-N 120.847 1.338 . . . . 8.1600000000000001 113.103 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 p -85.14 -1.61 57.08 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.003 0.372 . . . . 11.130000000000001 112.003 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.61 142.97 51.64 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.059 -1.089 . . . . 18.030000000000001 108.059 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -86.07 157.77 19.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.444 -1.253 . . . . 10.220000000000001 109.939 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.15 -39.91 84.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 12.300000000000001 109.344 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -60.08 -38.58 83.34 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.912 -0.773 . . . . 36.509999999999998 108.912 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.417 ' HA ' HD21 ' A' ' 25' ' ' ASN . 10.6 m120 -65.68 -39.96 91.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.973 -0.691 . . . . 25.66 109.495 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.79 -43.95 99.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.671 -0.492 . . . . 8.1199999999999992 109.671 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -60.06 -39.93 87.71 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.379 -0.6 . . . . 15.470000000000001 109.379 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.18 89.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.799 -0.637 . . . . 11.449999999999999 110.422 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -64.69 -39.67 94.06 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.702 -0.481 . . . . 24.98 109.702 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.41 HG21 ' OE1' ' A' ' 41' ' ' GLN . 63.4 mt -64.5 -40.08 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.852 -0.425 . . . . 9.4600000000000009 109.852 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -59.96 -44.26 94.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.382 0.61 . . . . 14.76 109.464 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -62.03 -40.2 94.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.099 -0.955 . . . . 26.289999999999999 111.252 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -80.96 -42.37 21.38 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.95 1.093 . . . . 30.059999999999999 113.95 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.35 -11.26 14.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.856 1.799 . . . . 25.190000000000001 115.856 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.74 10.44 85.14 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 120.799 -0.715 . . . . 7.4100000000000001 113.136 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mt -83.77 130.6 54.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.291 -0.633 . . . . 9.4900000000000002 109.291 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.57 133.07 16.78 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.392 1.394 . . . . 11.42 112.2 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.91 -30.66 24.5 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 122.833 2.355 . . . . 12.0 115.084 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 60.8 t0 -71.9 -17.96 62.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.413 0.552 . . . . 35.549999999999997 111.559 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 72' ' ' ARG . 16.1 mm100 -99.98 -0.02 40.16 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.927 0.343 . . . . 20.52 111.927 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' OE1' HG21 ' A' ' 30' ' ' ILE . 62.7 mt-30 -106.1 139.59 40.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.948 1.092 . . . . 7.1299999999999999 113.948 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -126.28 122.66 36.13 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.469 -1.242 . . . . 36.390000000000001 108.125 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -103.36 129.99 50.56 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.246 0.546 . . . . 9.5500000000000007 110.082 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.36 136.13 61.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.25 -0.887 . . . . 13.9 111.589 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -138.08 128.99 27.04 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.105 -0.952 . . . . 6.8600000000000003 109.62 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 40.16 21.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.968 -0.56 . . . . 11.15 112.006 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.95 0.47 85.44 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.764 -0.653 . . . . 13.93 114.296 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -112.88 138.56 49.54 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.44 1.12 . . . . 23.920000000000002 111.691 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -78.33 129.42 34.98 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.349 -0.982 . . . . 23.23 108.349 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 mt -86.85 136.4 32.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.827 0.346 . . . . 9.1099999999999994 111.192 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.99 149.94 21.26 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.142 -0.481 . . . . 33.439999999999998 112.254 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.22 -20.05 65.63 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.493 0.923 . . . . 28.370000000000001 113.493 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.48 3.13 68.41 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 121.04 -0.6 . . . . 15.0 113.203 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -110.94 166.21 11.23 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.768 0.784 . . . . 25.5 111.37 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.2 p -107.52 167.38 9.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.568 0.699 . . . . 11.949999999999999 112.294 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.06 -42.35 94.3 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.842 -1.072 . . . . 10.17 111.143 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.2 p -61.92 -30.05 70.63 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.613 -0.835 . . . . 13.59 111.777 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -62.39 -28.3 69.68 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.524 -0.47 . . . . 11.699999999999999 110.813 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.77 14.21 31.05 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 111.6 0.222 . . . . 12.949999999999999 111.6 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 50.03 39.8 19.83 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.022 0.378 . . . . 25.449999999999999 112.022 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.18 121.73 35.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 107.547 -1.279 . . . . 14.6 107.547 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -106.64 168.96 8.82 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.294 0.569 . . . . 33.229999999999997 112.089 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -51.2 141.31 14.82 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.129 -0.941 . . . . 25.969999999999999 111.479 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 66.9 22.96 10.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.085 -0.961 . . . . 32.609999999999999 112.667 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 m -77.6 148.37 35.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.946 -1.131 . . . . 10.56 107.946 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.5 m -111.85 124.47 52.42 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.447 -0.575 . . . . 5.3300000000000001 109.447 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.2 mp -104.44 159.15 15.97 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.511 -1.292 . . . . 11.66 107.511 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -113.44 132.48 55.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.547 -0.751 . . . . 16.300000000000001 109.431 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 tp -105.92 132.48 51.98 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.705 -0.85 . . . . 9.9600000000000009 108.705 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.02 137.78 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.027 -1.472 . . . . 9.7599999999999998 107.027 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.7 mt -103.73 137.74 41.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.25 -0.886 . . . . 19.57 110.044 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.544 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 75.1 ttt180 -119.88 139.99 51.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.18 -0.463 . . . . 35.079999999999998 109.832 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.8 mt -117.37 173.96 6.4 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.401 -0.363 . . . . 32.310000000000002 110.923 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 60.02 82.37 0.16 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.779 -0.646 . . . . 42.75 110.262 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.96 -164.36 32.24 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.038 -0.825 . . . . 36.310000000000002 111.038 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.434 ' O ' ' OE1' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.219 -0.801 0 CA-C-O 118.042 -1.421 . . . . 36.200000000000003 111.052 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.612 -0.514 . . . . 17.170000000000002 109.612 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -98.77 140.85 32.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.251 0.548 . . . . 21.890000000000001 110.387 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.9 pt -130.08 167.91 24.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.183 -0.917 . . . . 10.83 109.463 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -124.01 138.77 54.41 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.182 -0.463 . . . . 10.609999999999999 111.16 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.54 124.0 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.327 -0.99 . . . . 9.1300000000000008 108.327 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -99.94 142.7 31.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.854 0.359 . . . . 20.550000000000001 110.577 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.7 p -102.27 165.73 10.97 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 122.029 0.918 . . . . 11.779999999999999 110.976 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.89 -18.75 64.5 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.65 -1.614 . . . . 19.309999999999999 111.214 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.9 p -94.22 2.58 55.9 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.205 0.446 . . . . 23.140000000000001 112.205 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.14 14.19 56.43 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.192 -0.528 . . . . 19.739999999999998 113.627 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -90.26 143.09 27.09 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.299 -0.56 . . . . 21.93 110.157 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -117.41 127.55 54.14 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.642 -0.873 . . . . 12.33 108.642 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mt -111.84 139.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.825 -0.435 . . . . 17.079999999999998 109.825 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.0 m -103.62 131.78 50.45 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 108.571 -0.9 . . . . 16.300000000000001 108.571 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -127.53 149.98 49.89 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.577 0.227 . . . . 15.880000000000001 110.533 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -102.14 122.21 43.7 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.326 -1.731 . . . . 28.899999999999999 106.326 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.01 167.7 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.629 0.728 . . . . 12.050000000000001 111.73 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -117.85 151.53 48.86 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.362 -1.347 . . . . 18.170000000000002 107.362 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.37 -24.46 74.6 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 CA-C-N 120.911 1.361 . . . . 8.1600000000000001 112.974 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 t -85.98 -1.88 57.76 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 112.025 0.38 . . . . 11.130000000000001 112.025 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -70.79 143.9 51.02 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.832 -1.173 . . . . 18.030000000000001 107.832 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.422 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 71.4 p -87.07 157.0 19.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.086 -1.415 . . . . 10.220000000000001 109.746 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 23' ' ' ILE . 34.5 mm -60.73 -38.57 79.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.392 -0.822 . . . . 12.300000000000001 109.497 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -60.08 -39.48 86.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.206 -0.664 . . . . 36.509999999999998 109.206 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.422 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 21.9 m120 -64.66 -40.23 95.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.753 -0.779 . . . . 25.66 108.958 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -62.27 -43.82 98.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.25 -0.432 . . . . 8.1199999999999992 109.936 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 21.5 mttt -59.97 -40.13 88.03 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 109.519 -0.548 . . . . 15.470000000000001 109.519 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.94 88.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.831 -0.622 . . . . 11.449999999999999 110.436 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -65.6 -38.13 88.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.672 -0.492 . . . . 24.98 109.672 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.3 mt -65.71 -40.37 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.569 -0.53 . . . . 9.4600000000000009 109.569 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.0 -44.78 94.31 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.331 -0.618 . . . . 14.76 109.331 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -60.26 -39.94 88.58 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.014 -0.994 . . . . 26.289999999999999 110.607 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -80.66 -42.32 22.28 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.297 1.221 . . . . 30.059999999999999 114.297 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.23 -13.75 13.93 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.272 1.953 . . . . 25.190000000000001 116.272 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.3 10.85 84.15 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 120.823 -0.703 . . . . 7.4100000000000001 113.003 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -85.31 115.73 62.55 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.473 -0.566 . . . . 9.4900000000000002 109.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.41 134.72 63.19 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 CA-C-N 120.463 1.201 . . . . 11.42 112.384 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.63 -31.06 23.75 Favored 'Trans proline' 0 N--CA 1.506 2.239 0 C-N-CA 122.791 2.327 . . . . 12.0 114.375 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -71.59 -15.48 62.26 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.119 -0.632 . . . . 35.549999999999997 111.673 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -100.01 0.7 41.5 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.813 0.301 . . . . 20.52 111.813 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -107.1 139.87 40.83 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.279 1.214 . . . . 7.1299999999999999 114.279 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -126.47 123.37 37.67 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.501 -1.227 . . . . 36.390000000000001 108.109 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.9 mt -106.01 130.1 54.0 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.208 0.528 . . . . 9.5500000000000007 110.573 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mp -124.06 139.48 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.381 -0.827 . . . . 13.9 110.582 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -138.8 127.58 23.53 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.139 -0.937 . . . . 6.8600000000000003 109.011 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 39.99 20.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.987 -0.552 . . . . 11.15 111.717 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.17 0.19 88.51 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.356 -0.691 . . . . 13.93 114.648 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -112.63 139.08 48.53 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.708 1.254 . . . . 23.920000000000002 111.686 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -78.8 128.72 33.76 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.177 -1.045 . . . . 23.23 108.177 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.25 136.86 32.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.438 -0.346 . . . . 9.1099999999999994 111.197 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -90.49 149.98 21.98 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.204 0.526 . . . . 33.439999999999998 111.81 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 40.5 m-20 -69.01 -20.04 64.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.256 -0.884 . . . . 28.370000000000001 113.244 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.76 3.71 71.35 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 121.168 -0.539 . . . . 15.0 112.881 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -110.71 165.42 11.84 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.61 0.705 . . . . 25.5 111.372 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.9 p -106.82 167.16 10.06 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.604 0.716 . . . . 11.949999999999999 112.215 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.95 -42.65 94.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.682 -1.145 . . . . 10.17 110.906 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.9 p -61.81 -30.25 70.7 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.723 -0.791 . . . . 13.59 111.881 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -62.34 -28.29 69.65 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.503 -0.479 . . . . 11.699999999999999 110.484 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.73 14.61 29.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.648 -0.251 . . . . 12.949999999999999 111.619 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 50.02 39.46 19.03 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.797 0.439 . . . . 25.449999999999999 112.055 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.43 124.51 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.045 -1.094 . . . . 14.6 108.045 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -107.02 169.03 8.8 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.34 0.591 . . . . 33.229999999999997 112.287 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -51.97 140.76 19.4 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.034 -0.985 . . . . 25.969999999999999 112.032 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 67.4 23.92 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.82 -1.082 . . . . 32.609999999999999 112.211 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.0 m -77.31 150.24 35.25 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.227 -1.027 . . . . 10.56 108.227 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -110.6 126.05 54.04 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.248 0.547 . . . . 5.3300000000000001 110.033 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.21 157.49 17.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.582 -1.266 . . . . 11.66 107.582 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -116.32 131.35 56.97 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.188 -0.671 . . . . 16.300000000000001 109.188 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -105.2 131.77 52.25 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.38 -0.6 . . . . 9.9600000000000009 109.38 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.38 135.71 60.66 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 N-CA-C 107.862 -1.162 . . . . 9.7599999999999998 107.862 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.2 mt -99.93 130.01 46.07 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.967 -1.015 . . . . 19.57 110.27 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -105.33 74.5 1.1 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.379 -0.373 . . . . 35.079999999999998 110.006 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 tp -125.21 16.74 8.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.526 0.679 . . . . 32.310000000000002 110.235 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -150.77 159.81 44.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.186 -0.916 . . . . 42.75 110.445 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.26 -44.83 97.6 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.22 -0.752 . . . . 36.310000000000002 111.22 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.778 0 CA-C-O 117.986 -1.452 . . . . 36.200000000000003 110.879 -179.817 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.633 -0.506 . . . . 17.170000000000002 109.633 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -98.65 140.43 32.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.34 0.59 . . . . 21.890000000000001 110.585 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 pt -130.15 167.35 25.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.104 -0.953 . . . . 10.83 108.999 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -124.35 139.06 54.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.307 -0.406 . . . . 10.609999999999999 111.277 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.62 124.23 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.414 -0.958 . . . . 9.1300000000000008 108.414 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -100.01 142.56 31.32 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.891 0.377 . . . . 20.550000000000001 110.484 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 p -102.41 166.13 10.72 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 122.1 0.952 . . . . 11.779999999999999 110.861 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.96 -19.25 65.0 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.548 -1.66 . . . . 19.309999999999999 111.534 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -93.79 4.02 54.56 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.142 0.423 . . . . 23.140000000000001 112.142 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.7 14.32 58.35 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.215 -0.517 . . . . 19.739999999999998 113.617 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -90.45 143.58 26.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.163 -0.615 . . . . 21.93 109.938 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -116.94 127.55 54.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.888 -0.782 . . . . 12.33 108.888 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mt -111.22 138.73 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.798 -0.445 . . . . 17.079999999999998 109.798 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.8 m -103.7 131.36 50.93 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.53 -0.915 . . . . 16.300000000000001 108.53 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.4 mt -127.04 149.98 49.66 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.553 0.215 . . . . 15.880000000000001 110.676 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -102.73 122.44 44.46 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 106.213 -1.773 . . . . 28.899999999999999 106.213 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.96 167.85 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.565 0.698 . . . . 12.050000000000001 111.79 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -117.55 150.64 47.07 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.142 -1.429 . . . . 18.170000000000002 107.142 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.56 -24.86 71.98 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 CA-C-N 120.907 1.36 . . . . 8.1600000000000001 113.248 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 p -85.03 -0.38 54.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.072 0.397 . . . . 11.130000000000001 112.072 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -71.29 142.54 50.49 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.01 -1.108 . . . . 18.030000000000001 108.01 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -86.14 157.55 19.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.449 -1.25 . . . . 10.220000000000001 109.903 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 23' ' ' ILE . 29.0 mm -61.47 -40.05 85.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.807 -0.633 . . . . 12.300000000000001 109.585 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -60.17 -36.81 78.43 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.246 -0.65 . . . . 36.509999999999998 109.246 177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 54.3 t-20 -67.55 -42.89 81.94 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.356 -0.609 . . . . 25.66 109.356 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.57 -41.31 87.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.435 -0.58 . . . . 8.1199999999999992 109.435 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 19.2 mttt -60.0 -40.16 88.27 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 109.216 -0.661 . . . . 15.470000000000001 109.216 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.62 -38.29 89.62 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.714 -0.676 . . . . 11.449999999999999 110.857 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 44.8 mttp -65.13 -39.38 92.96 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.638 -0.425 . . . . 24.98 109.907 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.1 mt -64.67 -40.09 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 109.498 -0.556 . . . . 9.4600000000000009 109.498 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.95 -43.97 94.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.33 -0.618 . . . . 14.76 109.33 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.77 90.26 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.977 -1.011 . . . . 26.289999999999999 110.557 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -81.61 -40.6 22.73 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.582 1.327 . . . . 30.059999999999999 114.582 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.64 -14.47 14.04 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 116.286 1.958 . . . . 25.190000000000001 116.286 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.78 11.41 82.85 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 121.025 -0.607 . . . . 7.4100000000000001 113.153 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mt -86.04 117.1 68.11 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 109.585 -0.524 . . . . 9.4900000000000002 109.585 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.99 135.18 64.89 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 120.479 1.207 . . . . 11.42 111.995 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.72 -31.46 25.68 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.536 2.157 . . . . 12.0 114.501 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.22 -16.07 62.49 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.064 -0.654 . . . . 35.549999999999997 111.88 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -99.56 0.82 43.05 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.138 -0.225 . . . . 20.52 111.487 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -105.24 140.01 39.04 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.319 0.859 . . . . 7.1299999999999999 113.319 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -128.63 120.82 27.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 108.072 -1.084 . . . . 36.390000000000001 108.072 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.3 mt -103.21 130.01 50.31 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.382 0.61 . . . . 9.5500000000000007 111.187 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.43 139.79 50.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.017 -0.992 . . . . 13.9 111.178 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -140.27 130.98 25.74 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.583 -0.735 . . . . 6.8600000000000003 109.965 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 35.76 10.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.057 0.391 . . . . 11.15 112.057 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.17 -0.56 89.67 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.015 -0.881 . . . . 13.93 115.139 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -112.5 139.91 47.68 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.186 1.493 . . . . 23.920000000000002 111.104 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -77.86 127.45 32.4 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.496 -0.927 . . . . 23.23 108.496 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.24 136.25 33.24 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.917 0.389 . . . . 9.1099999999999994 111.117 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.93 149.9 21.71 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.282 0.563 . . . . 33.439999999999998 111.891 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 62.5 m-20 -68.38 -20.08 64.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.219 -0.9 . . . . 28.370000000000001 113.027 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.86 3.81 74.46 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 121.222 -0.513 . . . . 15.0 113.144 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -109.21 165.22 11.77 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 117.884 0.842 . . . . 25.5 111.134 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.1 p -106.67 167.35 9.92 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.559 0.695 . . . . 11.949999999999999 111.706 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.98 -44.38 94.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.929 -1.032 . . . . 10.17 110.417 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -62.01 -30.21 70.8 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 119.95 -0.7 . . . . 13.59 111.83 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.11 -27.72 69.58 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.37 -0.532 . . . . 11.699999999999999 110.218 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.429 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 66.0 m-85 -99.8 14.43 30.33 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.355 -0.384 . . . . 12.949999999999999 111.442 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 60' ' ' ASN . 2.6 p-10 49.8 39.3 17.74 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 122.844 0.458 . . . . 25.449999999999999 112.158 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.54 124.04 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.003 -1.11 . . . . 14.6 108.003 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -107.34 169.07 8.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.409 0.623 . . . . 33.229999999999997 112.084 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -51.4 141.69 14.98 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.027 -0.988 . . . . 25.969999999999999 111.613 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 66.85 23.57 9.97 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.966 -1.015 . . . . 32.609999999999999 112.751 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -78.01 149.22 34.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.05 -1.093 . . . . 10.56 108.05 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.4 m -110.64 126.56 54.63 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.293 0.568 . . . . 5.3300000000000001 109.951 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -103.79 157.21 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.71 -1.219 . . . . 11.66 107.71 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -115.18 131.08 57.04 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.729 -0.841 . . . . 16.300000000000001 108.729 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.4 tp -105.42 131.7 52.51 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.76 -0.829 . . . . 9.9600000000000009 108.76 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.79 148.47 24.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 107.945 -1.131 . . . . 9.7599999999999998 107.945 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.9 mt -105.24 139.92 39.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.892 -1.049 . . . . 19.57 109.907 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -119.81 137.41 54.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 35.079999999999998 109.961 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.9 mt -120.03 139.99 51.68 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.265 -0.425 . . . . 32.310000000000002 110.059 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -128.62 129.99 46.66 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.229 -0.441 . . . . 42.75 110.368 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.06 -179.95 44.14 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.88 -0.888 . . . . 36.310000000000002 110.88 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.825 0 CA-C-O 118.053 -1.415 . . . . 36.200000000000003 111.105 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.597 -0.52 . . . . 17.170000000000002 109.597 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -98.77 141.54 31.44 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.322 0.582 . . . . 21.890000000000001 110.301 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 pt -129.98 167.9 24.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.218 -0.901 . . . . 10.83 109.452 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -124.49 138.49 54.34 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.15 -0.477 . . . . 10.609999999999999 110.937 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.54 124.62 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.836 -0.801 . . . . 9.1300000000000008 108.836 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -100.78 138.84 37.3 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.895 -0.409 . . . . 20.550000000000001 109.895 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -99.01 162.45 13.06 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.368 0.604 . . . . 11.779999999999999 110.444 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -64.64 -11.77 38.82 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.947 -1.024 . . . . 19.309999999999999 110.704 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -96.62 0.95 50.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.848 0.356 . . . . 23.140000000000001 110.879 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.05 11.84 60.93 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 116.07 -0.514 . . . . 19.739999999999998 114.23 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -88.99 142.16 27.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.072 -0.651 . . . . 21.93 109.715 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -114.85 127.11 55.52 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 120.366 -0.534 . . . . 12.33 109.627 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mt -110.77 137.9 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.632 -0.507 . . . . 17.079999999999998 109.632 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -104.36 130.01 52.24 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.397 -0.964 . . . . 16.300000000000001 108.397 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.49 149.8 43.39 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.883 -0.414 . . . . 15.880000000000001 109.883 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -102.63 121.53 42.6 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 104.951 -2.24 . . . . 28.899999999999999 104.951 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.08 169.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.475 0.655 . . . . 12.050000000000001 111.557 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -117.79 149.34 45.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.332 -1.359 . . . . 18.170000000000002 107.332 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.38 -24.92 63.12 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 CA-C-N 120.908 1.36 . . . . 8.1600000000000001 113.201 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 t -85.76 -1.0 56.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.569 -0.287 . . . . 11.130000000000001 111.743 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -70.74 143.59 51.21 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.769 -1.197 . . . . 18.030000000000001 107.769 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -86.45 157.2 19.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.195 -1.366 . . . . 10.220000000000001 109.924 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.7 mm -61.76 -38.83 81.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.76 -0.655 . . . . 12.300000000000001 109.398 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -59.96 -37.78 80.55 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.544 -0.91 . . . . 36.509999999999998 108.544 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.06 -42.32 89.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.286 -0.635 . . . . 25.66 109.286 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.16 -44.32 98.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.845 -0.428 . . . . 8.1199999999999992 109.845 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.162 -0.681 . . . . 15.470000000000001 109.162 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.86 87.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.692 -0.685 . . . . 11.449999999999999 110.612 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -65.08 -39.08 92.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.859 -0.422 . . . . 24.98 109.859 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.9 mt -65.2 -40.02 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 109.836 -0.431 . . . . 9.4600000000000009 109.836 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -60.0 -44.57 94.45 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.384 0.612 . . . . 14.76 109.654 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.81 -40.4 92.56 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.033 -0.985 . . . . 26.289999999999999 111.0 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -81.8 -39.91 23.35 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.031 1.122 . . . . 30.059999999999999 114.031 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -111.89 -14.37 13.52 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.089 1.885 . . . . 25.190000000000001 116.089 -174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 11.32 82.5 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.867 -0.682 . . . . 7.4100000000000001 113.472 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.3 mt -86.29 116.94 67.75 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 109.745 -0.465 . . . . 9.4900000000000002 109.745 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.27 134.53 59.63 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 120.535 1.227 . . . . 11.42 112.243 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.29 -30.11 18.98 Favored 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.693 2.262 . . . . 12.0 114.536 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.26 -16.19 61.92 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.082 -0.647 . . . . 35.549999999999997 111.701 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -99.99 1.07 42.21 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.75 0.278 . . . . 20.52 111.75 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -107.16 139.46 41.56 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.851 1.056 . . . . 7.1299999999999999 113.851 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.634 ' NH2' HH11 ' A' ' 72' ' ' ARG . 88.2 mtt180 -125.95 121.91 34.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.727 -1.124 . . . . 36.390000000000001 108.123 176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.7 mt -105.53 130.3 53.62 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.142 0.496 . . . . 9.5500000000000007 110.694 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.64 138.25 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.506 -0.77 . . . . 13.9 110.654 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -137.37 126.17 24.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.339 -0.846 . . . . 6.8600000000000003 109.051 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.47 38.45 14.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.017 -0.538 . . . . 11.15 111.613 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.01 89.49 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.48 -0.622 . . . . 13.93 114.64 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -112.3 138.56 48.85 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.637 1.218 . . . . 23.920000000000002 111.886 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -79.45 129.45 34.48 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 107.524 -1.287 . . . . 23.23 107.524 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.7 mt -86.93 136.96 32.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.816 0.341 . . . . 9.1099999999999994 111.66 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.73 148.66 22.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.166 -0.47 . . . . 33.439999999999998 112.113 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -66.44 -22.43 66.21 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.782 1.03 . . . . 28.370000000000001 113.782 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.1 2.99 76.25 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 121.117 -0.563 . . . . 15.0 113.364 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -110.07 165.44 11.73 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.895 0.848 . . . . 25.5 111.517 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.0 p -106.96 167.01 10.18 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.547 0.689 . . . . 11.949999999999999 111.88 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.7 mt -59.99 -42.85 95.12 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.837 -1.074 . . . . 10.17 110.852 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.6 p -61.61 -30.32 70.62 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 119.804 -0.759 . . . . 13.59 111.956 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.23 -28.96 70.06 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.68 -0.408 . . . . 11.699999999999999 110.334 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -99.81 14.21 31.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.34 -0.391 . . . . 12.949999999999999 111.645 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 49.98 39.88 19.82 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.84 0.456 . . . . 25.449999999999999 112.137 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -81.62 124.73 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.011 -1.107 . . . . 14.6 108.011 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -108.58 169.79 8.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.465 0.65 . . . . 33.229999999999997 112.144 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -51.77 141.69 16.53 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.899 -1.046 . . . . 25.969999999999999 111.708 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.94 23.07 9.95 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.039 -0.982 . . . . 32.609999999999999 112.872 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -77.49 148.53 35.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.993 -1.114 . . . . 10.56 107.993 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.5 m -110.48 126.27 54.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.391 0.615 . . . . 5.3300000000000001 109.67 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.59 156.79 17.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.61 -1.256 . . . . 11.66 107.61 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -114.83 132.73 56.4 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.149 -0.686 . . . . 16.300000000000001 109.149 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 tp -108.2 131.19 54.92 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.469 -0.567 . . . . 9.9600000000000009 109.469 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.78 132.71 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 N-CA-C 107.351 -1.352 . . . . 9.7599999999999998 107.351 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.0 mt -102.18 130.19 48.76 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.377 -0.829 . . . . 19.57 111.303 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.634 HH11 ' NH2' ' A' ' 42' ' ' ARG . 80.2 ttt180 -111.68 121.4 45.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.423 -0.584 . . . . 35.079999999999998 109.423 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.53 119.72 39.63 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.651 0.262 . . . . 32.310000000000002 110.761 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -60.38 -41.15 93.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.17 0.51 . . . . 42.75 110.465 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.02 98.44 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.7 -0.96 . . . . 36.310000000000002 110.7 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.72 0 CA-C-O 117.967 -1.463 . . . . 36.200000000000003 110.842 -179.848 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.537 -0.542 . . . . 17.17 109.537 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.425 HE22 ' HB2' ' A' ' 16' ' ' GLU . 67.1 mm-40 -95.83 142.35 28.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.474 0.654 . . . . 21.89 110.231 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -131.49 165.43 31.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 114.898 -1.046 . . . . 10.83 108.31 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.4 139.94 53.42 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.722 0.296 . . . . 10.61 111.273 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.87 123.74 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.62 -0.881 . . . . 9.13 108.62 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -100.05 142.3 31.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.908 0.385 . . . . 20.55 110.473 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 p -101.82 166.03 10.88 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 122.085 0.945 . . . . 11.78 111.064 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.96 -19.61 65.26 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.61 -1.632 . . . . 19.31 111.209 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -93.34 -0.02 56.77 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.151 0.426 . . . . 23.14 112.151 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 13.87 52.22 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.173 -0.537 . . . . 19.74 113.698 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -90.17 144.92 25.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.147 -0.621 . . . . 21.93 109.708 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -117.96 127.87 54.25 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.079 -0.711 . . . . 12.33 109.079 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.56 139.0 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.888 -0.412 . . . . 17.08 109.888 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.4 m -105.12 132.02 51.87 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.735 -0.839 . . . . 16.3 108.735 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -127.31 150.3 49.64 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.534 0.207 . . . . 15.88 110.572 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.425 ' HB2' HE22 ' A' ' 2' ' ' GLN . 86.5 tt0 -100.96 122.19 43.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.333 -1.729 . . . . 28.9 106.333 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.03 168.01 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.615 0.722 . . . . 12.05 111.859 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -118.5 150.86 48.82 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 107.172 -1.418 . . . . 18.17 107.172 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.14 -24.24 65.56 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 CA-C-N 120.926 1.366 . . . . 8.16 112.695 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 p -85.26 -1.79 57.33 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.062 0.393 . . . . 11.13 112.062 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -70.46 143.29 51.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.949 -1.13 . . . . 18.03 107.949 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 71.7 p -86.29 157.2 19.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.238 -1.346 . . . . 10.22 109.921 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.96 -39.75 84.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.715 -0.675 . . . . 12.3 109.29 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -38.32 82.18 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.728 -0.842 . . . . 36.51 108.728 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 7.4 m-20 -66.17 -40.05 90.2 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.168 -0.679 . . . . 25.66 109.168 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.94 -43.73 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.833 -0.432 . . . . 8.12 109.833 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.265 -0.643 . . . . 15.47 109.265 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.85 87.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.748 -0.66 . . . . 11.45 110.339 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -65.72 -39.0 90.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.748 -0.464 . . . . 24.98 109.748 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -64.98 -39.98 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.642 -0.503 . . . . 9.46 109.642 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.08 -44.14 95.0 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.322 -0.622 . . . . 14.76 109.322 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 53.7 t0 -60.35 -40.57 91.19 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.032 -0.985 . . . . 26.29 110.733 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -81.71 -40.27 23.0 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.371 1.249 . . . . 30.06 114.371 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.77 -14.94 13.93 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.277 1.954 . . . . 25.19 116.277 -174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.42 11.15 82.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 120.952 -0.642 . . . . 7.41 113.114 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mt -86.43 116.98 67.89 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.751 -0.463 . . . . 9.49 109.751 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.83 134.8 62.71 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 CA-C-N 120.417 1.185 . . . . 11.42 112.118 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.36 -31.37 22.84 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 122.631 2.221 . . . . 12.0 114.441 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.03 -16.31 62.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.621 0.646 . . . . 35.55 112.079 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -99.98 1.78 42.9 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.754 0.279 . . . . 20.52 111.754 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -107.99 139.46 42.58 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.908 1.077 . . . . 7.13 113.908 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -126.17 123.94 39.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.745 -1.116 . . . . 36.39 108.166 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -105.71 130.08 53.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.32 0.581 . . . . 9.55 110.899 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.17 138.06 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.214 -0.903 . . . . 13.9 110.533 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -139.31 127.05 21.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.258 -0.883 . . . . 6.86 108.887 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 39.16 18.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.068 -0.514 . . . . 11.15 111.429 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.04 0.03 89.12 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.28 -0.733 . . . . 13.93 114.863 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -112.24 139.27 47.92 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.777 1.289 . . . . 23.92 111.77 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.37 128.98 34.01 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.602 -1.259 . . . . 23.23 107.602 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.7 mt -86.93 136.53 32.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 9.11 111.559 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.16 149.91 21.59 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.224 0.535 . . . . 33.44 112.02 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.83 -20.04 64.29 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.555 0.946 . . . . 28.37 113.555 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.04 3.48 70.17 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 121.133 -0.556 . . . . 15.0 113.062 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -110.1 165.94 11.35 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 117.639 0.72 . . . . 25.5 111.286 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.1 p -107.55 167.35 10.0 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.536 0.684 . . . . 11.95 111.976 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.95 -42.94 95.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.843 -1.071 . . . . 10.17 110.986 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.0 p -61.87 -30.31 70.78 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 119.677 -0.809 . . . . 13.59 111.92 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.07 -29.02 70.01 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.687 -0.405 . . . . 11.7 110.498 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -99.89 13.81 32.58 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.268 -0.424 . . . . 12.95 111.657 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 50.07 39.98 20.44 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 112.056 0.391 . . . . 25.45 112.056 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -81.04 121.54 34.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.362 -1.347 . . . . 14.6 107.362 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.49 169.13 8.77 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.324 0.583 . . . . 33.23 112.042 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -51.14 141.22 14.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.121 -0.945 . . . . 25.97 111.65 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.74 23.35 10.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.771 -1.104 . . . . 32.61 112.929 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.9 m -76.83 148.7 36.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.013 -1.106 . . . . 10.56 108.013 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -112.83 124.04 51.69 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.528 -0.545 . . . . 5.33 109.528 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.0 mp -105.17 157.41 17.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.626 -1.25 . . . . 11.66 107.626 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -112.25 134.08 54.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.23 -0.655 . . . . 16.3 109.23 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.5 tp -106.16 132.7 51.92 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.919 -0.771 . . . . 9.96 108.919 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.71 144.83 28.35 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 107.609 -1.256 . . . . 9.76 107.609 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.3 mt -109.86 139.99 44.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.348 -0.842 . . . . 19.57 110.611 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 . . . . . 0 N--CA 1.464 0.266 0 CA-C-N 115.729 -0.669 . . . . 35.08 110.032 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.498 -0.556 . . . . 17.17 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.84 140.99 31.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.334 0.588 . . . . 21.89 110.165 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 pt -130.24 166.83 26.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.144 -0.935 . . . . 10.83 108.843 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -124.54 139.3 54.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.503 -0.317 . . . . 10.61 111.01 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.27 124.17 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.597 -0.89 . . . . 9.13 108.597 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -101.05 142.13 32.95 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.984 0.421 . . . . 20.55 110.499 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -103.96 162.58 13.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.716 0.77 . . . . 11.78 111.076 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.64 -14.46 52.04 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.38 -1.282 . . . . 19.31 111.768 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -95.72 2.45 53.95 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.734 -0.386 . . . . 23.14 111.566 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.4 13.67 56.84 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.355 -0.45 . . . . 19.74 113.919 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -91.17 142.1 28.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.286 -0.566 . . . . 21.93 110.42 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.1 m -116.96 127.56 54.33 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.681 -0.859 . . . . 12.33 108.681 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.3 mt -111.77 138.66 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 110.003 -0.369 . . . . 17.08 110.003 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -103.18 131.21 50.38 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.931 -0.766 . . . . 16.3 108.931 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.4 mt -127.19 149.92 49.76 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.703 0.287 . . . . 15.88 110.926 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.65 122.11 43.77 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.131 -1.803 . . . . 28.9 106.131 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.94 168.25 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.507 0.67 . . . . 12.05 111.485 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.81 149.22 44.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 107.227 -1.398 . . . . 18.17 107.227 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.24 -24.4 59.15 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 120.817 1.327 . . . . 8.16 112.844 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 p -85.28 -2.46 58.08 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 116.297 -0.41 . . . . 11.13 112.016 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.4 142.56 50.31 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.946 -1.131 . . . . 18.03 107.946 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -86.81 157.83 19.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.49 -1.232 . . . . 10.22 109.833 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.9 mm -61.27 -39.87 84.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.182 -0.917 . . . . 12.3 109.982 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.03 -37.63 80.35 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.73 -0.841 . . . . 36.51 108.73 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 55.2 t-20 -66.4 -42.82 87.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.475 -0.565 . . . . 25.66 109.475 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.5 t -60.61 -41.69 88.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 109.484 -0.562 . . . . 8.12 109.484 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.531 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 20.5 mttt -60.03 -39.98 87.79 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.342 -0.614 . . . . 15.47 109.342 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.25 89.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.755 -0.657 . . . . 11.45 110.543 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 47.5 mttp -65.21 -39.11 92.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.65 -0.5 . . . . 24.98 109.65 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mt -65.06 -40.05 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.713 -0.477 . . . . 9.46 109.713 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.01 -44.07 94.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.389 0.614 . . . . 14.76 109.361 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.83 -40.45 92.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.987 -1.006 . . . . 26.29 110.938 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -40.98 22.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.149 1.166 . . . . 30.06 114.149 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -111.12 -14.61 13.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.079 1.881 . . . . 25.19 116.079 -174.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.14 11.15 82.81 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.94 -0.648 . . . . 7.41 113.233 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.73 116.29 65.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 109.594 -0.521 . . . . 9.49 109.594 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.79 134.75 62.51 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.099 1.199 . . . . 11.42 112.415 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.46 -32.1 25.76 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 122.778 2.319 . . . . 12.0 114.684 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.8 -15.93 62.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.834 0.743 . . . . 35.55 112.179 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.06 2.45 43.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.765 0.284 . . . . 20.52 111.765 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -107.76 139.22 42.66 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.029 1.122 . . . . 7.13 114.029 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.57 124.34 39.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.217 -1.031 . . . . 36.39 108.217 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.24 131.05 54.61 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.238 0.542 . . . . 9.55 110.837 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -123.87 139.45 50.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.289 -0.869 . . . . 13.9 110.456 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -137.69 126.73 24.3 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.382 -0.827 . . . . 6.86 108.982 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.43 39.52 16.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.099 -0.5 . . . . 11.15 111.701 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.94 0.01 90.0 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.322 -0.71 . . . . 13.93 114.722 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -112.72 139.03 48.67 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.782 1.291 . . . . 23.92 111.74 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -78.86 129.67 34.82 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.216 -1.031 . . . . 23.23 108.216 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.02 136.88 32.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.847 0.356 . . . . 9.11 111.195 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -90.14 149.48 22.43 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.123 -0.49 . . . . 33.44 111.521 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.531 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 63.3 m-20 -69.64 -20.07 63.61 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.774 1.028 . . . . 28.37 113.774 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.25 5.99 68.4 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 120.992 -0.623 . . . . 15.0 112.487 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.31 164.03 13.71 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.18 0.49 . . . . 25.5 111.648 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.1 p -105.57 166.43 10.45 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.624 0.726 . . . . 11.95 112.519 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.97 -42.03 93.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.643 -1.162 . . . . 10.17 110.687 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.48 -31.08 71.04 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.021 -0.672 . . . . 13.59 111.848 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.99 -28.96 69.93 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.641 -0.424 . . . . 11.7 110.578 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.06 14.64 28.53 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.653 0.242 . . . . 12.95 111.653 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 50.01 39.42 18.9 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.944 0.498 . . . . 25.45 112.173 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -81.45 123.97 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.112 -1.07 . . . . 14.6 108.112 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.0 169.07 8.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.295 0.569 . . . . 33.23 112.122 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.4 141.41 15.51 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.218 -0.901 . . . . 25.97 111.489 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 67.03 23.21 9.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.941 -1.027 . . . . 32.61 112.768 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 m -77.2 149.36 35.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.996 -1.113 . . . . 10.56 107.996 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.2 m -110.61 126.74 54.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.302 0.573 . . . . 5.33 109.724 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.93 157.36 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.858 -1.164 . . . . 11.66 107.858 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -115.98 132.25 56.7 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.076 -0.713 . . . . 16.3 109.076 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -106.85 133.18 51.89 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.787 -0.449 . . . . 9.96 109.787 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.45 136.86 57.91 Favored 'Isoleucine or valine' 0 C--N 1.345 0.403 0 N-CA-C 107.931 -1.136 . . . . 9.76 107.931 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 71' ' ' LEU . 6.7 mp -102.16 129.84 48.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.301 -0.863 . . . . 19.57 111.564 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 . . . . . 0 N--CA 1.465 0.3 0 N-CA-C 108.942 -0.762 . . . . 35.08 108.942 178.578 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.641 -0.503 . . . . 17.17 109.641 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -97.06 140.89 30.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.403 0.62 . . . . 21.89 110.03 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -130.29 166.37 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.073 -0.967 . . . . 10.83 109.156 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.06 139.44 53.79 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.489 -0.323 . . . . 10.61 111.447 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.26 124.67 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.685 -0.857 . . . . 9.13 108.685 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -100.03 139.99 34.9 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.971 -0.381 . . . . 20.55 109.971 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -99.96 168.13 10.05 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.211 1.005 . . . . 11.78 110.703 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.409 HD11 ' H ' ' A' ' 71' ' ' LEU . 72.2 mt -64.42 -20.51 66.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.509 -1.678 . . . . 19.31 111.043 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -93.77 0.03 56.13 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.353 0.501 . . . . 23.14 112.353 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.91 14.96 50.83 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.28 -0.486 . . . . 19.74 113.809 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -90.0 144.15 26.16 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.359 -0.536 . . . . 21.93 109.999 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -118.27 128.68 54.91 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.293 -0.632 . . . . 12.33 109.293 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mt -112.04 138.42 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.962 -0.384 . . . . 17.08 109.962 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -103.49 131.16 50.84 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.811 -0.811 . . . . 16.3 108.811 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.2 mt -127.55 150.0 49.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.623 0.249 . . . . 15.88 110.882 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -100.33 121.93 42.3 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.178 -1.786 . . . . 28.9 106.178 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -139.94 167.15 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.573 0.702 . . . . 12.05 111.592 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -118.37 150.01 47.03 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.426 -1.324 . . . . 18.17 107.426 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -57.9 -24.99 67.52 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 CA-C-N 120.834 1.334 . . . . 8.16 113.293 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t -85.84 -1.75 57.56 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.901 0.334 . . . . 11.13 111.901 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -70.24 143.98 51.98 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.865 -1.161 . . . . 18.03 107.865 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.8 p -86.81 156.65 19.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.153 -1.385 . . . . 10.22 109.686 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -60.37 -38.96 79.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.595 -0.729 . . . . 12.3 109.22 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.98 -39.23 85.01 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.059 -0.719 . . . . 36.51 109.059 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -65.13 -40.46 94.47 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 119.847 -0.741 . . . . 25.66 109.382 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.68 -43.9 99.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.712 -0.477 . . . . 8.12 109.712 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -60.03 -40.0 87.8 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 109.315 -0.624 . . . . 15.47 109.315 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.12 89.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.861 -0.609 . . . . 11.45 110.645 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -65.46 -39.19 91.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.716 -0.475 . . . . 24.98 109.716 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.93 -39.97 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.556 -0.535 . . . . 9.46 109.556 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.05 -44.14 94.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.451 0.643 . . . . 14.76 109.609 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 -41.16 91.59 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.993 -1.003 . . . . 26.29 110.545 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -81.92 -40.25 22.6 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.421 1.267 . . . . 30.06 114.421 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -111.51 -14.27 13.72 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.189 1.922 . . . . 25.19 116.189 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.94 10.64 84.77 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.892 -0.67 . . . . 7.41 113.047 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -84.86 116.86 67.18 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 119.092 -0.48 . . . . 9.49 109.793 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.85 140.91 95.42 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 CA-C-N 120.551 1.232 . . . . 11.42 112.519 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.12 -31.71 84.19 Favored 'Trans proline' 0 N--CA 1.51 2.45 0 C-N-CA 122.557 2.172 . . . . 12.0 114.928 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.93 -16.47 62.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.783 0.719 . . . . 35.55 112.439 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 72' ' ' ARG . 78.4 mm-40 -100.02 2.96 43.89 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.92 0.341 . . . . 20.52 111.92 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -107.79 139.92 41.65 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.743 1.016 . . . . 7.13 113.743 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -126.37 122.4 35.27 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.007 -1.109 . . . . 36.39 108.007 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -105.44 130.4 53.54 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.307 0.575 . . . . 9.55 110.629 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.59 137.72 55.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.198 -0.91 . . . . 13.9 110.593 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -138.93 126.95 22.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.051 -0.977 . . . . 6.86 108.947 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 38.7 17.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.957 -0.565 . . . . 11.15 111.563 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.32 0.04 89.41 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.432 -0.649 . . . . 13.93 114.547 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -112.44 139.04 48.34 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.589 1.194 . . . . 23.92 111.827 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -78.48 128.71 33.96 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.755 -1.202 . . . . 23.23 107.755 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -86.52 136.26 33.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.841 0.353 . . . . 9.11 111.318 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.8 149.1 21.77 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.103 -0.499 . . . . 33.44 112.151 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.21 -20.88 65.76 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.572 0.953 . . . . 28.37 113.572 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.15 2.58 71.8 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 121.101 -0.571 . . . . 15.0 113.28 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -110.88 166.42 11.05 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.834 0.817 . . . . 25.5 111.398 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.437 ' OG1' ' OD2' ' A' ' 58' ' ' ASP . 70.4 p -107.49 167.55 9.86 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.605 0.717 . . . . 11.95 112.22 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.0 -41.8 92.88 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.504 -1.226 . . . . 10.17 111.029 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -60.8 -31.56 70.95 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 119.832 -0.747 . . . . 13.59 111.871 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' OD2' ' OG1' ' A' ' 55' ' ' THR . 7.2 m-20 -61.78 -29.05 69.88 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.445 -0.502 . . . . 11.7 111.14 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -99.0 13.31 33.21 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.668 0.247 . . . . 12.95 111.668 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 50.03 39.98 20.3 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.784 0.434 . . . . 25.45 112.036 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.6 mt -81.25 122.27 36.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.626 -1.25 . . . . 14.6 107.626 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.402 ' O ' ' OG ' ' A' ' 65' ' ' SER . 22.9 mm100 -106.91 169.19 8.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.384 0.612 . . . . 33.23 112.149 -177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -51.39 141.33 15.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.047 -0.979 . . . . 25.97 111.607 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.86 23.16 10.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.941 -1.027 . . . . 32.61 112.702 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 37.0 m -77.38 149.15 35.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.041 -1.096 . . . . 10.56 108.041 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -113.6 123.82 50.86 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.62 -0.511 . . . . 5.33 109.62 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.1 mp -104.02 158.98 16.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.557 -1.275 . . . . 11.66 107.557 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -114.23 132.95 55.94 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.205 -0.665 . . . . 16.3 109.205 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.6 tp -107.13 135.2 49.07 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.711 -0.477 . . . . 9.96 109.711 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -119.81 139.93 45.52 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 107.476 -1.305 . . . . 9.76 107.476 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.409 ' H ' HD11 ' A' ' 8' ' ' LEU . 62.8 mt -104.53 145.19 30.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.073 -0.967 . . . . 19.57 111.526 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.434 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 63.2 mtp180 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 115.394 -0.821 . . . . 35.08 109.819 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.413 -0.588 . . . . 17.17 109.413 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -97.86 140.67 31.87 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.402 0.62 . . . . 21.89 110.403 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.2 pt -130.02 166.97 26.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.067 -0.97 . . . . 10.83 108.851 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 27.4 m-85 -126.36 138.55 53.57 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.357 -0.383 . . . . 10.61 111.18 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -120.3 125.4 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 109.177 -0.675 . . . . 9.13 109.177 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -100.32 140.0 35.19 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.07 -0.345 . . . . 20.55 110.07 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -102.52 164.19 11.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.965 0.888 . . . . 11.78 110.764 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -20.01 54.73 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.887 -1.506 . . . . 19.31 110.809 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.3 p -94.38 5.57 51.37 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.313 0.486 . . . . 23.14 112.313 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.15 14.07 64.99 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 116.084 -0.507 . . . . 19.74 113.87 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -89.98 142.29 27.84 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.259 -0.576 . . . . 21.93 110.175 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.5 m -116.67 127.73 54.7 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.913 -0.773 . . . . 12.33 108.913 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 mt -111.45 138.23 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.677 -0.49 . . . . 17.08 109.677 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -102.25 130.87 49.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.645 -0.872 . . . . 16.3 108.645 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -127.07 149.36 49.96 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.667 0.27 . . . . 15.88 110.696 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -101.22 121.61 42.17 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 106.016 -1.846 . . . . 28.9 106.016 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.01 168.02 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.573 0.702 . . . . 12.05 111.35 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 16.3 mp0 -117.74 147.85 41.89 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 107.188 -1.412 . . . . 18.17 107.188 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -55.77 -24.29 45.84 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 CA-C-N 120.785 1.316 . . . . 8.16 112.769 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 p -85.02 -0.79 55.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.38 -0.373 . . . . 11.13 111.965 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -71.06 144.14 50.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.213 -1.032 . . . . 18.03 108.213 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.7 p -86.42 157.41 19.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.227 -1.352 . . . . 10.22 110.196 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.3 -40.7 86.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.717 -0.674 . . . . 12.3 109.881 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.98 -36.7 80.13 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.219 -0.66 . . . . 36.51 109.219 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -67.58 -44.13 78.94 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.779 -0.452 . . . . 25.66 109.779 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.02 -41.1 85.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.275 -1.009 . . . . 8.12 108.275 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HZ2' ' HB2' ' A' ' 27' ' ' LYS . 5.4 mtmp? -60.1 -40.08 88.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.848 -0.427 . . . . 15.47 109.848 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.03 89.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.255 -0.43 . . . . 11.45 110.238 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -65.85 -38.46 88.93 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.593 -0.521 . . . . 24.98 109.593 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mt -65.27 -40.22 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.574 -0.528 . . . . 9.46 109.574 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -60.02 -43.9 94.97 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.167 -0.679 . . . . 14.76 109.167 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -41.12 91.37 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.911 -1.04 . . . . 26.29 110.494 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -82.15 -39.45 23.22 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.472 1.286 . . . . 30.06 114.472 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.86 -15.47 13.35 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.131 1.901 . . . . 25.19 116.131 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.5 10.78 84.02 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.85 -0.691 . . . . 7.41 113.056 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.3 mt -84.66 116.1 63.67 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 109.67 -0.493 . . . . 9.49 109.67 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.77 135.87 66.6 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 CA-C-N 120.443 1.194 . . . . 11.42 112.911 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.02 -31.44 44.19 Favored 'Trans proline' 0 N--CA 1.509 2.39 0 C-N-CA 122.777 2.318 . . . . 12.0 115.076 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -71.42 -17.5 62.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.875 0.761 . . . . 35.55 112.025 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 72' ' ' ARG . 51.3 mm-40 -99.87 1.98 43.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.332 . . . . 20.52 111.279 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -106.86 138.8 42.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.601 0.963 . . . . 7.13 113.601 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.496 HH21 ' NH2' ' A' ' 72' ' ' ARG . 94.3 mtt-85 -126.41 122.47 35.4 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.968 -1.123 . . . . 36.39 107.968 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.5 mt -103.06 129.69 49.95 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.226 0.536 . . . . 9.55 110.383 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -127.84 137.54 57.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.313 -0.858 . . . . 13.9 111.571 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -139.0 130.13 26.67 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.361 -0.836 . . . . 6.86 109.977 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.18 40.35 21.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.864 -0.607 . . . . 11.15 111.9 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 0.62 85.71 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.73 -0.668 . . . . 13.93 114.109 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -113.36 138.36 50.18 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.572 1.186 . . . . 23.92 111.855 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -78.5 128.43 33.56 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.482 -0.933 . . . . 23.23 108.482 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.4 mt -87.03 136.68 32.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.825 0.345 . . . . 9.11 111.302 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -92.48 150.97 20.45 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.31 0.576 . . . . 33.44 112.459 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.78 -19.93 64.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.047 -0.979 . . . . 28.37 113.473 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.95 3.11 70.07 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 121.073 -0.584 . . . . 15.0 113.028 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -110.07 164.63 12.44 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.796 0.798 . . . . 25.5 111.465 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 p -106.76 167.11 10.09 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.62 0.724 . . . . 11.95 112.011 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.03 -43.52 95.24 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.692 -1.14 . . . . 10.17 110.863 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.9 m -60.34 -32.16 70.99 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 119.943 -0.703 . . . . 13.59 111.956 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.27 -27.89 68.79 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.478 -0.489 . . . . 11.7 110.829 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -99.98 14.7 29.65 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 111.89 0.33 . . . . 12.95 111.89 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 60' ' ' ASN . 28.7 t-20 50.05 39.55 19.35 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.81 0.338 . . . . 25.45 111.839 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.56 122.81 37.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.837 -1.172 . . . . 14.6 107.837 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -108.12 169.4 8.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.341 0.591 . . . . 33.23 112.279 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -51.59 141.78 15.59 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.066 -0.97 . . . . 25.97 111.626 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 67.18 23.17 9.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.127 -0.942 . . . . 32.61 112.455 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.1 m -78.11 148.71 34.06 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.017 -1.105 . . . . 10.56 108.017 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.6 m -110.49 126.11 54.01 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.202 0.525 . . . . 5.33 109.896 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.2 158.36 16.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.572 -1.269 . . . . 11.66 107.572 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -116.36 131.62 56.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.709 -0.678 . . . . 16.3 109.29 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -107.85 133.04 52.79 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.495 -0.557 . . . . 9.96 109.495 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.45 138.75 49.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 107.973 -1.121 . . . . 9.76 107.973 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.6 mt -100.01 130.03 46.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.635 -1.166 . . . . 19.57 111.28 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.496 ' NH2' HH21 ' A' ' 42' ' ' ARG . 59.2 ttp180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.476 -0.784 . . . . 35.08 109.826 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.688 -0.486 . . . . 17.17 109.688 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -98.59 142.2 30.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.29 0.567 . . . . 21.89 110.358 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -130.22 167.75 24.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.125 -0.943 . . . . 10.83 109.122 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.94 138.89 54.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.395 -0.366 . . . . 10.61 110.876 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.56 124.64 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.705 -0.85 . . . . 9.13 108.705 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -100.02 141.67 32.52 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.832 0.348 . . . . 20.55 110.419 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -102.08 170.04 8.36 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 122.367 1.08 . . . . 11.78 111.088 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.44 -21.26 66.63 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.004 -1.907 . . . . 19.31 111.178 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.9 p -93.6 7.54 44.28 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.481 0.548 . . . . 23.14 112.481 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.74 64.06 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.101 -0.571 . . . . 19.74 113.206 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.435 ' HZ3' ' HB3' ' A' ' 11' ' ' LYS . 6.7 ttpm? -90.3 140.58 29.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.506 -0.477 . . . . 21.93 110.088 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -115.27 126.21 54.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.581 -0.896 . . . . 12.33 108.581 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -110.79 138.67 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.891 -0.411 . . . . 17.08 109.891 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -102.66 131.09 49.68 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.45 -0.944 . . . . 16.3 108.45 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.8 mt -126.79 148.46 49.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.683 0.278 . . . . 15.88 110.569 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -103.11 122.24 44.26 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.964 -1.865 . . . . 28.9 105.964 176.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.408 ' C ' ' OE2' ' A' ' 18' ' ' GLU . 35.7 m -140.08 168.96 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.415 0.626 . . . . 12.05 111.228 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' OE2' ' C ' ' A' ' 17' ' ' VAL . 1.7 mp0 -116.93 149.24 43.77 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 107.357 -1.349 . . . . 18.17 107.357 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -57.28 -25.09 63.25 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 CA-C-N 120.912 1.361 . . . . 8.16 112.837 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 t -85.69 -1.69 57.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.371 -0.377 . . . . 11.13 111.715 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -69.99 144.01 52.43 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.714 -1.217 . . . . 18.03 107.714 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -86.29 156.78 20.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.084 -1.416 . . . . 10.22 109.898 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -61.27 -39.54 82.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.677 -0.692 . . . . 12.3 109.242 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.21 -38.06 82.19 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.896 -0.779 . . . . 36.51 108.896 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -66.41 -42.03 88.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.278 -0.638 . . . . 25.66 109.278 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.35 -42.27 93.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.482 -0.562 . . . . 8.12 109.482 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 24.1 mttt -60.0 -40.08 87.96 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.076 -0.713 . . . . 15.47 109.076 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.55 90.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.763 -0.653 . . . . 11.45 110.636 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.06 -38.92 92.36 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.428 -0.509 . . . . 24.98 109.91 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -64.94 -40.38 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.631 -0.507 . . . . 9.46 109.631 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.92 -44.73 94.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.381 0.61 . . . . 14.76 109.587 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.5 -40.19 90.48 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.941 -1.027 . . . . 26.29 110.918 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -82.0 -39.72 23.17 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.27 1.211 . . . . 30.06 114.27 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.29 -15.46 13.61 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.217 1.932 . . . . 25.19 116.217 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.14 10.96 83.1 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 120.912 -0.661 . . . . 7.41 113.115 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.1 mt -85.56 117.12 68.14 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 119.158 -0.449 . . . . 9.49 109.832 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.54 133.07 49.51 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 120.528 1.224 . . . . 11.42 112.315 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.32 -30.68 15.67 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 122.851 2.367 . . . . 12.0 114.53 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.88 -16.04 62.12 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.21 -0.596 . . . . 35.55 111.606 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.04 1.27 42.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.831 0.308 . . . . 20.52 111.831 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -105.91 138.57 41.88 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.586 0.958 . . . . 7.13 113.586 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.412 ' HE ' ' HD2' ' A' ' 72' ' ' ARG . 85.1 mtt-85 -125.71 121.66 34.08 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.727 -1.212 . . . . 36.39 107.727 176.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -104.52 129.97 52.52 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.241 0.543 . . . . 9.55 110.842 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -123.71 138.61 52.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.335 -0.848 . . . . 13.9 110.451 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -136.53 126.26 25.56 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.074 -0.966 . . . . 6.86 109.049 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.85 39.43 14.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.974 -0.557 . . . . 11.15 111.472 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.72 0.02 89.7 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.302 -0.721 . . . . 13.93 114.772 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -112.92 138.82 49.2 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.856 1.328 . . . . 23.92 111.872 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -78.61 129.56 34.9 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.421 -0.955 . . . . 23.23 108.421 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.12 136.9 32.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.723 0.297 . . . . 9.11 111.197 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.87 150.1 21.67 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.16 0.505 . . . . 33.44 111.61 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.496 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 39.3 m-20 -69.13 -19.99 64.04 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.631 0.975 . . . . 28.37 113.631 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.41 4.34 69.86 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 121.055 -0.593 . . . . 15.0 112.824 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -110.78 166.32 11.12 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.512 0.656 . . . . 25.5 111.253 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -107.58 167.33 10.03 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.579 0.704 . . . . 11.95 112.214 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.0 -42.24 93.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.702 -1.135 . . . . 10.17 111.138 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -61.96 -29.99 70.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 119.725 -0.79 . . . . 13.59 112.025 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.21 -27.98 69.36 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.607 -0.437 . . . . 11.7 110.822 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -99.7 15.34 27.12 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.625 0.231 . . . . 12.95 111.625 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 14.0 p30 49.78 38.85 16.61 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.768 0.427 . . . . 25.45 111.861 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.42 124.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.027 -1.101 . . . . 14.6 108.027 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -107.07 168.89 8.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.362 0.601 . . . . 33.23 112.139 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -51.81 141.46 17.17 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.137 -0.938 . . . . 25.97 111.821 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 67.01 23.6 9.74 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.949 -1.023 . . . . 32.61 112.633 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 m -77.01 149.93 35.84 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.064 -1.087 . . . . 10.56 108.064 176.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -110.46 126.19 54.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.228 0.537 . . . . 5.33 109.791 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -104.38 156.61 17.78 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.594 -1.261 . . . . 11.66 107.594 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -115.42 131.81 56.81 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.762 -0.829 . . . . 16.3 108.762 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.3 131.56 53.37 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.349 -0.611 . . . . 9.96 109.349 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.72 141.45 41.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 107.651 -1.24 . . . . 9.76 107.651 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 73.7 mt -103.48 137.11 42.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.098 -0.956 . . . . 19.57 110.863 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.412 ' HD2' ' HE ' ' A' ' 42' ' ' ARG . 70.0 ttt180 . . . . . 0 N--CA 1.466 0.354 0 CA-C-N 115.971 -0.558 . . . . 35.08 110.185 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.524 -0.547 . . . . 17.17 109.524 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -98.1 140.73 31.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.356 0.598 . . . . 21.89 110.228 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 pt -130.05 167.22 25.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.132 -0.94 . . . . 10.83 109.102 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -125.24 138.33 54.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.228 -0.442 . . . . 10.61 111.328 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.4 124.83 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.553 -0.906 . . . . 9.13 108.553 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -100.35 140.03 35.19 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.676 -0.491 . . . . 20.55 109.676 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -103.3 163.7 12.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.857 0.837 . . . . 11.78 110.68 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.87 -16.06 57.27 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.074 -1.421 . . . . 19.31 111.077 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -95.2 4.35 53.66 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.752 -0.379 . . . . 23.14 111.759 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.63 14.1 63.98 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 116.17 -0.468 . . . . 19.74 113.915 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -91.1 143.74 26.38 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.092 -0.643 . . . . 21.93 110.09 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -117.34 127.06 53.68 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.095 -0.705 . . . . 12.33 109.095 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.8 mt -110.81 137.82 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.809 -0.441 . . . . 17.08 109.809 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -102.78 131.12 49.85 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.796 -0.816 . . . . 16.3 108.796 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -126.63 148.55 49.79 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.679 0.276 . . . . 15.88 110.852 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -101.91 121.69 42.61 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 105.948 -1.871 . . . . 28.9 105.948 176.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.533 ' N ' ' OE2' ' A' ' 16' ' ' GLU . 33.8 m -140.74 169.65 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.461 0.648 . . . . 12.05 111.485 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 6.4 mp0 -117.08 147.64 40.66 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 106.772 -1.566 . . . . 18.17 106.772 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -55.41 -23.37 38.23 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 CA-C-N 120.787 1.317 . . . . 8.16 112.515 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -85.82 -0.32 54.99 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.254 0.464 . . . . 11.13 112.254 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 18' ' ' GLU . 4.1 m-20 -69.53 144.37 53.15 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.028 -1.101 . . . . 18.03 108.028 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -86.19 157.4 19.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.593 -1.185 . . . . 10.22 109.628 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.76 -39.99 83.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.597 -0.729 . . . . 12.3 109.284 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.98 -38.17 81.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.935 -0.765 . . . . 36.51 108.935 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -66.43 -43.14 86.52 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.411 -0.516 . . . . 25.66 109.72 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.43 -43.1 93.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.506 -0.553 . . . . 8.12 109.506 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -60.01 -40.0 87.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 109.405 -0.591 . . . . 15.47 109.405 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.13 89.33 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.752 -0.658 . . . . 11.45 110.474 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -64.94 -39.46 93.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.905 -0.405 . . . . 24.98 109.905 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.8 mt -64.41 -39.92 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.686 -0.487 . . . . 9.46 109.686 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.03 -44.42 94.65 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.306 -0.627 . . . . 14.76 109.306 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.04 -40.69 90.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.133 -0.939 . . . . 26.29 110.73 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -81.85 -40.34 22.6 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.51 1.3 . . . . 30.06 114.51 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.61 -13.98 14.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.189 1.922 . . . . 25.19 116.189 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.48 11.08 83.65 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 120.91 -0.662 . . . . 7.41 113.061 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.46 116.93 67.71 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.517 -0.549 . . . . 9.49 109.517 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -59.1 133.36 52.67 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 CA-C-N 120.54 1.229 . . . . 11.42 112.411 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.57 -29.94 15.14 Favored 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 122.836 2.357 . . . . 12.0 114.324 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.3 -16.87 61.9 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.208 -0.597 . . . . 35.55 111.263 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -100.07 -0.01 39.92 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.751 0.31 . . . . 20.52 111.523 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -106.06 138.82 41.58 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.53 0.937 . . . . 7.13 113.53 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtt85 -126.9 122.57 35.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.985 -1.007 . . . . 36.39 108.594 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.6 mt -104.42 129.99 52.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.26 0.552 . . . . 9.55 110.193 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mt -127.89 138.37 54.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.266 -0.879 . . . . 13.9 111.274 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -136.77 129.35 30.31 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.685 -0.689 . . . . 6.86 110.01 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 40.18 16.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.829 -0.623 . . . . 11.15 111.899 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.93 0.13 89.13 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.28 -0.733 . . . . 13.93 114.607 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -112.4 139.01 48.32 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.848 1.324 . . . . 23.92 111.425 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -79.31 129.09 34.12 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 107.906 -1.146 . . . . 23.23 107.906 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.6 mt -86.92 136.81 32.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.824 0.345 . . . . 9.11 111.453 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -91.4 149.97 21.47 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.056 0.455 . . . . 33.44 112.059 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -67.98 -20.09 65.0 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.599 0.963 . . . . 28.37 113.599 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.49 5.36 70.46 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 121.016 -0.611 . . . . 15.0 112.97 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -110.93 165.04 12.18 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.508 0.654 . . . . 25.5 111.456 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.3 p -107.83 167.3 10.07 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.498 0.666 . . . . 11.95 111.87 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.92 -42.11 93.22 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.85 -1.068 . . . . 10.17 110.898 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.9 m -60.83 -31.76 71.17 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 119.934 -0.706 . . . . 13.59 111.975 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.3 -28.53 69.26 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.641 -0.424 . . . . 11.7 110.85 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.98 15.2 27.95 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.935 0.346 . . . . 12.95 111.935 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 m120 49.95 39.66 19.2 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 122.811 0.445 . . . . 25.45 111.94 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.56 123.03 37.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.109 -1.071 . . . . 14.6 108.109 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -108.67 169.88 8.38 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.267 0.556 . . . . 33.23 112.238 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -51.66 141.82 15.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.132 -0.94 . . . . 25.97 111.43 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 66.78 22.57 10.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.013 -0.994 . . . . 32.61 112.636 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.8 m -77.32 149.25 35.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.952 -1.129 . . . . 10.56 107.952 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -110.26 126.03 53.74 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 121.275 0.559 . . . . 5.33 110.054 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -103.65 156.44 17.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.431 -1.322 . . . . 11.66 107.431 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -115.43 131.13 57.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.673 -0.862 . . . . 16.3 108.673 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.28 133.11 51.48 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.603 -0.518 . . . . 9.96 109.603 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.01 129.96 74.83 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 N-CA-C 107.791 -1.189 . . . . 9.76 107.791 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.6 mt -100.61 130.1 46.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.588 -1.187 . . . . 19.57 110.967 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 . . . . . 0 N--CA 1.466 0.365 0 N-CA-C 109.399 -0.593 . . . . 35.08 109.399 179.299 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.654 -0.499 . . . . 17.17 109.654 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -97.41 140.66 31.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.41 0.624 . . . . 21.89 110.067 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -130.25 166.62 27.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.033 -0.985 . . . . 10.83 108.859 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -124.63 139.99 53.36 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.451 -0.341 . . . . 10.61 111.194 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.97 124.58 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.873 -0.788 . . . . 9.13 108.873 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -99.72 140.02 34.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.965 -0.383 . . . . 20.55 109.965 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -99.82 169.98 8.85 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 122.228 1.014 . . . . 11.78 110.627 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.5 mt -63.42 -23.9 67.6 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.269 -1.787 . . . . 19.31 111.161 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -91.54 0.04 57.55 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.765 0.654 . . . . 23.14 112.765 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.44 15.15 51.76 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.082 -0.58 . . . . 19.74 113.478 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -89.61 144.87 25.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.699 -0.482 . . . . 21.93 109.699 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -118.4 128.9 55.06 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.626 -0.509 . . . . 12.33 109.626 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -112.02 139.39 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.9 -0.407 . . . . 17.08 109.9 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -101.03 130.68 47.08 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.699 -0.852 . . . . 16.3 108.699 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -125.41 147.39 49.2 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 110.043 -0.354 . . . . 15.88 110.043 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -102.2 121.72 42.78 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 105.753 -1.943 . . . . 28.9 105.753 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.0 167.75 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.659 0.742 . . . . 12.05 111.768 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 25.4 mp0 -118.66 149.7 46.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 107.418 -1.327 . . . . 18.17 107.418 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -57.35 -24.73 61.84 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 CA-C-N 120.847 1.338 . . . . 8.16 113.103 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 p -85.14 -1.61 57.08 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.003 0.372 . . . . 11.13 112.003 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.61 142.97 51.64 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.059 -1.089 . . . . 18.03 108.059 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -86.07 157.77 19.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.444 -1.253 . . . . 10.22 109.939 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.15 -39.91 84.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 12.3 109.344 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -60.08 -38.58 83.34 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.912 -0.773 . . . . 36.51 108.912 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -65.68 -39.96 91.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.973 -0.691 . . . . 25.66 109.495 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.79 -43.95 99.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.671 -0.492 . . . . 8.12 109.671 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -60.06 -39.93 87.71 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.379 -0.6 . . . . 15.47 109.379 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.18 89.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.799 -0.637 . . . . 11.45 110.422 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -64.69 -39.67 94.06 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.702 -0.481 . . . . 24.98 109.702 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.41 HG21 ' OE1' ' A' ' 41' ' ' GLN . 63.4 mt -64.5 -40.08 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.852 -0.425 . . . . 9.46 109.852 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -59.96 -44.26 94.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.382 0.61 . . . . 14.76 109.464 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -62.03 -40.2 94.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.099 -0.955 . . . . 26.29 111.252 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -80.96 -42.37 21.38 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.95 1.093 . . . . 30.06 113.95 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.35 -11.26 14.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.856 1.799 . . . . 25.19 115.856 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.74 10.44 85.14 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 120.799 -0.715 . . . . 7.41 113.136 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mt -83.77 130.6 54.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.291 -0.633 . . . . 9.49 109.291 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.57 133.07 16.78 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.392 1.394 . . . . 11.42 112.2 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.91 -30.66 24.5 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 122.833 2.355 . . . . 12.0 115.084 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 60.8 t0 -71.9 -17.96 62.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.413 0.552 . . . . 35.55 111.559 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 72' ' ' ARG . 16.1 mm100 -99.98 -0.02 40.16 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.927 0.343 . . . . 20.52 111.927 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' OE1' HG21 ' A' ' 30' ' ' ILE . 62.7 mt-30 -106.1 139.59 40.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.948 1.092 . . . . 7.13 113.948 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -126.28 122.66 36.13 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.469 -1.242 . . . . 36.39 108.125 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -103.36 129.99 50.56 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.246 0.546 . . . . 9.55 110.082 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.36 136.13 61.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.25 -0.887 . . . . 13.9 111.589 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -138.08 128.99 27.04 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.105 -0.952 . . . . 6.86 109.62 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 40.16 21.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.968 -0.56 . . . . 11.15 112.006 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.95 0.47 85.44 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.764 -0.653 . . . . 13.93 114.296 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -112.88 138.56 49.54 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.44 1.12 . . . . 23.92 111.691 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -78.33 129.42 34.98 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.349 -0.982 . . . . 23.23 108.349 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 mt -86.85 136.4 32.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.827 0.346 . . . . 9.11 111.192 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.99 149.94 21.26 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.142 -0.481 . . . . 33.44 112.254 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.22 -20.05 65.63 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.493 0.923 . . . . 28.37 113.493 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.48 3.13 68.41 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 121.04 -0.6 . . . . 15.0 113.203 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -110.94 166.21 11.23 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.768 0.784 . . . . 25.5 111.37 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.2 p -107.52 167.38 9.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.568 0.699 . . . . 11.95 112.294 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.06 -42.35 94.3 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.842 -1.072 . . . . 10.17 111.143 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.2 p -61.92 -30.05 70.63 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.613 -0.835 . . . . 13.59 111.777 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -62.39 -28.3 69.68 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.524 -0.47 . . . . 11.7 110.813 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.77 14.21 31.05 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 111.6 0.222 . . . . 12.95 111.6 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 50.03 39.8 19.83 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.022 0.378 . . . . 25.45 112.022 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.18 121.73 35.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 107.547 -1.279 . . . . 14.6 107.547 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -106.64 168.96 8.82 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.294 0.569 . . . . 33.23 112.089 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -51.2 141.31 14.82 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.129 -0.941 . . . . 25.97 111.479 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 66.9 22.96 10.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.085 -0.961 . . . . 32.61 112.667 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 m -77.6 148.37 35.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.946 -1.131 . . . . 10.56 107.946 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.5 m -111.85 124.47 52.42 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.447 -0.575 . . . . 5.33 109.447 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.2 mp -104.44 159.15 15.97 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.511 -1.292 . . . . 11.66 107.511 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -113.44 132.48 55.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.547 -0.751 . . . . 16.3 109.431 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 tp -105.92 132.48 51.98 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.705 -0.85 . . . . 9.96 108.705 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.02 137.78 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.027 -1.472 . . . . 9.76 107.027 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.7 mt -103.73 137.74 41.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.25 -0.886 . . . . 19.57 110.044 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.544 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 75.1 ttt180 . . . . . 0 C--N 1.331 -0.218 0 CA-C-N 116.18 -0.463 . . . . 35.08 109.832 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.612 -0.514 . . . . 17.17 109.612 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -98.77 140.85 32.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.251 0.548 . . . . 21.89 110.387 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.9 pt -130.08 167.91 24.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.183 -0.917 . . . . 10.83 109.463 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -124.01 138.77 54.41 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.182 -0.463 . . . . 10.61 111.16 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.54 124.0 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.327 -0.99 . . . . 9.13 108.327 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -99.94 142.7 31.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.854 0.359 . . . . 20.55 110.577 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.7 p -102.27 165.73 10.97 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 122.029 0.918 . . . . 11.78 110.976 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.89 -18.75 64.5 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.65 -1.614 . . . . 19.31 111.214 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.9 p -94.22 2.58 55.9 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.205 0.446 . . . . 23.14 112.205 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.14 14.19 56.43 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.192 -0.528 . . . . 19.74 113.627 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -90.26 143.09 27.09 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.299 -0.56 . . . . 21.93 110.157 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -117.41 127.55 54.14 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.642 -0.873 . . . . 12.33 108.642 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mt -111.84 139.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.825 -0.435 . . . . 17.08 109.825 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.0 m -103.62 131.78 50.45 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 108.571 -0.9 . . . . 16.3 108.571 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -127.53 149.98 49.89 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.577 0.227 . . . . 15.88 110.533 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -102.14 122.21 43.7 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.326 -1.731 . . . . 28.9 106.326 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.01 167.7 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.629 0.728 . . . . 12.05 111.73 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -117.85 151.53 48.86 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.362 -1.347 . . . . 18.17 107.362 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.37 -24.46 74.6 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 CA-C-N 120.911 1.361 . . . . 8.16 112.974 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 t -85.98 -1.88 57.76 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 112.025 0.38 . . . . 11.13 112.025 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -70.79 143.9 51.02 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.832 -1.173 . . . . 18.03 107.832 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.422 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 71.4 p -87.07 157.0 19.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.086 -1.415 . . . . 10.22 109.746 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 23' ' ' ILE . 34.5 mm -60.73 -38.57 79.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.392 -0.822 . . . . 12.3 109.497 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -60.08 -39.48 86.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.206 -0.664 . . . . 36.51 109.206 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.422 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 21.9 m120 -64.66 -40.23 95.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.753 -0.779 . . . . 25.66 108.958 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -62.27 -43.82 98.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.25 -0.432 . . . . 8.12 109.936 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 21.5 mttt -59.97 -40.13 88.03 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 109.519 -0.548 . . . . 15.47 109.519 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.94 88.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.831 -0.622 . . . . 11.45 110.436 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -65.6 -38.13 88.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.672 -0.492 . . . . 24.98 109.672 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.3 mt -65.71 -40.37 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.569 -0.53 . . . . 9.46 109.569 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.0 -44.78 94.31 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.331 -0.618 . . . . 14.76 109.331 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -60.26 -39.94 88.58 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.014 -0.994 . . . . 26.29 110.607 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -80.66 -42.32 22.28 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.297 1.221 . . . . 30.06 114.297 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.23 -13.75 13.93 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.272 1.953 . . . . 25.19 116.272 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.3 10.85 84.15 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 120.823 -0.703 . . . . 7.41 113.003 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -85.31 115.73 62.55 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.473 -0.566 . . . . 9.49 109.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.41 134.72 63.19 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 CA-C-N 120.463 1.201 . . . . 11.42 112.384 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.63 -31.06 23.75 Favored 'Trans proline' 0 N--CA 1.506 2.239 0 C-N-CA 122.791 2.327 . . . . 12.0 114.375 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -71.59 -15.48 62.26 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.119 -0.632 . . . . 35.55 111.673 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -100.01 0.7 41.5 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.813 0.301 . . . . 20.52 111.813 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -107.1 139.87 40.83 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.279 1.214 . . . . 7.13 114.279 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -126.47 123.37 37.67 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.501 -1.227 . . . . 36.39 108.109 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.9 mt -106.01 130.1 54.0 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.208 0.528 . . . . 9.55 110.573 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mp -124.06 139.48 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.381 -0.827 . . . . 13.9 110.582 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -138.8 127.58 23.53 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.139 -0.937 . . . . 6.86 109.011 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 39.99 20.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.987 -0.552 . . . . 11.15 111.717 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.17 0.19 88.51 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.356 -0.691 . . . . 13.93 114.648 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -112.63 139.08 48.53 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.708 1.254 . . . . 23.92 111.686 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -78.8 128.72 33.76 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.177 -1.045 . . . . 23.23 108.177 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.25 136.86 32.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.438 -0.346 . . . . 9.11 111.197 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -90.49 149.98 21.98 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.204 0.526 . . . . 33.44 111.81 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 40.5 m-20 -69.01 -20.04 64.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.256 -0.884 . . . . 28.37 113.244 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.76 3.71 71.35 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 121.168 -0.539 . . . . 15.0 112.881 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -110.71 165.42 11.84 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.61 0.705 . . . . 25.5 111.372 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.9 p -106.82 167.16 10.06 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.604 0.716 . . . . 11.95 112.215 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.95 -42.65 94.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.682 -1.145 . . . . 10.17 110.906 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.9 p -61.81 -30.25 70.7 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.723 -0.791 . . . . 13.59 111.881 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -62.34 -28.29 69.65 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.503 -0.479 . . . . 11.7 110.484 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.73 14.61 29.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.648 -0.251 . . . . 12.95 111.619 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 50.02 39.46 19.03 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.797 0.439 . . . . 25.45 112.055 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.43 124.51 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.045 -1.094 . . . . 14.6 108.045 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -107.02 169.03 8.8 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.34 0.591 . . . . 33.23 112.287 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -51.97 140.76 19.4 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.034 -0.985 . . . . 25.97 112.032 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 67.4 23.92 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.82 -1.082 . . . . 32.61 112.211 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.0 m -77.31 150.24 35.25 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.227 -1.027 . . . . 10.56 108.227 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -110.6 126.05 54.04 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.248 0.547 . . . . 5.33 110.033 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.21 157.49 17.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.582 -1.266 . . . . 11.66 107.582 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -116.32 131.35 56.97 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.188 -0.671 . . . . 16.3 109.188 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -105.2 131.77 52.25 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.38 -0.6 . . . . 9.96 109.38 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.38 135.71 60.66 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 N-CA-C 107.862 -1.162 . . . . 9.76 107.862 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.2 mt -99.93 130.01 46.07 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.967 -1.015 . . . . 19.57 110.27 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 116.379 -0.373 . . . . 35.08 110.006 179.697 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.633 -0.506 . . . . 17.17 109.633 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -98.65 140.43 32.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.34 0.59 . . . . 21.89 110.585 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 pt -130.15 167.35 25.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.104 -0.953 . . . . 10.83 108.999 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -124.35 139.06 54.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.307 -0.406 . . . . 10.61 111.277 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.62 124.23 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.414 -0.958 . . . . 9.13 108.414 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -100.01 142.56 31.32 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.891 0.377 . . . . 20.55 110.484 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 p -102.41 166.13 10.72 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 122.1 0.952 . . . . 11.78 110.861 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.96 -19.25 65.0 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.548 -1.66 . . . . 19.31 111.534 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -93.79 4.02 54.56 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.142 0.423 . . . . 23.14 112.142 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.7 14.32 58.35 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.215 -0.517 . . . . 19.74 113.617 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -90.45 143.58 26.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.163 -0.615 . . . . 21.93 109.938 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -116.94 127.55 54.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.888 -0.782 . . . . 12.33 108.888 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mt -111.22 138.73 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.798 -0.445 . . . . 17.08 109.798 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.8 m -103.7 131.36 50.93 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.53 -0.915 . . . . 16.3 108.53 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.4 mt -127.04 149.98 49.66 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.553 0.215 . . . . 15.88 110.676 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -102.73 122.44 44.46 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 106.213 -1.773 . . . . 28.9 106.213 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.96 167.85 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.565 0.698 . . . . 12.05 111.79 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -117.55 150.64 47.07 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.142 -1.429 . . . . 18.17 107.142 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.56 -24.86 71.98 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 CA-C-N 120.907 1.36 . . . . 8.16 113.248 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 p -85.03 -0.38 54.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.072 0.397 . . . . 11.13 112.072 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -71.29 142.54 50.49 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.01 -1.108 . . . . 18.03 108.01 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -86.14 157.55 19.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.449 -1.25 . . . . 10.22 109.903 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 23' ' ' ILE . 29.0 mm -61.47 -40.05 85.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.807 -0.633 . . . . 12.3 109.585 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -60.17 -36.81 78.43 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.246 -0.65 . . . . 36.51 109.246 177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 54.3 t-20 -67.55 -42.89 81.94 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.356 -0.609 . . . . 25.66 109.356 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.57 -41.31 87.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.435 -0.58 . . . . 8.12 109.435 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.52 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 19.2 mttt -60.0 -40.16 88.27 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 109.216 -0.661 . . . . 15.47 109.216 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.62 -38.29 89.62 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.714 -0.676 . . . . 11.45 110.857 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 44.8 mttp -65.13 -39.38 92.96 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.638 -0.425 . . . . 24.98 109.907 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.1 mt -64.67 -40.09 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 109.498 -0.556 . . . . 9.46 109.498 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.95 -43.97 94.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.33 -0.618 . . . . 14.76 109.33 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.77 90.26 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.977 -1.011 . . . . 26.29 110.557 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -81.61 -40.6 22.73 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.582 1.327 . . . . 30.06 114.582 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.64 -14.47 14.04 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 116.286 1.958 . . . . 25.19 116.286 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.78 11.41 82.85 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 121.025 -0.607 . . . . 7.41 113.153 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mt -86.04 117.1 68.11 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 109.585 -0.524 . . . . 9.49 109.585 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.99 135.18 64.89 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 120.479 1.207 . . . . 11.42 111.995 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.72 -31.46 25.68 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.536 2.157 . . . . 12.0 114.501 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.22 -16.07 62.49 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.064 -0.654 . . . . 35.55 111.88 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -99.56 0.82 43.05 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.138 -0.225 . . . . 20.52 111.487 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -105.24 140.01 39.04 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.319 0.859 . . . . 7.13 113.319 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -128.63 120.82 27.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 108.072 -1.084 . . . . 36.39 108.072 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.3 mt -103.21 130.01 50.31 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.382 0.61 . . . . 9.55 111.187 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.43 139.79 50.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.017 -0.992 . . . . 13.9 111.178 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -140.27 130.98 25.74 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.583 -0.735 . . . . 6.86 109.965 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 35.76 10.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.057 0.391 . . . . 11.15 112.057 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.17 -0.56 89.67 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.015 -0.881 . . . . 13.93 115.139 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -112.5 139.91 47.68 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.186 1.493 . . . . 23.92 111.104 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -77.86 127.45 32.4 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.496 -0.927 . . . . 23.23 108.496 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.24 136.25 33.24 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.917 0.389 . . . . 9.11 111.117 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.93 149.9 21.71 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.282 0.563 . . . . 33.44 111.891 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 62.5 m-20 -68.38 -20.08 64.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.219 -0.9 . . . . 28.37 113.027 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.86 3.81 74.46 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 121.222 -0.513 . . . . 15.0 113.144 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -109.21 165.22 11.77 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 117.884 0.842 . . . . 25.5 111.134 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.1 p -106.67 167.35 9.92 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.559 0.695 . . . . 11.95 111.706 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.98 -44.38 94.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.929 -1.032 . . . . 10.17 110.417 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -62.01 -30.21 70.8 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 119.95 -0.7 . . . . 13.59 111.83 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.11 -27.72 69.58 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.37 -0.532 . . . . 11.7 110.218 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.429 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 66.0 m-85 -99.8 14.43 30.33 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.355 -0.384 . . . . 12.95 111.442 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 2.6 p-10 49.8 39.3 17.74 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 122.844 0.458 . . . . 25.45 112.158 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.54 124.04 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.003 -1.11 . . . . 14.6 108.003 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -107.34 169.07 8.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.409 0.623 . . . . 33.23 112.084 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -51.4 141.69 14.98 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.027 -0.988 . . . . 25.97 111.613 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 66.85 23.57 9.97 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.966 -1.015 . . . . 32.61 112.751 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -78.01 149.22 34.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.05 -1.093 . . . . 10.56 108.05 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.4 m -110.64 126.56 54.63 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.293 0.568 . . . . 5.33 109.951 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -103.79 157.21 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.71 -1.219 . . . . 11.66 107.71 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -115.18 131.08 57.04 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.729 -0.841 . . . . 16.3 108.729 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.4 tp -105.42 131.7 52.51 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.76 -0.829 . . . . 9.96 108.76 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.79 148.47 24.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 107.945 -1.131 . . . . 9.76 107.945 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.9 mt -105.24 139.92 39.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.892 -1.049 . . . . 19.57 109.907 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 35.08 109.961 -179.616 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.597 -0.52 . . . . 17.17 109.597 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -98.77 141.54 31.44 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.322 0.582 . . . . 21.89 110.301 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 pt -129.98 167.9 24.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.218 -0.901 . . . . 10.83 109.452 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -124.49 138.49 54.34 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.15 -0.477 . . . . 10.61 110.937 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.54 124.62 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.836 -0.801 . . . . 9.13 108.836 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -100.78 138.84 37.3 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.895 -0.409 . . . . 20.55 109.895 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -99.01 162.45 13.06 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.368 0.604 . . . . 11.78 110.444 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -64.64 -11.77 38.82 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.947 -1.024 . . . . 19.31 110.704 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -96.62 0.95 50.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.848 0.356 . . . . 23.14 110.879 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.05 11.84 60.93 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 116.07 -0.514 . . . . 19.74 114.23 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -88.99 142.16 27.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.072 -0.651 . . . . 21.93 109.715 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -114.85 127.11 55.52 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 120.366 -0.534 . . . . 12.33 109.627 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mt -110.77 137.9 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.632 -0.507 . . . . 17.08 109.632 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -104.36 130.01 52.24 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.397 -0.964 . . . . 16.3 108.397 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.49 149.8 43.39 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.883 -0.414 . . . . 15.88 109.883 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -102.63 121.53 42.6 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 104.951 -2.24 . . . . 28.9 104.951 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.08 169.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.475 0.655 . . . . 12.05 111.557 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -117.79 149.34 45.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.332 -1.359 . . . . 18.17 107.332 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.38 -24.92 63.12 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 CA-C-N 120.908 1.36 . . . . 8.16 113.201 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 t -85.76 -1.0 56.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.569 -0.287 . . . . 11.13 111.743 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -70.74 143.59 51.21 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.769 -1.197 . . . . 18.03 107.769 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -86.45 157.2 19.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.195 -1.366 . . . . 10.22 109.924 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.7 mm -61.76 -38.83 81.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.76 -0.655 . . . . 12.3 109.398 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -59.96 -37.78 80.55 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.544 -0.91 . . . . 36.51 108.544 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.06 -42.32 89.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.286 -0.635 . . . . 25.66 109.286 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.16 -44.32 98.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.845 -0.428 . . . . 8.12 109.845 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.162 -0.681 . . . . 15.47 109.162 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.86 87.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.692 -0.685 . . . . 11.45 110.612 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -65.08 -39.08 92.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.859 -0.422 . . . . 24.98 109.859 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.9 mt -65.2 -40.02 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 109.836 -0.431 . . . . 9.46 109.836 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -60.0 -44.57 94.45 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.384 0.612 . . . . 14.76 109.654 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.81 -40.4 92.56 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.033 -0.985 . . . . 26.29 111.0 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -81.8 -39.91 23.35 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.031 1.122 . . . . 30.06 114.031 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -111.89 -14.37 13.52 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.089 1.885 . . . . 25.19 116.089 -174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 11.32 82.5 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.867 -0.682 . . . . 7.41 113.472 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.3 mt -86.29 116.94 67.75 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 109.745 -0.465 . . . . 9.49 109.745 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.27 134.53 59.63 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 120.535 1.227 . . . . 11.42 112.243 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.29 -30.11 18.98 Favored 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.693 2.262 . . . . 12.0 114.536 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.26 -16.19 61.92 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.082 -0.647 . . . . 35.55 111.701 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -99.99 1.07 42.21 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.75 0.278 . . . . 20.52 111.75 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -107.16 139.46 41.56 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.851 1.056 . . . . 7.13 113.851 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.634 ' NH2' HH11 ' A' ' 72' ' ' ARG . 88.2 mtt180 -125.95 121.91 34.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.727 -1.124 . . . . 36.39 108.123 176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.7 mt -105.53 130.3 53.62 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.142 0.496 . . . . 9.55 110.694 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.64 138.25 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.506 -0.77 . . . . 13.9 110.654 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -137.37 126.17 24.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.339 -0.846 . . . . 6.86 109.051 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.47 38.45 14.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.017 -0.538 . . . . 11.15 111.613 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.01 89.49 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.48 -0.622 . . . . 13.93 114.64 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -112.3 138.56 48.85 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.637 1.218 . . . . 23.92 111.886 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -79.45 129.45 34.48 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 107.524 -1.287 . . . . 23.23 107.524 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.7 mt -86.93 136.96 32.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.816 0.341 . . . . 9.11 111.66 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.73 148.66 22.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.166 -0.47 . . . . 33.44 112.113 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -66.44 -22.43 66.21 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.782 1.03 . . . . 28.37 113.782 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.1 2.99 76.25 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 121.117 -0.563 . . . . 15.0 113.364 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -110.07 165.44 11.73 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.895 0.848 . . . . 25.5 111.517 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.0 p -106.96 167.01 10.18 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.547 0.689 . . . . 11.95 111.88 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.7 mt -59.99 -42.85 95.12 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.837 -1.074 . . . . 10.17 110.852 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.6 p -61.61 -30.32 70.62 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 119.804 -0.759 . . . . 13.59 111.956 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.23 -28.96 70.06 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.68 -0.408 . . . . 11.7 110.334 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -99.81 14.21 31.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.34 -0.391 . . . . 12.95 111.645 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 49.98 39.88 19.82 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.84 0.456 . . . . 25.45 112.137 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -81.62 124.73 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.011 -1.107 . . . . 14.6 108.011 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -108.58 169.79 8.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.465 0.65 . . . . 33.23 112.144 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -51.77 141.69 16.53 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.899 -1.046 . . . . 25.97 111.708 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.94 23.07 9.95 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.039 -0.982 . . . . 32.61 112.872 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -77.49 148.53 35.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.993 -1.114 . . . . 10.56 107.993 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.5 m -110.48 126.27 54.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.391 0.615 . . . . 5.33 109.67 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.59 156.79 17.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.61 -1.256 . . . . 11.66 107.61 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -114.83 132.73 56.4 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.149 -0.686 . . . . 16.3 109.149 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 tp -108.2 131.19 54.92 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.469 -0.567 . . . . 9.96 109.469 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.78 132.71 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 N-CA-C 107.351 -1.352 . . . . 9.76 107.351 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.0 mt -102.18 130.19 48.76 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.377 -0.829 . . . . 19.57 111.303 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.634 HH11 ' NH2' ' A' ' 42' ' ' ARG . 80.2 ttt180 . . . . . 0 N--CA 1.464 0.262 0 N-CA-C 109.423 -0.584 . . . . 35.08 109.423 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.492 1.629 0 N-CA-C 109.537 -0.542 . . . . 17.17 109.537 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.425 HE22 ' HB2' ' A' ' 16' ' ' GLU . 67.1 mm-40 -95.83 142.35 28.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.474 0.654 . . . . 21.89 110.231 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -131.49 165.43 31.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 114.898 -1.046 . . . . 10.83 108.31 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.4 139.94 53.42 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.722 0.296 . . . . 10.61 111.273 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.87 123.74 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.62 -0.881 . . . . 9.13 108.62 177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -100.05 142.3 31.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.908 0.385 . . . . 20.55 110.473 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 p -101.82 166.03 10.88 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 122.085 0.945 . . . . 11.78 111.064 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.96 -19.61 65.26 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.61 -1.632 . . . . 19.31 111.209 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p -93.34 -0.02 56.77 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.151 0.426 . . . . 23.14 112.151 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.56 13.87 52.22 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.173 -0.537 . . . . 19.74 113.698 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -90.17 144.92 25.43 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 120.147 -0.621 . . . . 21.93 109.708 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -117.96 127.87 54.25 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.079 -0.711 . . . . 12.33 109.079 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.56 139.0 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 109.888 -0.412 . . . . 17.08 109.888 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.4 m -105.12 132.02 51.87 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 108.735 -0.839 . . . . 16.3 108.735 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.9 mt -127.31 150.3 49.64 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.534 0.207 . . . . 15.88 110.572 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.425 ' HB2' HE22 ' A' ' 2' ' ' GLN . 86.5 tt0 -100.96 122.19 43.07 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.333 -1.729 . . . . 28.9 106.333 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -140.03 168.01 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 121.615 0.722 . . . . 12.05 111.859 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -118.5 150.86 48.82 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 107.172 -1.418 . . . . 18.17 107.172 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.14 -24.24 65.56 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 CA-C-N 120.926 1.366 . . . . 8.16 112.695 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.0 p -85.26 -1.79 57.33 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 112.062 0.393 . . . . 11.13 112.062 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -70.46 143.29 51.81 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 107.949 -1.13 . . . . 18.03 107.949 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 71.7 p -86.29 157.2 19.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.238 -1.346 . . . . 10.22 109.921 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.96 -39.75 84.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.715 -0.675 . . . . 12.3 109.29 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -38.32 82.18 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 108.728 -0.842 . . . . 36.51 108.728 178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 7.4 m-20 -66.17 -40.05 90.2 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.168 -0.679 . . . . 25.66 109.168 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.94 -43.73 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.833 -0.432 . . . . 8.12 109.833 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -60.03 -39.96 87.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.265 -0.643 . . . . 15.47 109.265 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.45 -37.85 87.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.748 -0.66 . . . . 11.45 110.339 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -65.72 -39.0 90.72 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.748 -0.464 . . . . 24.98 109.748 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -64.98 -39.98 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 109.642 -0.503 . . . . 9.46 109.642 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.08 -44.14 95.0 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.322 -0.622 . . . . 14.76 109.322 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 32' ' ' ASP . 53.7 t0 -60.35 -40.57 91.19 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.032 -0.985 . . . . 26.29 110.733 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -81.71 -40.27 23.0 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 114.371 1.249 . . . . 30.06 114.371 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.77 -14.94 13.93 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.277 1.954 . . . . 25.19 116.277 -174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.42 11.15 82.5 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 120.952 -0.642 . . . . 7.41 113.114 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mt -86.43 116.98 67.89 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 109.751 -0.463 . . . . 9.49 109.751 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -58.83 134.8 62.71 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 CA-C-N 120.417 1.185 . . . . 11.42 112.118 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -49.36 -31.37 22.84 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 122.631 2.221 . . . . 12.0 114.441 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.03 -16.31 62.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.621 0.646 . . . . 35.55 112.079 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -99.98 1.78 42.9 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.754 0.279 . . . . 20.52 111.754 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -107.99 139.46 42.58 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.908 1.077 . . . . 7.13 113.908 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -126.17 123.94 39.37 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 114.745 -1.116 . . . . 36.39 108.166 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.7 mt -105.71 130.08 53.79 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.32 0.581 . . . . 9.55 110.899 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.17 138.06 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 115.214 -0.903 . . . . 13.9 110.533 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -139.31 127.05 21.96 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.258 -0.883 . . . . 6.86 108.887 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 39.16 18.24 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.068 -0.514 . . . . 11.15 111.429 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.04 0.03 89.12 Favored Glycine 0 CA--C 1.532 1.124 0 CA-C-O 119.28 -0.733 . . . . 13.93 114.863 176.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -112.24 139.27 47.92 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.777 1.289 . . . . 23.92 111.77 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -79.37 128.98 34.01 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 107.602 -1.259 . . . . 23.23 107.602 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.7 mt -86.93 136.53 32.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.874 0.368 . . . . 9.11 111.559 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.16 149.91 21.59 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.224 0.535 . . . . 33.44 112.02 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -68.83 -20.04 64.29 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.555 0.946 . . . . 28.37 113.555 -177.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.04 3.48 70.17 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 121.133 -0.556 . . . . 15.0 113.062 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -110.1 165.94 11.35 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 117.639 0.72 . . . . 25.5 111.286 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.1 p -107.55 167.35 10.0 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.536 0.684 . . . . 11.95 111.976 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.0 mt -59.95 -42.94 95.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.843 -1.071 . . . . 10.17 110.986 178.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.0 p -61.87 -30.31 70.78 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 119.677 -0.809 . . . . 13.59 111.92 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.07 -29.02 70.01 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 120.687 -0.405 . . . . 11.7 110.498 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -99.89 13.81 32.58 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.268 -0.424 . . . . 12.95 111.657 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 50.07 39.98 20.44 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 112.056 0.391 . . . . 25.45 112.056 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.1 mt -81.04 121.54 34.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.362 -1.347 . . . . 14.6 107.362 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -107.49 169.13 8.77 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.324 0.583 . . . . 33.23 112.042 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -51.14 141.22 14.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.121 -0.945 . . . . 25.97 111.65 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.74 23.35 10.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.771 -1.104 . . . . 32.61 112.929 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.9 m -76.83 148.7 36.39 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.013 -1.106 . . . . 10.56 108.013 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -112.83 124.04 51.69 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 109.528 -0.545 . . . . 5.33 109.528 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.0 mp -105.17 157.41 17.3 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.626 -1.25 . . . . 11.66 107.626 177.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -112.25 134.08 54.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.23 -0.655 . . . . 16.3 109.23 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.5 tp -106.16 132.7 51.92 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.919 -0.771 . . . . 9.96 108.919 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.71 144.83 28.35 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 N-CA-C 107.609 -1.256 . . . . 9.76 107.609 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.3 mt -109.86 139.99 44.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.348 -0.842 . . . . 19.57 110.611 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.6 ttt180 -119.2 130.11 55.32 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.729 -0.669 . . . . 35.08 110.032 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 79.7 mt -120.04 128.74 53.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.449 -0.341 . . . . 32.31 110.356 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -69.79 -39.88 76.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 42.75 110.062 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -89.89 -179.96 44.38 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.787 -0.925 . . . . 36.31 110.787 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.73 0 CA-C-O 118.002 -1.444 . . . . 36.2 110.955 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.498 -0.556 . . . . 17.17 109.498 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -97.84 140.99 31.38 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.334 0.588 . . . . 21.89 110.165 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 pt -130.24 166.83 26.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 115.144 -0.935 . . . . 10.83 108.843 178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -124.54 139.3 54.01 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.503 -0.317 . . . . 10.61 111.01 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.2 t -121.27 124.17 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.597 -0.89 . . . . 9.13 108.597 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -101.05 142.13 32.95 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.984 0.421 . . . . 20.55 110.499 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.0 p -103.96 162.58 13.01 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.716 0.77 . . . . 11.78 111.076 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.64 -14.46 52.04 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.38 -1.282 . . . . 19.31 111.768 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.9 p -95.72 2.45 53.95 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 120.734 -0.386 . . . . 23.14 111.566 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.4 13.67 56.84 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.355 -0.45 . . . . 19.74 113.919 177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -91.17 142.1 28.1 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.286 -0.566 . . . . 21.93 110.42 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.1 m -116.96 127.56 54.33 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.681 -0.859 . . . . 12.33 108.681 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.3 mt -111.77 138.66 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 110.003 -0.369 . . . . 17.08 110.003 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -103.18 131.21 50.38 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 108.931 -0.766 . . . . 16.3 108.931 178.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.4 mt -127.19 149.92 49.76 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.703 0.287 . . . . 15.88 110.926 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -102.65 122.11 43.77 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.131 -1.803 . . . . 28.9 106.131 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.94 168.25 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.507 0.67 . . . . 12.05 111.485 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -117.81 149.22 44.83 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 107.227 -1.398 . . . . 18.17 107.227 177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.24 -24.4 59.15 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 CA-C-N 120.817 1.327 . . . . 8.16 112.844 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 p -85.28 -2.46 58.08 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 116.297 -0.41 . . . . 11.13 112.016 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -71.4 142.56 50.31 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.946 -1.131 . . . . 18.03 107.946 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -86.81 157.83 19.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.49 -1.232 . . . . 10.22 109.833 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.9 mm -61.27 -39.87 84.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.182 -0.917 . . . . 12.3 109.982 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.03 -37.63 80.35 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.73 -0.841 . . . . 36.51 108.73 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 55.2 t-20 -66.4 -42.82 87.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.475 -0.565 . . . . 25.66 109.475 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.5 t -60.61 -41.69 88.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 109.484 -0.562 . . . . 8.12 109.484 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.531 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 20.5 mttt -60.03 -39.98 87.79 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.342 -0.614 . . . . 15.47 109.342 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.61 -38.25 89.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.755 -0.657 . . . . 11.45 110.543 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 47.5 mttp -65.21 -39.11 92.36 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.65 -0.5 . . . . 24.98 109.65 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.2 mt -65.06 -40.05 87.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 109.713 -0.477 . . . . 9.46 109.713 178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -60.01 -44.07 94.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.389 0.614 . . . . 14.76 109.361 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.83 -40.45 92.83 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 114.987 -1.006 . . . . 26.29 110.938 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -81.55 -40.98 22.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.149 1.166 . . . . 30.06 114.149 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -111.12 -14.61 13.85 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.079 1.881 . . . . 25.19 116.079 -174.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.14 11.15 82.81 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 120.94 -0.648 . . . . 7.41 113.233 178.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.73 116.29 65.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 109.594 -0.521 . . . . 9.49 109.594 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -58.79 134.75 62.51 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.099 1.199 . . . . 11.42 112.415 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.46 -32.1 25.76 Favored 'Trans proline' 0 N--CA 1.507 2.268 0 C-N-CA 122.778 2.319 . . . . 12.0 114.684 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -70.8 -15.93 62.69 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.834 0.743 . . . . 35.55 112.179 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -100.06 2.45 43.29 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.765 0.284 . . . . 20.52 111.765 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -107.76 139.22 42.66 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 114.029 1.122 . . . . 7.13 114.029 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -126.57 124.34 39.75 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.217 -1.031 . . . . 36.39 108.217 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.24 131.05 54.61 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.238 0.542 . . . . 9.55 110.837 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -123.87 139.45 50.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 115.289 -0.869 . . . . 13.9 110.456 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -137.69 126.73 24.3 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.382 -0.827 . . . . 6.86 108.982 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.43 39.52 16.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.099 -0.5 . . . . 11.15 111.701 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.94 0.01 90.0 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 119.322 -0.71 . . . . 13.93 114.722 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -112.72 139.03 48.67 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 118.782 1.291 . . . . 23.92 111.74 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -78.86 129.67 34.82 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 108.216 -1.031 . . . . 23.23 108.216 177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.02 136.88 32.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.847 0.356 . . . . 9.11 111.195 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -90.14 149.48 22.43 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.123 -0.49 . . . . 33.44 111.521 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.531 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 63.3 m-20 -69.64 -20.07 63.61 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.774 1.028 . . . . 28.37 113.774 -176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.25 5.99 68.4 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 120.992 -0.623 . . . . 15.0 112.487 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -112.31 164.03 13.71 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 117.18 0.49 . . . . 25.5 111.648 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.1 p -105.57 166.43 10.45 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.624 0.726 . . . . 11.95 112.519 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 76.4 mt -59.97 -42.03 93.24 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.643 -1.162 . . . . 10.17 110.687 178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.6 t -61.48 -31.08 71.04 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 120.021 -0.672 . . . . 13.59 111.848 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.99 -28.96 69.93 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.641 -0.424 . . . . 11.7 110.578 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -99.06 14.64 28.53 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 111.653 0.242 . . . . 12.95 111.653 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.0 m120 50.01 39.42 18.9 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 122.944 0.498 . . . . 25.45 112.173 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -81.45 123.97 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.112 -1.07 . . . . 14.6 108.112 178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -107.0 169.07 8.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.295 0.569 . . . . 33.23 112.122 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -51.4 141.41 15.51 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 115.218 -0.901 . . . . 25.97 111.489 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 67.03 23.21 9.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.941 -1.027 . . . . 32.61 112.768 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 m -77.2 149.36 35.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.996 -1.113 . . . . 10.56 107.996 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.2 m -110.61 126.74 54.79 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.302 0.573 . . . . 5.33 109.724 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.93 157.36 17.27 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 107.858 -1.164 . . . . 11.66 107.858 177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -115.98 132.25 56.7 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 109.076 -0.713 . . . . 16.3 109.076 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.4 tp -106.85 133.18 51.89 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.787 -0.449 . . . . 9.96 109.787 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -122.45 136.86 57.91 Favored 'Isoleucine or valine' 0 C--N 1.345 0.403 0 N-CA-C 107.931 -1.136 . . . . 9.76 107.931 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 71' ' ' LEU . 6.7 mp -102.16 129.84 48.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.301 -0.863 . . . . 19.57 111.564 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -109.53 120.0 41.15 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 108.942 -0.762 . . . . 35.08 108.942 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.8 mt -104.99 120.99 42.82 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.968 0.413 . . . . 32.31 111.186 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -64.33 -40.9 96.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.895 -0.593 . . . . 42.75 110.512 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.26 -179.98 43.85 Favored Glycine 0 CA--C 1.525 0.668 0 CA-C-N 115.306 -0.861 . . . . 36.31 111.393 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.701 0 CA-C-O 117.976 -1.458 . . . . 36.2 110.919 179.818 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.641 -0.503 . . . . 17.17 109.641 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -97.06 140.89 30.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.403 0.62 . . . . 21.89 110.03 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.1 pt -130.29 166.37 28.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-N 115.073 -0.967 . . . . 10.83 109.156 178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -125.06 139.44 53.79 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.489 -0.323 . . . . 10.61 111.447 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.1 t -122.26 124.67 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.685 -0.857 . . . . 9.13 108.685 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -100.03 139.99 34.9 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.971 -0.381 . . . . 20.55 109.971 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -99.96 168.13 10.05 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-O 122.211 1.005 . . . . 11.78 110.703 179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.409 HD11 ' H ' ' A' ' 71' ' ' LEU . 72.2 mt -64.42 -20.51 66.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 113.509 -1.678 . . . . 19.31 111.043 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -93.77 0.03 56.13 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.353 0.501 . . . . 23.14 112.353 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.91 14.96 50.83 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 121.28 -0.486 . . . . 19.74 113.809 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -90.0 144.15 26.16 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.359 -0.536 . . . . 21.93 109.999 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -118.27 128.68 54.91 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.293 -0.632 . . . . 12.33 109.293 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mt -112.04 138.42 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 N-CA-C 109.962 -0.384 . . . . 17.08 109.962 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -103.49 131.16 50.84 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.811 -0.811 . . . . 16.3 108.811 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.2 mt -127.55 150.0 49.9 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.623 0.249 . . . . 15.88 110.882 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -100.33 121.93 42.3 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.178 -1.786 . . . . 28.9 106.178 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -139.94 167.15 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.573 0.702 . . . . 12.05 111.592 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -118.37 150.01 47.03 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 107.426 -1.324 . . . . 18.17 107.426 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -57.9 -24.99 67.52 Favored 'Trans proline' 0 C--N 1.318 -1.051 0 CA-C-N 120.834 1.334 . . . . 8.16 113.293 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 t -85.84 -1.75 57.56 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 111.901 0.334 . . . . 11.13 111.901 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -70.24 143.98 51.98 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 107.865 -1.161 . . . . 18.03 107.865 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.8 p -86.81 156.65 19.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.153 -1.385 . . . . 10.22 109.686 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.2 mm -60.37 -38.96 79.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.595 -0.729 . . . . 12.3 109.22 178.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -59.98 -39.23 85.01 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.059 -0.719 . . . . 36.51 109.059 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -65.13 -40.46 94.47 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 119.847 -0.741 . . . . 25.66 109.382 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.68 -43.9 99.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 109.712 -0.477 . . . . 8.12 109.712 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -60.03 -40.0 87.8 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 109.315 -0.624 . . . . 15.47 109.315 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.87 -38.12 89.59 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.861 -0.609 . . . . 11.45 110.645 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -65.46 -39.19 91.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.716 -0.475 . . . . 24.98 109.716 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.9 mt -64.93 -39.97 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 N-CA-C 109.556 -0.535 . . . . 9.46 109.556 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.05 -44.14 94.9 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.451 0.643 . . . . 14.76 109.609 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.02 -41.16 91.59 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.993 -1.003 . . . . 26.29 110.545 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.4 mttp -81.92 -40.25 22.6 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 114.421 1.267 . . . . 30.06 114.421 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -111.51 -14.27 13.72 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 116.189 1.922 . . . . 25.19 116.189 -174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.94 10.64 84.77 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 120.892 -0.67 . . . . 7.41 113.047 178.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.5 mt -84.86 116.86 67.18 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 119.092 -0.48 . . . . 9.49 109.793 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.85 140.91 95.42 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 CA-C-N 120.551 1.232 . . . . 11.42 112.519 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.12 -31.71 84.19 Favored 'Trans proline' 0 N--CA 1.51 2.45 0 C-N-CA 122.557 2.172 . . . . 12.0 114.928 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -70.93 -16.47 62.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.783 0.719 . . . . 35.55 112.439 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 72' ' ' ARG . 78.4 mm-40 -100.02 2.96 43.89 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.92 0.341 . . . . 20.52 111.92 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -107.79 139.92 41.65 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.743 1.016 . . . . 7.13 113.743 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -126.37 122.4 35.27 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 108.007 -1.109 . . . . 36.39 108.007 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.2 mt -105.44 130.4 53.54 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.307 0.575 . . . . 9.55 110.629 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.59 137.72 55.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.198 -0.91 . . . . 13.9 110.593 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -138.93 126.95 22.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.051 -0.977 . . . . 6.86 108.947 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 38.7 17.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.957 -0.565 . . . . 11.15 111.563 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.32 0.04 89.41 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.432 -0.649 . . . . 13.93 114.547 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -112.44 139.04 48.34 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.589 1.194 . . . . 23.92 111.827 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -78.48 128.71 33.96 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 107.755 -1.202 . . . . 23.23 107.755 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -86.52 136.26 33.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.841 0.353 . . . . 9.11 111.318 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.8 149.1 21.77 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.103 -0.499 . . . . 33.44 112.151 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.21 -20.88 65.76 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.572 0.953 . . . . 28.37 113.572 -178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.15 2.58 71.8 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 121.101 -0.571 . . . . 15.0 113.28 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.8 mmt85 -110.88 166.42 11.05 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 117.834 0.817 . . . . 25.5 111.398 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.437 ' OG1' ' OD2' ' A' ' 58' ' ' ASP . 70.4 p -107.49 167.55 9.86 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.605 0.717 . . . . 11.95 112.22 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.0 -41.8 92.88 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 114.504 -1.226 . . . . 10.17 111.029 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.0 t -60.8 -31.56 70.95 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 119.832 -0.747 . . . . 13.59 111.871 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' OD2' ' OG1' ' A' ' 55' ' ' THR . 7.2 m-20 -61.78 -29.05 69.88 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.445 -0.502 . . . . 11.7 111.14 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -99.0 13.31 33.21 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.668 0.247 . . . . 12.95 111.668 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 50.03 39.98 20.3 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 122.784 0.434 . . . . 25.45 112.036 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.6 mt -81.25 122.27 36.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 107.626 -1.25 . . . . 14.6 107.626 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.402 ' O ' ' OG ' ' A' ' 65' ' ' SER . 22.9 mm100 -106.91 169.19 8.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.384 0.612 . . . . 33.23 112.149 -177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -51.39 141.33 15.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.047 -0.979 . . . . 25.97 111.607 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.86 23.16 10.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.941 -1.027 . . . . 32.61 112.702 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 62' ' ' GLN . 37.0 m -77.38 149.15 35.23 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.041 -1.096 . . . . 10.56 108.041 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.3 m -113.6 123.82 50.86 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.62 -0.511 . . . . 5.33 109.62 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.1 mp -104.02 158.98 16.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 107.557 -1.275 . . . . 11.66 107.557 177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -114.23 132.95 55.94 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 109.205 -0.665 . . . . 16.3 109.205 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.6 tp -107.13 135.2 49.07 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.711 -0.477 . . . . 9.96 109.711 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -119.81 139.93 45.52 Favored 'Isoleucine or valine' 0 C--N 1.344 0.338 0 N-CA-C 107.476 -1.305 . . . . 9.76 107.476 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.409 ' H ' HD11 ' A' ' 8' ' ' LEU . 62.8 mt -104.53 145.19 30.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.073 -0.967 . . . . 19.57 111.526 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.434 ' O ' ' OE1' ' A' ' 40' ' ' GLN . 63.2 mtp180 -119.98 139.9 51.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.394 -0.821 . . . . 35.08 109.819 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.8 mt -123.16 129.32 51.27 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.98 -0.378 . . . . 32.31 109.98 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -79.02 -28.15 43.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 42.75 110.668 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.04 -161.79 45.85 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.08 -0.808 . . . . 36.31 111.08 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.78 0 CA-C-O 117.997 -1.446 . . . . 36.2 110.921 179.955 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.413 -0.588 . . . . 17.17 109.413 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -97.86 140.67 31.87 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.402 0.62 . . . . 21.89 110.403 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.2 pt -130.02 166.97 26.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 115.067 -0.97 . . . . 10.83 108.851 178.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 27.4 m-85 -126.36 138.55 53.57 Favored 'General case' 0 C--O 1.22 -0.484 0 CA-C-N 116.357 -0.383 . . . . 10.61 111.18 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -120.3 125.4 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 109.177 -0.675 . . . . 9.13 109.177 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -100.32 140.0 35.19 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 110.07 -0.345 . . . . 20.55 110.07 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.9 p -102.52 164.19 11.8 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.965 0.888 . . . . 11.78 110.764 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.88 -20.01 54.73 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.887 -1.506 . . . . 19.31 110.809 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.3 p -94.38 5.57 51.37 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.313 0.486 . . . . 23.14 112.313 -178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.15 14.07 64.99 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-N 116.084 -0.507 . . . . 19.74 113.87 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -89.98 142.29 27.84 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 120.259 -0.576 . . . . 21.93 110.175 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.5 m -116.67 127.73 54.7 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.913 -0.773 . . . . 12.33 108.913 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 mt -111.45 138.23 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 109.677 -0.49 . . . . 17.08 109.677 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -102.25 130.87 49.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 108.645 -0.872 . . . . 16.3 108.645 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -127.07 149.36 49.96 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.667 0.27 . . . . 15.88 110.696 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -101.22 121.61 42.17 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 106.016 -1.846 . . . . 28.9 106.016 176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.01 168.02 18.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.573 0.702 . . . . 12.05 111.35 -178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 16.3 mp0 -117.74 147.85 41.89 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 107.188 -1.412 . . . . 18.17 107.188 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -55.77 -24.29 45.84 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 CA-C-N 120.785 1.316 . . . . 8.16 112.769 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 p -85.02 -0.79 55.59 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.38 -0.373 . . . . 11.13 111.965 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -71.06 144.14 50.46 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.213 -1.032 . . . . 18.03 108.213 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.7 p -86.42 157.41 19.84 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.227 -1.352 . . . . 10.22 110.196 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.2 mm -61.3 -40.7 86.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.717 -0.674 . . . . 12.3 109.881 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.98 -36.7 80.13 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.219 -0.66 . . . . 36.51 109.219 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -67.58 -44.13 78.94 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.779 -0.452 . . . . 25.66 109.779 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -60.02 -41.1 85.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 108.275 -1.009 . . . . 8.12 108.275 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HZ2' ' HB2' ' A' ' 27' ' ' LYS . 5.4 mtmp? -60.1 -40.08 88.39 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 109.848 -0.427 . . . . 15.47 109.848 177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.96 -38.03 89.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.255 -0.43 . . . . 11.45 110.238 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -65.85 -38.46 88.93 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.593 -0.521 . . . . 24.98 109.593 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mt -65.27 -40.22 87.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 N-CA-C 109.574 -0.528 . . . . 9.46 109.574 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -60.02 -43.9 94.97 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.167 -0.679 . . . . 14.76 109.167 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -59.99 -41.12 91.37 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.911 -1.04 . . . . 26.29 110.494 -178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.5 mttm -82.15 -39.45 23.22 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.472 1.286 . . . . 30.06 114.472 -177.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.86 -15.47 13.35 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.131 1.901 . . . . 25.19 116.131 -174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.5 10.78 84.02 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 120.85 -0.691 . . . . 7.41 113.056 178.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.3 mt -84.66 116.1 63.67 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 109.67 -0.493 . . . . 9.49 109.67 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.77 135.87 66.6 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 CA-C-N 120.443 1.194 . . . . 11.42 112.911 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.02 -31.44 44.19 Favored 'Trans proline' 0 N--CA 1.509 2.39 0 C-N-CA 122.777 2.318 . . . . 12.0 115.076 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -71.42 -17.5 62.38 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.875 0.761 . . . . 35.55 112.025 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.46 ' OE1' ' O ' ' A' ' 72' ' ' ARG . 51.3 mm-40 -99.87 1.98 43.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.332 . . . . 20.52 111.279 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -106.86 138.8 42.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 113.601 0.963 . . . . 7.13 113.601 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.496 HH21 ' NH2' ' A' ' 72' ' ' ARG . 94.3 mtt-85 -126.41 122.47 35.4 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.968 -1.123 . . . . 36.39 107.968 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.5 mt -103.06 129.69 49.95 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.226 0.536 . . . . 9.55 110.383 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -127.84 137.54 57.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 115.313 -0.858 . . . . 13.9 111.571 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -139.0 130.13 26.67 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 115.361 -0.836 . . . . 6.86 109.977 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.18 40.35 21.8 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.864 -0.607 . . . . 11.15 111.9 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 0.62 85.71 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.73 -0.668 . . . . 13.93 114.109 176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -113.36 138.36 50.18 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 118.572 1.186 . . . . 23.92 111.855 -178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -78.5 128.43 33.56 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.482 -0.933 . . . . 23.23 108.482 178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.4 mt -87.03 136.68 32.83 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.825 0.345 . . . . 9.11 111.302 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -92.48 150.97 20.45 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.31 0.576 . . . . 33.44 112.459 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.78 -19.93 64.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.047 -0.979 . . . . 28.37 113.473 -177.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.95 3.11 70.07 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 121.073 -0.584 . . . . 15.0 113.028 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -110.07 164.63 12.44 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.796 0.798 . . . . 25.5 111.465 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 53.2 p -106.76 167.11 10.09 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.62 0.724 . . . . 11.95 112.011 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.03 -43.52 95.24 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.692 -1.14 . . . . 10.17 110.863 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.9 m -60.34 -32.16 70.99 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 119.943 -0.703 . . . . 13.59 111.956 -178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.27 -27.89 68.79 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.478 -0.489 . . . . 11.7 110.829 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -99.98 14.7 29.65 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 111.89 0.33 . . . . 12.95 111.89 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' O ' ' CG ' ' A' ' 60' ' ' ASN . 28.7 t-20 50.05 39.55 19.35 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.81 0.338 . . . . 25.45 111.839 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.56 122.81 37.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 107.837 -1.172 . . . . 14.6 107.837 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -108.12 169.4 8.64 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.341 0.591 . . . . 33.23 112.279 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -51.59 141.78 15.59 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.066 -0.97 . . . . 25.97 111.626 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 67.18 23.17 9.57 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.127 -0.942 . . . . 32.61 112.455 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.1 m -78.11 148.71 34.06 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.017 -1.105 . . . . 10.56 108.017 175.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.6 m -110.49 126.11 54.01 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.202 0.525 . . . . 5.33 109.896 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.4 mp -104.2 158.36 16.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.572 -1.269 . . . . 11.66 107.572 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -116.36 131.62 56.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.709 -0.678 . . . . 16.3 109.29 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.1 tp -107.85 133.04 52.79 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 109.495 -0.557 . . . . 9.96 109.495 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.45 138.75 49.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 107.973 -1.121 . . . . 9.76 107.973 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.6 mt -100.01 130.03 46.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.635 -1.166 . . . . 19.57 111.28 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' NH2' HH21 ' A' ' 42' ' ' ARG . 59.2 ttp180 -106.68 137.09 45.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.476 -0.784 . . . . 35.08 109.826 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.4 mt -126.33 144.62 50.74 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.794 0.331 . . . . 32.31 110.422 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.1 ttm-85 -129.98 130.6 45.24 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.249 -0.432 . . . . 42.75 110.258 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.74 172.55 29.98 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.731 -0.948 . . . . 36.31 110.731 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.766 0 CA-C-O 117.992 -1.449 . . . . 36.2 110.977 179.916 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.688 -0.486 . . . . 17.17 109.688 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -98.59 142.2 30.47 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.29 0.567 . . . . 21.89 110.358 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -130.22 167.75 24.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 115.125 -0.943 . . . . 10.83 109.122 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -124.94 138.89 54.22 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.395 -0.366 . . . . 10.61 110.876 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.7 t -121.56 124.64 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 108.705 -0.85 . . . . 9.13 108.705 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -100.02 141.67 32.52 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.832 0.348 . . . . 20.55 110.419 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -102.08 170.04 8.36 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 122.367 1.08 . . . . 11.78 111.088 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.44 -21.26 66.63 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 113.004 -1.907 . . . . 19.31 111.178 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.9 p -93.6 7.54 44.28 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.481 0.548 . . . . 23.14 112.481 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.74 64.06 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.101 -0.571 . . . . 19.74 113.206 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.435 ' HZ3' ' HB3' ' A' ' 11' ' ' LYS . 6.7 ttpm? -90.3 140.58 29.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.506 -0.477 . . . . 21.93 110.088 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -115.27 126.21 54.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.581 -0.896 . . . . 12.33 108.581 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -110.79 138.67 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 109.891 -0.411 . . . . 17.08 109.891 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -102.66 131.09 49.68 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.45 -0.944 . . . . 16.3 108.45 178.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.8 mt -126.79 148.46 49.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.683 0.278 . . . . 15.88 110.569 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -103.11 122.24 44.26 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 105.964 -1.865 . . . . 28.9 105.964 176.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.408 ' C ' ' OE2' ' A' ' 18' ' ' GLU . 35.7 m -140.08 168.96 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.415 0.626 . . . . 12.05 111.228 -178.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' OE2' ' C ' ' A' ' 17' ' ' VAL . 1.7 mp0 -116.93 149.24 43.77 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 107.357 -1.349 . . . . 18.17 107.357 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -57.28 -25.09 63.25 Favored 'Trans proline' 0 C--N 1.32 -0.969 0 CA-C-N 120.912 1.361 . . . . 8.16 112.837 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 t -85.69 -1.69 57.43 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.371 -0.377 . . . . 11.13 111.715 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -69.99 144.01 52.43 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.714 -1.217 . . . . 18.03 107.714 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 p -86.29 156.78 20.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.084 -1.416 . . . . 10.22 109.898 178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -61.27 -39.54 82.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.677 -0.692 . . . . 12.3 109.242 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.21 -38.06 82.19 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 108.896 -0.779 . . . . 36.51 108.896 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -66.41 -42.03 88.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.278 -0.638 . . . . 25.66 109.278 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -61.35 -42.27 93.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.482 -0.562 . . . . 8.12 109.482 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 24.1 mttt -60.0 -40.08 87.96 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.076 -0.713 . . . . 15.47 109.076 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.55 90.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.763 -0.653 . . . . 11.45 110.636 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.06 -38.92 92.36 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.428 -0.509 . . . . 24.98 109.91 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.0 mt -64.94 -40.38 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.631 -0.507 . . . . 9.46 109.631 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.92 -44.73 94.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.381 0.61 . . . . 14.76 109.587 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -60.5 -40.19 90.48 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.941 -1.027 . . . . 26.29 110.918 -178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -82.0 -39.72 23.17 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.27 1.211 . . . . 30.06 114.27 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.29 -15.46 13.61 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.217 1.932 . . . . 25.19 116.217 -174.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.14 10.96 83.1 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 120.912 -0.661 . . . . 7.41 113.115 178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.1 mt -85.56 117.12 68.14 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-O 119.158 -0.449 . . . . 9.49 109.832 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.54 133.07 49.51 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 120.528 1.224 . . . . 11.42 112.315 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.32 -30.68 15.67 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 122.851 2.367 . . . . 12.0 114.53 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -71.88 -16.04 62.12 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.21 -0.596 . . . . 35.55 111.606 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -100.04 1.27 42.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 111.831 0.308 . . . . 20.52 111.831 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -105.91 138.57 41.88 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.586 0.958 . . . . 7.13 113.586 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.412 ' HE ' ' HD2' ' A' ' 72' ' ' ARG . 85.1 mtt-85 -125.71 121.66 34.08 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.727 -1.212 . . . . 36.39 107.727 176.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -104.52 129.97 52.52 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.241 0.543 . . . . 9.55 110.842 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -123.71 138.61 52.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-N 115.335 -0.848 . . . . 13.9 110.451 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -136.53 126.26 25.56 Favored 'General case' 0 CA--C 1.522 -0.128 0 CA-C-N 115.074 -0.966 . . . . 6.86 109.049 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.85 39.43 14.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.974 -0.557 . . . . 11.15 111.472 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.72 0.02 89.7 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.302 -0.721 . . . . 13.93 114.772 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -112.92 138.82 49.2 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 118.856 1.328 . . . . 23.92 111.872 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -78.61 129.56 34.9 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.421 -0.955 . . . . 23.23 108.421 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -87.12 136.9 32.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.723 0.297 . . . . 9.11 111.197 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -90.87 150.1 21.67 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.16 0.505 . . . . 33.44 111.61 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.496 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 39.3 m-20 -69.13 -19.99 64.04 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.631 0.975 . . . . 28.37 113.631 -177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.41 4.34 69.86 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 121.055 -0.593 . . . . 15.0 112.824 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -110.78 166.32 11.12 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.512 0.656 . . . . 25.5 111.253 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -107.58 167.33 10.03 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.579 0.704 . . . . 11.95 112.214 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.6 mt -60.0 -42.24 93.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.702 -1.135 . . . . 10.17 111.138 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -61.96 -29.99 70.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 119.725 -0.79 . . . . 13.59 112.025 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.21 -27.98 69.36 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.607 -0.437 . . . . 11.7 110.822 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -99.7 15.34 27.12 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.625 0.231 . . . . 12.95 111.625 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 14.0 p30 49.78 38.85 16.61 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 122.768 0.427 . . . . 25.45 111.861 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.42 124.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 108.027 -1.101 . . . . 14.6 108.027 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -107.07 168.89 8.89 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.362 0.601 . . . . 33.23 112.139 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -51.81 141.46 17.17 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.137 -0.938 . . . . 25.97 111.821 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 67.01 23.6 9.74 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.949 -1.023 . . . . 32.61 112.633 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.3 m -77.01 149.93 35.84 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.064 -1.087 . . . . 10.56 108.064 176.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -110.46 126.19 54.08 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.228 0.537 . . . . 5.33 109.791 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -104.38 156.61 17.78 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.594 -1.261 . . . . 11.66 107.594 178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -115.42 131.81 56.81 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.762 -0.829 . . . . 16.3 108.762 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.3 131.56 53.37 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.349 -0.611 . . . . 9.96 109.349 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.72 141.45 41.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 N-CA-C 107.651 -1.24 . . . . 9.76 107.651 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 73.7 mt -103.48 137.11 42.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.098 -0.956 . . . . 19.57 110.863 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.412 ' HD2' ' HE ' ' A' ' 42' ' ' ARG . 70.0 ttt180 -120.01 134.94 55.1 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.971 -0.558 . . . . 35.08 110.185 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.0 140.04 51.57 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.21 -0.45 . . . . 32.31 110.093 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -128.2 129.54 46.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.152 -0.477 . . . . 42.75 110.153 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.33 -178.19 38.63 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.912 -0.875 . . . . 36.31 110.912 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.803 0 CA-C-O 118.027 -1.429 . . . . 36.2 110.872 179.802 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ptt? . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.524 -0.547 . . . . 17.17 109.524 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -98.1 140.73 31.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.356 0.598 . . . . 21.89 110.228 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 pt -130.05 167.22 25.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.132 -0.94 . . . . 10.83 109.102 178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -125.24 138.33 54.11 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.228 -0.442 . . . . 10.61 111.328 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.4 124.83 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.553 -0.906 . . . . 9.13 108.553 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -100.35 140.03 35.19 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 109.676 -0.491 . . . . 20.55 109.676 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 p -103.3 163.7 12.09 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.857 0.837 . . . . 11.78 110.68 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.9 mt -62.87 -16.06 57.27 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.074 -1.421 . . . . 19.31 111.077 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -95.2 4.35 53.66 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.752 -0.379 . . . . 23.14 111.759 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.63 14.1 63.98 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 116.17 -0.468 . . . . 19.74 113.915 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.8 tttp -91.1 143.74 26.38 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 120.092 -0.643 . . . . 21.93 110.09 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.2 m -117.34 127.06 53.68 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.095 -0.705 . . . . 12.33 109.095 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.8 mt -110.81 137.82 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.809 -0.441 . . . . 17.08 109.809 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -102.78 131.12 49.85 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.796 -0.816 . . . . 16.3 108.796 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.7 mt -126.63 148.55 49.79 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.679 0.276 . . . . 15.88 110.852 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 17' ' ' VAL . 0.4 OUTLIER -101.91 121.69 42.61 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 105.948 -1.871 . . . . 28.9 105.948 176.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.533 ' N ' ' OE2' ' A' ' 16' ' ' GLU . 33.8 m -140.74 169.65 15.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.461 0.648 . . . . 12.05 111.485 -178.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 6.4 mp0 -117.08 147.64 40.66 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 106.772 -1.566 . . . . 18.17 106.772 176.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -55.41 -23.37 38.23 Favored 'Trans proline' 0 C--N 1.315 -1.224 0 CA-C-N 120.787 1.317 . . . . 8.16 112.515 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 t -85.82 -0.32 54.99 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 112.254 0.464 . . . . 11.13 112.254 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 18' ' ' GLU . 4.1 m-20 -69.53 144.37 53.15 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 108.028 -1.101 . . . . 18.03 108.028 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.7 p -86.19 157.4 19.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.593 -1.185 . . . . 10.22 109.628 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.76 -39.99 83.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.597 -0.729 . . . . 12.3 109.284 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -59.98 -38.17 81.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.935 -0.765 . . . . 36.51 108.935 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -66.43 -43.14 86.52 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.411 -0.516 . . . . 25.66 109.72 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -60.43 -43.1 93.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 109.506 -0.553 . . . . 8.12 109.506 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -60.01 -40.0 87.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 109.405 -0.591 . . . . 15.47 109.405 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.13 89.33 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.752 -0.658 . . . . 11.45 110.474 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -64.94 -39.46 93.53 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.905 -0.405 . . . . 24.98 109.905 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.8 mt -64.41 -39.92 87.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 109.686 -0.487 . . . . 9.46 109.686 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.03 -44.42 94.65 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 109.306 -0.627 . . . . 14.76 109.306 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.04 -40.69 90.23 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.133 -0.939 . . . . 26.29 110.73 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -81.85 -40.34 22.6 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.51 1.3 . . . . 30.06 114.51 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.61 -13.98 14.13 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 116.189 1.922 . . . . 25.19 116.189 -174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.48 11.08 83.65 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 120.91 -0.662 . . . . 7.41 113.061 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.46 116.93 67.71 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.517 -0.549 . . . . 9.49 109.517 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -59.1 133.36 52.67 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 CA-C-N 120.54 1.229 . . . . 11.42 112.411 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.57 -29.94 15.14 Favored 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 122.836 2.357 . . . . 12.0 114.324 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -72.3 -16.87 61.9 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.208 -0.597 . . . . 35.55 111.263 -178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -100.07 -0.01 39.92 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.751 0.31 . . . . 20.52 111.523 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -106.06 138.82 41.58 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.53 0.937 . . . . 7.13 113.53 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 mtt85 -126.9 122.57 35.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.985 -1.007 . . . . 36.39 108.594 177.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.6 mt -104.42 129.99 52.35 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.26 0.552 . . . . 9.55 110.193 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mt -127.89 138.37 54.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 115.266 -0.879 . . . . 13.9 111.274 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -136.77 129.35 30.31 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.685 -0.689 . . . . 6.86 110.01 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.11 40.18 16.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.829 -0.623 . . . . 11.15 111.899 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.93 0.13 89.13 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 119.28 -0.733 . . . . 13.93 114.607 176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -112.4 139.01 48.32 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.848 1.324 . . . . 23.92 111.425 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -79.31 129.09 34.12 Favored 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 107.906 -1.146 . . . . 23.23 107.906 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.6 mt -86.92 136.81 32.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.824 0.345 . . . . 9.11 111.453 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -91.4 149.97 21.47 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.056 0.455 . . . . 33.44 112.059 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -67.98 -20.09 65.0 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.599 0.963 . . . . 28.37 113.599 -177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.49 5.36 70.46 Favored Glycine 0 CA--C 1.537 1.432 0 C-N-CA 121.016 -0.611 . . . . 15.0 112.97 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.4 mmm-85 -110.93 165.04 12.18 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 117.508 0.654 . . . . 25.5 111.456 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.3 p -107.83 167.3 10.07 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 121.498 0.666 . . . . 11.95 111.87 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.92 -42.11 93.22 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.85 -1.068 . . . . 10.17 110.898 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.9 m -60.83 -31.76 71.17 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 119.934 -0.706 . . . . 13.59 111.975 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.3 -28.53 69.26 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.641 -0.424 . . . . 11.7 110.85 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.98 15.2 27.95 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 111.935 0.346 . . . . 12.95 111.935 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 m120 49.95 39.66 19.2 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 122.811 0.445 . . . . 25.45 111.94 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.56 123.03 37.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.109 -1.071 . . . . 14.6 108.109 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -108.67 169.88 8.38 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.267 0.556 . . . . 33.23 112.238 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -51.66 141.82 15.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.132 -0.94 . . . . 25.97 111.43 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 66.78 22.57 10.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.013 -0.994 . . . . 32.61 112.636 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.8 m -77.32 149.25 35.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.952 -1.129 . . . . 10.56 107.952 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -110.26 126.03 53.74 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 121.275 0.559 . . . . 5.33 110.054 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.6 mp -103.65 156.44 17.79 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.431 -1.322 . . . . 11.66 107.431 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -115.43 131.13 57.03 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 108.673 -0.862 . . . . 16.3 108.673 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 45.9 tp -106.28 133.11 51.48 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.603 -0.518 . . . . 9.96 109.603 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.01 129.96 74.83 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 N-CA-C 107.791 -1.189 . . . . 9.76 107.791 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.6 mt -100.61 130.1 46.62 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.588 -1.187 . . . . 19.57 110.967 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.485 ' HG2' ' H ' ' A' ' 74' ' ' ARG . 45.2 ttt180 -108.81 130.11 55.4 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.399 -0.593 . . . . 35.08 109.399 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 73' ' ' LEU . 7.0 mp -100.97 32.25 3.28 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.01 0.374 . . . . 32.31 112.01 -178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.485 ' H ' ' HG2' ' A' ' 72' ' ' ARG . 65.2 ttt-85 -160.78 160.0 30.72 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.967 -0.293 . . . . 42.75 110.576 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.4 ' N ' ' CG ' ' A' ' 74' ' ' ARG . . . 89.97 -9.02 78.69 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.921 -0.871 . . . . 36.31 110.921 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.736 0 CA-C-O 118.046 -1.419 . . . . 36.2 110.821 -179.914 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.654 -0.499 . . . . 17.17 109.654 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -97.41 140.66 31.53 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.41 0.624 . . . . 21.89 110.067 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.5 pt -130.25 166.62 27.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.033 -0.985 . . . . 10.83 108.859 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -124.63 139.99 53.36 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.451 -0.341 . . . . 10.61 111.194 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.97 124.58 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 108.873 -0.788 . . . . 9.13 108.873 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -99.72 140.02 34.53 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.965 -0.383 . . . . 20.55 109.965 178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.5 p -99.82 169.98 8.85 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-O 122.228 1.014 . . . . 11.78 110.627 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.5 mt -63.42 -23.9 67.6 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 113.269 -1.787 . . . . 19.31 111.161 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -91.54 0.04 57.55 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.765 0.654 . . . . 23.14 112.765 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.44 15.15 51.76 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.082 -0.58 . . . . 19.74 113.478 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -89.61 144.87 25.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.699 -0.482 . . . . 21.93 109.699 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.4 m -118.4 128.9 55.06 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 109.626 -0.509 . . . . 12.33 109.626 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -112.02 139.39 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.9 -0.407 . . . . 17.08 109.9 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -101.03 130.68 47.08 Favored 'General case' 0 C--O 1.23 0.076 0 N-CA-C 108.699 -0.852 . . . . 16.3 108.699 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mp -125.41 147.39 49.2 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 110.043 -0.354 . . . . 15.88 110.043 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -102.2 121.72 42.78 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 105.753 -1.943 . . . . 28.9 105.753 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.0 167.75 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 121.659 0.742 . . . . 12.05 111.768 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 25.4 mp0 -118.66 149.7 46.83 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 107.418 -1.327 . . . . 18.17 107.418 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -57.35 -24.73 61.84 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 CA-C-N 120.847 1.338 . . . . 8.16 113.103 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.9 p -85.14 -1.61 57.08 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.003 0.372 . . . . 11.13 112.003 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -70.61 142.97 51.64 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.059 -1.089 . . . . 18.03 108.059 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -86.07 157.77 19.98 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.444 -1.253 . . . . 10.22 109.939 178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.9 mm -61.15 -39.91 84.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 12.3 109.344 178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -60.08 -38.58 83.34 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.912 -0.773 . . . . 36.51 108.912 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -65.68 -39.96 91.87 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.973 -0.691 . . . . 25.66 109.495 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.79 -43.95 99.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 109.671 -0.492 . . . . 8.12 109.671 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 mttm -60.06 -39.93 87.71 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.379 -0.6 . . . . 15.47 109.379 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.71 -38.18 89.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.799 -0.637 . . . . 11.45 110.422 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.1 mttp -64.69 -39.67 94.06 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.702 -0.481 . . . . 24.98 109.702 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.41 HG21 ' OE1' ' A' ' 41' ' ' GLN . 63.4 mt -64.5 -40.08 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 109.852 -0.425 . . . . 9.46 109.852 178.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -59.96 -44.26 94.53 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.382 0.61 . . . . 14.76 109.464 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -62.03 -40.2 94.92 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.099 -0.955 . . . . 26.29 111.252 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -80.96 -42.37 21.38 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.95 1.093 . . . . 30.06 113.95 -177.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -110.35 -11.26 14.54 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 115.856 1.799 . . . . 25.19 115.856 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.74 10.44 85.14 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 120.799 -0.715 . . . . 7.41 113.136 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mt -83.77 130.6 54.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.291 -0.633 . . . . 9.49 109.291 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.57 133.07 16.78 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 121.392 1.394 . . . . 11.42 112.2 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.91 -30.66 24.5 Favored 'Trans proline' 0 N--CA 1.507 2.28 0 C-N-CA 122.833 2.355 . . . . 12.0 115.084 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 39' ' ' ASP . 60.8 t0 -71.9 -17.96 62.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.413 0.552 . . . . 35.55 111.559 -178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 72' ' ' ARG . 16.1 mm100 -99.98 -0.02 40.16 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.927 0.343 . . . . 20.52 111.927 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' OE1' HG21 ' A' ' 30' ' ' ILE . 62.7 mt-30 -106.1 139.59 40.39 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.948 1.092 . . . . 7.13 113.948 -177.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -126.28 122.66 36.13 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 114.469 -1.242 . . . . 36.39 108.125 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -103.36 129.99 50.56 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.246 0.546 . . . . 9.55 110.082 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.4 mt -126.36 136.13 61.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.25 -0.887 . . . . 13.9 111.589 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -138.08 128.99 27.04 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.105 -0.952 . . . . 6.86 109.62 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.12 40.16 21.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.968 -0.56 . . . . 11.15 112.006 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.95 0.47 85.44 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.764 -0.653 . . . . 13.93 114.296 177.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -112.88 138.56 49.54 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.44 1.12 . . . . 23.92 111.691 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -78.33 129.42 34.98 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 108.349 -0.982 . . . . 23.23 108.349 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 mt -86.85 136.4 32.98 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.827 0.346 . . . . 9.11 111.192 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -91.99 149.94 21.26 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.142 -0.481 . . . . 33.44 112.254 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -67.22 -20.05 65.63 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 113.493 0.923 . . . . 28.37 113.493 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.48 3.13 68.41 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 121.04 -0.6 . . . . 15.0 113.203 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.5 mmt-85 -110.94 166.21 11.23 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 117.768 0.784 . . . . 25.5 111.37 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.2 p -107.52 167.38 9.98 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.568 0.699 . . . . 11.95 112.294 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.06 -42.35 94.3 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.842 -1.072 . . . . 10.17 111.143 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.2 p -61.92 -30.05 70.63 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.613 -0.835 . . . . 13.59 111.777 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -62.39 -28.3 69.68 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.524 -0.47 . . . . 11.7 110.813 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.77 14.21 31.05 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 111.6 0.222 . . . . 12.95 111.6 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 50.03 39.8 19.83 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 112.022 0.378 . . . . 25.45 112.022 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.18 121.73 35.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 107.547 -1.279 . . . . 14.6 107.547 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -106.64 168.96 8.82 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.294 0.569 . . . . 33.23 112.089 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -51.2 141.31 14.82 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.129 -0.941 . . . . 25.97 111.479 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 66.9 22.96 10.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.085 -0.961 . . . . 32.61 112.667 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.2 m -77.6 148.37 35.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.946 -1.131 . . . . 10.56 107.946 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.5 m -111.85 124.47 52.42 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.447 -0.575 . . . . 5.33 109.447 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.2 mp -104.44 159.15 15.97 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 107.511 -1.292 . . . . 11.66 107.511 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -113.44 132.48 55.63 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.547 -0.751 . . . . 16.3 109.431 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.3 tp -105.92 132.48 51.98 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 108.705 -0.85 . . . . 9.96 108.705 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.02 137.78 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.027 -1.472 . . . . 9.76 107.027 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.7 mt -103.73 137.74 41.34 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.25 -0.886 . . . . 19.57 110.044 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.544 ' O ' ' NE2' ' A' ' 40' ' ' GLN . 75.1 ttt180 -119.88 139.99 51.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.18 -0.463 . . . . 35.08 109.832 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.8 mt -117.37 173.96 6.4 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.401 -0.363 . . . . 32.31 110.923 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 60.02 82.37 0.16 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.779 -0.646 . . . . 42.75 110.262 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.96 -164.36 32.24 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.038 -0.825 . . . . 36.31 111.038 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.434 ' O ' ' OE1' ' A' ' 40' ' ' GLN . . . . . . . . 0 C--O 1.219 -0.801 0 CA-C-O 118.042 -1.421 . . . . 36.2 111.052 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.612 -0.514 . . . . 17.17 109.612 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -98.77 140.85 32.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.251 0.548 . . . . 21.89 110.387 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.9 pt -130.08 167.91 24.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.183 -0.917 . . . . 10.83 109.463 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -124.01 138.77 54.41 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.182 -0.463 . . . . 10.61 111.16 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.54 124.0 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 108.327 -0.99 . . . . 9.13 108.327 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -99.94 142.7 31.07 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.854 0.359 . . . . 20.55 110.577 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.7 p -102.27 165.73 10.97 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-O 122.029 0.918 . . . . 11.78 110.976 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -63.89 -18.75 64.5 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 113.65 -1.614 . . . . 19.31 111.214 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.9 p -94.22 2.58 55.9 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.205 0.446 . . . . 23.14 112.205 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.14 14.19 56.43 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.192 -0.528 . . . . 19.74 113.627 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -90.26 143.09 27.09 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.299 -0.56 . . . . 21.93 110.157 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -117.41 127.55 54.14 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.642 -0.873 . . . . 12.33 108.642 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mt -111.84 139.83 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 109.825 -0.435 . . . . 17.08 109.825 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.0 m -103.62 131.78 50.45 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 108.571 -0.9 . . . . 16.3 108.571 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.0 mt -127.53 149.98 49.89 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.577 0.227 . . . . 15.88 110.533 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -102.14 122.21 43.7 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 106.326 -1.731 . . . . 28.9 106.326 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -140.01 167.7 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.629 0.728 . . . . 12.05 111.73 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -117.85 151.53 48.86 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.362 -1.347 . . . . 18.17 107.362 177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -59.37 -24.46 74.6 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 CA-C-N 120.911 1.361 . . . . 8.16 112.974 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 t -85.98 -1.88 57.76 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 112.025 0.38 . . . . 11.13 112.025 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -70.79 143.9 51.02 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.832 -1.173 . . . . 18.03 107.832 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.422 ' OG1' ' OD1' ' A' ' 25' ' ' ASN . 71.4 p -87.07 157.0 19.51 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.086 -1.415 . . . . 10.22 109.746 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 23' ' ' ILE . 34.5 mm -60.73 -38.57 79.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.392 -0.822 . . . . 12.3 109.497 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -60.08 -39.48 86.24 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.206 -0.664 . . . . 36.51 109.206 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.422 ' OD1' ' OG1' ' A' ' 22' ' ' THR . 21.9 m120 -64.66 -40.23 95.08 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 119.753 -0.779 . . . . 25.66 108.958 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.8 t -62.27 -43.82 98.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.25 -0.432 . . . . 8.12 109.936 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 21.5 mttt -59.97 -40.13 88.03 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 109.519 -0.548 . . . . 15.47 109.519 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.94 88.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.831 -0.622 . . . . 11.45 110.436 -178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -65.6 -38.13 88.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.672 -0.492 . . . . 24.98 109.672 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.3 mt -65.71 -40.37 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 109.569 -0.53 . . . . 9.46 109.569 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -60.0 -44.78 94.31 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 109.331 -0.618 . . . . 14.76 109.331 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -60.26 -39.94 88.58 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.014 -0.994 . . . . 26.29 110.607 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -80.66 -42.32 22.28 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.297 1.221 . . . . 30.06 114.297 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -111.23 -13.75 13.93 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 116.272 1.953 . . . . 25.19 116.272 -174.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.3 10.85 84.15 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 120.823 -0.703 . . . . 7.41 113.003 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -85.31 115.73 62.55 Favored Pre-proline 0 CA--C 1.54 0.563 0 N-CA-C 109.473 -0.566 . . . . 9.49 109.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -58.41 134.72 63.19 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 CA-C-N 120.463 1.201 . . . . 11.42 112.384 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.63 -31.06 23.75 Favored 'Trans proline' 0 N--CA 1.506 2.239 0 C-N-CA 122.791 2.327 . . . . 12.0 114.375 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -71.59 -15.48 62.26 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.119 -0.632 . . . . 35.55 111.673 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -100.01 0.7 41.5 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.813 0.301 . . . . 20.52 111.813 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -107.1 139.87 40.83 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.279 1.214 . . . . 7.13 114.279 -177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -126.47 123.37 37.67 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.501 -1.227 . . . . 36.39 108.109 176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.9 mt -106.01 130.1 54.0 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.208 0.528 . . . . 9.55 110.573 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mp -124.06 139.48 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 115.381 -0.827 . . . . 13.9 110.582 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -138.8 127.58 23.53 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 115.139 -0.937 . . . . 6.86 109.011 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.01 39.99 20.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.987 -0.552 . . . . 11.15 111.717 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.17 0.19 88.51 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 119.356 -0.691 . . . . 13.93 114.648 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -112.63 139.08 48.53 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.708 1.254 . . . . 23.92 111.686 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -78.8 128.72 33.76 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 108.177 -1.045 . . . . 23.23 108.177 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.3 mt -87.25 136.86 32.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.438 -0.346 . . . . 9.11 111.197 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -90.49 149.98 21.98 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.204 0.526 . . . . 33.44 111.81 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 40.5 m-20 -69.01 -20.04 64.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.256 -0.884 . . . . 28.37 113.244 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.76 3.71 71.35 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 121.168 -0.539 . . . . 15.0 112.881 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -110.71 165.42 11.84 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 117.61 0.705 . . . . 25.5 111.372 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.9 p -106.82 167.16 10.06 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 121.604 0.716 . . . . 11.95 112.215 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.95 -42.65 94.53 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.682 -1.145 . . . . 10.17 110.906 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 80.9 p -61.81 -30.25 70.7 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 119.723 -0.791 . . . . 13.59 111.881 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -62.34 -28.29 69.65 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.503 -0.479 . . . . 11.7 110.484 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -99.73 14.61 29.59 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.648 -0.251 . . . . 12.95 111.619 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 50.02 39.46 19.03 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 122.797 0.439 . . . . 25.45 112.055 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -81.43 124.51 38.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.045 -1.094 . . . . 14.6 108.045 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -107.02 169.03 8.8 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.34 0.591 . . . . 33.23 112.287 -177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -51.97 140.76 19.4 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.034 -0.985 . . . . 25.97 112.032 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 67.4 23.92 9.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.82 -1.082 . . . . 32.61 112.211 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.0 m -77.31 150.24 35.25 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.227 -1.027 . . . . 10.56 108.227 176.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -110.6 126.05 54.04 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.248 0.547 . . . . 5.33 110.033 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.21 157.49 17.09 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 107.582 -1.266 . . . . 11.66 107.582 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -116.32 131.35 56.97 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.188 -0.671 . . . . 16.3 109.188 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -105.2 131.77 52.25 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.38 -0.6 . . . . 9.96 109.38 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 t -121.38 135.71 60.66 Favored 'Isoleucine or valine' 0 C--N 1.347 0.484 0 N-CA-C 107.862 -1.162 . . . . 9.76 107.862 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.2 mt -99.93 130.01 46.07 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.967 -1.015 . . . . 19.57 110.27 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -105.33 74.5 1.1 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.379 -0.373 . . . . 35.08 110.006 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 tp -125.21 16.74 8.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.526 0.679 . . . . 32.31 110.235 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -150.77 159.81 44.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.186 -0.916 . . . . 42.75 110.445 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.26 -44.83 97.6 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.22 -0.752 . . . . 36.31 111.22 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.778 0 CA-C-O 117.986 -1.452 . . . . 36.2 110.879 -179.817 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.633 -0.506 . . . . 17.17 109.633 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -98.65 140.43 32.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.34 0.59 . . . . 21.89 110.585 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 pt -130.15 167.35 25.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.104 -0.953 . . . . 10.83 108.999 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -124.35 139.06 54.27 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.307 -0.406 . . . . 10.61 111.277 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.5 t -121.62 124.23 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.414 -0.958 . . . . 9.13 108.414 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -100.01 142.56 31.32 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.891 0.377 . . . . 20.55 110.484 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.4 p -102.41 166.13 10.72 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 122.1 0.952 . . . . 11.78 110.861 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.96 -19.25 65.0 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.548 -1.66 . . . . 19.31 111.534 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.4 p -93.79 4.02 54.56 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.142 0.423 . . . . 23.14 112.142 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.7 14.32 58.35 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.215 -0.517 . . . . 19.74 113.617 177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -90.45 143.58 26.62 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.163 -0.615 . . . . 21.93 109.938 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -116.94 127.55 54.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.888 -0.782 . . . . 12.33 108.888 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mt -111.22 138.73 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.798 -0.445 . . . . 17.08 109.798 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.8 m -103.7 131.36 50.93 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 108.53 -0.915 . . . . 16.3 108.53 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.4 mt -127.04 149.98 49.66 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.553 0.215 . . . . 15.88 110.676 -179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -102.73 122.44 44.46 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 106.213 -1.773 . . . . 28.9 106.213 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.96 167.85 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-O 121.565 0.698 . . . . 12.05 111.79 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -117.55 150.64 47.07 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 107.142 -1.429 . . . . 18.17 107.142 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -58.56 -24.86 71.98 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 CA-C-N 120.907 1.36 . . . . 8.16 113.248 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.7 p -85.03 -0.38 54.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.072 0.397 . . . . 11.13 112.072 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -71.29 142.54 50.49 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.01 -1.108 . . . . 18.03 108.01 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.0 p -86.14 157.55 19.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 114.449 -1.25 . . . . 10.22 109.903 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 23' ' ' ILE . 29.0 mm -61.47 -40.05 85.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.807 -0.633 . . . . 12.3 109.585 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -60.17 -36.81 78.43 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.246 -0.65 . . . . 36.51 109.246 177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.536 ' OD1' ' NZ ' ' A' ' 29' ' ' LYS . 54.3 t-20 -67.55 -42.89 81.94 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.356 -0.609 . . . . 25.66 109.356 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.7 t -60.57 -41.31 87.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 109.435 -0.58 . . . . 8.12 109.435 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.52 ' NZ ' ' OD2' ' A' ' 52' ' ' ASP . 19.2 mttt -60.0 -40.16 88.27 Favored 'General case' 0 C--N 1.343 0.294 0 N-CA-C 109.216 -0.661 . . . . 15.47 109.216 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.62 -38.29 89.62 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.714 -0.676 . . . . 11.45 110.857 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.536 ' NZ ' ' OD1' ' A' ' 25' ' ' ASN . 44.8 mttp -65.13 -39.38 92.96 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.638 -0.425 . . . . 24.98 109.907 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.1 mt -64.67 -40.09 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 109.498 -0.556 . . . . 9.46 109.498 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.95 -43.97 94.67 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.33 -0.618 . . . . 14.76 109.33 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.77 90.26 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.977 -1.011 . . . . 26.29 110.557 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -81.61 -40.6 22.73 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.582 1.327 . . . . 30.06 114.582 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -110.64 -14.47 14.04 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 116.286 1.958 . . . . 25.19 116.286 -174.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.78 11.41 82.85 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 121.025 -0.607 . . . . 7.41 113.153 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mt -86.04 117.1 68.11 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 109.585 -0.524 . . . . 9.49 109.585 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -58.99 135.18 64.89 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 CA-C-N 120.479 1.207 . . . . 11.42 111.995 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.72 -31.46 25.68 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.536 2.157 . . . . 12.0 114.501 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.22 -16.07 62.49 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.064 -0.654 . . . . 35.55 111.88 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -99.56 0.82 43.05 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 121.138 -0.225 . . . . 20.52 111.487 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -105.24 140.01 39.04 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.319 0.859 . . . . 7.13 113.319 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -128.63 120.82 27.31 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 108.072 -1.084 . . . . 36.39 108.072 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.3 mt -103.21 130.01 50.31 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.382 0.61 . . . . 9.55 111.187 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.43 139.79 50.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.017 -0.992 . . . . 13.9 111.178 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -140.27 130.98 25.74 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.583 -0.735 . . . . 6.86 109.965 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.1 35.76 10.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.057 0.391 . . . . 11.15 112.057 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.17 -0.56 89.67 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 119.015 -0.881 . . . . 13.93 115.139 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -112.5 139.91 47.68 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.186 1.493 . . . . 23.92 111.104 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -77.86 127.45 32.4 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.496 -0.927 . . . . 23.23 108.496 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.24 136.25 33.24 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.917 0.389 . . . . 9.11 111.117 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -90.93 149.9 21.71 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.282 0.563 . . . . 33.44 111.891 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 62.5 m-20 -68.38 -20.08 64.67 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.219 -0.9 . . . . 28.37 113.027 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.86 3.81 74.46 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 121.222 -0.513 . . . . 15.0 113.144 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -109.21 165.22 11.77 Favored 'General case' 0 N--CA 1.481 1.081 0 CA-C-N 117.884 0.842 . . . . 25.5 111.134 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 58.1 p -106.67 167.35 9.92 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.559 0.695 . . . . 11.95 111.706 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.98 -44.38 94.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.929 -1.032 . . . . 10.17 110.417 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.3 p -62.01 -30.21 70.8 Favored 'General case' 0 C--N 1.344 0.341 0 C-N-CA 119.95 -0.7 . . . . 13.59 111.83 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.11 -27.72 69.58 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.37 -0.532 . . . . 11.7 110.218 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.429 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 66.0 m-85 -99.8 14.43 30.33 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.355 -0.384 . . . . 12.95 111.442 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' O ' ' ND2' ' A' ' 60' ' ' ASN . 2.6 p-10 49.8 39.3 17.74 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 122.844 0.458 . . . . 25.45 112.158 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.54 124.04 38.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.003 -1.11 . . . . 14.6 108.003 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -107.34 169.07 8.79 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.409 0.623 . . . . 33.23 112.084 -177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -51.4 141.69 14.98 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.027 -0.988 . . . . 25.97 111.613 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 66.85 23.57 9.97 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 114.966 -1.015 . . . . 32.61 112.751 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -78.01 149.22 34.08 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.05 -1.093 . . . . 10.56 108.05 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.4 m -110.64 126.56 54.63 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.293 0.568 . . . . 5.33 109.951 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -103.79 157.21 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.71 -1.219 . . . . 11.66 107.71 177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -115.18 131.08 57.04 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 108.729 -0.841 . . . . 16.3 108.729 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.4 tp -105.42 131.7 52.51 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.76 -0.829 . . . . 9.96 108.76 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.79 148.47 24.0 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 107.945 -1.131 . . . . 9.76 107.945 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.9 mt -105.24 139.92 39.17 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.892 -1.049 . . . . 19.57 109.907 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -119.81 137.41 54.0 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.997 -0.547 . . . . 35.08 109.961 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.9 mt -120.03 139.99 51.68 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.265 -0.425 . . . . 32.31 110.059 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -128.62 129.99 46.66 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.229 -0.441 . . . . 42.75 110.368 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.06 -179.95 44.14 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.88 -0.888 . . . . 36.31 110.88 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.825 0 CA-C-O 118.053 -1.415 . . . . 36.2 111.105 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.597 -0.52 . . . . 17.17 109.597 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -98.77 141.54 31.44 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.322 0.582 . . . . 21.89 110.301 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.6 pt -129.98 167.9 24.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 115.218 -0.901 . . . . 10.83 109.452 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 99.8 m-85 -124.49 138.49 54.34 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.15 -0.477 . . . . 10.61 110.937 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.54 124.62 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 108.836 -0.801 . . . . 9.13 108.836 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -100.78 138.84 37.3 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.895 -0.409 . . . . 20.55 109.895 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -99.01 162.45 13.06 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.368 0.604 . . . . 11.78 110.444 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 pp -64.64 -11.77 38.82 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.947 -1.024 . . . . 19.31 110.704 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.6 p -96.62 0.95 50.66 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.848 0.356 . . . . 23.14 110.879 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.05 11.84 60.93 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 116.07 -0.514 . . . . 19.74 114.23 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -88.99 142.16 27.87 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.072 -0.651 . . . . 21.93 109.715 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.3 m -114.85 127.11 55.52 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 120.366 -0.534 . . . . 12.33 109.627 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mt -110.77 137.9 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 109.632 -0.507 . . . . 17.08 109.632 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -104.36 130.01 52.24 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 108.397 -0.964 . . . . 16.3 108.397 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.49 149.8 43.39 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 109.883 -0.414 . . . . 15.88 109.883 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -102.63 121.53 42.6 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 104.951 -2.24 . . . . 28.9 104.951 175.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.08 169.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.475 0.655 . . . . 12.05 111.557 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -117.79 149.34 45.02 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.332 -1.359 . . . . 18.17 107.332 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -57.38 -24.92 63.12 Favored 'Trans proline' 0 C--N 1.318 -1.042 0 CA-C-N 120.908 1.36 . . . . 8.16 113.201 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 t -85.76 -1.0 56.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.569 -0.287 . . . . 11.13 111.743 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -70.74 143.59 51.21 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.769 -1.197 . . . . 18.03 107.769 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.1 p -86.45 157.2 19.87 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.195 -1.366 . . . . 10.22 109.924 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.7 mm -61.76 -38.83 81.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.76 -0.655 . . . . 12.3 109.398 178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -59.96 -37.78 80.55 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.544 -0.91 . . . . 36.51 108.544 178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.06 -42.32 89.62 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.286 -0.635 . . . . 25.66 109.286 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.3 t -61.16 -44.32 98.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 109.845 -0.428 . . . . 8.12 109.845 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.7 mttm -60.03 -39.97 87.72 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.162 -0.681 . . . . 15.47 109.162 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.86 87.77 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.692 -0.685 . . . . 11.45 110.612 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -65.08 -39.08 92.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.859 -0.422 . . . . 24.98 109.859 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.9 mt -65.2 -40.02 87.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 109.836 -0.431 . . . . 9.46 109.836 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -60.0 -44.57 94.45 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.384 0.612 . . . . 14.76 109.654 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.81 -40.4 92.56 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.033 -0.985 . . . . 26.29 111.0 -178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -81.8 -39.91 23.35 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.031 1.122 . . . . 30.06 114.031 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -111.89 -14.37 13.52 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.089 1.885 . . . . 25.19 116.089 -174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.18 11.32 82.5 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.867 -0.682 . . . . 7.41 113.472 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.3 mt -86.29 116.94 67.75 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 109.745 -0.465 . . . . 9.49 109.745 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.27 134.53 59.63 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 CA-C-N 120.535 1.227 . . . . 11.42 112.243 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -49.29 -30.11 18.98 Favored 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.693 2.262 . . . . 12.0 114.536 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -72.26 -16.19 61.92 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.082 -0.647 . . . . 35.55 111.701 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -99.99 1.07 42.21 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 111.75 0.278 . . . . 20.52 111.75 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -107.16 139.46 41.56 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 113.851 1.056 . . . . 7.13 113.851 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.634 ' NH2' HH11 ' A' ' 72' ' ' ARG . 88.2 mtt180 -125.95 121.91 34.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.727 -1.124 . . . . 36.39 108.123 176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.7 mt -105.53 130.3 53.62 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.142 0.496 . . . . 9.55 110.694 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -123.64 138.25 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.506 -0.77 . . . . 13.9 110.654 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -137.37 126.17 24.01 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.339 -0.846 . . . . 6.86 109.051 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.47 38.45 14.41 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.017 -0.538 . . . . 11.15 111.613 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.12 -0.01 89.49 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.48 -0.622 . . . . 13.93 114.64 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -112.3 138.56 48.85 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 118.637 1.218 . . . . 23.92 111.886 -179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -79.45 129.45 34.48 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 107.524 -1.287 . . . . 23.23 107.524 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.7 mt -86.93 136.96 32.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.816 0.341 . . . . 9.11 111.66 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -91.73 148.66 22.08 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.166 -0.47 . . . . 33.44 112.113 -179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -66.44 -22.43 66.21 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.782 1.03 . . . . 28.37 113.782 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.1 2.99 76.25 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 121.117 -0.563 . . . . 15.0 113.364 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -110.07 165.44 11.73 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 117.895 0.848 . . . . 25.5 111.517 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.0 p -106.96 167.01 10.18 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.547 0.689 . . . . 11.95 111.88 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.7 mt -59.99 -42.85 95.12 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 114.837 -1.074 . . . . 10.17 110.852 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.6 p -61.61 -30.32 70.62 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 119.804 -0.759 . . . . 13.59 111.956 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.23 -28.96 70.06 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 120.68 -0.408 . . . . 11.7 110.334 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -99.81 14.21 31.11 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.34 -0.391 . . . . 12.95 111.645 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 49.98 39.88 19.82 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 122.84 0.456 . . . . 25.45 112.137 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -81.62 124.73 39.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.011 -1.107 . . . . 14.6 108.011 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -108.58 169.79 8.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.465 0.65 . . . . 33.23 112.144 -177.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -51.77 141.69 16.53 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.899 -1.046 . . . . 25.97 111.708 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 66.94 23.07 9.95 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.039 -0.982 . . . . 32.61 112.872 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.0 m -77.49 148.53 35.29 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.993 -1.114 . . . . 10.56 107.993 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.5 m -110.48 126.27 54.18 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.391 0.615 . . . . 5.33 109.67 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.59 156.79 17.66 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.61 -1.256 . . . . 11.66 107.61 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -114.83 132.73 56.4 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 109.149 -0.686 . . . . 16.3 109.149 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 tp -108.2 131.19 54.92 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 109.469 -0.567 . . . . 9.96 109.469 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -120.78 132.71 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.062 0 N-CA-C 107.351 -1.352 . . . . 9.76 107.351 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.0 mt -102.18 130.19 48.76 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.377 -0.829 . . . . 19.57 111.303 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.634 HH11 ' NH2' ' A' ' 42' ' ' ARG . 80.2 ttt180 -111.68 121.4 45.0 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 109.423 -0.584 . . . . 35.08 109.423 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.8 mt -104.53 119.72 39.63 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.651 0.262 . . . . 32.31 110.761 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -60.38 -41.15 93.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.17 0.51 . . . . 42.75 110.465 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.37 -40.02 98.44 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.7 -0.96 . . . . 36.31 110.7 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.72 0 CA-C-O 117.967 -1.463 . . . . 36.2 110.842 -179.848 . . . . . . . . 0 0 . 1 stop_ save_